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Abstract 
This  work  aimed  to  investigate  and  exploit  the  hydrogen  bonds  generated  between 
heterocyclic aromatic compounds, namely benzimidazole and imidazole, and the carboxylic 
acid  group.  The  flexible  but  robust  hydrogen  bonds  generated  have  been  used  to  create 
molecular complexes, using practical and relevant co-molecules.  A systematic approach has 
been used in the selection of co-molecules on the basis of crystal engineering principles. A 
library of robust hydrogen bonds and primary structural motifs has been generated, which has 
been  used  to  explain  the  solid-state  assembly  of  the  collection  of  molecular  complexes 
produced in this work and in related published structures. The similarities in hydrogen bond 
strength, bonding motifs and proton transfer behaviour between very dissimilar molecular 
complexes  have been remarkable. The opposite is  also  true in other examples,  with very 
similar molecular complexes showing remarkable differences, but overall, a picture is built up 
of predictable use of crystal engineering principles in designing molecular complexes with 
anticipated structural and packing features. 
 
The phenomenon of polymorphism, widely known but poorly understood, is essential to many 
industrial processes.  A primary aim of this work was to promote and control the formation of 
molecular complex polymorphs through varying crystallisation conditions. Co-crystallisations 
involving  benzimidazole  with  the  whole  series  of  halo-benzoic  acid  molecules  were 
scrutinised  and  polymorphism  found  to  be  prominent  throughout.  Selective  growth  for 
individual forms has been achieved, offering the potential for polymorph selection, but not 
fully understood. 
 
The behaviour of the protons was investigated in the molecular complexes generated; proton 
transfer  was  prevalent.  This  was  achieved  through  three  methods;  firstly  with  the  use  of 
variable temperature X-ray and neutron diffraction experiments on the product, by altering the 
levels of pH during the crystallisation process and lastly by introducing competing acceptor 
sites through co-molecule selection.   
 
A feasibility study into the use of the relatively new solvent-free crystallisation processes was 
undertaken.  It  was  shown  to  be  a  successful  technique  in  screening  for  polymorphs  and 
molecular complexes. 
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protons was not published with the structure.   12 
Fig. 4.5 – LHS, the 4-hydroxybenzoic acid nicotinamide supramolecular synthon.  These hydrogen bond 
dimers are connected through a hydrogen bond between the hydroxyl and the heteroatom in the ring of 
the nicotinamide; RHS, the four molecule hydrogen bonded ring between 3-hydroxybenzoic acid and 4-
aminopyridinium. 
Fig. 4.6 – The carboxylic acid dimer motif and hydroxyl hydrogen bonds found in the structure of 4-
hydroxybenzoic acid. 
Fig. 4.7 – The ring system of the 2,4-dihydroxybenzoic acid structure. 
Fig. 4.8 – The criss-cross pattern of the imidazolium 2,4-dihydroxybenzoate molecular complex. 
Fig. 4.9 – LHS monoclinic form of 2,6-dihydroxybenzoic acid showing its carboxylic acid dimer motif, 
RHS  orthorhombic  forms  of  2,6-dihydroxybenzoic  acid  showing  a  more  linear  pattern  with  single 
hydrogen bonds between molecules. 
Fig. 4.10 – The structure of benzimidazole and 3,5-dihydroxybenzoic acid with its hydrogen bonded ring 
system. 
Fig. 4.11 – LHS, a typical benzimidazolium molecule in which both nitrogens are protonated. RHS, the 
Fourier difference map generated where one of the H atoms located on a nitrogen atom has been omitted 
from the model, clearly showing that both nitrogen atoms are protonated.   
Fig. 4.12 – Hydrogen bonding patterns that could lead to the formation of supramolecular synthons in the 
generation of crystal structures of the molecular complexes studied in this chapter.  The potential homo-
hydrogen bonds (A, B and C) and hetero-hydrogen bonds (D, E and F) that can be exhibited between a 
benzimidazole and carboxylic acid group. Hydrogen bonds G, H and I are those that could be generated 
between a benzimidazole and hydroxyl group. 
Fig. 4.13 – The derivatives of hydrogen bond patterns E, F and G that occur when there has been proton 
transfer. 
Fig.  4.14  –The  benzimidazolium  and  2-hydroxybenzoate  ions  which  are  generated  in  the  molecular 
complex/salt, with atom labelling.  
Fig.  4.15  –  The  main  motif  of  the  benzimidazolium  2-hydroxybenzoate  molecular  complex;  a  four 
molecule hydrogen bonded ring consisting of alternating co-molecules held together by partially charge 
assisted  N
ʴ+-H····O
ʴ-  hydrogen  bonds.  The  inset  shows  the  view  along  the  bc-diagonal  axis  that 
highlights the geometric positions of the hydrogen bonded ring system. 
Fig. 4.16 – LHS, the weak hydrogen bonds (-) that extend the hydrogen bonded rings, RHS displays how 
the rings arrange themselves into a stacking configuration due to the C1-H····O1
ʴ- hydrogen bond. 
Fig. 4.17 – The hydrogen bonded ring system; the main motif of the benzimidazolium 2-hydroxybenzate 
molecular complex, is extended by weak hydrogen bonds (circled in red).  
Fig. 4.18 – View highlighting the C-H····π interactions that extends the structure along the ac-diagonal. 
Fig. 4.19 – View of the interactions that exist between the molecules in main motif.  
Fig.  4.20  –  The  benzimidazolium  and  3-hydroxybenzoate  ions  which  are  generated  in  the  molecular 
complex, with atom labelling.  
Fig. 4.21 – The 3-hydroxybenzoate molecules create chains with the mean planes of alternate molecules 
tilted at 104.4º from each other.     13 
Fig.  4.22  –  The  3-hydroxybenzoate  molecules  chains  which  are  held  together  through  a  hydroxyl-
carboxylate  hydrogen  bond  are  bridged  together  by  hydrogen  bonding  through  a  benzimidazolium 
molecule.  The inset shows the view along the c-axis, indicating that the benzimidazolium molecules sit 
on two distinct positions due to the twisting nature of the 3-hydroxybenzoate chains. 
Fig. 4.23 – LHS - The alternating layers that exist on the a-face of the benzidazoline 3-hydroxybenzoate 
molecular complex are connected through a weak hydrogen bond on each alternate layer (red). RHS, the 
alternate layer is held together by a weak hydrogen bond (yellow circle) and C-H····π interactions (red 
circle). 
Fig.  4.24  –  LHS,  view  along  the  c-axis  highlighting  how  the  benzimidazolium  molecules  form  into 
channels. RHS, view along the b-axis that shows the 3-hydroxybenzoate chains. 
Fig. 4.25 – The different benzimidazolium molecules. From, left to right, molecules 1 and 2 hydrogen 
bond to one another over a glide plane, molecule 3 hydrogen bonds to itself through a inversion centre 
along the N6····N6 contact, molecule 4 also hydrogen bonds to itself due to an inversion centre along the 
N7····N7 contact. In every case a proton is split over two sites. 
Fig. 4.26 – MCE
33 Fourier difference maps of the residual electron density. LHS, when the hydrogen 
split between nitrogen N2 and N3 is removed, RHS, when the hydrogen is removed from the N6 nitrogen 
(the same 50:50 split proton image is seen when the proton bonded to N7 is removed).
 
Fig. 4.27 – The two 4-hydroxybenzoate molecules found in the molecular complex, with associated atom 
labelling. 
Fig. 4.28 – The 4-hydroxybenzoate molecules create chains with the molecules alternately sit on two 
positions.   
Fig. 4.29 – LHS, view along the a-axis highlighting how each 4-HBA
- chain is involved in hydrogen 
bond in four different directions. RHS, view along the  b-axis indicating the connections between each 
chain. bottom –view along the c-axis of the BZNH
+ 4HBA
- molecular complex with the backbone of the 
structure, the 4HBA
_ chains, being held together by the BZNH
+ dimers that criss-cross between them. 
Fig.  4.30  –  The  different  benzimidazolium  molecules:  from,  left  to  right,  molecules  1  and  2  that 
hydrogen bond to one another with the relevant atoms labelled, and the 4-hydroxybenzoate molecule 
with associated atom labelling. 
Fig. 4.31 – MCE
33 Fourier difference maps of the residual electron density when the hydrogen split over 
nitrogen N2 and N4 is removed.  
Fig.  4.32  –  The  3-hydroxybenzoate  molecules  create  close-to-planar  chains  through  a  hydroxyl 
carboxylate hydrogen bond.  
Fig. 4.33 – LHS, the 3-hydroxybenzoate molecules chains which are held together through a hydroxyl-
carboxylate hydrogen are bridged together by hydrogen bonding through a benzimidazolium dimer. RHS, 
the  view  along  the  a-axis indicating  the planar  nature  of  the  chains  and  highlighting  the  role of  the 
BZNH
+ dimer.   
Fig. 4.34 – The 3-hydroxybenzoate molecules hydrogen bond along the  bc-face which creates a sheet 
along the a-axis view along the a-axis indicating the planar nature of the chains and highlighting the role 
of the BZNH
+ dimer.     14 
Fig. 4.35 – The weak interactions that are used to extend the structure along the c-axis, C-H····O3 (red), 
C4-H···· O2
ʴ-(yellow) and C4-H···· O2
ʴ- (green).  
Fig. 4.36 – LHS, the BZN and BZNH
+ molecules form dimers, through a single hydrogen bond.  There 
are two of these dimers in the reduced unit cell. RHS, the 3-HBA
- molecules also form single hydrogen 
bonded dimers.  
Fig. 4.37 – The 3-hydroxybenzoate molecules create chains through a hydroxyl carboxylate hydrogen 
bond.  
Fig.  4.38  –  The  3-hydroxybenzoate  molecules  chains  which  are  held  together  through  a  hydroxyl-
carboxylate hydrogen bond are bridged together by four distinct hydrogen bonds of two types, a and  b.   
Fig. 4.39 – LHS, Form II, The ladder structure consists of stiles of 3-hydroxybenzoate molecules and 
rungs of hydrogen bonded dimers of BZNH
+. RHS, Form I, The ladder structure consists of stiles of 3-
hydroxybenzoate molecules and alternate rungs of hydrogen bonded dimers of BZNH
+.   
Fig. 4.40 – The ladder structure consists of stiles of 3-hydroxybenzoate molecules and the double rungs 
of hydrogen bonded dimers of BZNH
+.   
Fig. 4.41 – The 3-hydroxybenzoate molecules are involved in two ladders by hydrogen bonding in two 
directions adopting a Z and inverse Z shape (indicated by the red lines).    
Fig. 4.42 –LHS, view along the b-axis highlighting the creation of sheets of 3-HBA
- molecules through 
weak  C-H∙∙∙O
ʴ-  (red)  and  C-H∙∙∙O  (green)  hydrogen  bonds  along  the  a-axis.  The  blue  interactions 
represent the moderate hydrogen bonds that make up the chains of 3-HBA
- molecules. RHS, the weak 
hydrogen  bonds  in  which  the  BZNH
+    ions  are  involved  –  one  C-H∙∙∙O
ʴ-  (yellow)  and  one  C-H∙∙∙O 
(yellow and circled). 
Fig. 4.43 – view along the  a-axis of the extended benzimidazolium 3-hydroxybenzate 2:1 polymorph 
Form I molecular complex. 
Fig 4.44 – Schematic diagram highlighting the possible hydrogen bonds that could be generated between 
the water molecule and the other starting materials and their charged species.  
Fig. 4.45 – The BZNH
+, BZN, 4-HBA
- and water molecule that are involved in the BZN BZNH
+ 4-HBA
- 
hydrate, with atom labelling.  
Fig.  4.46 – LHS, highlighting the hydrogen bonds in which the water molecule is involved.  RHS, view 
along the c-axis highlighting the zigzag nature of the rungs (BZN BZNH
+).  
Fig. 4.47 – LHS, Fourier difference map in 2D and, RHS, Fourier difference map in 3D showing the 
possible elongation of the hydrogen atom involved in the hydrogen bond. 
Fig. 4.48 – LHS –the staggered chains of 4-HBA
- that are held together by the stiles of BZN and BZNH
+ 
in the 2:1 hydrate.  Note that another BZN and BZNH
+ group is present, oriented diagonally between the 
two that are shown. RHS, view along the b-axis of the BZN BZNH
+ 4-HBA
- molecular complex showing 
the main motifs for comparison.  
Fig. 4.49  – The short contacts that exist between the molecules in the BZN BZNH
+ 4-HBA
- hydrate 
molecular complex. Highlighted are the areas that show the C-H---π interactions. 
Fig. 4.50 – view along the a-axis of the BZN BZNH
+ 4-HBA
- hydrate. The chains of 4-HBA
- molecules 
expand the structure along the b-axis (red line). The BZN BZNH
+ group holds two chains together via   15 
hydrogen bonding to a water molecule in one side and through
 hydrogen bond pattern F in the other 
direction (blue line).   
Fig. 4.51 – The BZNH
+ 2-HBA
- and 2-HBA molecules which are generated in the molecular complex 
with atom labelling.  
Fig.  4.52  –  View  along  the  a-axis  of  the  main  motif  of  the  BZNH
+  2-HBA
-  and  2-HBA  molecular 
complex; linear chains of 2-HBA
- 2-HBA pairs are held together by BZNH
+ molecules that run along the 
b-axis.  
Fig. 4.53 – LHS, the C1-H····O5
ʴ- weak hydrogen bonds (-) that stack the hydrogen bonded chains upon 
one another with the assist of two C-H∙∙∙π interactions (-)(-).  RHS, view of the a-axis displays how the 
chains stack upon one another (-). 
Fig. 4.54 – Two chains of the main motif are held by weak C-H∙∙∙O hydrogen bonds which are located 
inside the black box. Inset, A blow-up of the black box highlighting the weak C-H∙∙∙O hydrogen bonds. 
Fig.  4.55  –  The  benzimidazolium  and  3,5-dihydroxybenzoate  molecules  which  are  generated  in  the 
molecular complex with atom labelling.  
Fig. 4.56 – The extended structure of the BZNH
+ 3,5-DHBA
- molecular complex which consist of chains 
of  3,5-DHBA
- molecules which are held together by BZNH
+ molecules.  
Fig. 4.57 – The hydrogen bonded rings that are made up of four 3,5 DHBA
- molecules. 
Fig. 4.58 – Two views of the 3,5 DHBA
- hydrogen bonded rings that expand along the bc diagonal and c 
dimensions. 
Fig. 4.59 – The hydrogen bonds that the BZNH
+  molecule is involved with in the BZNH
+ 3,5-DHBA
- 
molecular complex, a is a  partially charged assisted N
ʴ+-H····O
ʴ- hydrogen bond while b is a birfuricated 
hydrogen bond of  two N
ʴ+-H····O interactions. 
Fig. 4.60 – View along the c-axis of an extended image of the BZNH
+ 3,5-DHBA
- molecular complex. 
Fig.  4.61  –  DSC  thermograms  from  the  product  of  the  co-crystallisation  of  benzimidazole  with  4-
chlorobenzoic acid crystallised from propanol (-) acetone (-), ethanol (-), methanol (-) and by the solvent 
free  method  (-).  The  results  indicate  that  the  solvent  free  method  replicates  the  more  traditional 
evaporation technique. 
Fig. 4.62 – DSC thermogram from the product of the solvent free co-crystallisation of benzimidazole 
with 3-chlorobenzoic acid with grinding times of 30 seconds (-), 2 minutes (-) and 5 minutes (-). The 
results indicate that the thermodynamic product is favoured with increasing grinding time.  
Fig. 4.63 – DSC traces of the product of the solvent free co-crystallisation of benzimidazole with 3-
chlorobenzoic acid grinding for 2 minutes and stored for no time (-), 24 hours (-) and 2 weeks (-). The 
results indicate that the thermodynamic product is favoured with increasing storage time.  
Fig. 4.64 – DSC patterns of starting materials benzimidazole (-), 5-chlorosalicylic acid (-) and the co-
crystallisation product of the two (-) formed by the solvent-free method. 
Fig.  4.65  –  DSC  thermogram  of  the  product  from  co-crystallisation  of  benzimidazole  and  5-
chlorosalicylic acid at 30ºC in propanol (-), acetone (-), ethanol (-) and methanol (-). Inset,  selective 
polymorph  growth  has  been  achieved  for  two  of  the  co-crystal  polymorphs  by  recrystallisation  from 
methanol (-) Form I and ethanol (-) Form III.   16 
Fig. 4.66 – above - Powder patterns of the products of crystallisation from three different environmental 
conditions to promote growth of single component of; form I (blue) using methanol at 10ºC, form I and 
II mix phase (red) using ethanol at 10ºC and form III (yellow) using ethanol at 30ºC. Two different 
products can clearly be identified from these powder patterns, while form II is mixed with form I. 
Fig. 4.66 – below – Powder x-ray diffraction pattern of benzimidazole and 5-chloro-2-hydroxybenzoic 
acid cocrystallised from methanol at 10ºC (blue) overlaid with the simulated powder pattern from solved 
structure solution of form I.  
Fig. 4.67 – The benzimidazolium and 5-chloro-2-hydroxybenzoate molecules which are generated in the 
molecular complex with atom labelling.  
Fig. 4.68 – The main motif of the benzimidazolium 5-chloro-2-hydroxybenzoate molecular complex; a 
four molecule hydrogen bonded ring consisting of alternating co-molecules with partially charge assisted 
N
ʴ+-H····O
ʴ- hydrogen bonds.  
Fig. 4.69 – The main motif of the benzimidazolium 5-chloro-2-hydroxybenzoate molecular complex; the 
four molecule hydrogen bonded ring consisting of alternating co-molecules, are expanding along the b-
axis by a weak hydrogen bond and π∙∙∙π stacking interactions. Inset black box– An expanded image of 
the  π∙∙∙π  stacking  interactions  that  connect  the  hydrogen  bonded  rings  together.  Inset  red  box–  An 
expanded image of the π∙∙∙π stacking interactions that connect the hydrogen bonded rings together. 
Fig. 4.70 – The two weak hydrogen bonds, C-H∙∙∙C and C-H∙∙∙O, which expand the structure along the a-
axis.  
Fig. 4.71  – The  main  motif  of  the  benzimidazolium  5-chloro-2-hydroxybenzoate  molecular  complex;  
four molecule hydrogen bonded ring consisting of alternating co-molecules, are expanding along the a-
axis by two weak hydrogen bonds, C-H∙∙∙C and C-H∙∙∙O, that are circled in red. 
Fig.  4.72  –  Halogen  bonds,  Cl∙∙∙H-C,  connect  the  main  motif  of  the  benzimidazolium  5-chloro-2-
hydroxybenzoate molecular complex along the c-axis (green circle). 
Fig. 4.73 – The benzimidazolium and aspartate molecules which are generated in the molecular complex 
with atom labelling.  
Fig. 4.74 – The main hydrogen bonds within the BZNH
+ aspartate molecular complex create a linear 
chain of alternating co-molecules. 
Fig. 4.75 – The amine group of the aspartate molecule is involved in three hydrogen bonds, N3-H∙∙∙O1
ʴ- 
(green), N3-H∙∙∙O4
ʴ- (red) and N3-H∙∙∙O1
ʴ-(blue).  
Fig.  4.76  –  The  weak  hydrogen  bonds  within  the  BZNH
+  aspartate  molecular  complex:  bifurcated 
hydrogen bonds (a) and C5-H∙∙∙O3
ʴ- hydrogen bonds (b). 
Fig. 4.77 – View along the b-axis of the expanded benzimidazolium aspartate molecular complex. The 
red line (-) indicates the chain of alternating co-molecule (Figure 4.74), the yellow  box (-) indicates 
hydrogen bonds involving the amine group of the aspartate (Figure 4.75) and the black box is where the 
lesser interactions  between the BZNH
+ molecules operate(Figure 4.76). 
Fig. 4.78  – The C-H∙∙∙π edge to face interactions between the BZNH
+ molecules. 
Fig.  4.79  –  The  four  unique  hydrogen  bonds  that  were  the  only  hydrogen  bonds  in  all  the  crystal 
structures in Chapter 4, in order or occurrence 1, N
ʴ+-H∙∙∙O
ʴ-, 2, O-H∙∙∙O
ʴ-, 3, N
ʴ+-H∙∙∙ N
ʴ+, 4, O-H∙∙∙O.   17 
Fig.  4.80  –  The  motifs  of  the  molecular  complexes  from  Section  4.5  excluding  benzimidazolium  4-
hydroxybenzoate hydrate and benzimidazolium 3,5-dihydroxybenzoate. The three unique hydrogen bond 
motifs are shown, the hydrogen bonded rings (BENZH
+ 2HBA
- 1:1), chains hydroxybenzoic acid dimers 
and the ladder motif. 
Fig. 5.1 – 2-fluorobenzoic acid. 
Fig. 5.2 – Basic building block of the 2-fluorobenzoic acid: 4-(1H-pyrazol-1-ylmethyl)benzamide molecular 
complex structure found in the CSD with a fluorine atom on one of the fluorobenzoic acid groups is disordered 
over two sites 
Fig. 5.3 – LHS, 3-fluorobenzoic acid; RHS, 3-fluorobenzoic acid : 4-acetylpyridine molecular complex with the 
fluorine atom disorded over two positions (common with fluorine atoms) explaining the overlap of the hydrogen 
and fluorine atoms.  
Fig. 5.4 – Basic building block of the 4-fluorobenzoic acid crystal structure, RHS,  4-fluorobenzoic acid. 
Fig. 5.5 – Basic building block of the 4-fluorobenzoic acid : isonicotinamide molecular complex. 
Fig. 5.6 - The carboxylic acid dimer that is the main supramolecular synthon in the 2-chlorobenzoic acid 
crystal structure; RHS, 2-chlorobenzoic acid. 
Fig. 5.7 – The main building block of the 2-chlorobenzoic acid : 2-methylbenzoic acid molecular complex. Both 
independent molecules have the chloro and methyl substituents disordered over two sites of equal occupancy 
Fig. 5.8 – Crystal structure of the 3-chlorobenzoic acid molecule; RHS, 3-chlorobenzoic acid. 
Fig. 5.9 – Building block of the 3-chlorobenzoic acid 2-picoline N-oxide molecular complex.  
Fig. 5.10 – Structure of 4-chlorobenzoic acid highlighting the carboxylic acid dimer being held together 
by a chlorine-chlorine halogen bond, RHS, 4-chlorobenzoic acid. 
Fig. 5.11 – LHS, structure of the 4-chlorobenzoic acid : N,N-dimethylformamide molecular complex,  
RHS, 4-chlorobenzoic acid : sulfadimidine molecular complex. 
Fig. 5.12 – 2-bromobenzoic acid molecule. 
Fig. 5.13 – 3-bromobenzoic acid molecule. 
Fig.  5.14  –  The  4-bromobenzoic  acid  structure  highlighting  the  carboxylic  acid  dimers  being  held 
together by weak C-H∙∙∙O hydrogen bonds; RHS, 4-bromobenzoic acid. 
Fig. 5.15 – Structure of 2-iodobenzoic acid (CSD reference - OIBZAC01); the carboxylic acid dimer is 
held together by iodine-iodine halogen bonds. RHS, 2-iodobenzoic acid. 
Fig. 5.16 – LHS- 3-iodobenzoic acid; RHS, structure of 3-iodobenzoic acid and N-carboxymethyl-N,N'-
dimethylpiperazine molecular complex. 
Fig.  5.17  –  The  structure  of  4-iodobenzoic  acid;  carboxylic  acid  dimers  are  held  together  by  iodine 
iodine interactions. RHS, 4-iodobenzoic acid. 
Fig. 5.18 – Top left, basic building block of the 3-(AMP-P)  toluene 4-iodobenzoic acid solvate with CSD 
reference – COWHOM, top right, the 3-(AMP-P) 2,3,5,6-tetrafluoro 4-iodobenzoic acid  molecular complex 
main hydrogen bond motif with CSD reference – COWHUS, bottom left, the molecular complex of 4-(AMP-P) 
4-iodobenzoic acid which has CSD – reference COWJAA and lastly bottom right, 1-(AMP-P) 4-iodobenzoic 
acid with CSD reference – COWJOO.   18 
Fig. 5.19 – LHS, a typical benzimidazolium molecule where both nitrogens are protonated; RHS, the 
Fourier difference map generated where the H atoms located on a nitrogen atom have been omitted from 
the model, clearly shows that both nitrogen atoms are protonated.   
Fig. 5.20 – The potential homo-hydrogen bonds (A, B and C) and hetero-hydrogen bonds (D, E and F) 
that can be exhibited between a benzimidazole and carboxylic acid group.  
Fig. 5.21 – The most prominent hydrogen bonds within the benzimidazole : halobenzoic acid molecular 
complexes: N-H∙∙∙N hydrogen bond (A), N-H∙∙∙O hydrogen bond (B) and O-H∙∙∙O hydrogen bond (C).  
Fig. 5.22 – DSC data from the products of crystallisation of benzimidazole and 3-chlorobenzoic acid 
from four common solvents. Two different polymorphs can be clearly identified by two distinct melting 
points, but a third polymorph can also be identified in the samples crystallised from 1-propanol (1proh) 
and acetone. The shoulder on the principal peaks in these traces, representing the third polymorph, can 
be seen in the enlarged inset, taken from the acetone trace. 
Fig. 5.23 – Powder patterns of the products of crystallisation from four common solvents propanol (-), 
acetone (-), methanol (-) and ethanol (-). Two different products can clearly be identified from these 
quick  powder  patterns  (collected  on  the  Rigaku  R-axis/RAPID  single  crystal  diffractometer)  with 
crystallisation from propanol and acetone forming one product and methanol and ethanol the other.  
Fig.  5.24  –  Powder  patterns  of  the  products  of  crystallisation  from  three  different  environmental 
conditions to promote growth of single component of; form I (blue) using propanol at 10ºC, form II 
(yellow) using acetone at ~2-4ºC and form III (red) using acetone at 10ºC. Three different products can 
clearly be identified from these powder patterns.  
Fig. 5.25 – Powder pattern of benzimidazole and 3-chlorobenzoic acid Form III collected over a 33 hour 
period.   
Fig. 5.26 – LHS, Fourier difference map of the residual electron density in BZN : 3-ClBA molecular 
complex with the proton associated with the carboxylic acid group removed, RHS, the BZN and 3-ClBA 
molecules involved in the molecular complex with associated atom labelling. 
Fig.  5.27  –  LHS,  the  main  motif  of  the  BZN  :  3-ClBA  Form  I  molecular  complex;  an  equimolar 
hydrogen bonded ring system held together by N-H···O and O-H∙∙∙N hydrogen bonds;  RHS, view along 
the b- axis that highlights the spatial arrangement of the equimolar hydrogen bonded ring system. 
Fig. 5.28 – View along the a-axis of the BZN : 3-ClBA Form I molecular complex highlighting how the 
chlorine chlorine interaction connects the rings together (green circles). 
Fig. 5.29 – LHS, view along the b-axis of the BZN 3-ClBA Form I molecular complex highlighting how 
the hydrogen bonded rings stack upon one another. RHS, the weak hydrogen bond, C1-H∙∙O2, which 
stacks the rings upon one another. 
Fig. 5.30 – View along the a-axis of the BZN 3-ClBA Form I molecular complex. The hydrogen bonded 
rings, the main motif of the structure, are expanded along the b-axis by weak C-H∙∙∙O hydrogen bonds. 
Fig. 5.31 – An extended view along the  a-axis of the BZN 3-ClBA Form I molecular complex. The 
hydrogen bonded ring motif (blue circle), is expanded along the b-axis by weak C-H∙∙∙O hydrogen bonds 
(red circle) and the ab-diagonal by chlorine-chlorine interactions. 
Fig. 5.32 – The co-molecules involved in the BZNH
0.5+ : 3-ClBA
0.5- molecular complex (BZN : 3-ClBA 
Form II) with atom labelling.   19 
Fig. 5.33 – LHS, a MCE Fourier difference map generated where the H atoms located on the N atom 
have been omitted from the model, clearly showing that the proton is split over two sites; RHS, a MCE 
Fourier difference map generated where the H atoms located on the carboxylic acid group have been 
omitted from the model, again clearly showing that this proton is split over two sites. 
Fig. 5.34 – LHS, the supramolecular synthon of the BZN : 3-ClBA Form II molecular complex, co-
molecule dimers, linked together through N
ʴ+-H∙∙∙O
ʴ-  hydrogen bonds, RHS, the main motif of the BZN : 
3-ClBA  Form  I  molecular complex,  an  equimolar  hydrogen  bonded  ring  system  held  together  by  N-
H···O and O-H∙∙∙N hydrogen bonds. 
Fig. 5.35 – The secondary supramolecular synthon of the BZN : 3-ClBA Form II molecular complex that 
links the motifs together along the a-axis. 
Fig. 5.36 – The lesser interactions c, halogen bond and d, C-H∙∙∙π interaction, that expand the structure 
along the c-axis. 
Fig. 5.37 – LHS, an extended view along the a-axis of the BZN : 3-ClBA Form II molecular complex. 
The motif, a chain of alternating co-molecule dimers (blue) is expanded along the  c-axis via halogen 
bonds (green), RHS, an extended view along the a-axis of the BZN : 3-ClBA Form I molecular complex. 
The hydrogen bonded ring motif (red circle) is expanded along the  b-axis by weak C-H∙∙∙O hydrogen 
bonds (red box) and along the ab-diagonal by chlorine-chlorine interactions (green circle). 
Fig.  5.38  –  DSC  thermogram  of  the  products  from  benzimidazole  and  4-chlorobenzoic  acid  co-
crystallisations in acetone (-) ethanol (-), methanol (-) and propanol (-). It can clearly be seen that there 
are two distinct endothermic changes that relate to phase changes around 123ºC and 132ºC. 
Fig.  5.39  –  Powder  patterns  of  the  products  of  crystallisation  from  two  different  environmental 
conditions to promote growth of single component of Form I (blue) using ethanol at room temperature 
and a mixed phase of Forms I and II (red) using acetone also at room temperature.   
Fig.  5.40  –  The  molecular  ions,  two  of  each  co-molecule  BZNH
+  and  4-ClBA
-  that  make  up  this 
molecular complex, with atom labelling.  The numbers, 1 to 4, designate their molecule number. 
Fig. 5.41 – The supramolecular synthon, the hydrogen bonded rings, involves one of each co-molecule. 
Fig. 5.42 – The motif  of the BZNH
+ and 4-ClBA
- molecular complex with molecules coloured that are 
symmetry  related,  i.e.  molecule  1  yellow,  molecule  2  red,  molecule  3  green  and  molecule  4  blue. 
Highlighted by a red circle is the BZNH
+ molecules that further expand the structure. 
Fig. 5.43 – The halogen bond and halogen–π interactions that exist between the two 4-ClBA
- molecules. 
Fig. 5.44 –  LHS, view along the b-axis of the BZNH
+ : 4-ClBA
- molecular complex; RHS, view along 
the c-axis. Both images show the hydrogen bonded network that is held together by halogen interactions 
(green box and line). 
Fig.  5.45  –  DSC  thermogram  of  the  products  of  benzimidazole  and  4-bromobenzoic  acid  co-
crystallisations  in  acetone  (-)  and  methanol  (-).  It  can  clearly  be  seen  that  there  are  two  distinct 
endothermic changes that relate to phase changes around 123ºC and 142ºC. 
Fig.  5.46  –  Powder  patterns  of  the  products  of  crystallisation  from  four  different  environmental 
conditions to promote growth of single component of Form I (blue) using propanol and ethanol and Form 
II (red)  using acetone and methanol all at room temperature.     20 
Fig. 5.47 –  LHS, View along the b-axis of the BZNH
+ : 4-BrBA
- molecular complex; RHS, view along 
the c-axis. Both images show the hydrogen bonded network that is held together by halogen interactions 
(green box and line). 
Fig.  5.48  –  Powder  patterns  of  the  products  of  crystallisation  from  three  different  environmental 
conditions to promote the growth the benzimidazole : 3-bromobenzoic acid molecular complex using 
methanol at 10ºC (red) ethanol at 10ºC (blue) and acetone at 10ºC (yellow).    
Fig. 5.49 – LHS, the supramolecular synthon of the BZNH
+ : 3-BrBA
- molecular complex, dimers of 
each  co-molecule  are  connected  through  a  N
ʴ+-H∙∙∙O
ʴ-  moderate  hydrogen  bond,  RHS,  the  secondary 
supramolecular synthon of  that links the motifs together along the a-axis. 
Fig. 5.50 – View along the a-axis of the extended structure of the BZNH
+ : 3-BrBA
- molecular complex, 
the motifs (blue box) are held together through weak halogen and C-H∙∙∙π interactions (brown box).  
Fig. 5.51 – The BZNH
+, 2-FBA and 2-FBA
- molecules, from left to right, that make up the BZNH
+ : 2-
FBA
- : 2-FBA molecular complex, with atom labelling. 
Fig. 5.52 – The primary hydrogen bonds within the BZNH
+ : 2-FBA : 2-FBA
- molecular complex.  
Fig. 5.53 – The motif of the BZNH
+ : 2-FBA : 2-FBA
- molecular complex, zigzag chains between the 
BZNH
+ and 2-FBA
- co-molecules using the N-H∙∙∙O form B hydrogen bond. LHS, view along the a-axis; 
RHS, view of the b-axis. 
Fig. 5.54 – LHS, two motifs of the BZNH
+ : 2-FBA : 2-FBA
- molecular complex held together along the 
ac-diagonal axis by halogen bonds (yellow circle); RHS, view of the halogen bonds, C-H∙∙∙F.   
Fig. 5.55 – The C-H∙∙∙O hydrogen bond that expands the structure along the bc-diagonal axis. 
Fig  5.56  –  top,  X-ray  powder  diffraction  patterns  of  benzimidazole  :  3-fluorobenzoic  acid  (red),  3-
fluorobenzoic acid (blue) and benzimidazole (green) clearly indicating a new product has been produced, 
bottom,  DSC  thermogram  of  the  same  materials;  benzimidazole  :  3-fluorobenzoic  acid  (purple),  3-
fluorobenzoic acid (red) and benzimidazole (green)  again indicating a new product is formed, insert, 
patterns of other co-crystallisations experiments.  
Fig. 5.57 – LHS, the BZNH
+ and BZN dimers with atom labelling; RHS, the 4-FBA
 and 4-FBA dimers 
with associated labelling . 
Fig. 5.58 – View along the a-axis of the BZN : 4-FBA molecular complex, showing the main motif, a 
zigzag chain of dimers held together by N
ʴ+-H∙∙∙O
ʴ-  hydrogen bonds that expand the structure along the 
ab-diagonal axis. 
Fig. 5.59 – The a-axis of the BZN : 4-FBA molecular complex, showing the main motifs (blue line) held 
together along the c-axis by C-H∙∙∙F halogen bonds (a and b). 
Fig. 5.60 – The a-axis is expanded by two interactions; a C-H∙∙∙O weak hydrogen bond (blue circle) and 
a C-H∙∙∙π interaction (red circle).   
Fig. 5.61 – Top, view along the c-axis of the BZN: 4-FBA molecular complex which highlights the two 
types interactions that exist between the layers: a π∙∙∙π stacking interaction between the BZN dimers 
(yellow  circle)  and  the  weak  C-H∙∙∙O  hydrogen  bonds  (green  circle)  between  the  4-FBA  molecules, 
bottom LHS, π∙∙∙π stacking interactions, bottom RHS,  C-H∙∙∙O weak hydrogen bonds.   21 
Fig.  6.1 – The  structure of  picolinic acid showing  the  main  hydrogen  bonds between  the  molecules. 
Proton  disorder  can  be  seen  between  the  carboxylic  acid  hydrogen  bond  and  the  weaker  N-H∙∙∙H-N 
hydrogen bond. 
Fig. 6.2 –LHS, protonated picolinic acid : L-tartrate acid molecular complex; RHS, the molecular complex of 
picolinate and 2-amino-5-methylpyridinium, where the picolinic acid  has been deprotonated.  
Fig. 6.3 – Basic building block of the acetoguanaminium 3-hydroxypicolinate monohydrate molecular 
complex. 
Fig. 6.4 – LHS, the structure of 6-hydroxypicolinic acid (2-oxo-1,2-dihydropyridine-6-carboxylic acid) 
and, RHS, a hydrate form.  
Fig. 6.5 – The molecules involved in the 6-hydroxypicolinic acid 2-amino-5-chloropyridinium molecular 
complex. 
Fig. 6.6 – The nicotinic acid supramolecular synthon showing the dominating O-H∙∙∙N hydrogen bond. 
Fig. 6.7 – LHS, 3-carboxypyridinium hydrogen (2R,3R)-tartrate molecular complex where the nitrogen 
has been protonated; RHS, the molecular complex 2-amino-5-methylpyridinium nicotinate, where the 
carboxylic group on the nicotinic acid has been deprotonated.  
Fig.  6.8  –  LHS,  the  O-H····N  hydrogen  bond.in  the  crystal  structure  of  isonicotinic  acid;  RHS,  the 
molecular complex of isonicotinic acid protocatechuic acid monohydrate, with the zwitterionic form of 
isonicotinic acid. 
Fig. 6.9 – LHS, the hydrogen bonded dimer of 2-nitrobenzoic acid with the two molecules related by an 
inversion centre in the middle of the hydrogen bonded ring and the nitro- groups twisted out of the plane; 
RHS, the molecular complex of benzimidazolium 2-nitrobenzoate bis(2-nitrobenzoic acid) showing some 
of the hydrogen bonds between the molecules. 
Fig. 6.10 – The hydrogen bonded carboxylic acid dimer of benzimidazolium and 2-nitrobenzoic acid.  
Fig. 6.11 –  LHS,  the  supramolecular  synthon of benzimidazolium  and 3-nitrobenzoic acid;  RHS,  the 
supramolecular synthon of imidazolium and 3-nitrobenzoic acid. 
Fig. 6.12 – The hydrogen bonded dimer of 4-nitrobenzoic acid. 
Fig.  6.13  –  LHS,  benzimidazolium  4-nitrobenzoate  molecular  complex  that  contains  the  synthon 
N
ʴ+H∙∙∙O
ʴ-, which forms into zig-zag chains; RHS, the imidazolium 4-nitrobenzoate molecular complex 
also forms N
ʴ+H∙∙∙O
ʴ- hydrogen bonds, which in this case assemble to form hydrogen bonded rings. 
Fig. 6.14 – LHS, a typical benzimidazolium molecule where both nitrogens are protonated; RHS, the 
Fourier difference map generated where the H atoms located on a nitrogen atom have been omitted from 
the model, clearly showing that both nitrogen atoms are protonated.   
Fig. 6.15 – A diffraction pattern frame from the single crystal X-ray diffraction experiment on a crystal 
of the benzimidazole : picolinic acid molecular complex showing the strong diffuse scattering. 
Fig. 6.16 – LHS, the disordered model for the benzimidazolium picolinate hydrate molecular complex; 
RHS,  the  likely  hydrogen  bonded  unit  when  considering  the  local  ordering,  i.e.  with  the  disorder 
removed.  
Fig. 6.17 – The water molecule connects the layers of alternately hydrogen bonded co-molecules 
together.   22 
Fig. 6.18 – The main motif of the BZNH
+ PA
 molecular complex is a flat chain of alternating hydrogen 
bonded co-molecules. 
Fig.  6.19  –  The  water  molecule,  with  two  0.5  occupied  hydrogens  (yellow)  and  one  fully  occupied 
hydrogen (white) connects the layers of alternately hydrogen bonded co-molecules 
Fig.  6.20  –  LHS,  the  hydrogen  bonded  ring  (hydrogen  bonds  shown  in  blue)  involving  two  water 
molecules and two picolinate molecules that connect two flat chains of hydrogen bonded BZNH
+ PA
 
molecules; RHS, view along the c-axis emphasising that the water molecule sits just out of the plane of 
the flat sheets of  hydrogen bonded BZNH
+ PA
 molecules. 
Fig.  6.21  –  LHS,  the  view  along  the  c-axis  of  the  BZNH
+  PA
  molecular  complex  showing  the 
herringbone layers connected by water molecules; RHS, the view along the  b-axis of the BZNH
+ PA
 
molecular complex showing the channels of water. 
Fig. 6.22 – LHS, weak CH∙∙∙O
- hydrogen bonds that lie along the a-axis; RHS, view showing that the 
BZNH
+ molecules lie directly parallel thus improving the chances of  π∙∙∙π stacking interactions. 
Fig.  6.23  –  The  atom  labelling  for  the  molecular  complex  of  benzimidazolium  (LHS)  and  3-
hydroxypicolinate. (RHS).  
Fig. 6.24 – LHS, the supramolecular synthon for the BZNH
+ 3-HPA
 molecular complex; a hydrogen 
bonded ring system held together by partially charge assisted N
ʴ+H····O
ʴ- and N
ʴ+H····N hydrogen 
bonds; RHS, the Fourier difference map (generated using MCE), where the hydrogen adjoining N2 has 
been removed from the model, showing the hydrogen atom to be clearly located on the N atom of the 
benzimidazolium  molecule  ion.  The  elongation  of  the  electron  density  along  the  hydrogen  bond 
illustrates the influence of the neighbouring oxygen molecule. 
Fig. 6.25 – the stacking of the hydrogen bonded rings held together by π-π interactions. 
Fig. 6.26 – The supramolecular synthons of the BZNH
+ 3-HPA
 molecular complex, are connected by 
weak  bifurcated  hydrogen  bonds  (circled  in  red)  along  the  c-axis.  Inset  shows  the  bifurcated  weak 
hydrogen bond circled in red in the main figure. 
Fig.  6.27  –  LHS,  view  of  the  c-axis  of  the  BZNH
+ 3-HPA
  molecular  complex,  which  indicates  the 
interactions between the layers (circled in yellow); RHS an expanded view of the interactions that hold 
the layers together, with C-H∙∙∙π interactions circled in yellow. 
Fig.  6.28  –  The  intermolecular  interactions  in  the  BZNH
+  3-HPA
  molecular  complex,  with  the 
supramolecular synthon circled in blue, the weak bifurcated hydrogen bonds in red and the C-H····π 
contacts in yellow. The π-π stacking goes into the plane of the page. 
Fig. 6.29 – The atomic labelling for the two independent molecules of each type in the imidazolium 3-
hydroxypicolinate molecular complex.  
Fig. 6.30 – Top,  view along the b-axis of the main motif of the IMDH
+ 3-HPA
 molecular complex, a  
zigzag  chain  of  alternate  co-molecules  held  together  by  partially  charge  assisted  hydrogen  bonds; 
bottom,  view along the a-axis of the main motif of the IMDH
+ 3-HPA
 molecular complex.  
Fig. 6.31 – LHS, the CH∙∙∙O
ʴ- hydrogen bonds (-) along the ac-diagonal, RHS, view along the c-axis of 
the staggered face-to-face π∙∙∙π stacking interactions that extend the structure along the b-axis.   23 
Fig. 6.32 – View along the b-axis of the extended IMDH
+ 3HPA
- molecular complex. The main motif, the 
zigzag chains of alternate hydrogen bonded co-molecules, is shown by the green line (-) and the weak 
hydrogen bonds are located within the transparent blue box (-). Inset shows the C-H∙∙∙π interactions that 
extend the structure along the b-axis. 
Fig. 6.33 – LHS, the benzimidazolium and 6-hydroxypicolinate molecule ions which are generated in the 
molecular complex, with atom labelling.  
Fig.  6.34  –  schematic  diagram  of  the  lactam  -  lactim  tautomerism  (imidic  acid)  that  the  6-
hydroxypicolinic acid molecule undergoes, forming 2-oxo-1,2-dihydropyridine-6-carboxylic acid.
 
Fig. 6.35 – The main motif of the BZNH
+ 6-HPA
 molecular complex; a hydrogen bonded ring system 
held together by 6-HPA
 dimers (e) and partially charge assisted N
ʴ+H····O
ʴ- (f) and N
ʴ+H····O (g) 
hydrogen bonds. 
Fig. 6.36 – the chain of BZNH
+ 6-HPA
 rings along the b-axis, viewed along a. 
Fig.  6.37  –  LHS,  the  weak  hydrogen  bonds  C1H∙∙∙  O1
ʴ-  and  π∙∙∙π  interactions  between  two  chains. 
These are two interactions that stack the chains along the a-axis. Middle, view along the b-axis showing 
the stacking of the chains. Highlighted in red are the interactions viewed in Figure 6.33, LHS. Circled in 
blue  are  those  interactions  from  Figure  6.33,  RHS.  The  interactions  within  the  green  circle  are  the 
moderate hydrogen bonds involved in the hydrogen bond ring motif. RHS, the CH∙∙∙π interactions are 
the blue dotted lines in the centre of the image. 
Fig. 6.38 – The CH∙∙∙O
ʴ- weak hydrogen bonds connect three different chains within the BZNH
+ 6-
HPA
 molecular complex. 
Fig. 6.39 – The benzimidazolium, 6-hydroxypicolinate and acetic acid molecules which are generated in 
the molecular complex, with atom labelling.  
Fig. 6.40 – The hydrogen bonded chains of the BZNH
+ : 6-HPA
 acetic acid solvate molecular complex 
is a flat linear chain of alternating hydrogen bonded co-molecules. 
Fig. 6.41 – The hydrogen bonding scheme in tha BZNH
+ 6-HPA
 acetic acid solvate molecular complex, 
highlighting the role of the acetic acid molecules in creating the linear chain. 
Fig. 6.42 – Two motifs of the BZNH
+ 6-HPA
 diacetic acid molecular complex showing how the two 
adjacent linear chains are connected along the c-axis through weak CH∙∙∙O hydrogen bonds (circled in 
red) between the acetic acid molecules; inset – expanded image of these hydrogen bonds. 
Fig. 6.43 – LHS, view along the c-axis showing the layered nature with the weaker interactions along the 
ab-diagonal,  weak  hydrogen  bonds  (light  blue)  and  π∙∙∙π  interactions  (dark  blue);  middle,  the  π∙∙∙π 
interaction (blue); RHS, the weak C-H∙∙∙O hydrogen bonds between the acetic acid molecules. 
Fig. 6.44 – The structure of the nitro group. 
Fig. 6.45 – The structures of 1, benzimidazolium 4-nitrobenzoate 2, benzimidazolium 3-nitrobenzoate 3, 
imidazolium 3-nitrobenzoate 4, imidazolium 3-nitrobenzoate. 
Fig. 6.46 – The benzimidazolium 3-nitrobenzoate molecular complex structure viewed along the c-axis. 
The spiral hydrogen bond motif runs along the b-axis with the weak CH∙∙∙O
ʴ- hydrogen bonds (circled 
in red) connecting adjacent spirals.    24 
Fig. 6.47 – The benzimidazolium 4-nitrobenzoate molecular complex structure viewed along the c-axis. 
The spiral hydrogen bond motif runs along the b-axis with the weak CH∙∙∙O
ʴ- hydrogen bonds (circled 
in red) connecting adjacent spirals.  
Fig. 6.48 – The imidazolium 3-nitrobenzoate molecular complex structure viewed along the a-axis. The 
hydrogen bonded rings (green boxes) are connected by weak carbon oxygen hydrogen bonds (circled in 
red) and π∙∙∙π interactions (blue).   
Fig. 6.49 – The imidazolium 3-nitrobenzoate molecular complex structure viewed along the a-axis. The 
hydrogen bonded rings (green boxes) are connected by weak carbon oxygen hydrogen bonds (circled in 
red).   
Fig. 6.50 – The bifurcated hydrogen bond of the BZNH
+ : 3-HPA
- molecular complex, with the major 
component the N-H∙∙∙N hydrogen bond and minor component being N-H∙∙∙O. 
Fig. 7.1 – Structure of phthalic acid, which is seen to exploit the carboxylic acid dimer motif. 
Fig. 7.2 – LHS, crystal structure of the molecular complex of phthalic acid and benzene-1,2-dicarboxylic 
acid; RHS, the phthalate ion in the ionic complex formed with 2,6-dimethylpyridinium. 
Fig. 7.3 – The crystal structure of isophthalic acid, which exhibits the common carboxylic acid dimer 
motif. 
Fig. 7.4 – LHS, structure of the benzimidazole : isophthalic acid molecular complex; RHS, the structure 
of the imidazole : isophthalic acid molecular complex. 
Fig. 7.5 – The carboxylic acid dimer that exists in all the terephthalic acid structures.  
Fig. 7.6 – The imidazole : terephthalic acid molecular complex.  
Fig. 7.7 – The carboxylic acid dimer motif adopted in the fumaric acid structure. 
Fig. 7.8 – The ladder motif of the imidazolium hydrogen fumarate structure, with the uprights consisting 
of fumaric acid chains and the steps of imidazolium molecules.  
Fig. 7.9 – top, the carboxylic acid dimer that is the main hydrogen bonding pattern for both polymorphs 
of succinic acid, with the packing shown below, LHS, triclinic form, RHS, monoclinic form. 
Fig. 7.10 – Basic building block of the imidazolium succinate ionic molecular complex. 
Fig. 7.11 – The structure of maleic acid Form I, showing the main hydrogen bonding pattern.  
Fig. 7.12 – The hydrogen bonded ring motif of the imidazolium maleate molecular complex.  
Fig. 7.13 – The basic dimeric hydrogen bonded building block of all the polymorphic forms of malonic 
acid. 
Fig. 7.14 – The  imidazolium  malonate  hydrate  structure consists of  chains  of  alternate co-molecules 
connected through the disordered water molecules.  
Fig. 7.15 – The carboxylic acid dimer that is the building block of the benzoic acid structure. 
Fig 7.16 – The linear chain of alternating hydrogen bonded co-molecules that exists in the imidazolium 
benzoate molecular complex. 
Fig.  7.17  –  LHS,  the  imidazolium  molecule  with  4-bromobenzoate,  in  which  both  nitrogens  are 
protonated. RHS, the MCE Fourier difference map generated where the H atoms located on a nitrogen 
atom have been omitted from the model, clearly showing that both nitrogen atoms are protonated.   
Fig. 7.18 – The library of hydrogen bond patterns that the molecular complexes are highly likely to 
adopt. E, F, G, H, I and J are all seen in other molecular complexes. The motifs are defined as the   25 
general descriptor of these interactions; K is the ladder motif, L is the hydrogen bonded ring motif, M is 
the co-molecule dimer motif while N is an example of a linear chain of alternate co-molecules.   
Fig.  7.19  –  The  imidazolium  and  2-hydroxybenzoate  ions  which  are  generated  in  the  molecular 
complex/salt, with atom labelling.  
Fig. 7.20 – The two main hydrogen bonds within the molecular complex, a, N-H∙∙∙O forming pattern E 
and b, N-H∙∙∙O forming pattern F; RHS, the resulting arrow head chain of alternate co-molecules. 
Fig. 7.21 – LHS, the weak C-H∙∙∙O hydrogen bond, c, involving the hydroxyl oxygen, RHS, the C-H∙∙∙π 
interaction, d, that expands the structure along the bc diagonal. 
Fig. 7.22 –  LHS, the C-H∙∙∙O weak hydrogen bond, e, that connects two of the chains together, RHS, 
another C-H∙∙∙O hydrogen bond, f, this time expanding the structure along the c-axis. 
Fig. 7.23 – An expanded image of the IMDH
+ 2-HBA
- molecular complex showing the hydrogen bonded 
chains (blue line) being connected by two C-H∙∙∙O hydrogen bonds (red box).  
Fig.  7.24  –  The  imidazolium  and  3-hydroxybenzoate  ions  which  are  generated  in  the  molecular 
complex/salt, with atom labelling.  
Fig. 7.25 – LHS, an expanded view of the IMDH
+ 3-HBA
- molecular complex along the a-axis, it can be 
seen that the structure is made up of hydrogen bonded boxes (red box) stacked upon each other, RHS, a 
expanded view of the yellow circle highlighting the corners of each box with the three hydrogen bonds 
that originate from this point.  
Fig. 7.26 – LHS, bifurcated hydrogen bond and RHS, C-H∙∙∙O weak hydrogen bond that expands the 
stacks of boxes along the b-axis. 
Fig.  7.27  –  The  imidazolium  and  3-hydroxybenzoate  ions  which  are  generated  in  the  molecular 
complex/salt, with atom labelling.  
Fig.  7.28  –  LHS,  the  view  along  the  c-axis  of  the  motif  of  the  IMDH
+ 4-HBA
-  molecular  complex, 
hydrogen bonded squares (red box) stack upon one another, RHS, extract from the yellow circle which 
shows the corners of the boxes with hydrogen bonds E, F and G highlighted.  
Fig. 7.29 – View along the a-axis showing two stacks of boxes held together along the c-axis by C-H∙∙∙π 
interactions (circled in red). 
Fig. 7.30 – The double weak hydrogen bonds that expand the stacks of hydrogen bonded boxes along the 
ac-diagonal. 
Fig. 7.31 – (top) The imidazolium and 4-fluorobenzoate ions which are generated in the molecular complex/salt, 
with atom labelling. 
Fig. 7.31 – (bottom) LHS, the main motif of the IMDH
+ 4-FBA
- molecular complex, a spiral chain of alternate 
co-molecules  held  together  through  N-H∙∙∙O  hydrogen  bonds,  E  and  F,  RHS,  view  along  the  b-axis  of  an 
extended spiral chain showing its cyclical nature. 
Fig. 7.32 – LHS, the C-H∙∙∙O weak hydrogen bond that binds two spiral chains to one another, RHS, the 
effect the binding of the two spirals (red circle) has on the structure. 
Fig. 7.33 – View along the b-axis of the extended structure of the IMDH
+ 4-FBA
- molecular complex 
showing the spiral chains (highlighted in red) held together by weak hydrogen bonds (yellow lines) that 
connect the chains along the a- and c-axes.   26 
Fig.  7.34  –  The  imidazolium  and  3-bromobenzoate  ions  which  are  generated  in  the  molecular 
complex/salt, with atom labelling.  
Fig. 7.35 – The main motif of the IMDH
+ 4-BrBA
- molecular complex, a zigzag chain of alternate co-
molecules connected through moderate hydrogen bonds. 
Fig. 7.36 – The motifs, zigzag chains of alternative co-molecules, are stacked upon one another along the 
c-axis held by weak C-H∙∙∙O hydrogen bonds; RHS, the weak hydrogen bonds that exists between the 
layers. 
Fig. 7.37 – The halogen bonds, C-H∙∙∙Br, that exist between the zigzag chains along the b-axis. 
Fig.  7.38  –  An  extended  image  of  the  IMDH
+  4-BrBA
-  molecular  complex  viewed  along  the  a-axis, 
showing  the  main  motif  (blue  line),  the  weaker  C-H∙∙∙O  hydrogen  bonds  (red  box)  and  the  bromine 
halogen bonds (brown box).   
Fig. 7.39 – The motif of the BZNH
+ : BA
-: BA molecular complex, an  ) 24 (
4
4 R  hydrogen bond ring 
system containing two of each molecule held together by N-H∙∙∙O (a‘, b‘, c‘, d‘, f‘ and g‘) and O-H∙∙∙O 
(e‘ and h‘) hydrogen bonds. The BA and BA
- molecules are labelled 1 to 4. 
Fig.  7.40  –  View  along  the  c-axis  highlighting  the  stacking  behaviour  of  the  motifs  with  the  π∙∙∙π 
interactions (red and blue ovals, and expanded in the blue and red boxes) that hold it them together. 
Fig. 7.41 – The C-H∙∙∙O weak hydrogen bond that expands the structure along the b-axis. 
Fig. 7.42 – LHS, the blue shaded circles show where the C-H∙∙∙O weak hydrogen bonds (Figure 7.41) 
hold  the  motifs  together;  RHS,  view  along  the  b-axis  highlighting  the  zigzag  pattern  formed  by  the 
motifs. 
Fig. 7.43 – LHS, the a-axis, RHS, the c-axis of the extended structure showing how the main motif (blue 
areas) is expanded by weak C-H∙∙∙O hydrogen bonds (yellow areas).  
Fig. 7.44 – LHS, the linear chain of hydrogen bonded alternating co-molecules is the main motif in the 
imidazolium benzoate structure
33; RHS, shows the cylcial nature of the motif. 
Fig.  7.45  –  The  molecules  involved  in  the  benzimidazolium  phthlate  molecular  complex,  with  atom 
labelling. 
Fig. 7.46 – LHS, view of the main motif, linear chain of alternating hydrogen bonded co-molecules; 
RHS, view along the a-axis that highlights the spiral nature of the chain. 
Fig.  7.47  –  View  along  the  a-axis  of  three  motifs,  spiral  chains  of  alternating  hydrogen  bonded  co-
molecules, that are held together by C-H∙∙∙O weak hydrogen bonds (blue circles). 
Fig. 7.48 – The weak hydrogen bond, C-H∙∙∙O (green line) and C-H∙∙∙π interaction (purple line), that 
expand the structure along the c-axis. 
Fig. 7.49 – The extended structure viewed along the a-axis, showing how the motif (red) is expanded 
along the b-axis by weak C-H∙∙∙O hydrogen bonds (blue) and finally along the c-axis by C-H∙∙∙O(green) 
and C-H∙∙∙C hydrogen bonds (purple).  
Fig. 7.50 – LHS, the molecules involved in the imidazolium isophthlate molecular complex; RHS, those 
involved in the benzimidazole isophthalic acid molecular complex, with the carboxylic acid protons in 
undetermined positions. 
Fig. 7.51 – The main motif of the structure, a double linear chain of alternate co-molecules held together 
through N-H∙∙∙O and O-H∙∙∙O hydrogen bonds.   27 
Fig. 7.52 – An extended structure showing the motifs (blue box) being expanded along the  c-axis by 
carbon  carbon hydrogen bonds (yellow box). 
Fig. 7.53 – top, the view along the  a-axis of the chains of isophthalic acid hydrogen bonding to the 
imidazolium molecule, bottom, view of the b-axis highlighting how the imidazolium molecule hydrogen 
bonds to two different chains on different layers. 
Fig. 7.54 – LHS, the benzimidazolium and terephthalate molecules involved in the molecular complex 
with  atom  labelling;  RHS, the  three  main  hydrogen bonds  involved  in the  molecular complex, a‘  N-
H∙∙∙O, b‘ N-H∙∙∙O and c‘ O-H∙∙∙∙O. 
Fig.  7.55  –  The  main  motif  of  the  benzimidazolium  terephthalate  molecular  complex,  a  ladder  with 
uprights of terephthalate molecules and rungs of benzimidazolium molecules.  
Fig. 7.56 – The main motif, a ladder of terephthalic acid uprights and benzimidazole rungs, stack upon 
one  another  through  C-H∙∙∙O  hydrogen  bonds  (red  circle);  insert,  blown-up  image  of  the  C-H∙∙∙O 
hydrogen bond. 
Fig.  7.57  –  The  extended  structure  of  the  benzimidazolium  terephthalate  molecular  complex  viewed 
along the c-axis (LHS) and a-axis (RHS). 
Fig. 7.58 – LHS, the linear chain of alternating co-molecules that is the motif of the molecular complex; 
RHS, view along the b-axis highlighting the spiral nature of the chain.  
Fig. 7.59 – LHS, the motif, spiral chains (blue box), expands along the b-axis and ac-diagonal forming 
sheets; RHS, the C-H∙∙∙O weak hydrogen bond (red box) connects these sheets together along the a-axis.  
Fig.  7.60  –  The  benzimidazolium  and  fumarate  ions  (two  protons  are  shown,  but  both  have  0.5 
occupancy levels) which are generated in the molecular complex/salt, with atom labelling 
Fig. 7.61 –  LHS, The  carboxylic  acid  dimer of  the  fumaric  acid  structure;  RHS,  the  hydrogen bond 
between the fumarate molecules of the benzimidazolium complex, with the shared proton split over the 
two sites. 
Fig. 7.62 – The box comb chain of fumarate molecules held together by oxygen  – oxygen hydrogen 
bonds, a‘ and b‘. The hydrogens on the carboxylic acid groups have been removed.  
Fig. 7.63 – The co-molecules arrange themselves into hydrogen bonded alternating co-molecules which 
expand along the b-axis. 
Fig. 7.64 – LHS, the benzimidazolium molecules connect the fumarate chains along the a-axis, resulting 
in the layers of fumarate and alternating co-molecules interconnecting to form columns of layers, RHS. 
Fig. 7.65 – the columns consisting of interconnected chains of fumarate molecules and alternating co-
molecules are expanded along the c-axis by lesser interactions (yellow box), inset, expanded view of the 
lesser interactions.  
Fig. 7.66 – The main motif of the imidazolium fumarate molecular complex, an amalgamation of the 
ladder and linear chain motifs. 
Fig. 7.67 – The benzimidazolium and succinate ions which are generated in the molecular complex/salt, 
with atom labelling. 
Fig. 7.68 – The main motif of the benzimidazolium succinate molecular complex, the ladder style with 
uprights of succinate ions and rungs of benzimidazolium ions.   28 
Fig. 7.69 – the extended structure of benzimidazolium succinate molecular complex viewed along the b-
axis, highlighting how the main motif (blue line) extends along the c-axis through C-H···π interactions 
(red box); inset, the C-H···π interaction. 
Fig. 7.70 – the chain that is created through the N-H∙∙∙O hydrogen bonds between the co-molecules in the 
imidazolium succinate molecular complex. 
Fig. 7.71 – The main motif of the imidazolium succinate structure, layers consisting of linear chains of 
alternating co-molecules that expand along the ac-diagonal (chains) and a-axis. 
Fig.  7.72  –  LHS,  the  benzimidazolium  and  maleate  molecules  which  are  generated  in  the  molecular 
complex, with atom labelling. RHS, the Fourier difference map generated with the H atoms located on 
the N atoms omitted from the model; this clearly shows that both N atoms are protonated.   
Fig. 7.73 – The maleic acid molecule (top) and the maleate ion (bottom) showing the differences in the 
bond characteristics. 
Fig. 7.74 – LHS, 2D Fourier difference map, RHS, 3D Fourier difference map (MCE); both images show 
a slightly asymmetric location of the hydrogen atom in the intramolecular hydrogen bond of the maleate 
molecule. 
Fig. 7.75 – The main motif of the benzimidazolium maleate molecular complex; a chain of alternating 
co-molecules held together by alternating charge assisted N
ʴ+-H····O
ʴ- hydrogen bonds 
Fig.  7.76  –  The  zigzag  chains  that  are  the  main  synthon  in  the  benzimidazolium  maleate  molecular 
complex are held together by weak hydrogen bonds connecting the maleate ions (insert). 
Fig. 7.77 – View along the b-axis showing the main motif (-) of the benzimidazolium maleate molecular 
complex connected by the C-H---O
ʴ- hydrogen bond from the benzimidazolium molecule (-) (insert) to 
make a two layer block. 
Fig. 7.78 – The weak hydrogen bond between the maleate and benzimidazolium ions. 
Fig. 7.79 – View along the b-axis of the expanded benzimidazolium maleate molecular  complex. The 
blue line (-) indicates the planes of the main motif (Figure 7.75), the red line (-) indicates the weak 
hydrogen bond that holds the planes together in alternate layers (Figure 7.75) with the green line (-) 
indicating the other weak hydrogen bond (Figure 7.76).  
Fig.  7.80  –  View  along  the  c-axis  of  the  motif  of  the  imidazolium  maleate  structure,  showing  the 
hydrogen bonded ring. 
Fig 7.81 – LHS, the main motif, hydrogen bonded ring, are expanded by C-H···O hydrogen bonds along 
the ab-diagonal (blue circle) and ac-diagonal (red circle); RHS, the view along the a-axis of an extended 
imidazolium maleate structure. 
Fig. 7.82 – The malonate ion found in molecular complexes with (from left to right) benzimidazolium, 
imidazolium, imidazolium hydrate, and in its native form, with atom labelling. 
Fig. 7.83 – The benzimidazolium and malonate molecules which are generated in the molecular complex, 
with atom labelling.  
Fig. 7.84 – the main motif of the benzimidazolium malonate structure, linear chain of alternate hydrogen 
bonded  co-molecules.  Two  of  the  motifs  are  connected  together  through  carbon  –  oxygen  hydrogen 
bonds (blue circle).   29 
Fig 7.85 – RHS, the chains of motifs are held together along the  b-axis by two alternating layers of 
interactions, a relatively stronger carbon – oxygen hydrogen bond (blue box), and a relatively weaker 
carbon – oxygen hydrogen bond (red circles); LHS, view of the b-axis with the interactions coloured in 
blocks to show the alternating layered nature. 
Fig. 7.86 – the a-axis is expanded by two lesser interactions that stack the layers of motifs upon one-
another. The  shortest is  a C-H···O  hydrogen bond (yellow  circle)  while  the other is  a π∙∙∙π  stacking 
interaction between the benzimidazolium molecules (green circle). Insert LHS, the C-H···O hydrogen 
bond; insert RHS, the π∙∙∙π stacking interactions. 
Fig. 7.87 – The imidazolium and malonate ions which are generated in the molecular complex/salt, with 
atom labelling. 
Fig.  7.88  –  The  main  motif  of  the  imidazolium  malonate  molecular  complex,  the  ladder  style  with 
uprights of malonate ions and rungs of imidazolium, viewed along, LHS, the c-axis, middle, the b-axis, 
and RHS, the a-axis. 
Fig.  7.89  –  The  motif  of  the  structure  (blue  interactions)  is  expanded  along  the  b-axis  by  C-H···O 
hydrogen bonds (green interaction) and an oxygen – oxygen interaction (red line). 
Fig. 7.90 – LHS, view along the c-axis of the extended structure; RHS, view along the  b-axis of the 
extended structure, with the main  motif (blue shading) being expanded along the  b-axis by carbon – 
oxygen weak hydrogen bonds (red shading). 
Fig. 7.91 – LHS, extract from Fig. 7.33, view along the b-axis of the extended structure of imidazole 4-
fluorobenzoate showing the spiral chains held together by halogen bonds (yellow lines) that connect the 
chains along the a- and c-axis; RHS, extract from Fig. 7.68 – the carbon - carbon weak hydrogen bond 
that expands the benzimidazolium succinate structure along the b-axis. 
Fig. 8.1 – The library of hydrogen bond patterns that the molecular complexes discussed in this work are highly 
likely to adopt: E (N
ʴ+H∙∙∙O
ʴ-), F (OH∙∙∙O
ʴ-), G (N
ʴ+H∙∙∙ N
ʴ+) and H (OH∙∙∙O). The recurrent motifs found 
are defined as the general descriptor of these interactions: K is the ladder motif, L is the hydrogen bonded ring 
motif, M is the co-molecule dimer motif, while N is an example of a linear chain of alternate co-molecules.   
Fig. 8.2 – The molecular complexes that formed the ladder motif, with uprights of the carboxylic acid containing 
molecule and rungs of benzimidazole. From top to bottom, left to right, benzimidazolium : 3-hydroxybenzate, 
benzimidazolium  :  4-hydroxybenzoate  2:1,    benzimidazolium:  3-hydroxybenzoate  2:1  Form  I, 
benzimidazolium :  3-hydroxybenzoate  2:1  Form  II,  imidazolium  :  malonate,  benzimidazole  :  terephthalate, 
benzimidazole : succinate and imidazolium : succinate.   
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1  Introduction 
 
This work has concentrated on designing and creating new crystalline structures using crystal 
engineering principles.   To achieve the new  crystalline materials,  be  they  in  the  form  of 
molecular  complexes,  co-crystals,  salts  or  solvates,  required  the  use  of  co-crystallisation 
techniques  while  the  realisation  of  the  structures  were  achieved  mainly  though  X-ray 
diffraction. This introduction shall discuss the basis of the project; examine the naming of the 
crystalline  structures,  introduce  hydrogen  bonding  and  other  weaker  intermolecular 
interactions, explain the use of crystal engineering and summarise some previous research 
into polymorphism. 
 
1.1.1  Molecular Complexes, Salts, Co-Crystals? 
 
Firstly, what is a co-crystal, how is it different from a molecular complex and where should 
the term co-crystal be used properly describe a material? These questions have come to light 
in recent years with its ever increasing use and its widening meaning. Authors Desiraju
1 and 
Dunitz
2 gave their respective opinions, Desiraju taking the view that a co-crystal must denote 
a crystal stuck together with another crystal. This implies that the term co-crystal should refer 
to some ―multiple crystal‖ in which each component retains some of its individual crystal 
identity. In this view, two (or more) molecules co-crystallised together to form a new complex 
with completely new crystal identity should more correctly be called a molecular complex. 
Dunitz
 2 on the other hand argued that the popularity of the term co-crystal has its reasons, ―as 
it provides an inelegant definition of what it is intended to describe, a crystal containing two 
or more components together‖. Therefore this definition would encompass a range of terms 
including  molecular  complexes,  solvates  and  multi-component  crystals.  Dunitz  ends  by 
suggesting that is it so popular that it will be hard to displace, so the pragmatic approach is to 
stick with it. In spite of these differing views, the two authors agree on one thing, that there 
should always be a hyphen! There have been others who have included a definition explicitly 
when using the term co-crystal, for example Aakeroy
3 in 2005 used the condition, ―made from 
reactants that are solids at ambient conditions‖, which was seized upon and used to define a 
pharmaceutical  co-crystal  in  a  review  paper  in  2006  by  Zaworotko
4,  ―formed  between  a 
molecular or ionic API and a co-crystal former that is solid under ambient conditions‖.  Later   36 
Bond
5 argues that the solid state condition should be dropped and that the term co-crystal 
should be seen as a synonym for multi-component molecular crystal. This would include all 
the  materials  suggested  by  Desiraju,  Dunitz,  Aakeroy  and  and  Zaworotko;  molecular 
complexes,  solvates,  clathrates,  inclusion  compounds  and  solid  solutions,  however  still 
leaving  one  grey  area  –  cases  where  there  is  not  full  understanding  of  the  nature  of  the 
chemical bonding in the material. In this work, the term molecular complexes will be used to 
describe  the  vast  majority  of  the  new  materials  formed,  including  cases  where  there  are 
charged species that would normally be termed a salt. 
 
Co-crystallisation is the combination of two or more molecular components to form a new 
heteromeric crystalline structure where intermolecular forces, particularly hydrogen bonds, 
hold  the  constituents  together.  Achieving  this  goal  depends  on  an  understanding  of  the 
relationships between the structures of the materials involved. However the understanding of 
the relationships involved is still in its infancy, with the provocative quote from Maddox
6 in 
1988 still of some relevance today: ―One of the continuing scandals in the physical sciences is 
that it remains in general impossible to predict the structures of even the simplest crystalline 
solids from a knowledge of their chemical composition‖.  
 
1.1.2  Co-crystallisation 
 
Synthesis of molecular complexes using co-crystallisation experiments usually involves the 
evaporation  of  solvent  from  a  solution  containing  the  co-crystal  components  in  a  chosen 
stoichiometric ratio. However the method of synthesis can vary greatly depending on a range 
of factors from the physical form of the starting materials to the desired product outcome. The 
methods used during this work are discussed in Section 3.1.1, which concentrates on the 
solvent  evaporation  technique,  however  there  are  many  different  approaches  including 
sublimation
7, growth from the melt
8, slurries
9 and supercritical fluids
10.  
 
1.2 Pharmaceutical Co-Crystals and Other Applications 
 
Co-crystals as a valuable material type have also become an area of emerging importance 
within the pharmaceutical sector, with a diverse and relevant research field in the formation of   37 
co-crystals with an active pharmaceutical ingredient
11 (API). So-called pharmaceutical co-
crystals, ―co-crystals that are formed between a molecular or ionic API and a co-crystal 
former that are solid under ambient conditions‖
4, represent a subset of multiple component 
crystals that includes salts solvates, clathrates, inclusion crystals and hydrates.  Crystalline 
APIs are preferred due to their relative ease of isolation, the rejection of impurities during the 
crystallisation process and the inherent stability of crystalline solids; however they also have 
poorer solubility and often form polymorphs, solvates and hydrates. It is thought that the use 
of co-crystallisation experiments will offer the ability to modify the chemical and physical 
properties of the API, such as solubility, stability, dissolution rate and bioavailability, without 
the need to make or break covalent bonds, which helps to retain their biological activity
12. 
This  method  has  great  potential  due  to  the  tendency  of  APIs  to  have  external  hydrogen 
bonding  sites,  at  times  numerous,  available  to  form  intermolecular  interactions.  These 
external  hydrogen  bonding  sites  can  be  exploited  to  produce  new  forms.  Using  crystal 
engineering  principles,  there  is  now  the  ability  to  rationally  design  and  construct  new 
structures  and  pharmaceutical  co-crystals  that  have  improved  medicinal,  chemical  and 
physical  properties
13.  For  example,  Tan
14  successfully  co-crystallised  ethenzamide 
(nonsteroidal anti-inflammatory drug) and gentisic acid (nonsteroidal anti-inflammatory and 
anti ageing properties) together to create pharmaceutical  co-crystals  containing two APIs. 
Zaworotko
15 has also generated a pharmaceutical co-crystal containing two APIs, piracetam 
(nootropic drug) and gentisic acid (Figure 1.1 LHS), which are both polymorphic in their 
natural states but found to be non-polymorphic as a co-crystal. There have been numerous 
examples  of  co-crystallisations  of  single  APIs  with  co-molecules  utilising  robust  and 
predictable hydrogen bonds, for example the robust pyridine-carboxylic acid heterosynthon 
was  exploited  to  generate  pharmaceutical  co-crystals  of  4,4‘-bipyridine  and  4,4‘-
dipyridylethene  with  aspirin,  ibuprofen  and  flurbiprofen
16  (Figure  1.1  RHS)  and 
isonicotinamide with nicotinamide (Vitamin B), clofibric acid (antihyperlipidemic drug) and 
diclofenac (nonsteroidal anti-inflammatory)
17. 
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Fig.  1.1  –  LHS,  a  pharmaceutical  co-crystal  containing  two  APIs,  piracetam  and  gentisic  acid,  RHS,  the 
pharmaceutical co-crystals of 4,4‘-bipyridine and 4,4‘-dipyridylethene with flurbiprofen. 
 
Co-crystallisation also provides the opportunity to isolate or purify single component APIs 
during processing, with the added benefit that the co-molecule may be able to be discarded 
before formulation. Wales
18 used multi-component crystallisation routes to form the single 
component of the elusive paracetamol form II, using a range of carboxylic acids and solvents. 
It was found to have an improved yield (100%) to those obtained with other preparation 
routes, with greater stability of the pure single component project. 
 
Co-crystallisation reactions have also been used in the synthesis of organic compounds using 
solvent free conditions
19 (see Section 1.5), which has been the subject of much recent research 
activity. Molecular complexes have been used in the photographic industry to create non-
covalently bonded derivatives of hydroquinone which are used as the chemical that makes the 
latent image on the film or print visible. This method of synthesis is seen as much more 
environmentally  friendly  than  traditional  techniques
20,  21.  Using  organic  small  molecules 
capable of binding and activating substrates through non-covalent interactions has emerged as 
an important approach in organo-catalysis. This is seen as a less rigid approach than using 
traditional  covalently  bonded  catalysis  mechanisms  and  has  many  advantages,  but  also 
challenges
22. The thiourea  organo-catalyst  is  used to  accelerate and stereochemically alter 
organic  transformations  through  double  hydrogen  bonding  interactions,  for  example  in 
Stecker
23 reactions (Figure 1.2)
24. Co-crystals have also been used to generate compounds that 
have second harmonic generation properties, these non-linear optical (NLO) materials are 
able  to  combine  photons  effectively  to  generate  new  photons  with  double  the  energy.  A 
number of phenol–pyridine co-crystals have been found to exhibit such properties by Byrn 
and co-workers
25.   39 
 
 
Fig. 1.2 – Crystal structure of the thiourea catalyst used in Stecker reactions. 
 
All the applications of co-crystallisation exploit non-covalent interactions, mainly hydrogen 
bonds that can form between molecules. It is this exploitation of intermolecular interactions 
that has been very widely researched and comes under the term crystal engineering. Even 
though it was first coined in 1971 by Schmidt
26, it was Desiraju
27 in 1989 that defined the 
term  in  a  structural  chemistry  context  and  made  popular;  ―the  understanding  of 
intermolecular  interactions  in  the  context  of  crystal  packing  and  the  utilization  of  such 
understanding in the design of new solids with desired physical and chemical properties‖.  
 
1.3 Hydrogen Bonding and other Intermolecular Interactions 
 
The  hydrogen  bond  has  such  a  ubiquitous  influence  in  gaseous,  liquid  and  solid-state 
chemistry that its consequences were discovered well before the interaction was identified and 
given  a  name;  late  19
th  and  20
th  century  literature  shows  many  references  to  many 
observations which are now known as the effects of hydrogen bonding. In 1931 Pauling wrote 
a general paper on the nature of the chemical bond where he discussed the [H:F:H]
 ion, using 
the  term  hydrogen  bond  possibly  for  the  first  time.  Later  in  1935  he  followed  up  these 
remarks with a paper on hydrogen bonds in water and ice before releasing his famous book 
Nature  of  the  Chemical  Bond
28  where  these  two  statements  originate;  ―Under  certain 
conditions an atom of hydrogen is attracted by rather strong forces to two atoms instead of 
only one, so that it may be considered to be acting as a bond between them. This is called a 
“hydrogen bond” ‖ and ―A hydrogen atom with only one stable orbital cannot form more 
than one pure covalent bond and the attraction of the two atoms observed in hydrogen bond 
formation must be due largely to ionic forces‖.   40 
 
Hydrogen bonds in the gas phase can be regarded as relatively simple interactions; however, 
this is not the case in the solid state. There is extensive literature, summarized by Jeffrey 
(1997)
  29, using a wide range of diffraction and spectroscopic methods, indicating that the 
hydrogen bond in crystalline systems is a highly varied and complex interaction. It is clear 
that the architecture of hydrogen bonding in the solid state can be controlled by the choice of 
systems  and  substituents  forming  the  basis,  for  example,  of  the  rapidly  growing  field  of 
crystal engineering and supramolecular assembly. 
 
A hydrogen bond can be described by a donor atom, D, covalently bonded to a hydrogen 
atom, and an acceptor atom, A.  Hydrogen bonds are formed when the electronegativity of D 
relative to H in a DH covalent bond is such as to withdraw electrons and leave the proton 
partially unshielded. To interact with this donor DH bond, the acceptor A must have a lone-
pair or polarisable π electrons. In 2011 the IUPAC (International Union of Pure and Applied 
Chemistry) commissioned a task group to come up with a modern definition for the hydrogen 
bond. The task group was chaired by Aruan and proposed an initial recommendation for the 
definition of the hydrogen bond as ―The hydrogen bond is an attractive interaction between a 
hydrogen  atom  from  a  molecule  or  a  molecular  fragment  X–H  in  which  X  is  more 
electronegative than H, and an atom or a group of atoms in the same or a different molecule, 
in which there is evidence of bond formation”
30. The review, seeking comments on the new 
definition, closed on the 31
st March 2011 with the final recommendation anticipated shortly.  
 
This simple definition does not tell the whole story, as strong hydrogen bonds are similar to 
covalent bonds and weak hydrogen bonds are closer to van der Waals forces in strength, with 
the  majority  of  hydrogen  bonds  being  somewhere  in  the  middle  of  this  range.  Jeffery 
categorises hydrogen bonds into strong, moderate and weak in strength by use of the bond 
lengths,  bond  angles  and  energy  associated  with  the  hydrogen  bond  (Table  1.1)
29.  These 
categories, are however not rigid and there may be some overlap and exceptions present. 
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  Strong  Moderate  Weak 
DH---A interaction  mostly covalent  mostly electrostatic  electrostatic 
Bond lengths       
H---A (Å)  ~1.2-1.5  ~1.5-2.2  2.2-3.2 
D---A (Å)  2.2-2.5  2.5-3.2  3.2-4.0 
Bond angles (º)  175-180  130-180  90-150 
Bond energy (kcal mol
1)  14-40  4-15  <4 
Table  1.1  –  Extract  from  Jeffrey  ―An  Introduction  to  Hydrogen  Bonding‖  Table  2.1,  Properties  of  strong, 
moderate and weak hydrogen bonds.  Relabeled in terms of the DH…A nomenclature for donor-acceptor H 
bonds used in the present work. 
 
Even though it can be seen that hydrogen bonds are weaker than the traditional chemical 
bonds of metallic, ionic and covalent types, the hydrogen bond is extremely important in a 
wide range of materials. The presence of hydrogen bonds in materials can have a dramatic 
effect  on  their  chemical  and  physical  properties.  Higher  boiling  and  melting  points  in 
materials like water and ammonia compared to analogues such as hydrochloric acid, and the 
high  water  solubility  of  ammonia,  are  effects  that  are  due  to  the  hydrogen  bond.  Other 
properties affected by hydrogen bonding can be the crystal structure, viscosity, molar volume, 
reactivity and colour, among many others. 
 
Hydrogen bonds play a key role in biological systems, the three-dimensional structures in 
proteins and nucleic acids are formed through hydrogen bonds.  In these macromolecules, 
bonding between parts of the same macromolecule cause it to fold into a specific shape, 
which helps determine the molecule's physiological or biochemical role. An example is the 
double helical structure of DNA, which is largely held together by hydrogen bonds between 
base pairs that link one complementary strand to the other and enables replication. 
 
1.3.1  Strong Hydrogen Bonds 
 
The strong hydrogen bond can have an associated energy in excess of 40 kcal mol
1 which 
can be of the same order as some covalent bonds and are sometimes referred to as ionic 
hydrogen bonds, positive- or negative-ion hydrogen bonds and low-barrier hydrogen bonds. 
They are formed when the proton is shared by two strong bases such as in the [F—H—F]
 ion 
(Figure 1.3)
31 or in molecules where there is a deficiency of electron density on the donor   42 
group or an excess of electron density on the acceptor group.  This is to be expected by 
considering the definition, as a deficiency of electrons on the donor group will further de-
shield the proton, while an excess of electrons on the acceptor group increases its negative 
charge and thus its interaction with the proton. The proton in such strong hydrogen bonds will 
often sit close to the mid-point of the hydrogen bond and have a low energy barrier double 
well potential or a single minimum flat potential, which results in the hydrogen atom position 
being sensitive to external conditions such as variation of temperature and pressure or the 
local crystal environment
32. Strong hydrogen bonds can also occur when the acceptor and 
donor atoms are forced by molecular configurations into much closer contact than the sum of 
their van der Waals radii, for example in the formation of a short intramolecular hydrogen 
bond in the potassium hydrogen maleate structure
33 (Figure 1.3). 
 
       
Fig. 1.3 – LHS, the 1-ethyl-3-methylimidazolium hydrogen difluoride structure with the strong hydrogen bond 
between the fluoride ions, RHS the catena-(hydrogen maleate)-potassium) structure with a strong intramolecular 
hydrogen bond. 
 
1.3.2  Moderate Hydrogen Bonds 
 
The moderate hydrogen bond, more commonly known as the normal hydrogen bond due to its 
extensive occurrence in nature, is  formed between a neutral  donor, D, and neutral  atoms 
containing at least one lone-pair of electrons.  Moderate hydrogen bonds also occur in some 
charged molecules. Nature extensively uses hydrogen bonds involving nitrogen and oxygen in 
small molecules to determine the packing and in macromolecules to influence conformation.  
 
The hydrogen bond is very flexible and in the moderate hydrogen bond the D-H∙∙∙A angle can 
range from 130º to 180º and the D∙∙∙A length from 2.5Å to 3.2Å. This results in a wider 
variety of hydrogen bonds compared to the more rigid strong hydrogen bond, with a much 
wider variety of hydrogen bond donors and acceptors that can be involved.   There are many   43 
examples of intermolecular moderate hydrogen bonds between the different classes of small 
molecule, including carboxylic acids, amino acids, carbohydrates, purines and pyrimidines 
(Figure 1.4). As with strong hydrogen bonds, moderate intramolecular hydrogen bonds can 
also form. This was recognised by Sidgwick
34 (1924) as being the reason for the differences 
in ortho-, meta- and para- hydroxy and amino benzene derivatives. Moderate hydrogen bonds 
can also form with transition metals, these can be terminal or bridging.  
 
       
Fig. 1.4 – LHS, an example of carboxylic acid and piridyl containing molecules, 1,8-naphthalenedicarboxylic 
acid trans-1,2-bis(4-pyridyl)ethylene, RHS, an example of a amino acid containing complex;  L-leucine : D-
valine. 
 
1.3.3  Weak Hydrogen Bonds 
 
There are many different varieties of interactions that come under the weak hydrogen bond 
classification. The most relevant to the solid state and the most controversial are hydrogen 
bonds involving the CH group. These occur when the CH group is involved in multiple 
bonds  or  attached  to  electron  withdrawing  groups.  They  are  controversial  since  it  is  still 
unclear  how  significant  they  are  in  determining  molecular  configuration  or  packing  in 
molecular complexes.  
 
1.3.4  Bifurcated Hydrogen Bonds 
 
The flexibility found in moderate and weak hydrogen bonds can support the generation of 
hydrogen bonds involving two acceptor sites (Figure 1.5 LHS). These are referred to as three-
centred hydrogen bonds as the hydrogen is bonded to three atoms
35. They are more commonly 
known as bifurcated hydrogen bonds and are quite common with around a quarter of normal 
hydrogen  bonds  from  carbohydrate  and  nucleic  acid  structures  being  three-centered
29. 
Bifurcated hydrogen bonds can arise when there is a proton deficiency, i.e. greater acceptor 
functionality than the number of hydrogen bonds available. They can range from symmetrical,   44 
R1 ≈ R2, ʱ1 ≈ ʱ2 to asymmetrical,  R1 > R2, ʱ1 > ʱ2 (Figure 1.5 RHS) with the latter much more 
common.  As  in  single  hydrogen  bonds,  the  bifurcated  hydrogen  bond  has  geometric 
constraints.  The  three  individual  bonds/interactions  that  make  up the  bifurcated  hydrogen 
bond are all attractive forces and cause the hydrogen involved to lie close to the plane made 
up of the donor and two acceptor atoms. An indication of this is that the closer the sum of the 
angles ʱ1, ʱ2 and ʱ3 is to 360°, the more planar the bifurcated hydrogen bond
36. 
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Fig. 1.5 – LHS, example of a hydrogen bond containing two acceptors, RHS, extract from Jeffrey ―An 
Introduction to Hydrogen Bonding‖ , a three-centered hydrogen bond with labeling of the scalar quantities; 
hydrogen - acceptor distance (R1 and R2), hydrogen bond angle (ʱ1 and ʱ2) and angle between the hydrogen 
bonds (ʱ3). 
 
With asymmetrical bifurcated hydrogen bonds there will be a major and minor component, 
with  the  major  component  being  the  stronger  hydrogen  bond.  This  can  have  properties 
comparable  to  moderate  hydrogen  bonds  while  the  minor  component  is  often  more 
comparable to a weak hydrogen bond. In symmetrical bifurcated hydrogen bonds the two 
components are relatively even, with similar hydrogen bond lengths and angles. There are 
even examples of four-centred hydrogen bonds, with three acceptor groups, these are however 
extremely rare due to geometric constraints as by definition all hydrogen bonds must have a 
D-H∙∙∙A angle of greater than 90º. 
 
1.3.5  Hydrogen Bond Disorder  
 
Disorder in hydrogen bonds occurs when the donor and acceptor groups wholly or partially 
switch their functions.  This can be a static effect (configurational), with split occupancy of 
the  hydrogen  atom  position,  or  a  more  dynamic  effect  (conformational),  with  the  proton 
moving position, occurring as a result of varying the temperature or pressure. Conformational 
disorder can occur in two situations; in strong single minimum hydrogen bonds, the hydrogen 
can migrate across the hydrogen bond from the donor to acceptor as the temperature is varied 
(e.g. in urea phosphoric acid
37); or when there is orientational freedom of the DH bond and 
D H
A
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  ʱ3   45 
the protons can switch bonds by means of rotation about a single covalent bond (Figure 1.6) 
(e.g. in cyclodextrin hydrate
38). 
 
 
Fig. 1.6 – An example of conformational disorder in a hydrogen bonded system.  
 
Where there are two crystallographically distinct positions in  which the hydrogen can sit 
resulting from a double minimum potential well characteristic of moderate hydrogen bonds, 
and  where  the  occupancies  are  not  related  by  symmetry  (e.g.  50:50  disorder  across  an 
inversion centre), the occupation of the secondary site can often be found to increase as the 
temperature  is  increased.  Common  examples  would  be  enol  –  keto  and  amino  –  imino 
transformations (Figure 1.7) which do not occur in crystals but when still in solution. 
 
 
Fig. 1.7 – A reaction diagram showing amino - imino transformation (tautomerism). 
 
1.3.6  Proton Transfer 
 
Proton transfer is the basis of acid-base chemistry. When a hydrogen ion moves from one 
chemical to another, an acid-base reaction has taken place. Hydrogen bonding can promote 
proton transfer and in some cases restrict it; this phenomenon is considered by many as the 
most important property of the hydrogen bond. The ability to transmit protons and OH
– ions 
in water provides a catalytic mechanism for many water based reactions
39 and is becoming 
increasingly recognised as important in enzyme catalysis reactions and for transmitting ions 
through  membranes.  Proton  transfer  can  result  in  hydrogen  bonds  between  the  charged 
species that are much stronger than the non-charged species. Charge assisted hydrogen bonds 
can  be  as  much  as  0.4Å  shorter  than  the  corresponding  neutral  hydrogen  bond  and  are 
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commonly used by crystal engineers to  generate new structures  of small molecules
40 and 
organometallics
41.  
 
When conducting co-crystallisation experiments, understanding if and when a proton  will 
transfer is critical to understanding if a salt or co-crystal will form. It is generally accepted 
that a reaction of an acid with a base will be expected to form a salt if the ∆pKa (∆pKa = pKa- 
(base) - pKa(acid)) is greater than ~2-3
42. A smaller ∆pKa (less than 0) will result in co-crystal 
formation, therefore when the ∆pKa is between 0 and 3 accurately predicting salt or complex 
formation is inconclusive and is a keen area of research
43. It is also not always possible to 
determine if a solid is a salt or co-crystal because either the proton is shared or the structure 
contains disordered ionized and non-ionized states. There are further limitations to the ∆pKa 
rule apart from the grey area between ∆pKa values of 0 to 3, where salt, cocrystal, shared 
protons or mixed ionisation states can form. The ∆pKa
50% point, where there is an equal 
amount of the conjugate acid to conjugate base in solution, is temperature dependent
44 which 
along with using non dimeric stoichiometric ratios
45 (not 1:1) has been found to produce 
results not in keeping with the empirical ∆pKa rule.  Table 1.2 shows the pKa values of 
selected molecules that  have been used during  this  research, values are taken from CRC 
handbook of Chemistry and Physics
46. 
 
It has been found by Aakeroy
47 that proton transfer between molecules vastly decreases the 
probability of generating a targeted supramolecular synthon. 45% of molecular complexes 
generated between carboxylic acids and n-heterocycles when proton transfer has occurred 
resulted in unpredictable chemical or stoichiometric compositions, this drops to 5% when no 
proton transfer has occurred.  
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Acid  pKa  Conjugate Base 
Benzimidazolium  5.53  Benzimidazole 
Imidazolium  6.99  imidazole 
Benzoic acid  4.20  benzoate 
2-hydroxybenzoic acid  2.98  2-hydroxybenzoate 
3-hydroxybenzoic acid  4.08  3-hydroxybenzoate 
4-hydroxybenzoic acid  4.57  4-hydroxybenzoate 
2-fluorobenzoic acid  3.27  2-fluorobenzoate 
3-fluorobenzoic acid  3.86  3-fluorobenzoate 
4-fluorobenzoic acid  4.15  4-fluorobenzoate 
2-bromobenzoic acid  2.85  2-bromobenzoate 
3-bromobenzoic acid  3.81  3-bromobenzoate 
4-bromobenzoic acid  3.96  4-bromobenzoate 
2-chlorobenzoic acid  2.90  2-chlorobenzoate 
3-chlorobenzoic acid  3.84  3-chlorobenzoate 
4-chlorobenzoic acid  4.00  4-chlorobenzoate 
Picolinic Acid  0.99/ 5.39*  Picolinate 
3-hydroxypicolinic acid  1.14  3-hydroxypicolinate 
Table 1.2 – pKa values of selected acids that are used during this research, with the name of the conjugate base. 
*Picolinic acid has two values as there are two parts of the molecule that can be deprontated, the carboxylic acid 
and pyridine 
 
1.3.7  Halogen Bonds 
 
The halogen bond is an attractive interaction where the halogen atom acts as the electron 
density acceptor. It was introduced to name any D∙∙∙X-Y interaction in which X is the halogen 
(Lewis acid), D is any donor of electrons (Lewis base) and Y can be a carbon, nitrogen, 
halogen,  etc
48.  Halogen  bonding  is  similar  to  hydrogen  bonding  in  that  in  both  types  of 
bonding, an electron donor/electron acceptor relationship exists. The difference between the 
two is in what species can act as the electron donor/electron acceptor. In hydrogen bonding, a 
hydrogen atom acts as the electron acceptor and forms a non-covalent interaction by accepting 
electron density from an electron rich site (electron donor). In halogen bonding, a halogen 
atom is the electron acceptor. The utilisation of these bonding interactions stems from their 
directional preference of their positions relative to each other, of which there are two types: 
Type I, both Y-X∙∙∙X angles (θ1, θ2) are the same and around 160 ±10° or Type II, C-X∙∙∙X 
angles are roughly perpendicular to each other (θ1 ≈ 175°, θ2 ≈ 80°). 21 The significance of 
this is that the Type I arrangement lends itself to the formation crystal structures that contain 
inversion centres, two-fold rotation axes and mirror planes, while Type II arrangements are 
characteristic of two-fold screw axes or glide planes and both monoclinic and orthorhombic   48 
space groups
49. Due to this, halogen bonding has become increasingly important in the design 
and engineering of molecular complexes. Nguyen
50 was the first to use the halogen bond to 
create  targeted  liquid  crystals  by  using  alkoxystilbazoles  and  pentafluoroiodobenzene. 
Meyer
48 gives a review of halogen bonds in which he describes it as a strong, specific and 
directional  interaction  and  gives  examples  where  the  halogen  bond  prevails  over  other 
interactions  including  hydrogen  bonding
51  and  π∙∙∙π  stacking
52.  Halogen  bonding  has  also 
been  used  to  separate  enantiomers
53  and  is  able  to  bind  selectively  small  molecules  to 
synthetic
54 and natural receptors
55.  
 
1.3.8  π – Interactions  
 
There  are  various  classifications  of  interactions  that  involve,  in  at  least  one  part,  the  π-
electrons. These all tend to be very weak interactions, however are often fundamental in the 
packing of the dominant structural motif in the structure. One of the common interactions is 
π∙∙∙π stacking, where aromatic rings effectively stack upon one another in either a; centred, 
off-centred or T-shape assembly (Figure 1.8). Π-stacking is instrumental within biological 
systems,  for  example  in  DNA  -stacking  where  it  helps  stabilise  the  double  helix 
conformation and in proteins where it can help fold macromolecules
56. Cation–π interactions, 
also known as the Dougherty effect, is a non-covalent molecular interaction between the face 
of an electron-rich π system (e.g. aromatic ring) with an adjacent cation (e.g. Li
+, Na
+) (Figure 
1.8).  The  opposite  interactions  are  lone  pair-π  interactions  (also  known  as  anion-π 
interactions) which involve bonding between a neutral electron-rich molecule and an electron-
poor π ring. It is effectively the opposite to cation-π interactions where the charge distribution 
of the π system has to be reversed
57.  
 
            
Fig. 1.8 – Schematic of the most prevalent π∙∙∙π stacking forms, LHS, off-centred, middle, T-shape, RHS, an 
example of an cation- π interaction, between benzene and sodium.  
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1.4 Crystal Engineering 
 
Crystal  engineering  is  seen  as  the  bottom-up  construction  of  functional  materials  from 
molecular or ionic building blocks
58. These building blocks (motifs) are influenced, primarily, 
by  relatively  strong  interactions  which  often  display  considerable  consistency  and  are 
commonly  known  as  supramolecular  synthons.  Defined  as  ―structural  units  within 
supermolecules which can be formed and/or assembled by known or conceivable synthetic 
operations involving intermolecular interactions‖
59. This area of research has accelerated in 
recent times after the term crystal engineering was first used by Pepinksy
60 in 1955. It is seen 
as a highly interdisciplinary area and attracts interest from many traditional fields including 
organic, inorganic, and organometallic chemistry, theoretical chemistry, crystallography and 
crystal growth. The area of crystal engineering is growing as it is seen as an intelligent way 
to:  develop  sophisticated  devices,  understand  self-assembly  /  molecular  recognition  and 
understand the fundamental issues of nucleation and crystal growth
61. Crystal engineering 
uses  many  strategies  in  forming  supramolecular  synthons;  most  common  is  using  the 
understanding  of  hydrogen  and  coordination  bonds,  however  more  recently  increasing 
attention  has  been  applied  to  the  weaker  and  less  predictable  halogen  bonds
62  and  π-π 
interactions
63. These weaker and less well-defined interactions can have strong effects on the 
packing of the dominating structural motif, which is one area of real challenge in crystal 
engineering. There is a real need to improve the understanding of how the balance between 
the relatively strong and weak interactions influences the outcome of the crystallisation. For 
example, Polito
64 investigated the experimental and theoretical structures of molecules with 
similarly sized substituents, namely 2-methylbenzoic acid, 2-chlorobenzoic acid and a 1:1 co-
crystal of these two components. All three structures contained the same primary hydrogen 
bond  interactions  creating  a  ribbon  arrangement.  However  the  structures  were  not 
isostructural (see Section 1.5.3) as the ribbons are arranged differently within each lattice. 
This simple example highlights the difficulties extrapolating from the primary hydrogen bond 
motif to the crystal structure. Predicting and exploiting the primary hydrogen bond, the goal 
of  crystal  engineering,  was  made  simpler  by  a  set  of  rules  formalised  (not  exclusively 
devised) by Etter in 1990
65. The general rules, applying to all system, are; all good proton 
donors  and  acceptors  are  used  in  hydrogen  bonding,  six-membered-ring  intramolecular 
hydrogen  bonds  form  in  preference  to  intermolecular  hydrogen  bonds  and  lastly  the  best 
proton donors and acceptors remaining after intramolecular hydrogen bond formation form   50 
intermolecular hydrogen bonds to one another. There are additional rules for specific classes 
of functional groups. However the use of these rules explain why some of the stronger, more 
robust  supramolecular  synthons  often  contain  the  functional  groups  carboxylic  acid
66 
hydroxyl
67,  amide
68  and  pyridine
69  and  are  often  found  together  or  in  mixtures  creating 
hydrogen bond patterns that are seen in a vast array of structures. The rules also explain why a 
survey  of  the  CSD  revealed  that  hydrogen  bonded  molecular  complexes  prepared  with 
suitable functional groups preferred to interact heteromerically rather than homomerically, i.e 
best  hydrogen  bond  donor:  acceptor  rule
3.  The  common  examples  are  N-containing 
heterocycle molecules with carboxylic acids, where in every case a N-H····O hydrogen bond 
is formed in preference to the starting materials reforming. It is possible to define the main 
hydrogen bond patterns in terms of 0-D, 1-D, 2-D and 3-D motifs depending on the type of 
intermolecular  interactions  that  are  present  within  and  between  the  co-molecules.  0-D 
assemblies  can  be  thought  of  as  discrete  aggregates  and  include:  dimers,  for  example 
carboxylic acid : carboxylic acid, pyrrole-2-carboxylate : pyrrole-2-carboxylate, pyridine : 
carboxylic acid (Figure 1.9); trimers, for example bipyridine : carboxylic acid (1:2)
70; and 
tetramers, for example isonicotinamide : carboxylic acid (2:2)
71. 
  
 
Fig. 1.9 – a, the carboxylic acid dimer, b, a pyrrole-2-carboxylate dimer, and c, a carboxylate hydrogen bonded 
to part of a pyridine molecule. 
 
Co-crystals that are regarded as 1-D include those that have 1-dimensional motifs, i.e. chains 
and ribbons. Bipyridine : dihydroxybenzoic acid
72 is a co-crystal with a 1-D array (Figure 
1.10). 2-D assemblies are when the hydrogen bond motif is expanded in two directions, for 
example in the diaminotriazine : uracil
73 and piperazine : carboxylic acid
74 (Figure 1.10) co-
crystals. Finally, the case of 3-D assemblies is when the motif expands the structure in all 
dimensions, examples include the iodoform : hexamethylenetetramine co-crystal
75.  
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Fig. 1.10 – LHS, the bipyridine dihydroxybenzoic acid co-crystal is an example of a 1-D assembly, RHS, the 2-
D assembly from the piperazine : carboxylic acid co-crystal. 
 
Another  important  way  to  define  structural  motifs  and  patterns  uses  the  idea  that  some 
interactions are more important than others. Etter
76 developed a system based on so-called 
graph-set notation that allowed structural motifs to be described in a consistent way while 
recognising the multiply significant interactions. The graph-set approach uses four principal 
motifs:  chains  (C),  dimers  (D),  rings  (R)  and  intramolecular  hydrogen  bonds  (S)  with 
numbers to describe: the number of atoms involved, the number of hydrogen bond donors and 
the number of hydrogen bond acceptors. Thus the robust carboxylic acid dimer has the graph-
set notation ) 8 (
2
2 R , for the eight atoms that make up the ring, with two each of hydrogen bond 
donors  and  acceptors.  Arguably  the  greatest  expansion  of  crystal  engineering has  come 
recently  in  the  area  of  metal-organic  frameworks  (MOF)
77. MOFs,  extended metal-ligand 
networks  with  bridging  organic  ligands,  have  become  an  increasingly  important  area  in 
chemistry with the potential to develop storage devices for hydrogen
78 and carbon dioxide 
storage
79,  gas  purification
80,  gas  separation
80  and  catalysis
80.  While  it  is  the  potential 
applications that drive the research in MOFs, the ability to predict or design the structures is 
far from fully understood
81. Crystal engineering principles are being used to design MOFs 
synthetically, utilising not only the robust coordination interactions (metal to ligand) but also 
solvent selection
82 and π-stacking interactions
83. Since there are many research groups from 
numerous  specialties  using  crystal  engineering  principles  to  design  and  develop  new 
materials,  not  all  have  been  discussed  here.  There  are  however  some  common  basic 
challenges  that  face crystal  engineers, the most fundamental  is  the  crystallisation process 
where there is no way of knowing if a particular recipe will form a powder, single crystal or 
amorphous material. There is also lack of knowledge on the role that solvent plays during the   52 
crystallisation process, how is facilitates the nucleation process and drives the final product. 
The main consequence is the serendipitous nature of polymorph formation (Section 1.5) and 
the alternative materials obtained from the grinding technique (Section 1.6). On top of this, 
when crystals do form, we are unable to foretell their size, shape or space group, if they will 
be metastable, polymorphic or contain solvent. 
 
1.5 Polymorphism  
 
The area of the study of the occurrence and formation of polymorphs has been of emerging 
importance and debate. Polymorphism, the existence of more than one crystalline form of a 
compound,  is  an  intensely  studied  phenomenon,  yet  it  remains  poorly  understood  and 
controlled
84.  It is of critical importance to many industries, where the existence of various 
polymorphic forms of a material with different crystal lattices can result in different physical 
and chemical properties. Nowhere is this more relevant than in the pharmaceutical sector 
since APIs contain multiple-functional groups (therefore containing multiple sites for possible 
intermolecular interactions) and where polymorphism can result in changed bioactivity and 
bioavailability. Full characterisation of solid materials is thus critical in the determination of 
their ultimate use. As expected, the literature describing studies of polymorphism has grown 
in magnitude and detail, however, observations of polymorphism in multi-component crystals 
have been comparatively uncommon until recently, possibly due at least in part to the factors 
suggested by McCrone, that ―the number of forms known for a compound is proportional to 
the time and money spent in research on the compound‖
85. With the increasing time and 
money  being  spent  on  co-crystallisations  to  generate  new  materials,  especially  in  the 
pharmaceutical sector, polymorphism has relatively recently become increasingly observed in 
these materials.    
 
1.5.1  Controlling Polymorphism 
 
There are many thousands of examples of polymorphism; with statistically 85% of all active 
pharmaceutical  ingredients  known  to  exhibit  multiple  forms
84.  This  has  led  to  the 
development of techniques not only to screen for polymorphs but also predict if multiple 
forms will occur. Florence
87,  88 has been one of the pioneers in developing an automated   53 
parallel crystallisation approach, which can systematically set-up crystallisations using over 
sixty solvents, with control over solution temperature, filtration, agitation, cooling-rate and 
solution concentration all achievable. This technique allows for over six hundred different 
crystallisations to be set-up methodically. There is much emphasis on polymorph prediction 
as a way to reduce cost and time over the screening approach that not matter how substantial 
can  be  insufficient  in  exploring  fully  the  possible  crystallisation  parameter  space.  Initial 
studies used a best hydrogen bond donor/acceptor approach which has now evolved into a 
knowledge based approach that assesses crystal stability using hydrogen bond predictions
89. 
The approach quantifies the likelihood of hydrogen bond formation for a specified target 
compound by way of probability modelling of hydrogen bonding data from known, related 
structures, called the logit hydrogen-bonding propensity (LHP) method. Thus, it can be used 
to  calculate  the  potential  for  polymorphism  to  occur  and  the  relative  stabilities  of  the 
predicted  forms.  This  technique  has  been  used  in  biological  systems,  e.g.  protein-ligand 
docking
90  and  to  study  the  Ritonavir  case.  In  the  latter  ―Ritonavir‖  story,  the  large  scale 
production of an anti HIV drug, Ritonavir, was abruptly halted when new batches of the drug 
produced had a crystal form different to that previously observed and believed to be the most 
stable  form  –  crucially  more  stable  than  the  original  form.    This  new  form  of  the  drug 
problematically  had  a  decrease  in  solubility  which  entailed  a  loss  in  bioavailability.  
Numerous  efforts  were  made  to  return  to  the  production  of  the  original  crystal  form  by 
changing  reaction  conditions,  removing  all  traces  of  the  second  form  and  drastically 
rebuilding the manufacturing facility.  All this however, was to no avail.  In essence, the 
original  crystal  form  had  ―disappeared‖  with  the  new,  more  stable  form  seeding  its  own 
growth and preventing the production of the original form.  The product was removed from 
the market and the simple tablet formulation was eventually replaced by a less convenient 
pre-dissolved liquid-gel capsule with a loss of over five hundred million dollars in sales and 
expenditure for the company
91.  
 
1.5.1.1 Disappearing Polymorphs 
 
The  Ritonavir  story  is  not  the  only  case  of  ―disappearing‖  polymorphs.  1,2,3,5-Tetra-O-
acetly-D-riboruranose was first prepared in Cambridge in 1946 by Howard and had a melting 
point  of  58ºC  (Form  A).  A  more  rigorous  study  was  conducted  in  a  US  laboratory  by 
Hoepfner who found Form A and another form of higher melting point, 85ºC (Form B). After   54 
some time, Form A transformed to Form B with Form A impossible to re-produce. Crystals of 
Form A made in Cambridge were sent to the US, when upon opening, immediately became 
opaque  and  transformed  into  Form B. During this  time the initial  crystals  of  Form  A in 
Cambridge also transformed form B. Studies in Manchester and Los Angeles by different 
groups went the same way, initially Form A was produced, before transforming into Form B 
with Form A never to be produced again. The form was deemed to be an unstable, metastable 
form
92. This phenomenon of ‗disappearing‘ polymorphs is not uncommon.  For example, 
studies on a trimorphic dimethyl derivative, initially studied by Bürgi
93 reported cell constants 
for the compound (Form I). Bernstein re-examined the compound and after an interim of 
about eight months, these crystals were found no longer to diffract well. Over a three-year 
period, subsequent recrystallisation experiments, often preceded by a fresh synthesis of the 
material, resulted in the discovery of two previously unknown polymorphs, but failed to yield 
form I
94. After opening a new laboratory (over a kilometre away) recrystallisation using new 
reagents, new glassware, and a 'new' student proved successful. These examples add weight to 
the claims by McCrone and Woodard
95 regarding the difficulties in crystallising metastable 
polymorphic forms in an environment in which a more stable form has been obtained. 
 
1.5.2  Polymorphism in Co-Crystals 
 
The  growing  field  of  pharmaceutical  co-crystals  (see  Section  1.1.3)  (which  allows  the 
combination of an API with a co-molecule that can improve physio-chemical properties while 
retaining the bioactivity of the API, for example improved bioavailability
96 and shelf life
97) 
has inevitably led to the detection of multiple phases of these molecules. This can be seen in 
the increasing number of papers published in this area. Polymorphism, the existence of more 
than one crystalline form of multi-component crystals, has been recorded in co-crystals of 4-
hydroxybenzoic acid with tetramethlypyrazine
98, chlorzoxazone with 2,4-dihydroxybenzoic 
acid
97 and three forms of the urea-barbituric acid co-crystal
100. Multiple phases have also been 
found  in  pharmaceutical  co-crystals  as  in  the  case  of  carbamazepine  (anticonvulsant  and 
mood-stabilizing)  isonicotinamide
101  (Figure  1.11)  and  ethenzamide  (analgesic)  with  3,5-
dinitrobenzoic acid
102.   
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Fig. 1.11 – The co-crystal polymorphs formed by carbamazepine and isonicotinamide
99.
 
 
1.5.3  Isostructures 
 
Two crystals are said to be isostructural if they have the same structure, but not necessarily 
the same unit cell dimensions nor the same chemical composition, and with a comparable 
variability in the atomic coordinates to that of the cell dimensions and chemical composition. 
This  has  been  found  between  many  structures.  For  example  triiodoresorcinol  (TIR)  and 
triiodophloroglucinol  (TIG)  crystallized  as  orthorhombic  (P212121)  and  monoclinic  (P21/n) 
polymorphs  mediated  via  inter-halogen  I I  interactions,  where  the  orthorhombic  and 
monoclinic  polymorphs  are  isostructural
103.  Recently  there  have  even  been  cases  of  co-
crystals that are isostructural; work by Jones
104 found this to be the case in the tetrafluoro-1,4-
diiodobenzene (tifb) : 1,4-thixane and tifb : 1,4-thiomorpholine co-crystals
104 (Figure 1.12). 
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Fig.  1.12  –  Two  co-crystals;  LHS,  tetrafluoro-1,4-diiodobenzene  :  1,4-thixane  and,  RHS,  tetrafluoro-1,4-
diiodobenzene: 1,4-thiomorpholine, that are isostructural.    
 
1.6 Solvent Free Co-Crystallisation 
 
As  stated,  there  are  various  routes  to  generate  crystalline  molecular  complexes,  the most 
common being the solvent evaporation method. Over recent years, however, another area has 
seen an exponential increase in the interest and pace of research – the synthesis of compounds 
through  solvent-free  methods.  With  the  emerging  importance  of  crystal  engineering  in 
research laboratories and in industry alike, it is a natural progression in modern day science 
that leads us to look into greener, more environmentally-friendly ways of generating new 
materials.  Through  the  green  chemistry  practices  now  being  more  widely  adopted
105, 
crystallisation experiments can be significantly improved if the amount of waste generated 
and  the  number  of  auxiliary  substances  that  are  used  can  be  reduced.  This  has  led  to 
developments  of  techniques  such  as  solvent  free  co-crystallisation.  Once  again  there  are 
various terms used to describe the method, mostly altered based on the field the paper is 
directed towards. Mechanochemistry
106, (co-)grinding
107, solvent free synthesis
108, solid-state 
grinding
109 and solid-state synthesis
110 are some of the terms used to describe what will be 
called here solvent-free co-crystallisation (see Section 3.1.2). Further to this, there are various 
techniques that come under the umbrella of solvent-free co-crystallisation where the method 
has  been  altered  to  improve  or  target  the  compounds  grown,  including  solvent-drop 
grinding
111 and kneading
112, which uses a micro quantity of solvent; vapour digestion
112, wet 
compression
112 and solid-vapour reactions
112 where there is a mixture of the solid reactant(s) 
in an atmosphere of solvent(s). Solvent-free reactions can provide fast and quantitative routes 
to the preparation of common organic
113 and inorganic compounds
114.
 These methods have 
been predominantly used in conjunction with traditional methods to show the viability and the 
success of the processes with known molecules
112, however
 more importantly, these processes 
have  been  shown  to  be  able  to  prepare  new  molecular  complexes
115  and  polymorphs
116 
unobtainable  from  traditional  methods.  Solvent-free  co-crystallisations  have  also  been 
exploited to generate co-crystals that have subsequently undergone reactions also in the solid-
state,  for  example  concomitant  [2+2]  cycloaddition  reactions  from  hydrogen  bonded  co-
crystals  of  trans-1,2-bis(2-pyridyl)ethylene  (2,2‘-bpe)  :  fumaric  acid  and  (2,2‘-bpe)  : 
mesaconic acid were reported in 2009
117.    57 
 
1.6.1  Co-Grinding/ Mechanical Mixing 
 
The  simplest  techniques  that  come  under  the  solvent-free  umbrella  are  co-grinding  and 
mechanical mixing, where the co-molecules are ground together in a pestle and mortar or a 
ball mill. These techniques were the focus of a review in 2007
118 by Braga that highlighted 
several  successful  experiments.  One  particular  example  is  between  dicarboxylic  acids  of 
variable  chain  lengths  with  a  solid  base,  1,4-diazabicyclooctane.  Polymorphic  crystalline 
forms of the salt are obtained depending on preparation technique, with Form I from grinding 
and Form II from traditional solvent evaporation methods. James in 2006
119 described the first 
solvent-free synthesis of a microporous metal-organic framework, of copper and isonicotinic 
acid.  Previously  structures  of  discrete  coordination  polymers
120  and  1-dimensional 
polymers
121  had  been  formed  using  this  technique,  but  this  was  the  first  example  of  a 
microporous structure.  In spite of this grinding (co-grinding) and ball milling (mechanical 
mixing)  reactions  are  not  popular  in  academic  laboratories  (mainly  due  to  the  lack  of 
understanding of the mechanisms and non-controllable parameters) but are widely used in 
industry.  
 
1.6.2  Solvent-drop Grinding / Solvent Catalyst Method 
 
Solvent-drop grinding is the use of a small amount of solvent to speed up solid-state reactions 
and to provide a lubricant for molecular diffusion, it has been described as solvent catalysis 
and is commonly used at industrial level. This method is generally more popular than just 
grinding, as the kinetics of the co-crystallisation are increased
122 and control over the product 
is  much  more  achievable,  offering  a  wider  range  of  applications.  For  example,  Trask
123 
showed  how  use  of  small  amounts  of  an  appropriate  solvent  can  achieve  control  of  the 
polymorph  outcome  in  single  component  crystallisations  involving  anthranilic  acid  and 
succinic acid. This can also be achieved in multi-component systems, for example co-crystals 
of  benzoic  acid  with  diazabicyclo[2.2.2]octane  and  benzoic  acid  with  2-aminopyrimidine 
form different polymorphs using the solvent-drop grinding and solution based techniques, 
with the product of the grinding having a higher crystal density and packing coefficient
124.  
Pharmaceutical co-crystals have also been generated using the solvent-drop grinding method,   58 
with polymorphic forms of the co-crystal caffeine : glutaric acid being achieved; using micro 
amounts of n-hexane produces Form a, while chloroform produces Form b
107 (Figure 1.13).   
 
    
Fig.  1.13  –  Extract  from  Trask  et  al
107  showing  the  two  different  packing  arrangements  for  the  co-crystal 
polymorphs of caffeine and glutaric acid. 
  
1.6.3  Understanding the Mechanisms Involved  
 
There is a lack of clear understanding on the mechanism of the grinding process, an issue that 
is limiting its commercial use. This can be seen from the many different postulates there have 
been used to explain the outcomes: for example, Kuroda
125 produced co-crystals of racemic-
bis-b-naphthol : benzoquinone by solid state grinding and postulated that the shearing and 
molecular diffusion processes occurring during grinding generated a different adduct structure 
to that recovered from solution. In the work of Rastogi
126 with picric acid complexes, on the 
other hand, vapor diffusion was suggested as a mass transfer mechanism during solid state 
grinding.  Shan
122  explained  solvent-drop  grinding  on  the  basis  of  additional  degrees  of 
freedom,  enhancement  of  molecular  collisions  and  formation  of  tiny  co-crystal  seeds. 
Rothenberg
127 has presented evidence suggesting the formation of a liquid phase in the binary 
phase diagram as essential to facilitate intermolecular contacts, mass transfer and chemical 
reaction  for  solid-state  reactions.  Recently  Kaupp
128  proposed  a  three  step  solid-state 
mechanism,  derived  from  atomic  force  microscopy  studies,  which  involves  long-range 
anisotropic  molecular  migration.  Another  postulate  comes  from  Chadwick  &  Davey
129  in 
work on benzophenone and diphenylamine that was formed from co-grinding with a mortar 
and pestle at  ambient temperature.  They suggest that a melt is formed between the solid 
phases with ―The shear induced by the grinding and the contact between the liquid and the 
residual solid surfaces then induces the nucleation and growth of the co-crystal from the 
liquid phase, much in the same way as a synthetic chemist might scratch the wall of a reaction 
vessel to induce crystallization of a reaction product.” They also go on to suggest that “The   59 
closer  the  eutectic  temperature  and  co-crystal  melting  point  are,  the  slower  will  be  the 
production rate of co-crystal and for those systems in which this temperature is above room 
temperature co-crystallisation will possibly require the addition of small amounts of solvent”.
 
 
1.7 Benzimidazole  
 
Benzimidazole  (BZN)  is  a  heterocyclic  aromatic  organic  compound  made  up  of  a  fused 
benzene ring and imidazole molecule (Figure 1.14 LHS). BZN derivatives have been used as 
low use-rate, broad-spectrum fungicides that have been used commercially for the control of 
plant diseases since the late 1960‘s
130. At the time of their introduction, they represented a 
ground-breaking class of fungicides with unique properties including systemic and curative 
activity that allowed extended spray intervals
130. World-wide, BZN fungicides are registered 
in  many  countries  for  use  on  more  than  70  crops  including  cereals,  grapes,  fruits  and 
vegetables. Thiabendazole (TBZ) was the first BZN to be marketed (Figure 1.13 middle), 
while  BZN  derivatives  currently  commercially  available  include  the  following  active 
ingredients: benomyl, carbendazim (MBC), thiabendazole, thiophanate, thiophanate-methyl 
and fuberidazole (Figure 1.14 RHS). 
 
                            
Fig. 1.14 – Schematic of BZN and derivatives, left to right, BZN, thiabendazole and fuberidazole. 
 
There are two structurally determined polymorphs of BZN, alpha and beta, which are both 
orthorhombic, found within the Cambridge structural database
131 (CSD – version 5.32 update 
May 2011). The latest version of the alpha form, which was discovered first, was published as 
a private communication in 2001
132 (Figure 1.15, LHS) while the beta form was published in 
2005
133 (Figure 1.15, RHS). The structures are similar in that the main hydrogen bond, N-
H∙∙∙N, is the same and that these create chains of BZN molecules. However they differ in two 
critical ways, firstly the alternate BZN molecules in the alpha chain are tilted at an angle of 
77.49º to one another, while in the beta form the BZN molecules are head to tail. Next, the 
secondary interactions differ, in the alpha form, the chains connect via C-H∙∙∙π interactions 
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involving the carbon located between the two nitrogen atoms, while in the beta form the same 
carbon is involved in an interaction of 3.3Å in length with a symmetry-related copy of itself. 
 
           
Fig. 1.15 – LHS, the alpha form of BZN, RHS, the beta form of BZN, middle top, secondary interaction of the 
alpha form, middle bottom, secondary interaction of the beta form. 
 
Within the CSD, BZN is found in a wide range of organometallic complexes, for example 
with  osmium
134,  lanthanium
135  and  cobalt
136  amongst  many  more.  There  are  however  no 
structures within the CSD of BZN in its native form in a complex with another small organic 
molecule. There may be several reasons for this. Firstly when in a basic solution with another 
co-molecule, BZN has a great affinity for itself, which would tend to favour its crystallising 
out in one of its polymorphic forms. Secondly BZN is a very good proton acceptor and in the 
presence of a carboxylic acid it will always deprotonat that group. The latter explains why 
there is a range of molecular complexes of the protonated form of BZN, benzimidazolium 
(BZNH
+),  for  example  benzimidazolium  3-carboxyphenoxyacetate
137  (Figure  1.16,  LHS), 
benzimidazolium  hydrogen  phenylmalonate
138  (Figure  1.16,  RHS),  benzimidazolium 
hydrogen nitroterephthalate
138 and benzimidazolium 2-chloro-4-nitrobenzoate
140 among a few 
others.  All  of  the  structures  containing  BZNH
+  contain  partially  charged  assisted  N-H∙∙O 
hydrogen bonds. 
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Fig. 1.16 – The basic building blocks from the structures of, LHS, benzimidazolium 3-carboxyphenoxyacetate, 
RHS, benzimidazolium hydrogen phenylmalonate.  
 
1.8 Imidazole 
 
Imidazole  (IMD)  is  an  aromatic  heterocyclic  and  is  one  of  the  two  diazoles.  The  term 
imidazole is also commonly used to refer to an IMD molecule with a substituent, which can 
be  variable.  Synthetic  imidazoles  are  present  in  many  fungicides  and  antifungal
141, 
antiprotozoal, and antihypertensive medications. IMD is part of the theophylline molecule, 
found in tea leaves and coffee beans, which stimulates the central nervous system
142. It is 
present in the anticancer medication mercaptopurine, which combats leukaemia by interfering 
with DNA activities. The crystal structure of IMD has been determined by both X-ray and 
neutron diffraction, the latest structure deposited within the CSD was in 2008, in a private 
communication
143. The structure is made up of chains of IMD molecules held together by N-
H∙∙∙N  hydrogen  bonds  (Figure  1.17,  LHS).  These  chains  are  then  expanded  by  carbon  – 
nitrogen weak hydrogen bonds utilising the carbon located between the nitrogens, and the 
unprotonated nitrogen (Figure 1.17 – black circle).  
 
         
Fig. 1.17 – LHS, building block of the imidazolium structure with the carbon-nitrogen weak hydrogen bond 
circled in black, RHS, view along the b-axis of the extended structure of the imidazole crystal structure. 
 
There are a wide range of molecular complexes and organometallic compounds containing 
either IMD and/or its protonated form imidazolium, IMDH
+, deposited within the CSD. Those 
that are key to this research are discussed thoroughly at the appropriate stage, for example 
Chapter  7  discusses  and  compares  the  molecular  complexes  obtained  from  the  co-
crystallisation of BZN and IMD with dicarboxylic acids. As in the BZN case, there are a vast   62 
array of organometallic complexes containing IMD, for example, with copper
144, nickel
145 and 
silver
146. There are a wide range of motivations for this research, from creating 3-dimensional 
supramolecular structures
147 to investigating its binding capabilities for use in medicines
148.  
There  are  currently  253  structures  deposited  within  the  CSD  containing  the  imidazolium 
cation, of which 97 are defined as organic. These range from inclusion complexes with 18-
crown-6
149 (Figure 1.18 LHS) to complexes / salts with small simple organic molecules such 
as oxamate
150 (Figure 1.18 RHS). 
 
       
Fig. 1.18 – LHS, crystal structure of the dibenzo-18-crown-6-imidazolium complex, RHS, the structure of the 
imidazolium oxamate molecular complex. 
 
1.9 Aims  and Objectives 
 
This  work  aimed  to  investigate  and  exploit  the  hydrogen  bonds  generated  between 
heterocyclic aromatic compounds, namely benzimidazole and imidazole, and the carboxylic 
acid group. Using crystal engineering principles the projects primary objectives were to: 
 
  generate    and  determine  (mainly  by  single  crystal  X-ray  diffraction)  previously 
undiscovered molecular complexes 
  create a library of robust hydrogen bonds to selectively generate molecular complexes 
  promote and control the formation of molecular complex polymorphs through varying 
crystallisation conditions 
  investigate  unusual  proton  behaviour  through  single  crystal  X-ray  and  neutron 
diffraction 
  explore the relatively new solvent-free crystallisation process   63 
  use a range of analytical techniques to investigate products and reactants including X-
ray powder diffraction and DSC  
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2  Theory 
 
2.1   Crystallography 
 
Crystallography
1,2
 is the analysis of crystalline solids using a beam of either electromagnetic 
radiation or particles to determine the structure of the material via diffraction - a form of 
elastic scattering. Crystallography is the only technique that allows the determination of the 
relative positions of atoms from the data, which is fundamentally different to other forms of 
spectroscopy  (NMR,  UV)  that  require  the  analyst  to  propose  a  structure  and  check  if  it 
matches the experimental data. This skill is still required in crystallography, but to a much 
lesser degree. The determination of the relative position of the atoms or ions in the structure 
leads to quantifying of the scalar quantities between atoms, (bond lengths, bond angles and 
torsion angles etc) and the relationships between the atoms (interaction distance and thus 
interaction type). The understanding of the structure, may it be previously undiscovered, or 
known but structurally undetermined (existence is known but structure is not), can lead to 
further studies that can utilise properties to manufacture superior materials.  
 
2.1.1  The Crystal 
 
A perfect crystalline solid material is made up of a large number of identical molecules or 
ions, which are arranged in a precisely regular way forming units which are repeated in all 
directions  to  give  a  highly  ordered  structure
1.  It  is  only  necessary  to  know  the  simplest 
repeating unit (unit cell) to be able to describe the crystal structure. This unit cell can be a 
single molecule or a more complicated building block. 
 
2.1.2  The Lattice 
 
Each unit  cell can be  mapped onto  another  by  symmetry  operations  with  the three basis 
vectors, a, b, c, describing the translation of the unit in space
3. If each unit cell was described 
using a single point, by applying the symmetry operations, a regular repeating pattern in all 3   69 
directions would be produced; this is called the lattice. The lattice is an abstract mathematical 
concept and the origin of the lattice can be any point in the crystal structure, for example on 
an atom or in space. It is the regular translational symmetry of crystalline materials that gives 
rise to discrete spots in an X-ray diffraction pattern. 
 
2.1.3  The Unit Cell 
 
As mentioned, the unit cell is the smallest repeating volume of the lattice and is described by 
the basis vectors a, b, c and three angles, , β and γ, also called unit cell parameters (Figure 
2.1). The three basis vectors enclose a shape called a parallelepiped. By convention the angle 
 is between vectors b and c, β between vectors a and c and γ between a and b, with the 
length of the basis vectors (unit cell dimensions) typically ranging from around 3Å to 40Å for 
small molecules.  
 
 
Fig. 2.1 – 3-dimensional unit cell, defined in terms of the unit cell dimensions a, b, c, , , . 
 
2.1.4  The Seven Crystal Systems 
 
A molecule can undergo transformations called symmetry operations, which include inversion 
through  a  point,  rotation  about  a  line,  or  reflection  in  a  plane,  that  leave  the  molecule 
afterwards with an identical appearance
4. Any rotation or reflection symmetry in the solid 
state imposes restrictions on the values of the unit cell parameters.  For example, if there is a 
mirror plane in the crystal normal to the b-axis, the a- and c- axes must lie in this plane and 
hence be themselves perpendicular to the b-axis. If a 3-fold rotation axis lies parallel to the c-  70 
axis, the angle between a and b (γ) must be 120º. Full consideration of the possible symmetry 
implications on the lattice results in only seven different allowed geometries, called crystal 
systems (Table 2.1).  
 
Triclinic  a ≠ b ≠ c  ʱ ≠ β ≠ γ ≠ 90º  P 
Monoclinic  a ≠ b ≠ c  ʱ = γ = 90º β ≠ 90º  P + C 
Orthorhombic  a ≠ b ≠ c  ʱ = β = γ = 90º  P + C + F + I 
Tetragonal  a = b ≠ c  ʱ = β = γ = 90º  P + I 
Trigonal  a = b ≠ c  ʱ = β = 90º γ = 120º  R 
Hexagonal  a = b ≠ c  ʱ = β = 90º γ = 120º  P 
Cubic  a = b = c  ʱ = β = γ = 90º  P + I + F 
Table 2.1 – The seven crystal systems with the restrictions on unit cell parameters and corresponding Bravais 
lattice type, P primitive, C centred, I body centred, F face centred and R rhombohedral. 
 
2.1.5  The Fourteen Bravais Lattices 
 
A unit cell that contains one lattice point is called a primitive cell. There are times when it is 
beneficial to describe the unit cell with larger parameters to simplify defining the symmetry 
elements, in some cases 2, 3 or even 4 times the volume of the primitive cell.  Such cells are 
called centred and contain more than one lattice point. There are eight centred lattices; C 
corresponds to a centred lattice where the second lattice point sits on either of the faces, A-
face (between the b- and c- axis), B- face (between a- and c- axis) or C-face (between a- and 
b- axis).  If the additional lattice points sit on all the faces it is labelled F,  face centred, and 
has four times the volume of primitive cell, and lastly I represents body centred where the 
additional lattice point is at the centre of the cell and has double the volume of primitive
3 
(Table 2.1). 
 
2.1.6  Space Groups 
 
Within three-dimensional crystals, the presence of translation makes other kinds of symmetry 
possible. For example a mirror plane can be combined with a translation equal to half a cell 
unit repeat one of the axes instead of just a reflection; this is called a glide plane. Similarly,   71 
combining a rotation with a translation gives a screw axis, described by the symbol 21 for a 
two fold rotation with translation half cell length. The translation is always along the axis of 
the rotation
4. In a single molecule the symmetry elements pass through one point, and the 
combinations of symmetry elements are known as point groups. In the crystal, the symmetry 
elements do not necessarily pass through one point, and thus the symmetry groups are called 
space groups.  There are exactly 230 possible arrangements of symmetry elements in the solid 
state and thus 230 space groups. They are all fully described in the International Tables for 
Crystallography Volume A
5. 
 
2.1.7  Theory of Diffraction 
 
The diffraction phenomenon occurs when a wave encounters an obstacle. It is described as the 
apparent bending of waves around small obstacles and the spreading out of waves past small 
openings. The effects of diffraction of light were first observed and characterised by Franceso 
Maria  Grimaldi
6  in  the  1600s.  He  coined  the  term  diffraction,  from  the  Latin  word 
diffreignere that means ―to break into pieces‖.  
 
Diffraction occurs in all waves, including water, sound, and radio and importantly here in 
electromagnetic  waves  such  as  X-rays.  Also  due  to  the  wave-particle  duality  concept  by 
which all matter exhibits both wave-like and particle-like properties, diffraction experiments 
can also be carried out using particles such as electrons and neutrons.  
 
The key benefit of X-ray diffraction is that the typical wavelength of X-rays is of a similar 
value to the spacing between the lattices in a structure. The most widely used laboratory X-
ray sources are based on molybdenum or copper targets, which yield X-rays with principal 
characteristic  wavelengths  of  0.71073Å  and  1.54184Å  respectively.  Copper  radiation  is 
beneficial for a small or weakly diffracting crystals since from a typical laboratory X-ray 
generator, a higher flux of photons is generated in this case. It also has benefits when using 
crystals  with  larger  unit  cell  dimensions  since  the  longer  wavelength  spreads  out  the 
diffraction pattern further.  However, use of a molybdenum source allows collection of data to 
a higher resolution and absorption effects are less serious.  
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2.1.8  The Laue and Bragg Equations 
 
Every atom within a crystal structure scatters the incident X-ray beam in all directions and 
these scattered X-rays can undergo constructive and destructive interference. For X-rays to 
interfere completely constructively, the path difference must be equal to an integral number of 
wavelengths;  
 
Path difference = a cos ʱ – a cos ʱ0 = hλ 
 
where ʱ0 and ʱ are the angles of incident and diffracted beams, a is the 1-dimensional lattice 
spacing and h is an integer. 
 
For a crystal, the diffracted intensity is effectively zero in all directions apart from where 
constructive interference has occurred.  In a three dimensional array, as in crystals, there are 
three equations that must be met simultaneously for diffraction to occur, these are called the 
Laue equations; 
 
a ( cos α – a cos α0) = hλ 
b ( cos β – b cos β0) = kλ 
c ( cos γ – c cos γ0) = lλ 
 
Where h, k and l are integers and a, b and c are interatomic spacings. These equations provide 
a  mathematical  interpretation  of  diffraction  geometry.  However  W.H.  and  W.L.  Bragg 
provided a simpler, more physically meaningful interpretation, the Bragg Equation
7; 
 
nλ = 2 dhkl sinθ 
 
This equation showed that the crystal could be thought of as a series of parallel planes from 
which the incoming beam are scattered (Figure 2.2), and the Bragg equation results from the 
requirement for the path difference between two parallel beams to equal an integral number of 
wavelengths.   73 
 
Fig. 2.2 – The Bragg construction for diffraction by a three-dimensional crystal structure. 
 
2.1.9  Reciprocal Lattice 
 
Each set  of lattice planes  is  indexed using the so-called Miller indices,  which define the 
geometry of this plane within the unit cell using three integers, h, k and l. A vector can be 
defined for each set of places, with direction perpendicular to the planes, and magnitude dhkl. 
Each Bragg reflection is thus associated with a vector, whose direction is directly linked to the 
unit cell. For example the (100) planes lie parallel to the bc face of the unit cell (Figure 2.3). 
The result is a set of vectors whose end points define a lattice with dimensions inversely 
related to the dimensions of the crystal lattice, the reciprocal lattice.  
 
Fig. 2.3 – The cubic crystal system with the directions [hkl] defining a vector normal to the surface of a face. 
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2.1.10 The Ewald Construction 
 
The reciprocal lattice is very useful in describing the practical implementation of a diffraction 
experiment. This is seen from using the Ewald construction
8 (Figure 2.4). Firstly consider a 
crystal, K, it will have a set of planes in the direct lattice shown on the LHS of the diagram. If 
an appropriate orientation for diffraction required by Braggs law is achieved, d, corresponding 
reciprocal vectors are produced shown on the RHS of the diagram with length 1/dhkl. A circle 
of 1/λ is then drawn around the crystal, K, where λ is the wavelength of the radiation used 
(hence can be changed / tuned). Bragg‘s law is satisfied when the scattered vector, d
#, ends on 
the circle; this circle is called the Ewald  circle, and in  3-dimensions is called the Ewald 
sphere. If the scattered vector (or a reciprocal lattice point) does not lie on the sphere, Bragg‘s 
law is not satisfied and a reflection will not be observed. The orientation of the reciprocal 
lattice can be moved by rotating the crystal around the incident beam, or vice versa.  
 
 
Fig. 2.4 – The Ewald Construction. 
 
2.1.11 Collecting X-ray Diffraction Data 
 
The first step is to determine a unit cell; this is achieved by indexing the diffraction pattern, 
which entails the assigning of hkl indices to each measured reflection. The space group can   75 
then be determined by measurements of the distribution of reflection intensities, assigning a 
Laue group and crystal system. To narrow down the choice of possible space groups from 
this, systematic absences are used. Systematic absences occur in the presence of a centred 
lattice,  glide  planes  or  screw  axes.  This  allows  destructive  interference  to  occur  in  a 
systematic way, therefore producing zero intensity for sets of Bragg reflections. For a centred 
lattice, the absences occur throughout the lattice, with a glide plane they occur in the zero 
layer parallel to the glide plane and for screw axis they occur on the central reciprocal lattice 
row parallel to the axis
3. Once the unit cell and crystal system is defined, a strategy for the 
data collection can then be determined using the diffractometer software. The actual data 
collection measures anywhere between 10000 to 50000 reflections, achieved by rotating the 
crystal relative to the X-ray beam. A diffraction pattern always has inversion symmetry so 
only  a  hemisphere  of  data  ever  has  to  be  measured  to  ensure  all  unique  reflections  are 
accessed. Cells with more symmetry need even less; a monoclinic cell needs less data than a 
triclinic one, with orthorhombic and higher symmetries requiring even less.  
 
Over the past 40 years advancements in diffractometers have meant that a data collection can 
be done in a morning rather than a week, mainly down to the use of area detector systems. 
There are a range of these detectors; charged coupled devices (CCD), which use CCD-chips 
to record the X-rays as they hit the surface and image plates which undergo a reaction when 
struck  with  an  X-ray  that  can  be  read  by  laser  scanning.  Both  types  of  detectors  have 
advantages  and  disadvantages.  Recent  advances  in  diffractometer  technology  have 
increasingly looked at further mechanisation of diffraction experiments, with machines that 
are able to take a mounted crystal from bench to structure solution.  
 
2.2   Structure Solution 
 
Once the reflections have been measured, the structure can be solved, i.e. the location of the 
atoms in the unit cell determined. Some concepts need to be accounted for before describing 
the method for solving the structure. Firstly, X-rays are scattered by electrons, so the electron 
density  distribution  is  measured.  The  electrons  are  never  stationary,  with  the  diffraction 
experiments only taking a picture of the electrons at a certain time; this means the electron 
density is averaged out over time and over the vibrations of the atom. The structure can then 
be described in terms of positions and displacements of the atoms with each atom having its   76 
own electron density distribution about its centre. Atoms are usually calculated as spherical 
objects, with their contributions to the X-ray scattering (atomic scattering factors) derived 
from quantum mechanics. Each element has a unique atomic scattering factor that decreases 
with increasing Bragg angle (Figure 2.5).  
 
 
Fig. 2.5 – X-ray atomic form factors of oxygen (blue), chlorine (green), Cl
- (magenta), and K
+ (red); smaller 
charge distributions have a wider form factor. 
 
Since atoms are also constantly moving, known as atomic displacement, the electron density 
is further spread out over a larger area and usually in an unequal way (due to bonding). This 
effect  can  be  described  by  a  set  of  anisotropic  displacement  parameters,  which  uses  six 
parameters and results in an ellipsoid shape for the atom. In total, the parameters that are used 
to describe an atom are: atomic scattering factor, x, y, z coordinates, site occupancy factors 
(this  helps  if  an  atom  does  not  fully  occupy  a  given  position  within  the  unit  cell)  and 
anisotropic displacement parameters.  
 
The  scattering  amplitude,  Fc,  for  a  unit  cell  can  be  calculated  from  the  known  atomic 
parameters.  Due to the phase shift of scattering from the different atoms in the unit cell, the 
scattered  wave  can be  described by  a complex quantity which is  linked to  the scattering   77 
amplitudes  and  relative  phases.  All  of  the  atoms,  j,  in  the  unit  cell  will  have  their  own 
amplitudes and their individual phase shifts and the resultant scattered wave for the entire 
structure – called the structure factor – is obtained for each reflection hkl by equation 1. 
 
        
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The square of the amplitude of the structure factor gives the intensity that is generated in a 
diffraction experiment. The phase angle can be calculated, but is not directly measureable 
experimentally (see 2.3.2).  
 
2.2.1  Fourier Transform 
 
The crystal structure that is to be determined is related to the X-ray diffraction pattern by a 
mathematical process called the Fourier transform, i.e. if all the individual X-ray waves are 
known (that is their structure factor Fo with their phases), a Fourier transform will give the 
electron density, therefore the structure:  
 
ρ(xyz) =  
hkl V
1
Fhkl exp[-2πi(hx + ky + lz)]      (2) 
 
From this the electron density, ρ, can be determined for every point x,y,z in the unit cell. V is 
the volume of the unit cell, F is the structure factor for the reflection with indices h, k and l. 
Unfortunately the experimental measurements only give the intensities of the structure factor, 
i.e. only the amplitudes are known and the phase information has been lost.  This loss of 
phase information is called the phase problem.  
 
2.2.2  Phase Problem 
 
The phase problem arises because the diffraction experiments only collect the intensities of 
the reflections, with the phase information of the structure factor being lost. If the phase 
information can be calculated and combined with the observed structure factor values, Fo, the   78 
resulting  Fourier  synthesis  calculations  will  give  the  full  structure  (or  a  model  which 
refinement methods can improve).  Various methods have been devised for solving the phase 
problem, which for most small molecule structures is now fairly routine. 
 
2.2.3  Patterson Method 
 
One of the two main ways to solve the phase problem is to use the Patterson method, which 
basically replaces the vector from equation (2), Fhkl, with its square, removing the phases from 
the calculation (3).  
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The result is that the electron density is not calculated; the peaks on a Patterson map do not 
correspond to individual atoms, but to vectors between pairs of atoms. The height of Patterson 
peaks are related to the scattering powers of the two atoms involved in the vector, which 
means  that  this  method  is  suited  to  crystals  that  contain  heavy  atoms,  for  example 
organometallics. With the heavy atoms found, approximate phases can be calculated and the 
remaining atoms located using difference Fourier syntheses and then refined to completion. 
 
2.2.4  Direct Methods 
 
Direct methods is the more common of the two techniques and makes use of the relationship 
between the intensities of the various reflections which lead directly to a solution of the phase 
problem. It is essentially a trial and error method, based on the knowledge that structure 
factors  are  linked  to  phases  through  the  electron  density.  Characteristics  of  the  correct 
electron density can be expressed as mathematical constraints on ρ(density), for example the 
scattering density is positive throughout and that atoms are in discrete positions.  Since the ρ 
is linked to the structure factor by Fourier transform, constraining ρ also puts constraints on 
the structure factor. Since the amplitudes of the structure factor are known, the constraints are 
on  the  phases  and  in  some  cases  determine  the  values  of  these  directly.  One  of  these 
constraints is called the triplet relationship, where when the Miller indices of three strong   79 
reflections have well-defined relationships with one another, the values of the three phases of 
the reflections involved in the triplet are also related, with the probability of this relationship 
being  proportional  to  the  intensities  of  the  contributing  reflections.  Multiple  iterations  of 
possible deduced phase sets are tried (often several hundred) and from this the best solution is 
picked and a density map generated. This results in a list of peaks from which fragments of 
the  structure  can  often  be  seen,  either  by  the  user  or  with  additional  refinements  by  the 
structure solution program. There are several variables that can be changed for direct methods 
to improve the possibility of getting a better solution. The two main variables are the number 
of  triplet  reflections  relations  used  or  the  number  of  variations  of  phase  relationships 
attempted, both increasing the chances of finding a solution although the time required for the 
calculation gets progressively longer. Direct methods are very successful in solving small 
molecule structures and are by far the most common method used. 
 
2.2.5  Superflip 
 
Superflip
8 is a relatively new method for solving the phase problem which uses the concept of 
charge flipping
9, which is a mathematical algorithm that gives approximate electron densities 
from structure factor amplitudes. Whilst direct and Patterson methods need relatively large 
amounts of prior information about the material to solve the structure, charge flipping needs 
much less, not even chemical composition. The method uses an algorithm (4) which goes 
through a cycle of operations with the 0
th cycle assigning random starting phases (φrand(H)) to 
all experimental amplitudes and making all unobserved amplitudes equal to zero.  
 
)) ( exp( ) ( { ) (
) 0 ( H i H F H F rand
obs          (4) 
 
Where  ) (H F
obs  is the experimental structure factor. Within the algorithm all operations are 
performed in the whole unit cell with symmetry space group P1, therefore the origin of the 
structure is not fixed and the structure can emerge anywhere in the unit cell. An inverse 
Fourier transform is performed that calculates the electron density; from this if there is any 
negative electron density, the sign at this point is flipped (thus charge flipping). The next step 
is calculating temporary structure factors by Fourier transform and from this the calculated 
phases can be added to the experimental amplitudes to generate the new structure factors.   80 
These new structure factors are then inserted in the beginning of the next cycle. The success 
of  the  operations  can  be  monitored  observing  the  R-value  of  amplitudes  with  respect  to 
) (H F
obs  . It is large in the initial cycles  however once there is a sharp decrease of the R -
value and this becomes steady, the process is said to have  converged. The final R-values are 
not a measure of the quality of the structure, but merely as an indicator of convergence. Since 
the calculation is carried out in the  P1 space group, the actual space group still needs to be 
determined. This is carried out directly from the electron density after the unit cell is modelled 
and a list of symmetry operations that are compatible with the lattice can be drawn up and 
evaluated by how well they match with the electron density. From the symmetry elements that 
are a good match, a space group is assigned that fits best.  
 
2.2.6  Fourier Refinement 
 
From  a  partially  known  structure  (model),  a  set  of  calculated  phases  can  be  obtained.  
Combining these with the observed structure factor magnitudes leads to the observed structure 
factors, Fo. By subtracting from each point an identical summation based on the calculated 
structure factor, Fc, a ―difference  Fourier‖ map can be calculated. The peaks  that remain 
represent the missing atoms in the structure, since effectively the model calculated density has 
been removed from the experimental calculated electron density. With each new model, a new 
difference  Fourier  map  can  be  calculated,  this  improves  the  phases  that  are  used  in  the 
calculations, creating a cycle that if repeated determines the complete structure. The structure 
that has been achieved will describe the structure reasonably well; however there are still 
errors in the parameters, due to the approximations in the calculations used and in the quality 
of data collected; for example the experiment is not carried out at 0K so thermal parameters 
must  be  included.  Therefore  the  calculated  structure  factor,  Fo,  does  not  agree  with  the 
observed values. The next step is better to match the calculated and observed structure factor 
values,  which  is  done  through  least  squares  refinement.  This  can  be  used  in  structure 
refinement as the parameters are said to be over determined i.e. there are significantly more 
observations than parameters (for a good data set, the data/parameter ratio is typically more 
than 10). In addition, during the least squares refinement process, other factors affecting the 
agreement  of  model  with  data  are  optimised,  including  absorption  corrections,  which  are 
required to account for the weakening of the X-ray beams by elastic and inelastic scattering as   81 
they pass through the crystal; this absorption is affected by the atom types in the structure and 
the size and shape of the crystal, 
 
2.2.7  Location of Hydrogen atoms 
 
Hydrogen atoms have very little scattering power, but depending on the number of them in 
the structure can contribute significantly to the electron density. After the main features of the 
structure  have  been  optimised  by  refinement,  difference  Fourier  maps  can  be  calculated. 
Using these maps it is possible to find the hydrogen atoms and to spot if an atom has been 
mis-assigned.  
 
2.2.8  R-Values 
 
In order to determine how well the model actually fits to the experimental data, residuals, 
normally named R-factors (5), are used. The R-factor gives the average relative deviation 
between the observed, Fo, and calculated, Fc, structure factors:  
 
R = 
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 
hkl
o
hkl
c o
F
F F
          (5) 
 
The higher the value of the R-factor the worse the model and data match, so the lower the 
better, with typical published data having R-factors around 0.02-0.07. The weighted R-factor 
(6) works in the same way but with weighting factors for the reflections based on the σ(F
2) 
values and is directly related to the statistical quantity that is minimized in the least squares 
refinement. Good weighted R-factors tend to be around 0.12-0.15 (12- 15%).  
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A further quantity is used to measure the quality of the refinement, S (7), the goodness of fit. 
 
S= 
n m
F F
hkl
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          (7) 
 
where m is the number of reflections and n the number of parameters; the difference in these 
numbers gives the over determination of the structure.  A good refined data set will have a S 
value of close to 1. 
 
2.3   Powder Diffraction 
 
In contrast to single crystal X-ray diffraction, powder X-ray diffraction can test the properties 
of  a  bulk  sample.  A  powder  diffraction  experiment  can  be  undertaken  on  a  whole 
crystallisation  experiment  and  be  achieved  to  a  high  resolution  in  less  than  30  minutes. 
Testing of bulk properties using single crystal experiments would require the diffraction of 
10s of samples which would take time and may well be impossible if suitable crystals were 
not generated of all crystalline forms present in the sample. The benefit of analysing the bulk 
sample over selected single crystals is two-fold: to obtain the composition of the bulk material 
and to determine the degree of crystallinity of the sample. It is also possible to determine unit 
cell information and powder data can also sometimes lead to full structural determination. 
Information of the composition is vital as it can quickly find if the sample has new products, 
for  example  a  molecular  complex,  or  just  starting  material.  Powder  diffraction  can  also 
determine if the sample is pure or a mixture which is vital in identifying polymorphism in a 
material.  The  type  of  sample  used  (powders)  lends  a  greater  degree  of  flexibility  in 
experimental conditions over the single crystal experiments. Using non-ambient conditions, 
such  as  high  pressure,  temperature  or  magnetic  field  is  much  easier  to  undertake  on  a 
powdered  sample  than  a  crystal,  as  single  crystals  are  much  more  vulnerable  to  these 
conditions. Powder diffraction studies using non-ambient conditions can provide real time 
information  on  the  kinetics  of  the  reactions  involved,  phase  change  information  and  the 
changes of the unit cell parameters. 
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2.3.1  Powder Diffraction Experiments 
 
A  powder  is  a  collection  of  randomly  oriented  crystallites;  the  sample  is  called 
polycrystalline. In a diffraction experiment each of these crystallites can be thought of giving 
rise to its own diffraction pattern, and the random orientation of the many crystallites in the 
experiment leads to the spots becoming spread out into rings of diffracted intensity (Figure 
2.6). This generates a plot of total diffraction intensity against diffraction angle, 2θ. 
 
 
Fig.  2.6  –  (a)  Shows  diffraction  from  a  single  crystal,  (b)  from  a  collection  of  four  crystals,  (c)  from  a 
polycrystalline sample. (d) is the resulting powder pattern from the polycrystalline sample
10. 
 
The inherent problem with powder diffraction is that the 3D intensity distribution of single 
crystal experiments is compressed into a 1D distribution in 2θ space. The result is a loss of 
information and peak overlap, with the latter being the only problem that can be resolved, to a 
certain extent. This peak overlap is more severe for larger and lower symmetry unit cells, and 
making molecular materials with chosen symmetry is still beyond crystal engineers. Therefore 
to  reduce  peak  overlap,  optimising  experimental  parameters  (such  as  diffractometer 
resolution, sample quality) that will sharpen the widths of the reflections as much as possible 
are required.   
 
2.3.2  Powder Diffractometers 
 
There are a wide range of X-ray powder diffractometers available, with each instrument set-
up  producing  advantages  and  disadvantages.  A  traditional  flat  plate  set-up  for  a  powder   84 
diffractometer is shown in Figure 2.7. In this set-up the sample is scanned through an angle θ 
as the detector is moved through 2θ to accumulate the diffraction pattern. There are different 
sources and detectors with different associated properties, with the most common set-up being 
a sealed copper tube and a point detector with reflection geometry. As can be seen from 
Figure 2.7, between the source and the sample there is a divergence slit, this controls the 
amount of sample that is illuminated by the X-rays. It is crucial that the slit size is smaller 
than the sample size to ensure that diffraction intensities are useful. A similar slit is placed 
between the sample and the detector, the anti-scatter slit, which is used to reduce the axial 
divergence of the scattered X-rays. The smaller the slits, the higher the resolution, but that is 
at the cost of a decrease in intensity (for example, a 0.05mm detector slit will only result in ¼ 
of the count rate of a 0.2mm slit). The flat plate method – in which the powder sample is 
deposited on a flat sample holder, is prone to an effect called preferred orientation; this is 
when  the  crystallites  arrange  themselves  into  a  non-random  arrangement,  due  to  their 
morphology.    This  can  severely  affect  the  diffraction  intensities  and  skew  results.  The 
simplest way of reducing preferred orientation is to use a capillary set-up where a constantly 
rotating capillary tube is used to contain the sample instead of a flat plate.  
 
 
Fig. 2.7 – Schematic of a traditional flat plate X-ray powder diffractometer. 
 
2.3.3  Powder Pattern 
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Information about the material is found in three distinct features of the powder pattern. The 
peak  positions  give  information  on  the  size,  shape  and  symmetry  of  the  unit  cell.  Peak 
intensities relate to the arrangement of scattering density within the unit cell, which relate to 
the unit cell contents, point group symmetry and in multi-sample experiments, the relative 
quantities  of  each  phase  (quantitative  analysis).  Lastly  from  the  peak  shape  and  width, 
information on the crystallite size and the extent of defects or strains in the sample can be 
determined.  As discussed in Section 2.4.2, experimental factors (sources, optics, detectors) 
can also affect the width of the peaks.  
 
2.3.4  Structure Solution from Powder X-ray Diffraction Data 
 
For  structure  determination  from  powder  data  (SDPD),  the  data  needs  to  be  of  the  best 
possible quality. Recommendations to ensure this include the use of a rotating capillary set-
up, small step size, varying the data collection time with angle (see Table 2.3 below for 
example of a variable count time strategy), and carrying out many short scans rather than one 
long run. Primarily the goal of these is to reduce background and at high angles of 2, reduce 
overlap of peaks and strengthen the weak signals produced.  
Starting (2θ)  End(2θ)  Step size  Time (secs) 
3  28  0.017  2 
28  45  0.017  6 
45  55  0.017  16 
55  70  0.017  32 
Table 2.3 – Typical variable count time scan set-up for SDPD. 
There are normally several steps in the structure solution process; firstly the highest quality 
data possible  is  obtained. Unit cell parameters  are then obtained  from  the observed peak 
positions.  This  indexing  stage  is  performed  similarly  to  single  crystal  experiments  and 
requires careful peak fitting. The space group can be determined from systematic absences; 
however, where overlap between peaks at high 2 is significant this causes difficulties with 
peak picking.  
Next, a Pawley refinement
11 is performed; this method is basically a peak fitting exercise (not 
based upon a structural model) where only the allowed peaks that correspond to the unit cell   86 
and the symmetry are included. If the calculated peaks are not fitting well with the observed 
peaks, this indicates that either the unit cell or space group is wrong or impurities are present. 
The Pawley refinement gives a numerical indication of the best fit that will be achieved in the 
Rietveld (structure) refinement stage. 
There are many options for the next stage; processes similar to direct methods and Patterson 
synthesis can be used to solve the structure. Charge-flipping algorithms have recently been 
used. The SDPD method which is used in the DASH software is a direct-space structure 
solution method that uses information about the molecular fragments and their geometry. 
The latter method works by generating a trial structure model from the molecular cell contents 
and compares the calculated diffraction pattern from the model to the experimental diffraction 
pattern. Using a simulated annealing approach, adjustments are made to the structure in a 
random way and for each move the agreement between the observed and calculated patterns is 
examined. The move is then accepted or rejected and the process is repeated until the best 
agreement is obtained. 
Lastly, a Rietveld refinement is performed; this is a whole pattern fitting least-squares method 
that allows the adjustment of structural parameters such as unit cell size, fractional atomic 
coordinates and thermal parameters to minimise the difference between the observed (yobs) 
and calculated (ycalc) patterns point by point. The quality of the model can be assessed by 
considering the goodness of fit (χ
2) (8) which compares the agreement factor Rwp against the 
Rexp which is the statistically expected value. The goodness of fit should be as close to the 
result of the Pawley refinement as possible. 
exp
2
R
Rwp       (8) 
It  is  often  best  to  use  a  visual  inspection  of  the  difference  profile  (diffraction  pattern 
subtracted by calculated pattern) as high background can artificially lower the Rwp values 
(Figure 2.8).   87 
 
Fig. 2.8 – The powder pattern of benzimidazole 5-chlorosalicylic acid obtained from structure solution with 
DASH (blue) and the experimental data (red). The purple line indicates the differences between the two sets of 
data; this is an indication of the good fit between the two.  
 
2.4   DSC 
 
Differential  scanning  calorimetry  (DSC)  is  a  technique  that  investigates  the  thermal 
transitions of a material and works according to the heat flow principle. Thermal transitions 
are those in which there is an energy exchange with the sample environment as it is heated. 
This  includes  things  like glass transitions,  phase transitions,  melting, and recrystallisation 
(Figure 2.9). DSC is a useful technique when dealing with multi-component materials as it is 
able to determine quickly if the sample is pure, the different phases a material adopts as a 
function of temperature, degree of crystallinity and, importantly, to screen for polymorphs.  
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Fig.  2.9  –  Thermogram  showing  the  three  main  types  of  event  that  be  detected  by  DSC,  glass  transition, 
crystallisation and melting. For a multiple phase sample, each component will follow its own thermal profile. 
 
2.4.1  DSC Experiments 
 
A small amount of the sample is placed in the sample pan and in parallel with an empty 
reference pan, they are then heated at a set rate. The difference in energy required to heat the 
sample pan compared to the reference pan is  measured and plotted as the  temperature is 
increased. This thermogram (normally heat flow vs. temperature) provides information on any 
endothermic or exothermic transitions  that the  sample has  undergone.  For  example when 
there has been an endothermic transition (e.g. melting), the sample absorbs heat and requires 
an  increased  amount  of  energy  to  retain  the  same  heating  rate.  This  is  represented  as  a 
negative peak in the DSC thermogram. The opposite is seen for an exothermic transition (e.g. 
crystallisation) where heat released by the material therefore less energy is required to keep 
the same heating rate so a positive peak is seen on the thermogram. The DSC scan can also be 
undertaken  when  the  sample  is  being  cooled  which  tends  to  indicate  when  materials 
recrystallise, however this is very rarely seen clearly in multi-component materials.  
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3  Techniques and Instruments 
 
The techniques deployed were primarily intended to prepare and characterise single crystals 
of previously undiscovered multi-component materials. The techniques used to grow single 
crystals were predominately the solvent evaporation technique with slight derivatives of this. 
There were a wide range of analytical techniques used to determine what materials were 
generated and in some cases their properties. 
 
3.1   Single Crystal Formation 
 
The formation of a crystal depends on the relative rates of nucleation and growth. If rate of 
nucleation  is  larger  than  rate  of  growth,  the  result  will  be  generation  of  polycrystalline 
material, i.e. powder. On the other hand, if the rate of growth is too large, the crystal will 
undoubtedly develop defects, strains and stresses
1.  Therefore the growth of the crystals is an 
essential stage to be optimised in sample preparation with certainly no ―one size fits all‖ 
approach available. Also to be taken into consideration is the size of crystal required for the 
analytical technique to be used. Single crystal X-ray diffraction requires crystals of dimension 
typically between 0.1  –  0.4mm on a side, while neutron diffraction requires  much larger 
crystal sizes, of volume around 1mm
3.  
 
3.1.1  Solvent Evaporation Method 
 
The main methods for obtaining a single crystals of a material are from solution, melt or by 
sublimation. In this body of work, the only method used was crystallisation from solution 
however there are benefits to using both the melt and sublimation methods with all these 
methods reviewed in a paper by Hulliger
2.  The solution method basically consisted of the 
dissolving of the target materials in appropriate solvent and leaving the solution to evaporate 
over time to produce formation of the desired materials – including the assembly of molecular 
complexes from multi-component solutions – and generate the required size of crystal.  
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Although apparently simple, there are a large variety of different variables in this method 
including container vessel, ratio of starting materials, selection of solvent, temperature and 
rate of evaporation control. There were a range of different types of glassware used including 
round bottom, volumetric and conical flasks, however the majority of crystallisations were 
conducted  using  a  7mm
3  volume  glass  vial.  There  were  also  attempts  made  using 
crystallisation-specific glassware, including U- and H- tubes (Figure 3.1). There were also 
target materials in which different stoichiometric ratios of starting materials were required. A 
wide  range  of  solvents  were  used  to  dissolve  the  starting  materials  including  methanol, 
ethanol, propanol  and acetone, with solvent selection tailored to suit the solubility of the 
starting  materials  and  to  try  and  influence  the  outcome  of  the  crystallisations.    Multi-
component crystallisation experiments were set-up to produce complexes in which it was 
intended to control the proton transfer that occurs between benzimidazole and a carboxylic 
acid containing group, with the pH of the solvent tailored to encourage proton transfer, for 
example acetic acid, and to discourage transfer, for example ammonia. In some cases when 
starting  materials  dictated,  a  mixture  of  solvents  was  used.  When  trying  to  control  the 
formation of polymorphs, a relatively small change in crystallisation conditions can influence 
the  product,  for  example  using  methanol  instead  of  ethanol,  can  be  the  difference  in 
determining which polymorph is formed. The same can be true for temperature – there are 
examples in this work where a temperature difference of 10ºC can be the deciding factor in 
selecting formation of a particular polymorph. Often the control of a constant temperature for 
a crystallisation, or use of a carefully controlled temperature ramp is a vital component. A 
wide range of temperatures were used including: 2~4ºC in a cold room; 10 and 20ºC using a  
ReactArray Microvate
3 (able to programme a temperature from -30 to 160ºC with ramps or 
constant temperature control); 30, 40 and 50ºC using Asynt magnetic hotplates
4 and the less 
controlled wide range of ambient temperatures achievable during the year in Glasgow (Figure 
3.1). 
   92 
       
Fig.  3.1  –  From  left  to  right,  ReactArray  Microvate,  Asynt  hotplate  and  H-tubes,  the  latter  containing 
crystallisations of chloranilic acid and 3,5-dimethyl pyrazole at different stages. 
 
While temperature is one way to control the rate of evaporation, another is using blockers to 
reduce the rate of solvent loss. For the 7mm
3 vials this is best achieved using the associated 
plastic lids, however with other glassware parafilm was used to cover. If a powdered material 
was the object of the crystallisation then use of a vial with no lid, with a high evaporation 
temperature, would produce the quickest results. 
 
3.1.2  Solubility Phase Diagrams 
 
It is essential that the solubilities of the starting 
materials are taken into account; if the solubility 
of the molecular complex is lower than that of 
the individual components, there exists a driving 
force  for  the  cocrystallisation  to  occur
5.  Phase 
diagrams show when thermodynamically distinct 
phases  occur  at  equilibrium  with  the  lines 
indicating  the  conditions  at  which  multiple 
phases can coexist. The phase diagram in Figure 
3.2  shows  that  the  cinnamic  acid  nicotinamide 
Fig. 3.2 - The two-component phase diagram 
for  the  trans-cinnamic  acid  nicotinamide 
system
6. 
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co-crystal Form I will occur when there is a 1:1 molar ratio of the components. When there 
are a stoichiometric excess of one component ( below 0.4 and above 0.7), then the starting 
materials  are  obtained.  Ternary  phase  diagrams  are  required  to  evaluate  the  influence  of 
solvents during the crystallisation and these can vary significantly on changing the solvent of 
crystallisation. Figure 3.3 uses the cinnamic acid nicotinamide system to highlight this; region 
1 indicates an undersaturated solution, 2 is solid cinnamic acid, 4 is where solid nicotinamide 
is  formed,  3  indicates  where  the  molecular  complex  forms  and  5  and  6  are  mixtures  of 
molecular complex and starting material. When both co-molecules have equal solubility in the 
solvent, for example in methanol for this system (Figure 3.3 LHS), the molecular complex (in 
a 1:1 ratio) is formed when the solubility curve of the molecular complex (b to c) crosses the 
molecular complex component stoichiometric line (e to f). In the case of water (Fig 3.3 RHS) 
where there is a wide difference in the solubilities of the two components, the region where 
the molecular complex is stable, is skewed giving an asymmetric phase diagram and shows 
that  the  region  for  co-crystal  formation  never  crosses  the  1:1  stoichiometric  line  (e  to  f) 
indicating that the molecular complex will not form.   This indicates that a successful co-
crystallisation is more likely to happen when the two components have similar solubilities
6.  
 
 
Fig. 3.3 – LHS, the three component phase diagram for the trans-cinnamic acid nicotinamide system in methanol 
at 20ºC, RHS, in water at 20º
6.  Regions 5 and 6 are areas of molecular complex/ starting material mixture, 1 a 
undersaturated solution, 2 and 4 is regions of solid starting material and 3 where the molecular complex is form. 
The letters indicate starting points of solubility curves. 
 
3.1.3  Solvent-Free Co-crystallisation  
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Solvent-free co-crystallisation involves the grinding together of the component molecules. 
There  are  various  techniques  and  methodologies  that  come  under  the  umbrella  term  of 
solvent-free co-crystallisation (see Section 1.5), two of which were used during this research: 
solvent-free grinding and solvent drop grinding. Both these methods involve the grinding of 
the co-molecules with a mortar and pestle (Figure 3.4) for roughly three minutes, with the 
solvent drop grinding method including adding trace amounts of solvent. In all cases, the 
product was then stored at room temperature.  
 
 
Fig. 3.4 – Mortar and Pestle for use in the solvent free grinding experiments. 
 
3.2  Single Crystal Diffractometers 
 
Once the crystals have been grown, it is necessary to determine if they are suitable for single 
crystal  X-ray  diffraction.  The  quickest  way  is  to  visually  examine  the  crystals  under  a 
polarised microscope, with three aims. Firstly, to inspect the size and shape of the crystals; 
those  that  are  curved,  deformed,  have  significant  secondary  crystallites  (small  crystals 
attached) or have a re-entrant angle (an interior angle of a polygon that is greater than 180 
degrees)  should  be  rejected.  Next,  with  a  polarised  lens  in  place,  crystals  will  transmit 
polarised light (with exceptions including cubic crystals); those that do not can be rejected. 
Lastly for those crystals that do transmit polarised light, when the polariser is turned 90º the 
crystal will turn dark, then when turned another 90º will turn light again. This is a sign of a 
good quality single crystal. If during this process only half the crystal changes colour, then the 
crystal is likely to be twinned. When carrying out the evaluation it is essential not to damage 
the crystals,  for example if the crystal  is  taken from  a non-fully  evaporated vial (always 
advised if using the solvent evaporation technique) there is a chance if solvent is within the   95 
crystal then it may escape. If the crystal passes these tests, the next stage is to determine how 
it behaves on a diffractometer. Reflections need to be of strong intensity and well shaped, not 
split and preferably not broadened. If the diffractometer software provides a sensible unit cell 
which is not already published in the CSD
7 then it is likely that an unknown structure is under 
investigation and a full data collection scan can be initiated. 
 
They  were  three  different  diffractometers  used  in  this  project  with  two  distinct  types  of 
detectors. A Nonius / Bruker Kappa with a CCD area detector
8, a Bruker APEX-II
9 also with 
a  CCD  area  detector,  and  a  Rigaku  R-Axis  RAPID
10  equipped  with  an  image  plate  area 
detector (Figure 3.5).  
 
     
Fig. 3.5 –left to right, the Nonius / Bruker Kappa CCD, Bruker APEX-II and Rigaku R-Axis RAPID. 
 
All the diffractometers used a Mo/K source with wavelength 0.71074Å and were all capable 
of providing data collection temperatures down to 100K using sample cooling devices. Both 
the  Nonius  /  Bruker  Kappa  and  Rigaku  R-Axis  RAPID  contained  Oxford  Cryosystems 
cryostream devices attached to a liquid nitrogen cylinder while the Bruker APEX-II used the 
Oxford Cryosystems Helix which normally operates using a gaseous nitrogen supply but can 
also allow access to temperatures as low as 20K using a helium source.  
 
3.2.1  Nonius / Bruker Kappa CCD and Bruker APEX-II 
 
There were slight differences between all the diffractometers in their set-up.  The RAPID uses 
a 3-axis Eulerian goniometer while the Kappa and APEX II are both equipped with the kappa 
geometry, but the main difference is in the type of area detector used. The Charge Coupled 
Device  (CCD)  system  is  used  in  the  Nonius  /  Bruker  Kappa  CCD  and  Bruker  APEX-II 
(Figure 3.6) diffractometers. These use CCD-chips to record data and are based on a layer of 
fluorescent material, usually a gadolinium oxide sulphide which is sensitive to X-rays, with   96 
the X-ray intensities collected very quickly. The downside to CCD detectors is that they can 
collect high levels of background, which can be reduced by cooling the chip to -50ºC but this 
feature can make it unsuitable for long exposures which are needed for weakly scattering 
materials. These chips are large at 1024 x 1024 mm and have a resolution of 4096 x 4096 
pixels.  In order to collect all the reflection data the crystal must be rotated hence the detector 
is mounted on a 3- or 4- circle diffractometer. 
 
 
Fig. 3.6 – The working area of the Bruker APEX-II with labelling of the CCD detector, crysostream. X-ray 
direction and sample location. 
 
3.2.2  Rigaku R-Axis RAPID 
 
The Rigaku R-axis RAPID diffractometer uses a 3-axis Eulerian goniometer and has an image 
plate detector (Figure 3.7). The image plate has a detection size of 465mm by 258mm and 
works by having a layer of BaBrF doped with Eu
2+; when incident X-ray quanta strike the 
image plate, they are converted to colour centres (free electrons in interstitial lattice sites) 
with the Eu
2+ being oxidised to Eu
3+. The resulting image on the plate is read by a laser 
scanner in a similar manner to how a CD is read. The laser causes the free electrons to reduce 
back  to  Eu
2+,,  this  produces  an  emission  of  photons  in  blue-green  region  of  the  visible 
spectrum, these photons can be measured using a photocell with a photomultiplier (extremely 
CCD 
Detector  X-rays 
Sample 
Cryostream   97 
sensitive  detectors  of  light  in  the  UV,  Vis,  near  IR  and  electromagnetic  regions  which 
multiple the current produced by the incident light by as much as 100 million times). Once the 
plate has been read it is exposed to intense white light to remove any remaining colour centres 
and is ready for re-use. This reading process takes longer than the read-out on CCD systems, 
however the image plate detectors collect very low backgrounds and are almost exclusively 
sensitive to scattered X-ray radiation. The large detector size makes it possible to measure an 
entire data collection by limited rotations of the crystal, and the image plates are cheaper to 
manufacture than CCD systems. 
 
 
Fig.  3.7  –The  Rigaku  R-Axis  RAPID  diffractometer  with  labelling  of  the  image  plate,  cryostream.  X-ray 
direction and sample location. 
 
3.2.3  Data Collection and Structure Solution  
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All  the  diffractometers  have  specific  software  that  guide  the  user  through  the  process  of 
indexing  to  data  collection,  to  producing  the  .hkl  file  that  can  then  be  used  to  solve  the 
structure. In all the diffractometers the unit cell is determined by collecting a small set of 
frames. These frames are indexed as set out in section 2.2.4 to produce the primitive unit cell, 
crystal system and Bravais lattice. It is always advisable at this stage to choose the lowest 
possible symmetry lattice to ensure sufficient data is collected during the full data collection. 
A data collection strategy is then calculated, with collections typically lasting between a few 
hours to a day depending on the unit cell size, symmetry and atom form factors of the crystal, 
however in all cases a completeness level of 100% with high redundancy is always aspired to. 
Once the full data collection strategy has finished, the data needs to be integrated. At this 
stage it can be wise to re-determine the unit cell and symmetry of the crystal to ensure that 
weaker reflections, that may be lost in the initial quick scans, are accounted for. During the 
integration process the software scans a rectangular or elliptical area around the predicted 
position for each reflection with all the pixels summed to give the raw intensity, with the 
edges of the area used to estimate the background. The background is subtracted from the raw 
intensity  to  give  the  net  reflection  intensity.  This  net  intensity  is  subjected  to  several 
correction methods in the data reduction program, including Lp correction, Lorentz factor, 
standard  extinction  and  absorption  corrections.    Once  these  are  complete  a  .hkl  file  is 
produced. The .hkl file is then input into a structure solution and refinement program such as 
CRYSTALS
11 or WINGX
12 to solve the structure (see section 2.3 for details of this process). 
Analysing the solved structure is normally achieved using a structure visualisation program 
such as MERCURY
13.  
 
3.3  Powder Diffraction 
 
The powder diffractometer used during this research was a Bruker D8 Advance
14 (Figure 3.8) 
equipped with a Mo/K source and capillary holder. The layout is identical to that shown in 
Figure 3.6, using the reflection geometry but with the capillary holder instead of the flat plate. 
Most experiments used a capillary of diameter 0.7mm, however smaller ones were used when 
more accurate data was required. The typical scan range covered a 2 range of 3 to 50º with a 
scan rate of roughly 1º per minute. Analysing and comparing the collected powder patterns 
were  achieved  using  initially  the  Eva
15  program  supported  by  Bruker  then  latterly  with   99 
HighScore Plus
16 from PANalytical. The majority of powder patterns displayed throughout 
the chapters are visualised from the HighScore Plus software.   
 
       
Fig. 3.8 – LHS, the Bruker D8 Advance used for powder X-ray diffraction; RHS, the Q200 DSC. 
 
3.4  Differential Scanning Calorimetry (DSC) 
 
The DSC used was a Q200 differential scanning calorimeter from TA Instruments (Figure 
3.7, right)
17. Analysis of the thermograms was carried out through the Universal Analysis 
2000
18 software produced by TA instruments. 
 
3.5  References For Chapter 3 
 
(1) W. Massa, Crystal Structure Determination, Springer, 2003. 
(2) J. Hulliger, Angewandte Chemie International Edition, 1994, 106, 151-171. 
(3) Reactarray Microvate – http://www.reactarray.com/ 
(4) Asynt Magnetic Hotplate Stirrer – http://www.asynt.com/ 
(5) S. J. Nehm, B. Rodriguez-Spong, N. Rodriguez-Hornedo, Crystal Growth and Design, 2006, 6, 592-600 
(6) R. A. Chiarella, R. J. Davey and M. L. Peterson, Crystal Growth and Design, 2006, 7, 1223-1226 
(7) F. H. Allen, Acta Crystallographica section B, 2002, 58, 380-388. 
(8) Nonius Kappa-CCD Four circle diffractometer -  http://www.nonius.nl/products/ 
(9)  APEX2: Bruker AXS, 2007 - http://www.bruker-axs.com/ 
(10)  CRYSTALCLEAR: Rigaku - http://www.rigaku.com/software/crystalclear.html 
(11)  D.  J.  P.  Watkin,  C.K.,  Carruthers,  J.R.,  Betteridge,  P.W.,  Cooper,  R.I.,  ,  Journal  of  Applied 
Crystallography, 2003, 36, 1487. 
(12) L. J. Farrugia, Journal of Applied Crystallography, 1999, 32, 837-838. 
(13) C. F. Macrae, P. R. Edgington, P. McCabe, E. Pidcock, G. P. Shields, R. Taylor, M. Towler and J. van de 
Streek, Journal of Applied Crystallography, 2006, 39, 453-457.   100 
(14) Bruker D8 Advance – http://www.bruker-axs.com/d8_advance.html 
(15) Powder Diffraction Software – http://www.bruker-axs.com/eva.html 
(16) Powder Diffraction Software – http://www.panalytical.com/index.cfm?sid=212 
(17) DSC instrument – http://www.tainstruments.co.uk/product/   101 
4  Towards Selective Molecular Complex Formation: Challenging 
Crystal Engineering  
 
This chapter will focus on co-crystallisation experiments with the aim of using a systematic 
series  of  related  complexes  to  generate  a  library  of  interactions  which  could  be  used  to 
engineer new molecular complexes. 
 
Crystal engineering (refer to Section 1.3) is seen as the bottom-up construction of functional 
materials  from molecular or ionic building  blocks
1. These building  blocks are  commonly 
known  as  supramolecular  synthons  defined  by  Desiraju  as  “structural  units  within 
supermolecules which can be formed and or assembled by known or conceivable synthetic 
operations involving intermolecular interactions”
2 
 
Crystal engineering uses many strategies in forming supramolecular synthons; most common 
is  using  the  understanding  of  hydrogen  and  coordination  bonds,  while  more  recently 
increasing attention has been applied to the weaker and less predictable halogen bonds
3 and π-
π interactions
4.  
 
This  chapter  will  focus  on  the  synthons  and  hydrogen  bond  motifs  created  between 
benzimidazole,  carboxylic-  and  hydroxyl-  functional  groups.  Application  of  a  library  of 
complexes containing identical functional groups can allow simple motifs to be engineered to 
form predictable structures.  This chapter will also investigate the differences between the 
structures  by  studying  the  role  of  weaker  interactions,  the  ratios  of  molecules  in  the 
complexes, the effects of solvates and the effects on physical properties such as densities and 
melting points of the complexes generated. 
 
Lastly  the  chapter  will  investigate  the  use  of  solvent-free  method  of  co-crystallisation. 
Solvent-free co-crystallisation has increasingly been of importance for crystal engineers as 
these processes have been found to provide a simple route to the preparation of new materials 
and new polymorphic and solvate forms.    102 
Fig. 4.1 – The main hydrogen bonds in the salicylic 
acid structure 
4.1   Introduction – Hydroxybenzoic Acids 
 
Hydroxybenzoic acids are very important chemicals in many areas of industry, for example, 
2-hydroxybenzoic  acid  is  the  main  starting  material  for  the  preparation  of  aspirin  (2-
acetoxybenzoic acid; acetylsalicylic acid).  However, they are also widely used in crystal 
engineering studies due their ability to form predictable synthons and presence of multiple 
hydrogen  bonding  sites,  reflected  in  the  large  number  of  hydroxybenzoic  acid  molecular 
complexes found in the CSD.  
 
4.1.1  2-Hydroxybenzoic Acid 
 
2-hydroxybenzoic acid, commonly known as salicylic acid, is a naturally occurring organic 
acid named after the Latin for willow tree, salix. Salicylic acid has many uses, most of which 
are medicinal in nature. For example it is well known for reducing aches, pains and fevers. It 
is also a raw material in the production of various drugs including, rubefacent (ache relief), 
keratolytic
5 (treatment to remove warts) and non-steroidal anti-inflammatory drugs. 
 
The most recent study of its structure (Figure 4.1) was carried out in 2006 by P. Munshi
6 
(CSD ref SALIAC16). 
The main motif is, as might be expected, 
a carboxylic acid dimer reinforced by a 
hydroxyl  –  carbonyl  intramolecular 
hydrogen  bond.  There  are  a  host  of 
molecular complexes involving salicylic 
acid and its de-protonated form with co-
molecules in the CSD, within which there is roughly a 4:3 ratio in favour of the protonated 
form.  Salicylic  acid  has  also  been  used  to  form  coordination  complexes  with  a  range  of 
metals, including a series of lanthanide metals, such as cerium, praseodymium, gadolinium 
and terbium. Of particular interest amongst the molecular complexes that are not deprotonated 
are those with co-molecules 3,5-dimethyl-1H-pyrazole
7 (CSD ref‘ ODOHEV)  and 9H-purin-
6-amine
8 (CSD reference MUBRUD) which both contain an available basic nitrogen that 
might be expected to encourage de-protonation of the salicylic acid.(Figure 4.2).   103 
 
   
Fig.  4.2  –  LHS  –  The  main  supramolecular  synthons  in  the  bis(2-hydroxybenzoic  acid)  3,5-dimethyl-1H-
pyrazole molecular complex, RHS, the tris(2-hydroxybenzoic acid) 9H-purin-6-amine molecular complex which 
contains two moderate hydrogen bonds between the co-molecules.  
 
Of the deprotonated molecular complexes of salicylic acid (2-hydroxybenzoate) with another 
small organic molecule, the atom that is protonated on the second component is always a 
basic nitrogen. For example the 2-hydrobenzoate 2-amino-pyridine
9 molecular complex (CSD 
reference  SLCADB)  and  adeninium  2-hydroxybenzoate  methanol
10  (CSD  reference 
LOLDIA) shown in Figure 4.3, both show a dimer of hydrogen bonds with proton transfer 
occurring.   
  
     
Fig. 4.3 – LHS  - the  main  supramolecular  synthon between  salicylic acid and 2-amino-pyridine,  RHS, the 
adeninium 2-hydroxybenzoate methanol molecular complex. 
 
4.1.2  3-Hydroxybenzoic Acid 
 
3-hydroxybenzoic is mostly used in the agrochemical sector, for example it is an ingredient in 
the  production  of  the  synthetic  soy  bean  herbicide  metsulfuron,  broad-leaved  herbicides 
lactofen and acifluorofen and in the creation of fungicides
11. It has also been used as an 
intermediate in the production of high-grade paints and preservatives
12. 
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3-hydroxybenzoic  acid  has  two  polymorphs;  a  monoclinic  form  (Figure  4.4  LHS)  (CSD 
reference  BIDLOP)  and  an  orthorhombic  form  (Figure  4.4  RHS)  (CSD  reference 
BIDLOP01). These structures have two distinct hydrogen bonding motifs: the monoclinic 
form has the predictable carboxylic acid dimer with weaker hydrogen bonds between the 
hydroxyl group holding these dimers together. The orthorhombic form, on the other hand, is 
constructed of linear chains with the carboxylic acid groups hydrogen bonding to hydroxyl 
groups from two different molecules. 
 
      
Fig. 4.4 – LHS, the monoclinic form of 3-hydroxybenzoic acid exhibiting the carboxylic acid dimer motif; RHS, 
the linear chains of the orthorhombic form of 3-hydroxybenzoic acid, the full compliment of protons was not 
published with the structure. 
 
3-hydroxybenzoic acid  has been successfully cocrystallised with a  range of small organic 
molecules  including  nicotinamide  (Figure  5.5)  (CSD  reference  XAQQIQ), 
isonicotinamide(CSD reference LUNMEM), quinoxaline (CSD reference HONMEM),  and 
4,4‘bipyridine
13 (CSD reference HONVAI). There are currently only six structures in the CSD 
involving the deprotonated form of 3-hydroxybenzoic acid
14,15. The molecular complex with 
4-aminopyridinium
15 (CSD reference MOYRAU) (Figure 4.5 RHS) has a hydrogen bonded 
ring system, 
4
4 R (18), as the main motif. 
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Fig. 4.5 – LHS, the 4-hydroxybenzoic acid nicotinamide supramolecular synthon.  These hydrogen bond dimers 
are connected through a hydrogen bond between the hydroxyl and the heteroatom in the ring of the nicotinamide; 
RHS, the four molecule hydrogen bonded ring between 3-hydroxybenzoic acid and 4-aminopyridinium. 
 
4.1.3  4-Hydroxybenzoic Acid 
 
4-hydroxybenzoic acid is used in the production of parabens which are a class of chemicals 
that are used as preservatives in cosmetics and drugs. These compounds, and their salts, are 
used  primarily  for  their  bactericidal  and  fungicidal  properties.  They  can  be  found  in 
shampoos, commercial moisturisers, shaving gels, personal lubricants, pharmaceuticals, spray 
tanning solution and toothpaste. 
 
The  structure  of  4-hydroxybenzoic  acid  was  first  determined  in  1992  (CSD  reference 
JOZZIH
17) and has the predictable carboxylic acid dimer as the main motif with the hydroxyl 
groups hydrogen bonding together to generate the expanded structure (Figure 4.6). 
 
 
Fig.  4.6  –  The  carboxylic  acid  dimer  motif  and  hydroxyl  hydrogen  bonds  found  in  the  structure  of  4-
hydroxybenzoic acid. 
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There are a host of molecular complexes where the 4-hydroxybenzoic acid exists in its natural 
and deprotonated  form,  highlighting its  use in  crystal  engineering  and  MOF studies.  The 
natural  form  has  been  cocrystallised  with  many  other  small  organic  molecules,  namely 
nitrogen containing heterocyclic compounds, with the deprotonated form being found with a 
range of co-molecules including metals and organic molecules.  
 
4.1.4  2,4-Dihydroxybenzoic Acid 
 
2,4-dihydroxybenzoic  acid,  also  known  as  β-resorcylic  acid  is  a  starting  material  for  the 
production of dyestuffs, pharmaceuticals, reprographic chemicals, cosmetic preparations, and 
fine  organic  chemicals
18.  The  crystal  structure  was  intensely  studied  within  the  group  in 
2007
19  to  investigate  the  proton  behaviour  within  the  hydrogen  bonds  (CSD  reference 
ZZZEEU01-04). The structure exhibits a 6-membered hydrogen bonded ring system, R
6
6 (36), 
utilising all of the potential hydrogen bonding sites (Figure 4.7).  
 
 
Fig. 4.7 – The ring system of the 2,4-dihydroxybenzoic acid structure. 
 
There are  a few molecular complexes  with  2,4-dihydroxybenzoic acids reported; of most 
interest here is the protonated form with imidazole
20 (CSD reference HEFTUI). This complex 
structure basically consists of a criss-cross pattern, with each 3-dimensional box consisting of 
two of each of the co-molecules (Figure 4.8) 
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Fig. 4.8 – The criss-cross pattern of the imidazolium 2,4-dihydroxybenzoate molecular complex. 
4.1.5  2,6-Dihydroxybenzoic Acid 
 
2,6-dihydroxybenzoic acid, also know as γ-resorcylic acid is used as an antioxidant excipient 
in some pharmaceutical preparations. There are two known polymorphs, a monoclinic form
21 
(Figure 4.9 LHS) (CSD reference LEZJAB01) and an orthorhombic form
22 (Figure 4.9 RHS) 
(CSD reference LEZJAB). The monoclinic form exhibits the carboxylic acid dimer motif with 
the  intramolecular  hydrogen  bonds  contributing  to  this  to  the  distinct  dimer.  In  the 
orthorhombic form, a greater variety of hydrogen bonds is present, creating an interlinked 
structure. There are no molecular complexes of any form containing 2,6-dihydroxybenzoic 
acid in the CSD. 
 
Fig. 4.9 – LHS monoclinic form of 2,6-dihydroxybenzoic acid showing its carboxylic acid dimer motif, RHS 
orthorhombic forms of 2,6-dihydroxybenzoic acid showing a more linear pattern with single hydrogen bonds 
between molecules.   108 
4.1.6  3,4-Dihydroxybenzoic Acid 
 
3,4-dihydroxybenzoic acid, also known as protocatechuic acid, is used as a anticancer agent. 
It  has  mixed  effects  on  normal  and  cancer  cells  in  in  vitro  and  in  vivo  studies
23.  3,4-
dihydroxybenzoic acid has been reported to induce apoptosis of human leukemia cells, as well 
as malignant HSG1 cells taken from human oral cavities, but found to have mixed effects on 
TPA-induced mouse skin tumours
24,25. Depending on the amount of 3,4-dihydroxybenzoic 
acid and the time before application, it can have the effect of reducing or enhancing tumour 
growth
26. Only the structure of the hydrate form is reported (CSD reference BIJDON03)
27 and 
3,4-dihydroxybenzoic  acid  is  also  reported  within  a  cadmium  complex
28  (CSD  reference 
RUMDAE).  
 
4.1.7  3,5-Dihydroxybenzoic Acid 
 
3,5-dihydroxybenzoic acid, also known as ʱ-resorcylic acid, is used as an intermediate for the 
synthesis  of  many  pharmaceuticals  and  in  synthetic  resins.  The  crystal  structure  of  3,5-
dihydroxybenzoic  acid  has  yet  to  be  reported,  however  it  is  known  to  form  molecular 
complexes with other small organic molecules including BZN
29 (CSD reference XAZMIV). 
This molecular complex forms in a 1:1 ratio; the reported structure determination is at room 
temperature.  The  main  motif  in  this  structure  is  a  hydrogen  bonded  ring  system  R
4
4 (22) 
(Figure 4.10). Proton transfer has occurred with the carboxylic acid group losing a hydrogen 
to the initially non-protonated nitrogen on the benzimidazole.  
 
 
Fig.  4.10  –  The  structure  of  benzimidazole  and  3,5-dihydroxybenzoic  acid  with  its  hydrogen  bonded  ring 
system. 
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4.2   Summary of Molecular Complexes Produced 
 
Co-crystallisation experiments have produced an array of molecular complexes of BZN with 
mono-hydroxybenzoic  acids,  polymorphic  forms  of  starting  materials,  and  one  di-
hydroxybenzoic acid molecular complex.  
 
The BZN and mono-substituted benzoic acids crystal structures have been analysed primarily 
using single crystal X-ray diffraction due to the facile precipitation of single crystals. Single 
crystal neutron diffraction data collected on the VIVALDI instrument at the ILL facility in 
Grenoble, France were also obtained for a range of these complexes.  The aim of the neutron 
experiments was to allow accurate location of the hydrogen atoms and investigation of the 
extended hydrogen bonded networks and proton transfer effects present in these systems. 
 
The hydroxybenzoic acid : benzimidazole molecular complexes exhibited an increased level 
of complexity, with the potential to adopt different ratios of co-molecules to BZN. The BZN 
molecule is an efficient hydrogen atom abstractor from carboxylic acid groups, however the 
presence of an additional hydrogen bond donor in the form of a hydroxyl group, introduces 
competition  for  hydrogen  bonding  with  the  carboxylate  group.  The  complexes  found  are 
summarised in Table 4.1, illustrating the diverse range of molecular complexes obtained. 
 
Benzimidazole  1:1 - ratio  1:2 - ratio  2:1 - ratio 
2-hydroxybenzoic Acid       
3-hydroxybenzoic Acid      Two Polymorphs 
4-hydroxybenzoic Acid       
Table 4.1 – Summary of the molecular complexes successfully generated (blue) between benzimidazole and 
mono-substituted hydroxybenzoic acids.  Grey indicates where no molecular complex has been identified from 
single crystal X-ray diffraction. 
 
The main aim of this work was to engineer molecular complexes with predictable hydrogen 
bonded  units  using  knowledge  of  previously  obtained  motifs.    The  mono-substituted 
hydroxybenzoic acids co-crystallisation experiments gave a diverse library of such motifs and 
attempts were made to make molecular complexes with a range of di- substituted benzoic 
acids,  in  attempts  to  explore  the  robustness  of  the  motifs  found.  However,  in  these   110 
experiments only 3, 5-dihydroxybenzoic acid successfully generated crystals of a molecular 
complex (Table 4.2). 
 
  2,4-diOH-BA  2,6-diOH-BA  3,4-diOH-BA  3,5-diOH-BA 
Benzimidazole         
Table  4.2  –  Summary  of  the  results  from  the  co-crystallisation  experiments  between  benzimidazole  and  a 
selection of dihydroxybenzoic acids. Blue indicates where a new molecular complex has been found from single 
crystal X-ray diffraction data, grey indicates where there has been none. 
 
As a further level of complexity, it is clear that even using the most apparently predictable 
motifs,  structural  diversity  is  frequently  found;  also  reported  here  are  the  formation  of 
polymorphs of the molecular complex of benzimidazole and 3-hydroxybenzoic acid, induced 
by solvent effects.  
 
Experiments involving solvent free co-crystallisations were successful in verifying the ability 
of this relatively new technique to produce known forms, and in addition highlighted potential 
new molecular complexes. This method led to two new structurally determined molecular 
complexes: benzimidazolium 5-chloro-2-hydroxybenzoate and benzimidazolium aspartate.  
 
4.2.1  Benzimidazolium – Proton Transfer 
 
In cases where the crystallisation product is in a 1:1 stoichiometric ratio of benzimidazole and 
a carboxylic acid  containing molecule, the benzimidazole is protonated through hydrogen 
transfer from the carboxylic acid group onto the normally unprotonated nitrogen atom in the 
five-membered ring, creating a benzimidazolium molecule (BZNH
+) (Figure 4.11). The result 
of the proton  transfer on the benzimidazolium molecule is  a delocalisation of the charge 
across the five-membered ring, reflected in the equalisation of the internal bond lengths N
ʴ+-C 
and bond angles C-N
ʴ+-C. The delocalisation of the charge has the effect of creating a partial 
positive charge on both nitrogens. This effect has been reported in many structures involving 
BZN and IMD.  
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Fig. 4.11 – LHS, a typical benzimidazolium molecule in which both nitrogens are protonated. RHS, the Fourier 
difference map generated where both the H atoms located on a nitrogen atom has been omitted from the model, 
clearly showing that both nitrogen atoms are protonated.   
 
The consequence for the co-molecule that has been deprotonated is the creation of a negative 
charge, which is delocalised over the carboxylic acid group resulting in equalisation of the C-
O and C=O bond lengths in the carboxylate group. 
 
4.2.2  Potential Hydrogen Bonds and Supramolecular Synthons 
 
Consideration of the co-molecules involved in these sets of results would point to a series of 
possible hydrogen bond patterns and supramolecular synthons that could be generated (Figure 
4.12). All of these hydrogen bond patterns have many examples in the CSD and have been of 
interest in their own right.  
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Fig. 4.12 – Hydrogen bonding patterns that could lead to the  formation of  supramolecular synthons in the 
generation  of  crystal  structures  of  the  molecular  complexes  studied  in  this  chapter.    The  potential  homo-
hydrogen  bonds  (A,  B  and  C)  and  hetero-hydrogen  bonds  (D,  E  and  F)  that  can  be  exhibited  between  a 
benzimidazole and carboxylic acid group. Hydrogen bonds G, H and I are those that could be generated between 
a benzimidazole and hydroxyl group. 
 
The formation of the molecular ion species in many of the molecular complexes reduces the 
potential hydrogen bonds from those depicted in Figure 4.12, for example the homo-hydrogen 
bonds  A,  B  and  C.  Consequentially  it  also  promotes  the  charged  derivatives  of  certain 
hydrogen bonds, namely E, F and G (Figure 4.13). These hydrogen bond patterns utilise the 
charged species in the creation of the hydrogen bonds, which are inherently stronger. There 
are examples of hydrogen bond patterns E, F and G through-out the molecular complexes 
generated in this chapter and Table 4.3 bonds summarises the full hydrogen bond data. 
 
        
Fig. 4.13 – The derivatives of hydrogen bond patterns E, F and G that occur when there has been proton transfer. 
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Molecular Complexes  BZNH
+   
2-HBA
- 
BZNH
+  
3-HBA
- 
BZNH
+  
4-HBA
- 
BZN  BZNH
+ 
3-HBA
- II 
BZN  BZNH
+ 
3-HBA
- I 
BZN BZNH
+  
4-HBA
- hydrate 
BZNH
+    2-
HBA
-  2-HBA 
BZNH
+   
3,5-HBA
- 
Hydrogen Bonds 
N
ʴ+-
H····O
ʴ- 
 E and F 
D∙∙∙A(Å)  2.646(1) 
2.621(1) 
2.700(1) 
2.697(1) 
2.689(3) 
2.717(2) 
2.751(2) 
2.748(2) 
2.644(2) 
2.814(2) 
2.641(2)  2.709(2) 
2.672(1) 
2.700(1) 
D-H(Å)  0.99(2) 
0.99(2) 
0.88(1) 
0.90(1) 
0.91(3) 
0.93(3) 
0.84(3) 
0.94(3) 
0.92(2) 
0.98(2) 
0.96(3)  0.91(3) 
0.91(2) 
0.92(2) 
H∙∙∙A(Å)  1.67(2) 
1.64(2) 
1.82(1) 
1.80(1) 
1.78(3) 
1.79(3) 
1.93(3) 
1.81(3) 
1.68(2) 
1.89(2) 
1.72(3)  1.81(3) 
1.80(2) 
1.79(2) 
D-H∙∙∙A 
angle(º) 
169(2) 
171(2) 
178(1) 
173(1) 
173(3) 
170(3) 
165(3) 
177(2) 
165(2) 
177(2) 
161(2)  173(2) 
161(2) 
167(2) 
O-
H····O
ʴ- 
G 
D∙∙∙A(Å)  -  2.654(1) 
 
2.602(2) 
2.605(2) 
2.660(2)  2.540(1) 
2.565(1) 
2.634(2)  2.605(1)  2.625(1) 
2.640(1) 
D-H(Å)  -  0.87(1)  1.02(3) 
0.94(3) 
0.92(3)  0.97(2) 
1.02(2) 
0.91(3)  0.99(2)  0.92(2) 
0.95(2) 
H∙∙∙A(Å)  -  1.79(1)  1.60(3) 
1.69(3) 
1.74(3)  1.57(2) 
1.55(2) 
1.72(3)  1.62(2)  1.70(2) 
1.69(2) 
D-H∙∙∙A 
angle(º) 
-  172(1)  166(3) 
166(3) 
178(3)  173(2) 
179(2) 
174(3)  174(2)  17792) 
178(2) 
Table. 4.3 – The three scalar quantities and bond angle of the hydrogen bonds of N
ʴ+-H····O
ʴ- and  O-H····O
ʴ- found in the molecular complexes presented in Section 4.5.  114 
4.3   Crystallographic Data 
Compound  BZNH
+  2-HBA
-  BZNH
+ 3-HBA
-  BZNH
+ 4-HBA
- 
Formula  C7 N2 H7, C7 O3 H5  C7 N2 H7, C7 O3 H5  C42 N36 H8  O36 
ΔpKa (1:1)  4.01  2.91  2.42 
Crystallisation 
Conditions 
Methanol,  room 
temperature 
Acetone, 40ºC  Methanol, ~2-4ºC 
Molecular  weight  / 
gmol
-1 
256.26  256.26  748.80 
Temperature (K)  100  100  100 
Space Group  P 21/c  P b c n  P 21/c 
a (Å)  7.2866(1)  19.7452(3)  15.2728(3) 
b (Å)  6.6937(1)  8.6372(1)  12.0727(2) 
c (Å)  25.0118(4)  14.6758(2)  20.6951(3) 
ʱ (
o)  90  90  90 
β (
o)  95.428(1)  90  107.3180(10) 
γ (
o)  90  90  90 
Volume (Å
3)  1214.46(3)  2502.86(6)  3642.86(11) 
Z  4  8  4 
θ range (˚)  1.636-27.740  2.063-27.496  1-27.507 
Completeness (%)  98.5  99.5  99.5 
Refln Collected  42532  63734  53918 
Independent  2801  2852  8314 
Refln 
(obs.I>2sigma(I)) 
2334  2844  6261 
Rint  0.0624  0.0247  0.0607 
Parameters  220  220  657 
GooF on F
2  0.981  1.0031  1.0800 
R1 (Observed)  0.0384  0.0329  0.0607 
R1 (all)  0.0482  0.0358  0.0886 
wR2 (all)  0.1015  0.0847  0.1241 
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Compound  BZN BZNH
+      3-
HBA
-  II 
BZN BZNH
+  3-
HBA
-  I 
BZN BZNH
+  4-
HBA
-  hydrate 
Formula  C21 H18 N4 O3  C21 H18 N4 O3  C21 H20 N4 O4 
ΔpKa (1:1)  2.91  2.91  2.42 
Crystallisation Conditions  Methanol, 2~4ºC  Ethanol, 2~4ºC  Ethanol, 2~4ºC 
Molecular weight / gmol
-1  374.39  747.79  392.41 
Temperature (K)  100  100  110 
Space Group  P 21/c  P 21/c  P 21 
a (Å)  8.0799(7)  13.90550(10)  5.81540(10) 
b (Å)  17.5606(15)  18.7934(2)  15.2726(3) 
c (Å)  13.3960(11)  15.4338(2)  11.0557(2) 
ʱ (
o)  90  90  90 
β (
o)  103.432(4)  114.3120(6)  102.9910(10) 
γ (
o)  90  90  90 
Volume (Å
3)  1848.7(3)  3675.65(7)  956.79(3) 
Z  4  4  2 
θ range (˚)  1.946-28.805    1.448-27.486    1.890-27.211   
Completeness (%)  98.5  99.9  99.6 
Refn Collected  53224  81887  23409 
Independent  4753  8386  2304 
Refln (obs.I>2sigma(I))  4737  4720  2222 
Rint  0.0607  0.089  - 
Parameters  329  645  342 
GooF on F
2  1.1017  0.8340  1.0103 
R1 (Observed)  0.0589  0.0397  0.0259 
R1 (all)  0.0705  0.0979  0.0272 
wR2 (all)  0.1285  0.0941  0.0657  
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BZNH
+  2-HBA  2-
HBA
-  
BZNH
+  3,5-HBA
-   BZNH
+  
 5-CL-2-HBA
- 
benzimidazolium 
aspartate 
C7 N2 H7, C7 O3 H5, 
C7 O3 H6 
C7 N2 H7, C7 O5 H7  C7 N2 H7, C7 O3 Cl H4  C7 N2 H7, C4 O4   H6 
N1  
2.55  1.49    3.54 
Acetone, ~2-4ºC  Methanol/water, 
room temperature 
Methanol, 40ºC  Methanol/water, 
room temperature 
394.38  272.26  290.70  251.24 
100  100  100  100 
P -1  P b c n  P 21/c  P 21 
8.1123(5)  16.2063(14)  11.1639(14)  8.871(5) 
8.6367(5)  10.5665(11)  3.8182(4)  5.076(3) 
14.0347(8)  14.6614(11)  29.310(3)  12.324(7) 
98.618(3)  90  90  90 
104.238(3)  90  97.238(4)  103.221(7) 
99.515(3)  90  90  90 
921.15(10)  2510.7(4)  1239.4(2)  540.2(5) 
2  8  4  2 
1.528- 32.381  3.050-27.479  3.152-27.483  3.206- 27.479 
99.0  99.9  99.6  99.8 
32185  5260  16061  7174 
6529  2885  10142  1380 
5984  2880  7229  1299 
0.054  0.0247  0.0624  0.021 
334  229  225  215 
1.2168  1.0006  1.1056  1.0267 
0.0573  0.0350  0.0391  0.0257 
0.0641  0.0379  0.0599  0.0270 
0.1718  0.0930  0.1237  0.0655 
Table. 4.4 – Crystallographic data for all the molecular complexes within chapter 4 excluding benzimidazolium 
and aspartate. 
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4.4   Structural Descriptions of the Molecular Complexes 
 
4.4.1  Molecular Complex of Benzimidazolium and 2-Hydroxybenzoic Acid 1:1 
 
Previous results indicate that benzimidazole will abstract a proton from the carboxylic acid 
group of the 2-hydroxybenzoic acid. There is a potential for the proton to come from the 
hydroxyl group however, this would be highly unlikely due to the inability of the negative 
charge, which would be generated, to be delocalised over connecting atoms thus forming an 
unstable phenoxide anion. Therefore the formation of a benzimidazolium 2-hydroxybenzoate 
salt can be predicted. In terms of the predicted hydrogen bond scheme, if the molecular ratio 
is 1:1 then this rules out the possible hydrogen bonds of types A, B, C, D and H.  
 
With the formation of the benzimidazolium ion, there would then be competition for the 
primary hydrogen bond from this molecule between hydrogen bond types E, F and I (Figure 
12). There are examples of all of these in the literature, however hydrogen bond E is much 
more prolific. There is also likely to be competition from the homo-hydrogen bonds, mainly 
A and B, as the carboxylic acid dimer is a very robust and dependable motif.  
 
With the hydroxyl group in the 2-position, it is most likely, as in its natural structure, to 
hydrogen bond to the double bonded oxygen on the carboxylic acid group. There will be 
potential for it to be involved in weak hydrogen bonds with a motif similar to that seen in 
hydrogen bond I. 
 
There are many competing factors, however it would be reasonable to predict the formation of 
the charged species with the main hydrogen bonds being of forms E, F, G or I. 
 
Structure Description 
 
The molecular ions, BZNH
+ and 2-hydroxybenzoate (2-HBA
-) form a 1:1 molecular complex, 
or salt.  The molecular complex was obtained using the solvent evaporation method, with a 
1:1  stoichiometric  mixture  of  BZN  (12mg)  and  2-hydroxybenzoic  acid  (2-HBA)  (14mg) 
dissolved in the minimum amount of methanol followed by evaporation at room temperature.   118 
Fig. 4.14 – The BZNH
+ and 2-HBA
-) ions which 
are generated in the molecular complex/salt, with 
atom labelling.  
The crystals generated were cubic shaped and colourless. Single crystal X-ray diffraction data 
were obtained using a  Bruker-Nonius Kappa CCD diffractometer at 100K, equipped with 
graphite monochromated Mo K ʱ radiation (λ = 0.71073 Å). The structure was solved using 
SIR92
30 within the CRYSTALS
31 program.  The crystallographic data are summarised in 
Table 4.4 with the interactions involved in the molecular complexed outlined in Table 4.5. 
 
In the molecular complex, the BZN molecule is 
protonated through hydrogen transfer from the 
carboxylic  acid  group  on  the  2-HBA,  as 
described  in  section  4.2.1  (Figure  4.14).  The 
result is that the internal bond lengths are now 
normalised, to N1
ʴ+-C1 1.325(3)Å and N2
ʴ+-C1 
1.326(3)  Å,  and  bond  angles  to  C1-N1
ʴ+-C2 
108.05(19)º and C1-N2
ʴ+-C7 108.31(18)º.   
 
 
The 2-HBA molecule in its native crystal structure (Section 4.1.1) is configured such that 
there is an intramolecular hydrogen bond between the hydroxyl and carboxylic acid groups. 
Within  the  molecular  complex  with  BZNH
+  this  intramolecular  hydrogen  bond  persists 
despite the proton transfer of a hydrogen atom to the benzimidazole.  The intramolecular 
hydrogen bond is shorter than found in the native crystal structure with an O···O distance of 
2.551(3)Å (c.f. O···O distance of 2.6191(3)Å). This is due to the intramolecular hydrogen 
bond being charged assisted, a result of the deprotonation of the 2-HBA and is similar to that 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O3···O2  2.551(3)  0.93(2)  1.69(2)  153(―) 
N1···O2  2.622(1)  0.99(2)  1.64(2)  171(2) 
N2···O2  2.646(1)  0.99(2)  1.67(2)  169(2) 
C1····O1  3.092(1)  0.97(1)  2.15(1)  164(1) 
C13····O3  3.296(1)  0.97(2)  2.62(1)  125(1) 
C5····π  3.676  -  -  - 
Table  4.5  –  The  inter-  and  intramolecular  interactions  with  distances  found  in  the  BZNH
+and  2-HBA
- 
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found in other 2-HBA
- molecular complexes reported in the CSD. The negative charge is 
found to be delocalised over the carboxylic acid group indicated by the normalisation of the 
bond lengths in the carboxyl group, C8- O1
ʴ- 1.264(1)Å and C8- O2
ʴ- 1.273(1)Å.  
 
The supramolecular synthon in the benzimidazolium 2-hydroxybenzoate molecular complex 
is constructed through partially charge assisted N
ʴ+-H····O
ʴ- hydrogen bonds between both the 
nitrogens of the BZNH
+ and oxygens of the carboxylic acid group, a derivative of hydrogen 
bond motif E (Figure 12). These are of moderate strength, the distances being 2.622(1)Å (a) 
and 2.649(1)Å (b) (see Table 4.3 for full details), and arrange themselves into a four molecule 
hydrogen bonded ring consisting of alternating co-molecules that can be described by the 
graph set notation symbol 
4
4 R (16). This hydrogen bonded ring system is the main motif of 
the system and contains two of each co-molecule (Figure 4.15).  
 
 
Fig. 4.15 – The main motif of the benzimidazolium 2-hydroxybenzoate molecular complex; a four molecule 
hydrogen bonded ring consisting of alternating co-molecules held together by partially charge assisted  N
ʴ+-
H····O
ʴ- hydrogen bonds. The inset shows the view along the bc-diagonal axis that highlights the geometric 
positions of the hydrogen bonded ring system. 
 
There  are  three  interactions  that  connect  the  hydrogen  bonded  rings  together.  The  most 
influential is a weak hydrogen bond from a carboxylate oxygen to the carbon sandwiched 
between the nitrogens on the benzimidazole. The C1-H····O1
ʴ- hydrogen bond is 3.092(1)Å in 
length and connects the hydrogen bonded rings as seen in Figure 4.16.   
a 
a 
b 
b   120 
 
Fig. 4.16 – LHS, the weak hydrogen bonds (-) that extend the hydrogen bonded rings, RHS displays how the 
rings arrange themselves into a stacking configuration due to the C1-H····O1
ʴ- hydrogen bond. 
 
The hydroxyl  oxygen is  only involved in  one intermolecular interaction, which is  with  a 
methine group on another 2-HBA
- molecule. This weak hydrogen bond of length 3.296(1)Å 
expands the hydrogen bonded ring along the –ac diagonal (Figure 4.17).  
 
 
Fig.  4.17  –  The  hydrogen  bonded  ring  system;  the  main  motif  of  the  benzimidazolium  2-hydroxybenzate 
molecular complex, is extended by weak hydrogen bonds (circled in red).  
 
The last interaction that extends the hydrogen bonded ring system is a set of C-H····π contacts 
that extends the structure along the ac-diagonal. These contacts have a length of 3.676 Å 
from C5 to a centroid between C13 and C14 (Figure 4.18). 
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Fig. 4.18 – View highlighting the C-H····π interactions that extends the structure along the ac-diagonal. 
 
These  three  interactions,  the  C1-H····O1
ʴ-  and  C13-H····O3 
hydrogen bonds and C-H····π contacts, expand the main motif of 
the structure, the hydrogen bonded ring 
4
4 R (16), into the extended 
structure. There are other interactions in the molecular complex, 
however these complement the interactions that have already been 
mentioned. For example there are π····π stacking contacts between 
BZNH
+ molecules  which are in  the  same hydrogen bonded ring 
system. These contacts have a relatively short distance for π····π 
stacking (3.179 Å) and in all probability are a consequence of the 
hydrogen bonded ring system (Figure 4.19).  
 
 
Fig. 4.19 – View of the 
interactions  that  exist 
between the molecules 
in main motif.    122 
4.4.2  Molecular Complex of Benzimidazole and 3-Hydroxybenzoic Acid 1:1 
 
From the benzimidazolium 2-hydroxybenozate structure it can be seen that the hydrogen bond 
E is the most prominent in the molecular complex. Initial consideration of the benzimidazole 
and 3-hydroxybenzoic acid structure would suggest this could also be the same.  Firstly it can 
safely  be  assumed  there  will  be  proton  transfer  creating  the  charge  species  of  the  co-
molecules. 
 
When the hydroxyl group is in the meta position, there is a greater potential for this group to 
be  involved  in  a  primary  hydrogen  bond  that  influences  the  structure.  This  increases  the 
potential for hydrogen bond patterns G, H and I to be the more prominent in comparison to 
the benzimidazole and 2-hydroxybenzoic acid structure (Extract from Fig 4.11). Of these, 
hydrogen bond H would not be feasible due to the proton transfer and hydrogen bond G 
would be inherently stronger than I due to the strength of the hydrogen bond acceptor. 
 
 
Extract  from  Fig  4.11  –  Potential  hydrogen  bond  patterns  involving  the  hydroxyl  group  on  the  3-
hydroxybenzoic acid. G shows the potential hydrogen bond between the hydroxyl and carboxyl groups, H shows 
the potential hydrogen bond between the nitrogen lone pair and the hydrogen on the hydroxyl group and I shows 
the potential hydrogen bond between the oxygen lone pair and the hydrogen on the hydroxyl group. 
 
For this  potential molecular complex, there are two competing hydrogen bonds  that may 
prevail. Hydrogen bond E, as seen in the BZNH
+ 2-HBA
- molecular complex, could again 
create hydrogen bonded rings, whereas if hydrogen bond G is the primary bond, this could 
potentially create chains of 3-hydroxybenzoic acid molecules.  
 
Structure Description 
A 1:1 molecular complex containing the molecular ions, BZNH
+ and 3-hydroxybenzoate (3-
HBA
-) was obtained using the solvent evaporation method, with a 1:1 stoichiometric mixture 
of  BZN  (12mg)  and  3-hydroxybenzoic  acid  (3-HBA)  (14mg)  dissolved  in  the  minimum 
amount of acetone followed by evaporation at 10ºC using an Asynt hotplate . The crystals   123 
generated  were  block  shaped  and  colourless.    Single  crystal  X-ray  diffraction  data  were 
obtained using a Bruker-Nonius Kappa CCD diffractometer at 100K, equipped with graphite 
monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using SIR92
30 
within the CRYSTALS
31 program.  The crystallographic data are summarised in Table 4.4 
with the interactions involved in the molecular complexed outlined in Table 4.6 
 
As described in Section 4.2.1, the BZN molecule is protonated through hydrogen transfer 
from the carboxylic acid group on the 3-HBA molecule (Figure 4.20). This is reflected in the 
equalisation  of  the  internal  bond 
lengths,  N1
ʴ+-C1  1.3298(14)(3)Å 
and N2
 ʴ+-C1 1.3255(14)Å, and bond 
angles,  C1-N1
ʴ+-C2  108.55(9)º  and 
C1-N2
ʴ+-C7  108.50(9)º.  The 
negative charge on the deprotonated 
3-HBA  molecule  is  found  to  be 
delocalised over the carboxylic acid 
group, indicated by the normalisation 
of the bond lengths in the carboxyl 
group,  C8-O1
ʴ-  1.2702(12)Å  and 
C8- O2
ʴ- 1.2603(12)Å.  
 
 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O3···O1  2.645(1)  0.87(1)  1.79(1)  172(1) 
N1···O1  2.697(1)  0.90(1)  1.80(1)  173(1) 
N2···O2  2.700(1)  0.88(1)  1.82(1)  173(1) 
C1····O2  3.091(1)  0.93(1)  2.21(1)  157(1) 
C5····O3  3.298(1)  0.95(1)  2.60(1)  131(1) 
C3····π  3.501  -  -  - 
Table 4.6 – The inter- and intramolecular interactions with distances found in the BZNH
+and 2-HBA
- 
molecular complex 
Fig. 4.20 – The benzimidazolium and 3-hydroxybenzoate ions 
which  are  generated  in  the  molecular  complex,  with  atom 
labelling.    124 
There  are  two  primary  hydrogen  bonds  in  the  benzimidazolium  3-hydroxy-benzoate 
molecular complex. Both are similar in length and both play a pivotal role in the structure. 
They are slight modifications of hydrogen bond patterns F and G (from Figure 12) due to the 
introduction  of  the  charged  species.  Hydrogen  bond  G,  which  corresponds  to  the  O3-
H····O1
ʴ- hydrogen bond, is 2.6544(15)Å in length (see Table 4.3 for full details) and creates 
long chains of 3-HBA
- molecules along the c-axis. The mean planes of alternate 3-HBA
- 
molecules lie at angles of 104.4º to each other and always hydrogen bond through the O1 
atom of the carboxylic acid group (Figure 4.21). 
 
 
 
Fig. 4.21 – The 3-hydroxybenzoate molecules create chains with the mean planes of alternate molecules tilted at 
104.4º from each other.   
 
The derivative of hydrogen bond pattern F comprises two distinct N1
ʴ+-H····O1
ʴ- and N2
ʴ+-
H····O2
ʴ- hydrogen bonds with lengths 2.6996(15)Å and 2.6972(15)Å, respectively (refer to 
Table 4.3 for full details). These moderate hydrogen bonds have the role of holding the chains 
of 3-HBA
- to one another which extends the structure along the b-axis (Figure 4.22).  
 
 
Fig. 4.22 – The 3-hydroxybenzoate molecules chains which are held together through a hydroxyl-carboxylate 
hydrogen bond are bridged together by hydrogen bonding through a benzimidazolium molecule.  The inset   125 
shows the view along the c-axis, indicating that the benzimidazolium molecules sit on two distinct positions due 
to the twisting nature of the 3-hydroxybenzoate chains. 
 
While the two main hydrogen bonds, G which creates the chains of 3-HBA
- molecules and F 
which uses the BZNH
+ as a bridge between the chains, create a sheet along the bc face, it is 
the  role  of  weaker  interactions  that  extend  the  structure  along  the  a-axis.  The  a-axis  is 
configured in  a layered type network, with  the weaker interactions  filling the  gaps  in  an 
alternating arrangement.   
 
One of the layers uses a weak hydrogen bond that links the carbon sandwich between the two 
nitrogens  of the  BZNH
+ and an oxygen of the  carboxylate  group, C1-H···· O2
ʴ-,    that is 
3.0913(15)Å  in  length  (Figure  4.23  LHS).  The  other  layer  uses  a  weak  hydrogen  bond 
between  the  hydroxyl  oxygen  and  a  carbon  from  BZNH
+,  C5-H····O3
ʴ-  with  length 
3.2985(15)Å and a C-H····π interaction of around 3.501Å (Figure 4.23 RHS). 
 
 
Fig.  4.23  –  LHS,  The  alternating  layers  that  exist  on  the  a-face  of  the  benzidazoline  3-hydroxybenzoate 
molecular  complex  are  connected  through  a  weak  hydrogen  bond  on  each  alternate  layer  (red).  RHS,  the 
alternate layer is held together by a weak hydrogen bond (yellow circle) and C-H····π interactions (red circle). 
 
The extended structure of the BZNH
+ 3-HBA
- molecular complex can be seen in Figure 4.24. 
The supramolecular synthon, comprising 3-HBA
- chains, is easily indentified in both images 
with the chains arranging into a zigzag formation (note there are no interactions between the 
chains, all interactions are through BZNH
+ molecules). All the BZNH
+ molecules lie in the 
channels of the chains like a ladder with around 3.598Å separating each molecule (seen in 
Figure 4.24 RHS). They sit in four different geometric positions, all ―facing‖ outwards into a 
box shape, with the benzene part overlapping in the middle (seen in Figure 4.24 LHS).   
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Fig. 4.24 – LHS, view along the c-axis highlighting how the benzimidazolium molecules form into channels. 
RHS, view along the b-axis that shows the 3-hydroxybenzoate chains. 
 
4.4.3  Molecular Complex of Benzimidazole and 4-Hydroxybenzoic Acid 2:1 
 
After the discovery of the BZNH
+ 3-HBA
- molecular complex, it was predicted that the co-
crystallisation of BZN and 4-HBA would be as successful. As ever proton transfer would be 
inevitable and with the hydroxyl group moving to the 4-position, hydrogen bonding through 
this  group  would  be  readily  available.  A  structure  very  similar  to  the  BZNH
+  3-HBA
- 
molecular complex would be predicted with an extension between the BZNH
+ molecules most 
likely due to the increase in distance between 4-hydroxybenzoate molecules a result of the 
positioning of the hydroxyl group.  
 
Structure description 
 
The molecular ions, BZNH
+ and 4-hydroxybenzoate (4-HBA
-) form a 2:1 molecular complex. 
The  molecular  complex  was  obtained  using  the  solvent  evaporation  method,  with  a  1:1 
stoichiometric  mixture  of  BZN  (6.8mg)  and  4-hydroxybenzoic  acid  (4-HBA)  (8.8mg) 
dissolved in the minimum amount of methanol followed by evaporation at ~2-4ºC in the 
walk-in cold room. The crystals generated were block shaped and colourless.  Single crystal 
X-ray  diffraction  data  were  obtained  using  a  Rigaku  R-axis/RAPID  image  plate 
diffractometer  at  100K,  equipped  with  graphite  monochromated  Mo  Kʱ  radiation  (λ  = 
0.71073 Å). The structure was solved using SUPERFLIP
32 within the CRYSTALS
31 program.  
The crystallographic data are summarised in Table 4.4.  
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As  in  Section  4.2.1,  BZNH
+  molecules  are  generated  through  proton  transfer  from  the 
carboxylic acid group on the 4-HBA molecule onto the normally unprotonated nitrogen atom 
on the BZN molecules. However the stoichiometric ratio in this case is two BZNH
+ molecules 
to every one 4-HBA
-, therefore it would be chemically impossible for all nitrogen atoms to be 
fully protonated if only the carboxylic group is de-protonated, which is the case. The result is 
that four of the nitrogens are bonded to partially occupied hydrogens, i.e. a proton is shared 
between  BZN  molecules  (Figure  4.25).  In  one  case  the  two  half  protons  are  bonded  to 
nitrogens N6 and N7 that are hydrogen bonded to themselves (N6…H (50%)…N6‘; N7…H 
(50%)…N7‘) through an inversion centre, this accounts for one proton. The other proton is 
split in the hydrogen bond between the nitrogens N2 and N3. This proton is best resolved to a 
occupancy level of 0.4:0.6 in favour of nitrogen N2 (Figure 4.26). The result of the proton 
transfer  on  the  BZNH
+  molecules,  even  though  they  are  only  partially  protonated,  is  a 
delocalisation of the charge across the five-membered ring, reflected in the equalisation of the 
internal bond lengths and angle (Table 4.7). It was first thought that the nitrogens bonded to 
the partially occupied protons would be those that have been protonated, however this is 
unjustifiable for two reasons; firstly all the internal bond lengths and angles are normalised 
and secondly the partially protonated nitrogens are all hydrogen bonded to other partially 
protonated nitrogens therefore initially one of these nitrogens would have been unprotonated 
but which one cannot be identified.   
 
 
Fig. 4.25 – The different benzimidazolium molecules. From, left to right, molecules 1 and 2 hydrogen bond to 
one  another  over  a  glide  plane,  molecule  3  hydrogen  bonds  to  itself  through  a  inversion  centre  along  the 
N6····N6 contact,  molecule  4 also hydrogen bonds to itself due to an inversion centre along  the N7····N7 
contact. In every case a proton is split over two sites.   128 
 
 
        
Fig. 4.26 – MCE
33 Fourier difference maps of the residual electron density. LHS, when the hydrogen split 
between nitrogen N2 and N3 is removed, RHS, when the hydrogen is removed from the N6 nitrogen (the same 
50:50 split proton image is seen when the proton bonded to N7 is removed).
 
 
  Molecule 1  Molecule 2  Molecule 3  Molecule 4 
N-C (Å)  N1-C1 1.346(3)  N3-C2 1.327(3)  N5-C3 1.339(3)  N7-C4 1.323(3) 
C-N (Å)   C1-N2 1.323(3)  C2-N4 1.341(3)  C3-N6 1.322(3)  C4-N8 1.344(3) 
C-N-C (º)  N1 107.17(19)  N3 106.6(2)  N5 107.23(19)  N7 106.8(2) 
C-N-C (º)  N2 106.0(2)  N4 107.83(19)  N6 106.45(19)  N8 107.8(2) 
Table  4.7  –  Bond  length  and  bond  angle  data  for  the  four  different  benzimidazolium  molecules  from  the 
benzimidazolium 4-hydroxybenzate molecular complex. 
 
The 4-HBA
- molecules have a simpler role in this molecular complex. There are two distinct 
4-HBA
- molecules in the structure, with the extent of the twisting of the carboxylate group 
their distinguishing feature. As explained the carboxylic acid group has been deprotonated 
which creates a negative charge that is delocalised over the carboxylate group, as seen by the 
normalisation of the bond lengths in the carboxyl group (Figure 4.28, Table 4.6). 
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Fig. 4.27 – The two 4-hydroxybenzoate molecules 
found  in  the  molecular  complex,  with  associated 
atom labelling. 
Table 4.8 – Bond lengths and degree of twisting of 
the carboxylate group from the plane of the phenyl 
ring,  for  the  4-hydroxybenzoate  molecules  in  the 
benzimidazolium  4-hydroxybenzate  molecular 
complex. 
 
The main motif of the BZNH
+ 4HBA
 molecular complex is, as expected, very similar to that 
in BZNH
+ 3HBA.  These are two main differences which have a profound effect on the 
extended structure. The primary hydrogen bond is a derivative of pattern G (Figure 4.12) 
which  corresponds  to  the  hydroxyl  carboxylate  hydrogen  bond.    There  are  two  of  these 
hydrogen  bonds,  the  main  hydrogen  bonds  in  the  molecular  complex  with  lengths 
O3H····O2
ʴ- 2.605(3)Å and O6H····O4
ʴ- 2.602(3)Å (refer to Table 4.3 for full details).   
Molecule  1  2 
C-O(Å)  C5-O1 
1.253 (3) 
C12-O4 
1.271(3) 
C-O(Å)  C5-O1 
1.271(3) 
C12-O5 
1.258(2) 
Twisting (º)  3.13  23.06 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O3···O2  2.605(3)  1.02(3)  1.60(3)  166(3) 
O6···O4  2.602(3)  0.94(3)  1.69(3)  166(3) 
N2···N3  2.675(3)  1.01(6)  1.67(6)  173(6) 
N6···N6  2.682(3)  0.82(4)  1.86(4)  178(5) 
N8···O4  2.717(2)  0.93(3)  1.79(3)  170(3) 
N4···O1  2.695(2)  0.95(3)  1.78(3)  163(3) 
N1···O5  2.689(3)  0.91(3)  1.78(3)  173(3) 
Table 4.9 – The inter- and intramolecular interactions with distances found in the BZNH
+and 4-HBA
- 
molecular complex   130 
They link to create chains of 4-HBA
- molecules along the a-axis and the mean planes of 
alternating molecules lie at an angle of 29.96º to one another (Figure 4.28). By comparison 
the  chains  created  in  the  BZNH
+  3HBA
-  molecular  complex  have  longer  lengths 
(2.6544(15)Å) and lie to a greater degree of interplanar angle to one another (104.4 º) (Figure 
4.21). 
 
 
Fig.  4.28  –  The  4-hydroxybenzoate  molecules  create  chains  with  the  molecules  alternately  sitting  on  two 
positions.   
 
The derivative of pattern F, which is the N
ʴ+-H····O
ʴ- and N
ʴ+-H····O
ʴ- hydrogen bonds have 
lengths ranging from 2.689Å to 2.717Å (refer to Table 4.9 for details). These three moderate 
strength hydrogen bonds have the role of holding the chains of 4-HBA
- to one another, exactly 
the same as in the BZNH
+ 3HBA
- molecular complex. However, there are two differences, of 
which  one  might  be  expected  whereas  the  other  adds  complexities  to  the  structure.  The 
expected difference is in with the introduction of the extra BZNH
+, which has led to the 
molecular  complex  adopting  hydrogen  bond  C  (Figure  4.12),  N
ʴ+-H  ····H-  N
ʴ+.    These 
BZNH
+ dimers have lengths of N2
ʴ+-H ····H- N3
ʴ+ 2.675(3) Å, N6
ʴ+-H ····H- N6
ʴ+ 2.682(3) 
Å and N7
ʴ+-H ····H- N7
ʴ+ 2.737(3) Å which compares favourably to the N-H···N distance of 
2.884Å found in the BZN structure (CSD ref – BZDMAZ04)
34. Secondary, it is not simply 
the case that two chains of 4HBA
- are held together by the BZNH
+ dimers creating sheets. 
Instead, in this structure each chain is connected to four other chains through the dimers 
(Figure 4.29  LHS). Moving through the chain, each alternate 4-HBA
-  molecule hydrogen 
bonds  in  opposite  directions  thus  every  other  4HBA
-  molecule  is  involved  in  one  ladder 
structure  (Figure  29  RHS).    This  creates  a  criss-cross  pattern  for  the  extended  structure 
(Figure  29  bottom).  There  are  a  host  of  weaker  interactions  in  this  molecular  complex, 
however none are thought to be significant enough to influence the structure.    131 
 
 
 
Fig. 4.29 – LHS, view along the a-axis highlighting how each 4-HBA
 chain is involved in hydrogen bond in 
four different directions. RHS, view along the b-axis indicating the connections between each chain. bottom –
view along the c-axis of the BZNH
+ 4HBA
 molecular complex with the backbone of the structure, the 4HBA
 
chains, being held together by the BZNH
+ dimers that criss-cross between them. 
 
 
Effect of Stoichiometric ratio 
 
The BZNH
+ 4HBA
- molecular complex always adopts a 2:1 stoichiometric ratio no matter the 
ratio of the initial starting materials used: 1:1, 2:1 or 1:2. The use of excess 4-hydroxybenzoic 
acid results in a hydrate of the 4-HBA starting material, the BZNH
+ 4HBA
- 2:1 complex and   132 
in some cases the BZNH
+ 4HBA
- hydrate molecular complex being formed. Experiments 
using these ratios were also set-up for both 2-HBA and 3-HBA. As can be seen from Table 
1.1,  successful  molecular  complexes  were  generated  for  both  2-HBA  and  3-HBA.  The 
experiments between BZN and 3-HBA in a 2:1 ratio generated two polymorphs which differ 
in many aspects including the bonding motifs. 
 
4.4.4  Molecular complex of Benzimidazole 3-Hydroxybenzoic acid 2:1 Form II 
 
The trends in the other related structures indicates that this structure will adopt a structure 
similar to BZNH
+ 4HBA
- molecular complex which has supramolecular synthons of chains of 
4HBA
- using the hydrogen bond pattern G. These chains are connected to BZNH
+ by partially 
charge  assisted  hydrogen  bonds  of  form  F.  Further,  homo-hydrogen  bond  C  might  be 
expected to connect the two BZNH
+ molecules into dimers.  
 
Structure Description 
 
The molecular ions, BZNH
+ and 3-hydroxybenzoate (3-HBA
-) form a 2:1 molecular complex 
with  one  another.    The  molecular  complex  was  obtained  using  the  solvent  evaporation 
method, with a 2:1 stoichiometric mixture of BZN (24 mg) and 3-hydroxybenzoic acid (3-
HBA) (16 mg) dissolved in the minimum amount of methanol followed by evaporation at ~2-
4ºC using the walk in cold room. The crystals generated were block shaped and colourless.  
Single crystal X-ray diffraction data were obtained using a Bruker ApexII diffractometer at 
100K,  equipped  with  graphite  monochromated  Mo  Kʱ  radiation  (λ  =  0.71073  Å).  The 
structure  was  solved  using  SUPERFLIP
32  within  the  CRYSTALS
30  program.    The 
crystallographic data are summarised in Table 4.4.  
 
In this molecular complex, the BZN molecules are protonated forming BZNH
+ molecules as 
described in section 4.2.1. However the stoichiometric ratio is two BZNH
+ molecules to one 
3-HBA
-, the result is two of the nitrogens are bonded to partially occupied hydrogens, i.e. a 
proton is shared between BZN molecules (Figure 4.30). The proton is split in the hydrogen 
bond between the nitrogens N2 and N4 with the best model (lowest concluding R-factor) 
having occupancy levels of 0.55:0.45 in favour of  nitrogen N2 (Figure 4.31). The result of 
the proton transfer on the BZNH
+ molecules, even though they are only partially protonated,   133 
is a delocalisation of the charge across the five-membered ring, reflected in the equalisation of 
the internal bond lengths and angle (Table 4.10). As in the previous molecular complex it was 
first thought that the nitrogens bonded to the partially occupied protons would be those that 
have been protonated, however this is unjustifiable for two reasons; firstly all the internal 
bond lengths and angles are normalised and secondly the partially protonated nitrogens are all 
hydrogen  bonded  to  other  partially  protonated  nitrogens  therefore  initially  one  of  these 
nitrogens would have been unprotonated but which one cannot be identified.  
 
   
Fig. 4.30 – The different benzimidazolium molecules: from, left to right, molecules 1 and 2 that hydrogen bond 
to one another  with the relevant atoms labelled, and the 4-hydroxybenzoate  molecule  with associated atom 
labelling. 
 
              
Fig.  4.31  –  MCE
33  Fourier  difference  maps  of  the  residual  electron  density  when  the  hydrogen  split  over 
nitrogen N2 and N4 is removed.  
 
  Molecule 1    Molecule 2   
Bond Lengths (Å)  N3-C4 
N4-C4 
1.342(2) 
1.322(2) 
N2-C1 
N1-C1 
1.320(2) 
1.341(3) 
Bond Angle (º)  C5-N3-C4 
C6-N3-C4 
107.63(16) 
106.79(16) 
C2-N1-C1 
C3-N2-C1 
107.55(16) 
106.00(16)   134 
Table  4.10 –  Bond  length  and  bond  angle  data  for  the  two  different  benzimidazolium  molecules  from  the 
benzimidazolium 3-hydroxybenzoate molecular complex. 
 
The 3HBA
 molecule has been deprotonated with a proton from the carboxylic acid group 
transferring to the BZN, leading to a negative charge that is delocalised over the carboxylate 
group, C7-O1 1.269(2)Å  and C7-O2 1.256(2)Å.  
 
 The main motif of the BZNH
+ 3HBA
 2:1 molecular complex is, as expected, a hybrid of the 
BZNH
+ 3HBA
 1:1 and BZNH
+ 4HBA
 2:1 molecular complexes. It is expected because it 
might be predicted that the extra BZN molecule would behave as in the BZNH
+ 4HBA
 2:1 
structure, forming a BZNH
+ dimer. The supramolecular synthons will thus be identical to the 
BZNH
+ 3HBA
 1:1 structure and a ladder type molecular complex would be formed.  
 
The main hydrogen bond is a derivative of synthon G (Figure 4.12) which corresponds to the 
hydroxyl  carboxylate  hydrogen  bond.    This  hydrogen  bond,  O3-H····O2,  is  2.660(3)Å  in 
length and forms chains along the c-axis (refer to Table 4.3 for full details) as seen in Figure 
4.32. The molecules all lie on the same plane with the carboxylate group slightly twisting out 
of the plane by ~16º. The close planarity of the molecules in the chain in this case is in 
contrast to the chains created in the BZNH
+ 3HBA
- 1:1 molecular complex, which lie at a 
greater angle to one another (104.4 º) (Figure 4.21). 
 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N2···N4  2.676(3)  0.88(5)/0.94(5)  1.75(5)/1.80(5)  175(5)/171(5) 
O3···O2  2.660(3)  0.92(3)  1.74(3)  178(3) 
N1···O1  2.751(3)  0.84(3)  1.93(3)  165(3) 
N3···O1  2.748(3)  0.94(3)  1.81(3)  177(2) 
O3···C  3.446(3)  0.95(2)  2.50(2)  174(2) 
O2···C4  3.420(3)  0.97(2)  2.51(2)  156(2) 
O2···C1  3.338(3)  0.95(2)  2.42(2)  161(2) 
Table 4.11 – The inter- and intramolecular interactions with distances found in the BZNH
+ 3HBA
 2:1 
molecular complex.   135 
 
Fig. 4.32 – The 3-hydroxybenzoate  molecules create  close-to-planar chains  through a hydroxyl carboxylate 
hydrogen bond.  
 
The derivative of hydrogen bond pattern F corresponds to the hydrogen bonds N1
ʴ+-H····O1
ʴ- 
and N3
ʴ+-H····O1
ʴ-, which have lengths 2.751(3)Å and 2.748(3)Å respectively (refer to Table 
3.11 for all the interactions within the molecular complex). These moderate hydrogen bonds 
have the role of holding the chains of 3-HBA
- to one another, exactly the same as in the 
BZNH
+ 3HBA
- 1:1 molecular complex, but are longer in length by ~0.05Å. As expected, the 
introduction of the extra BZNH
+ has led to the molecular complex adopting hydrogen bond 
pattern C (Figure 4.12), N
ʴ+-H····H- N
ʴ+.  This BZNH
+ dimer has hydrogen bond length N2
ʴ+-
H····H- N4
ʴ+ 2.676Å which is identical to the dimers found in the BZNH
+ 4HBA
- molecular 
complex ( 2.675(3) Å and
 2.682(3) Å) (Figure 4.33 RHS). 
 
 
Fig.  4.33  –  LHS,  the  3-hydroxybenzoate  molecules  chains  which  are  held  together  through  a  hydroxyl-
carboxylate hydrogen are bridged together by hydrogen bonding through a benzimidazolium dimer. RHS, the 
view along the a-axis indicating the planar nature of the chains and highlighting the role of the BZNH
+ dimer.   
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The 3-HBA
 chains run along the a-axis, the dimers joins this motif to the next one creating 
ladders.  These  ladders  are  further  extended  along  bc-face  as  every  3-HBA
  molecule 
hydrogen bonds to two different BZN
+ dimers (Figure 4.34).  
 
 
Fig. 4.34 – The 3-hydroxybenzoate molecules hydrogen bond along the bc-face which creates a  sheet along the 
a-axis view along the a-axis indicating the planar nature of the chains and highlighting the role of the BZNH
+ 
dimer.   
 
This  structure  contains  three  weak  hydrogen  bonds  that  cooperate  together  to  extend  the 
packing along the c-axis (Figure 4.35). One is a hydrogen bond involving the oxygen of the 
hydroxyl group and a carbon from a 3HBA
 molecule, C-H····O3, that has length 3.446(3)Å 
and has been circled in red in Figure 4.35. The other two are C-H····O
ʴ- weak hydrogen bonds 
involving the carbons sandwiched between the nitrogens on the BZNH
+ and the oxygen of the 
carboxylate  that  is  involved  in  the  chain  motif,  O2.  They  have  lengths  C4-H····  O2
ʴ- 
3.420(3)Å and C1-H···· O2
ʴ-  3.338(3)Å and are circled in yellow and green.   137 
 
Fig. 4.35 – The weak interactions that are used to extend the structure along the c-axis, C-H····O3 (red), C4-
H···· O2
ʴ-(yellow) and C4-H···· O2
ʴ- (green).  
 
4.4.5  Molecular Complex of Benzimidazole 3-Hydroxybenzoic Acid 2:1  Form I 
 
The serendipitous discovery of a polymorph of benzimidazolium 3-hydroxybenzate was due 
to poor data collected from samples of the initial molecular complex. This meant that further 
unit cells scans were carried out, resulting in three different unit cells being discovered in 
crystals of benzimidazole and 3-hydroxybenzoic acid in a 2:1 mixture. However only the two 
discussed were reproducible as single crystals, with polymorph II forming greater quality 
crystals than Form I. Form II was discussed in Section 4.5.4 above, Form I is discussed here. 
 
Structure description 
 
The molecular ions, BZNH
+ and 3-hydroxybenzoate (3-HBA
-) form a 2:1 molecular complex, 
shown by unit cell screening to be a different polymorph from that discussed above (Form II).  
The  molecular  complex  was  obtained  using  the  solvent  evaporation  method,  with  a  2:1 
stoichiometric  mixture  of  BZN  (6.8mg)  and  3-hydroxybenzoic  acid  (3-HBA)  (8.8mg) 
dissolved in the minimum amount of ethanol followed by evaporation at ~2-4ºC using a walk 
in cold room. The crystals generated were block shaped and colourless.  Single crystal X-ray 
diffraction data were obtained using a Bruker ApexII diffractometer at 100K, equipped with 
graphite monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using   138 
SUPERFLIP
32 within the CRYSTALS
31 program.  The crystallographic data are summarised 
in Table 4.4.  
 
In this molecular complex, half of the BZN molecules are protonated as described in section 
4.2.1, forming BZNH
+ molecules. Since there are four BZN molecules in the reduced unit 
cell, the result is that two of the BZNs have been protonated while two remain unprotonated. 
The result of the proton transfer on the BZNH
+ molecules, is a delocalisation of the charge 
across  the  five-membered  ring,  reflected  in  the  equalisation  of  the  internal  bond  lengths, 
1.332(2)Å and 1.326(2)Å and angles 108.0(1)º and 108.0(1)º (Figure 4.36 LHS). The BZN 
molecules  where  no  protonation  has  occurred  retains  distinct  single  and  double  bond 
characteristics with bond lengths 1.312(2)Å and 1.334(2)Å and bond angles 104.7(1)º and 
106.8(1)º. The other BZN and BZNH
+ molecules in the unit cell have bond angles and lengths 
within the error range of the measurements given above. 
  
Fig. 4.36 – LHS, the BZN and BZNH
+ molecules form dimers, through a single hydrogen bond.  There are two 
of these dimers in the reduced unit cell. RHS, the 3-HBA
 molecules also form single hydrogen bonded dimers.  
 
The two distinct 3HBA
 molecules within the unit cell have both been deprotonated with a 
proton  from  each  carboxylic  acid  group  transferring  to  two  of  the  BZN  molecules.  The 
consequence is the normalisation of the bond lengths in the carboxyl group, 1.265(2)Å  and 
1.246(2)Å (Figure 4.36 RHS). The bond lengths of the other 3-HBA
 molecules within the 
unit cell are within the errors of measurements and are consistent with the geometry found in 
the Form II polymorph. 
  
The main motif of the BZNH
+ 3HBA
 2:1 Form I molecular complex is the same as the 
BZNH
+ 3HBA
 2:1 Form II molecular complex. The primary hydrogen bond is a derivative of 
synthon G (Figure 4.12) which corresponds to the hydroxyl carboxylate hydrogen bond.  This   139 
hydrogen bond, O-H····O, is 2.540(1)Å in length and forms chains along the ac-diagonal 
axis(see Table 4.3 for full details). The planes of the benzene rings of the molecules in the 
chain  tilt  with  respect  to  one  another  by  19.1º  (Figure  4.37).  However  the  twist  of  the 
carboxylate group plane and the benzene ring is 15.7º for both molecules in Form I. For 
comparison, the chains created in the BZNH
+ 3HBA
 2:1 Form II molecular complex have 
hydrogen bond lengths of 2.660(3)Å and lie on the same plane, with the carboxylate group 
slightly twisting out of the ring plane by ~15.9º (Figure 4.32).  
 
 
Fig. 4.37 – The 3-hydroxybenzoate molecules create chains through a hydroxyl carboxylate hydrogen bond.  
These chains are then held together, as in the other polymorph, by BZN dimers using the 
derivative of hydrogen bond F. Contrary to the Form II polymorph however, the chains are 
also  linked  using  hydrogen  bond  pattern  I.  The  hydrogen  bonds  involved  correspond  to 
N
ʴ+H····O
ʴ-(carboxylate  oxygen;  a)
  and  N
ʴ+H····O(hydroxyl  oxygen;  b)  (Figure  4.38). 
These hydrogen  bonds  have lengths  of 2.632(2)Å (a),  and 2.913(2)Å (b) and can clearly 
distinguish the charged assisted hydrogen bonds which are shorter than those involving the 
hydroxyl group (refer to Table 4.3 for full details). It is also worth noting the hydrogen bond 
lengths of the Form II polymorph, which are two N
ʴ+H····O
ʴ-(carboxylate oxygen) hydrogen 
bonds of length 2.751(3)Å and 2.748(3)Å respectively, sitting close to the middle of the range 
of the hydrogen bonds in Form I.  
 
The BZN - BZNH
+ dimers adopt a derivative of hydrogen bond C (Figure 4.12), N
ʴ+H ····N.  
These  have  lengths  of  2.710(2)Å  and  2.709(2)Å  which  is  slightly  longer  than  found  in 
polymorph Form II with length 2.676(3)Å.  
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Fig. 4.38 – The 3-hydroxybenzoate molecules chains which are held together through a hydroxyl-carboxylate 
hydrogen bond are bridged together by four distinct hydrogen bonds of two types, a and  b.   
 
There are marked differences between the ladder motifs of Forms I & II, with Form II having 
stiles of 3-hydroxybenzoate molecules and consecutive rungs of hydrogen bonded dimers of 
BZNH
+. While Form I, on the other hand, has alternate rungs of hydrogen bonded dimers 
(Figure 4.39). 
   
Fig. 4.39 – LHS, Form II, The ladder structure consists of stiles of 3-hydroxybenzoate molecules and rungs of 
hydrogen bonded dimers of BZNH
+. RHS, Form I, The ladder structure consists of stiles of 3-hydroxybenzoate 
molecules and alternate rungs of hydrogen bonded dimers of BZNH
+.   
 
a 
b 
a 
b   141 
The ladder description can be extended, to reveal a ―double‖ step, due to the hydroxyl along 
with the carboxylate group assisting in the hydrogen bonding (Figure 4.40). This double step 
occurs as one chain of 3-HBA
- molecules is involved in two ladders, as in the BZNH
+ 4-HBA
- 
structure. This expands the structure indefinitely along the ac-diagonal. Advancing through 
the chains, each alternate 4-HBA
- has hydrogen bonding connections in the shape of a Z, 
while the other has the inverse shape  (Figure 4.41).  
 
 
Fig. 4.40 – The ladder structure consists of uprightsa of 3-hydroxybenzoate molecules and the double rungs of 
hydrogen bonded dimers of BZNH
+.   
 
 
Fig.  4.41  –  The  3-hydroxybenzoate  molecules  are  involved  in  two  ladders  by  hydrogen  bonding  in  two 
directions adopting a Z and inverse Z shape (indicated by the red lines).    
 
The  structure  also  contains  various  weaker  interactions,  three  of  which  assist  in  forming 
sheets of 3-HBA
- molecules along the a-axis. Firstly the 3-HBA
- molecules hydrogen bond to 
one another via C-H∙∙∙O
ʴ- and C-H∙∙∙O
 hydrogen bonds of lengths 3.240(2)Å and 3.433(2)Å, 
respectively (Figure 4.42 LHS). These are linear in geometry and arrange themselves into a 
hydrogen bonded ring. The BZNH
+ (not the unprotonated form) also assist in the creation of   142 
the sheets by bonding to two different 3-HBA
- molecules that are adjacent to one another 
(Figure 4.42 LHS). This involves hydrogen bonds to one 3-HBA
- through the predictable N
ʴ+-
H····O
ʴ- synthon, then a further hydrogen bond to an adjacent 3-HBA
- molecule.  These are 
already hydrogen bonding via the weak hydrogen bonds mentioned above, with a C-H∙∙∙O
ʴ- 
interaction  involving  the  carbon  sandwiched  between  the  two  nitrogens  and  deprotonated 
oxygen (Figure 4.42 RHS). This weak hydrogen bond has a length of 3.186(2)Å. Another 
hydrogen bond, also involving the BZNH
+, is made from a carbon to the hydroxyl oxygen on 
the 3-HBA
- (Figure 4.42 RHS). This C-H∙∙∙O hydrogen bond has length 3.429(2)Å and again 
assists in creating the sheets of 3-HBA
- molecules 
 
 
Fig. 4.42 –LHS, view along the b-axis highlighting the creation of sheets of 3-HBA
 molecules through weak C-
H∙∙∙O
ʴ- (red) and C-H∙∙∙O (green) hydrogen bonds along the a-axis. The blue interactions represent the moderate 
hydrogen bonds that make up the chains of 3-HBA
 molecules. RHS, the weak hydrogen bonds in which the 
BZNH
+  ions are involved – one C-H∙∙∙O
ʴ- (yellow) and one C-H∙∙∙O (yellow and circled). 
 
There are other interactions in the structure of the benzimidazolium 3-hydroxybenzate 2:1 
polymorph Form I, however they only assist the major interactions that have already been 
mentioned. The extended structure can be seen in Figure 4.43, with the  3-HBA
 molecules 
creating  chains,  these  chains  connected  together  along  the  b-axis  via  the  BZN-BZNH
+ 
molecules with the weaker interactions extending the structure along the a-axis.   
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Fig. 4.43 – view along the a-axis of the extended benzimidazolium 3-hydroxybenzate 2:1 polymorph Form I 
molecular complex. 
 
4.4.6  Molecular  Complex  of  Benzimidazole  and  4-Hydroxybenzoic  Acid  2:1 
Hydrate  
 
The crystallisation attempts on benzimidazole and 4-hydroxybenzoic acid also resulted in a 
hydrate of the 2:1 molecular complex being formed. The crystal was obtained from ethanol at 
~2-4ºC and were flat plates in shape and colourless. Single crystal X-ray diffraction data were 
obtained using a Bruker-Nonius Kappa CCD diffractometer at 110K, equipped with graphite 
monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using SIR92
30 
within the CRYSTALS
31 program. The crystallographic data are summarised in Table 4.4. 
 
The  introduction  of  a  water  molecule  brings  a  large  number  of  possible  supramolecular 
synthons which are shown in Figure 4.44. However there are only a couple of designs that 
would use every possible interaction site.   
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Fig. 4.44  Schematic diagram highlighting the possible hydrogen bonds that could be generated between the 
water molecule and the other starting materials and their charged species.  
 
In this molecular complex BZNH
+ molecules are formed through proton transfer from the 
carboxylic acid group on the 4-HBA molecule onto the normally unprotonated nitrogen atom. 
However with the stoichiometric ratio being two BZN molecules to every one 4-HBA, it 
would be chemically impossible for all nitrogen atoms  to be fully protonated if only the 
carboxylic  group  is  deprotonated,  which  is  the  case.  Thus  one  BZN  molecule  is  left 
unprotonated. The result of the proton transfer on the BZNH
+ molecule, is a delocalisation of 
the charge across the five-membered ring, reflected in the equalisation of the internal bond 
lengths  and  angles  (Table  4.12).  The  BZN  molecule  where  no  protonation  has  occurred 
retains distinct single and double bond character (Figure 4.45). The intra- and intermolecular 
interactions are listed in Table 4.13. 
 
Fig. 4.45  The BZNH
+, BZN, 4-HBA
 and water molecule that are involved in the BZN BZNH
+ 4-HBA
 
hydrate, with atom labelling.    145 
 
Table. 4.12 – Bond length and bond angle data for the BZNH
+ and BZN molecules involved in the BZN BZNH
+ 
4-HBA
- hydrate molecular complex. 
 
 
Table 4.13 – The inter- and intramolecular interactions with distances found in the BZNH
+ 3HBA
 2:1 molecular 
complex. 
 
The 4HBA
- molecule has been deprotonated with a proton from the carboxylic acid group 
transferring to the BZN. This deprotonation leads to a negative charge that is delocalised over 
the carboxylate group, as seen by the normalisation of the bond lengths in the carboxyl group, 
C16-01 1.262(2)Å and C16-O2 1.258(2)Å.  
 
 
Figure 4.46 shows how the water molecule positions itself between two linear chains of 4-
HBA
 and the BZN. It results in every possible hydrogen bond interaction site of the water 
molecule being utilised. All  these hydrogen bonds  are of moderate strength: O4H∙∙∙O1
ʴ- 
2.765(2)Å,  O4H∙∙∙O2
ʴ-  2.805(2)Å  and  N4
ʴ+H∙∙∙O4  2.719(2)Å  (Figure  4.46  LHS).  The 
water molecule does not significantly disturb the main motifs compared with those found in to 
  BZNH
+    BZN   
Bond Lengths (Å)  N1-C1 
N2-C2 
1.331(2) 
1.328(2) 
N3-C8 
N4-C8 
1.321(2) 
1.347(3) 
Bond Angle (º)  C2-N1-C1 
C7-N2-C1 
108.0(0) 
106.7(1) 
C14-N3-C8 
C9-N4-C8 
104.7(1) 
107.0(2) 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O4···O1  2.765(2)  0.92(3)  1.86(3)  168(3) 
O4···O2  2.805(2)  0.86(2)  1.96(3)  168(3) 
N4···O4  2.719(2)  0.88(3)  1.84(2)  172(2) 
N1···O2  2.641(2)  0.96(3)  1.72(3)  161(2) 
N2···N3  2.702(2)  0.99(3)  1.71(3)  176(3) 
O3···O2  2.635(2)  0.91(3)  1.72(3)  174(3) 
C1···π  3.350  -  -  - 
O8···π  3.323  -  -  -   146 
the non-hydrated form; there are still linear chains of 4-HBA
 held together by dimers of 
BZN. There is also minimal difference between the calculated densities with 1.362 g.cm
3 for 
the hydrate and 1.365 g.cm
3 for the non-hydrate. However the introduction of the water 
molecule has resulted in two key differences: one is that the rungs of the ladder now have a 
zig-zag formation (Figure 4.46 RHS) and it expands the structure in two directions, while the 
packing in the third direction is through the chains of 4-HBA
.  
 
    
Fig. 4.46 – LHS, highlighting the hydrogen bonds in which the water molecule is involved.  RHS, view along 
the c-axis highlighting the zigzag nature of the rungs (BZN BZNH
+).  
 
The  hydrogen  bond  connecting  the  BZN  and  BZNH
+  molecules  has  a  distance  of 
N2
ʴ+H∙∙∙N3, 2.702(2)Å which is similar to that found in the non-hydrated form.  As seen in 
the other structures the hydrogen involved in the hydrogen bond shows signs of elongation 
(Figure 4.47). 
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Fig. 4.47 – LHS, Fourier difference map in 2D and, RHS, Fourier difference map in 3D showing the possible 
elongation of the hydrogen atom involved in the hydrogen bond. 
 
The 4-HBA
 chains form via hydroxyl – carboxylate O3H∙∙∙O2
ʴ- hydrogen bonds of length 
2.635(2)Å (refer to Table 4.3 for full details). They are slightly longer than the same hydrogen 
bond in the non-hydrated structure (2.603(3)Å) and form with a greater degree of staggered 
geometry (Figure 4.48).  
   
Fig. 4.48 – LHS, the staggered chains of 4-HBA
- that are held together by the stiles of BZN and BZNH
+ in the 
2:1 hydrate.  Note that another BZN and BZNH
+ group is present, oriented diagonally between the two that are   148 
shown, RHS, view along the b-axis of the BZN BZNH
+ 4-HBA
- molecular complex showing the main motifs for 
comparison.  
 
This structure contains various weaker interactions however none are significant and only 
assist the stronger hydrogen bonds. For example there are  C-H∙∙∙π interactions between a 
carbon of the benzimidazole and the benzene ring of the benzoic acids (Figure 4.49) with 
distances ranging from approximately 3.323 Å (purple boxes) to 3.560Å and 3.771Å (yellow 
boxes).  However as can be seen, these molecules are also connected through hydrogen bonds 
via the water molecule.  
 
 
Fig. 4.49  The short contacts that exist between the molecules in the BZN BZNH
+ 4-HBA
 hydrate molecular 
complex. Highlighted are the areas that show the CH---π interactions. 
 
As expressed, the water molecule expands the structure in two directions, one with the aid of 
the BZN BZN
+ group to connect two chains of 4-HBA
- molecules and in the other direction 
by hydrogen bonding to two 4-HBA
- molecules from two separate chains.  The chains expand 
the structure in the third dimension. Figure 4.50 is an extended image of the structure which 
highlights the main interactions.   149 
   
Fig. 4.50  view along the a-axis of the BZN BZNH
+ 4-HBA
- hydrate. The chains of 4-HBA
- molecules expand 
the structure along the b-axis (red line). The BZN BZNH
+ group holds two chains together via hydrogen bonding 
to a water molecule in one side and through
 hydrogen bond pattern F in the other direction (blue line).   
 
4.4.7  Molecular Complex of Benzimidazole 2-Hydroxybenzoate 1:2 
 
Molecular  ions,  BZNH
+  and  2-hydroxybenzoate(2-HBA
-)  and  molecule  2-hydroxybenzoic 
acid (2-HBA) form a 1:1:1 molecular complex with one another.  The molecular complex was 
obtained using the solvent evaporation method, with a 1:2 stoichiometric mixture of BZN 
(12mg) and 2-hydroxybenzoic acid (2-HBA) (28mg) dissolved in the minimum amount of 
acetone followed by  evaporation at  2~4ºC.  The crystals  generated were plate shaped and 
colourless.  Single crystal X-ray diffraction data were obtained using a Bruker ApexII CCD 
diffractometer  at  100K,  equipped  with  graphite  monochromated  Mo  Kʱ  radiation  (λ  = 
0.71073 Å). The structure was solved using SIR92
30 within the CRYSTALS
31 program.  The 
crystallographic data are summarised in Table 4.4. A BZNH
+ molecule is created through 
proton  transfer  as  discussed  in  Section  4.2.1  (Figure  4.51).  The  charge  on  the  BZNH
+   150 
molecule is delocalised across the five-membered ring, reflected in the equalisation of the 
internal bond lengths, N1
 ʴ+-C1 1.325(2)Å and N2
 ʴ+-C1 1.325(2) Å, and bond angles, C1-
N1
ʴ+-C2 108.5(1)º and C1-N2
ʴ+-C7 108.2(1)º.   
 
Fig. 4.51 – The BZNH
+ 2-HBA
- and 2-HBA molecules which are generated in the molecular complex with atom 
labelling.  
Table. 4.14 – The inter- and intramolecular interactions found within the BZNH
+ 2-HBA
- 2-HBA molecular 
complex 
 
The 2-HBA molecule in its native crystal structure (refer to Section 4.1.1) is configured such 
that  there  is  an  intramolecular  hydrogen  bond  between  the  hydroxyl  and  carboxylic  acid 
groups.  Within  the  molecular  complex  with  BZNH
+  this  intramolecular  hydrogen  bond 
persists in both 2-HBA
- and 2-HBA despite the proton transfer of a hydrogen atom to the 
benzimidazole.  The intramolecular hydrogen bond is shorter in the 2-HBA
- than the 2-HBA, 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O6···O5  2.624(2)  0.88(2)  1.83(3)  150(3) 
O3···O2  2.555(2)  0.92(3)  1.69(3)  155(3) 
O4···O1  2.605(1)  0.99(2)  1.62(2)  1.74(2) 
N2···O1  2.709(2)  0.91(3)  1.81(3)  173(2) 
N1···O2  2.672(1)  0.91(2)  1.80(2)  161(2) 
C1···O5  3.091(1)  0.94(2)  2.21(2)  157(2) 
C10···π  3.780(2)  -  -  - 
C13···π  3.541(2)  -  -  - 
C13···O6  3.642(2)  0.98(3)  2.66(3)  175(2) 
C20···O3  3.562(2)  1.00(3)  2.57(3)  171(2)   151 
as would be expected due to the carboxylate group containing a negative charge creating a 
charged  assisted  hydrogen  bond.  Table  4.15  highlights  the  differences  in  these  internal 
hydrogen bonds and bond lengths and compares then with the native 2-HBA molecule and 
that 2-HBA
- found in the BENZH
+ 2-HBA
- 1:1 molecular complex. It can be seen that the 
negative charge is found to be delocalised over the carboxylate group and the resulting effect 
on the intramolecular hydrogen bond is profound in comparison to the protonated form. 
 
  2-HBA  2-HBA (native)  2-HBA
-  2-HBA
- (1:1) 
Internal H-bond (Å)  2.624(2)  2.622Å  2.555(2)  2.551(3) 
Bond Lengths (Å)  1.234(2) 
1.325(2) 
1.2450(3) 
1.3113(3) 
1.274(2) 
1.262(2) 
1.273(1) 
1.264(1) 
Table  4.15  –  Internal  hydrogen  bond  and  C-O  bond  lengths  for  the  2-HBA  (BZNH
+  2-HBA
-  and  2-HBA 
molecular complex), 2-HBA(native crystal structure, 2-HBA(BZNH
+ 2-HBA
- and 2-HBA molecular complex) 
and 2-HBA
- (BZNH
+ 2-HBA
- molecular complex). 
 
The  structure  of  the  BZNH
+  2-HBA
-  2-HBA  molecular  complex  is  more  similar  to  the 
structures of 3-HBA and 4-HBA than to that of the BZNH
+ 2-HBA
- molecular complex. The 
motif is a chain that runs along the b-axis (Figure 4.52). This chain is made up of pairs of 2-
HBA
- and 2-HBA using hydrogen bonds G (Figure 4.12) being held together by BZNH
+ 
molecules using bonds of pattern E. For comparison the BZNH
+ 2-HBA
- molecular complex 
motif is a four molecule hydrogen bonded ring consisting of alternating co-molecules, while 
the 3-HBA and 4-HBA molecular complexes have ladder style structures. The 2-HBA
- and 2-
HBA pairs are connected through a moderate hydrogen bond between the carboxylic acid and 
carboxylate groups, O4-H∙∙∙O1
- with length 2.605(1)Å. They are two distinct type E hydrogen 
bonds, both are N
ʴ+-H····O
ʴ- interactions however the oxygens involved differ. The N2
ʴ+-
H····O1
ʴ- hydrogen bond has length 2.709(2)Å and the N1
ʴ+-H····O2
ʴ- hydrogen bond has 
length 2.672(1)Å (refer to Table 4.14 for full interactions list).   
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Fig. 4.52 – View along the a-axis of the main motif of the BZNH
+ 2-HBA
- and 2-HBA molecular complex; 
linear chains of 2-HBA
- 2-HBA pairs are held together by BZNH
+ molecules that run along the b-axis.  
 
There are a few weaker interactions that connect the chains together. The most influential is a 
weak  hydrogen  bond  from  a  carboxylic  oxygen  to  the  carbon  sandwiched  between  the 
nitrogens on the benzimidazole. The C1-H····O5
ʴ- hydrogen bond is 3.091(1)Å in length and 
connects  the  chains  as  seen  in  Figure  4.53.  Two  C-H∙∙∙π  interactions  assist  these  weak 
hydrogen  bonds  in  stacking  the  chains  (Figure  4.53  RHS),  these  are  of  length  C10-H∙∙∙π 
3.780(2)Å and C13-H∙∙∙π 3.541(2)Å. 
 
   153 
Fig. 4.53 – LHS, the C1-H····O5
ʴ- weak hydrogen bonds (-) that stack the hydrogen bonded chains upon one 
another with the assist of two C-H∙∙∙π interactions (-)(-).  RHS, view of the a-axis displays how the chains stack 
upon one another (-). 
 
Expanding the chain along the c-axis are C-H∙∙∙O hydrogen bonds involving the hydroxyl 
group from one of the 2-HBA 2-HBA
- molecules and a C-H group of the other (Figure 4.54). 
These are very weak hydrogen bonds with lengths C13-H∙∙∙O6, 3.642(2)Å (a), C20-H∙∙∙O3, 
3.562(2)Å (b) (Figure 4.54 inset). 
 
  
 
 
 
 
 
 
 
Fig. 4.54 – Two chains of the main motif are held by weak C-H∙∙∙O hydrogen bonds which are located inside the 
black box. Inset, a blow-up of the black box highlighting the weak C-H∙∙∙O hydrogen bonds. 
 
4.4.8  Molecular Complex of Benzimidazole 3,5-Dihydroxybenzoic Acid 1:1 
 
The crystal structure of the molecular complex benzimidazolium 3,5-dihydroxybenzoate has 
already  been  published  in  Acta  Crystallographica  Section  E
29,  however  the  experiment 
reported  in  that  work  was  undertaken  at  room  temperature.  As  mentioned  previously, 
experiments with the other di-hydroxybenzoic acids, 2,4-, 2,6- and 3,4- did not produce single 
crystal molecular complexes with benzimidazole or its derivatives. The aim of using the di-
hydroxybenzoic acids was to use the library of motifs and supramolecular synthons that have 
been  created  in  the  study  of  the  other  complexes  presented,  to  understand  the  hydrogen 
bonding patterns that could be found when there are a greater number of potential donor and 
acceptor sites. Unfortunately only the structure of a single example, benzimidazolium 3,5-
dihydroxybenzoate molecular complex, has been obtained.  The structure is discussed here. 
a 
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Fig.  4.55  –  The  benzimidazolium  and  3,5-dihydroxybenzoate  molecules  which  are  generated  in  the 
molecular complex with atom labelling.  
 
 
 
 
 
 
 
Table 4.16 – The inter- and intramolecular interactions seen in the BZNH
+ (3,5-DIHB
- molecular complex 
 
The molecular ions,  BZNH
+ and 3,5-dihydroxybenzoate(3,5-DIHB
-) form a 1:1 molecular 
complex.  This was produced using the solvent evaporation method, with a 1:1 stoichiometric 
mixture of BZN (12mg) and 3,5-dihydroxybenzoic acid (3-HBA) (16mg) dissolved in the 
minimum amount of a methanol/water mixture followed by evaporation at room temperature. 
The crystals generated were cubic shaped and colourless.  Single crystal X-ray diffraction 
data  were  obtained  using  a  a  Rigaku  R-axis/RAPID  image  plate  diffractometer  at  100K, 
equipped with graphite monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was 
solved  using  SIR92
30  within  the  CRYSTALS
31  program.    The  crystallographic  data  are 
summarised  in  Table  4.4.  The  BZNH
+  molecule  is  created  as  discussed  in  Section  4.2.1 
(Figure 4.55). The result of the proton transfer on the BZNH
+ molecule is a delocalisation of 
the charge across the five-membered ring, N1
 ʴ+-C1 1.328(1)Å and N2
 ʴ+-C1 1.328(1)Å, and 
bond angles, C1-N1
ʴ+-C2 108.89(9)º and C1-N2
ʴ+-C7 108.80(9)º.  The negative charge on the 
3,5-DIHB
- molecule is delocalised over the carboxylic acid group, C8- O1
ʴ- 1.250(1) Å and 
C8- O2
ʴ- 1.276(1) Å. 
 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O1···O4  2.640(1)  0.95(2)  1.69(2)  177(2) 
O2···O3  2.625(1)  0.92(2)  1.70(2)  178(2) 
N2···O2  2.700(1)  0.92(2)  1.79(2)  167(2) 
N1···O3  2.893(1)  0.89(2)  2.31(2)  123(1) 
N1···O4  2.813(1)  0.89(2)  1.99(2)  153(1)   155 
The increase in the amount of potential hydrogen bonding sites has  led to an increase in 
complexity of the structure obtained. The extended structure can be described very much like 
the other hydrobenzoic acid molecular complexes, a ladder style structure with uprights of 
3,5-DHBA
 and rungs of BZNH
+  molecules (Figure 4.56). 
 
 
Fig. 4.56 – The extended structure of the BZNH
+ 3,5-DHBA
 molecular complex which consist of chains of  3,5-
DHBA
- molecules which are held together by BZNH
+ molecules.  
 
The uprights of the ladder are created by hydrogen bonded rings of 3,5-DHBA
 molecules, 
described by graph set notation as 
4
4 R (24) (Figure 4.57). There are two moderate hydrogen 
bonds that hold the rings together, O-H∙∙∙O
ʴ- 2.640(1)Å (a) and O-H∙∙∙O
ʴ- 2.625(1)Å (b). Every 
3,5-DHBA
- molecule is  the top,  bottom, left or right  part of each ring (Figure 4.58) and 
expands the structure along the ba diagonal and c dimensions (refer to Table 4.16 for full 
details).    156 
 
Fig. 4.57 – The hydrogen bonded rings that are made up of four 3,5 DHBA
- molecules. 
 
Fig. 4.58 – Two views of the 3,5 DHBA
- hydrogen bonded rings that expand along the  bc diagonal and c 
dimensions. 
 
The BZNH
+ molecules hold the 3,5 DHBA
 chains together through hydrogen bonding to the 
carboxylate group in one direction (Figure 4.59 a) and a bifurcated hydrogen bond to two 
hydroxyl  groups  in  the  other  direction  (Figure  4.59  b).  The  single  hydrogen  bond  is  of 
moderate strength and has a greater degree of charged assistance than the bifurcated hydrogen 
bond,  which  is  also  of  moderate  strength.  The  single  hydrogen  bond  is  of  length 
N2
ʴ+H····O2
ʴ- 2.700(1)Å and the bifurcated hydrogen bonds are N1
ʴ+H····O3 2.893(1)Å 
and N1
ʴ+H····O4 2.813(1)Å. These hydrogen bonds expand the structure along the a-axis. 
a 
a 
b 
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Fig. 4.59 – The hydrogen bonds that the BZNH
+  molecule is involved with in the BZNH
+ 3,5-DHBA
 molecular 
complex, a is a  partially charged assisted N
ʴ+H····O
ʴ- hydrogen bond while b is a bifurcated hydrogen bond of 
two N
ʴ+H····O interactions. 
 
None  of  the  weaker  interactions  within  the  BZNH
+  3,5-DHBA
-  molecular  complex  are 
significant in defining the packing, they all assist the hydrogen bonds that have already been 
mentioned. Figure 4.60 is another extended image of the structure, it clearly shows the zig zag 
chains of 3,5-DHBA
 molecules that extend the structure along the b and c axis, while the 
BZNH
+ molecules hold these zigzag chains together along the a-axis. 
 
a 
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Fig. 4.60 – View along the c-axis of an extended image of the BZNH
+ 3,5-DHBA
 molecular complex. 
 
4.5   Solvent-Free Co-Crystallisations  
As  discussed  in  the  introduction  (Section  1.5)  solvent-free  co-crystallisation  involves  the 
mechanical  grinding  together  of  the  components.  There  are  various  techniques  and 
methodologies that come under the umbrella term of solvent free co-crystallisation, two of 
which were used during this research: solvent-free grinding and solvent drop grinding. Both 
these methods involve the grinding of the co-molecules with a mortar and pestle for roughly 
three minutes, with the  solvent drop grinding method including adding micro-amounts of 
solvent. The product was then stored at room temperature. 
 
As this technique was relatively new with only a limited number of papers published when 
this research was started, the initial aim was to investigate the effectiveness and limits of the 
technique.  Initial  studies  concentrated  on  already  discovered  and  researched  molecular 
complexes, particularly between benzimidazole and halo-benzoic acids.    159 
4.5.1  Feasibility Study 
 
The  initial  experiments  using  solvent  free  co-crystallisations  were  carried  out  to  test  its 
feasibility.  This  was  assessed  on  a  range  of  halo-benzoic  acids  co-crystallised  with 
benzimidazole.  These  had  already  been  studied  using  the  traditional  evaporation 
crystallisation techniques (see Chapter 5) in some detail. A range of experimental conditions 
were studied in the solvent-free attempts, including variations in time of grinding, amount of 
sample used and after storage temperature.   
 
Solvent free grinding experiments were carried out on BZN with co-molecules 3- and 4- 
chlorobenzoic acid, 3- and 4- bromobenzoic acid and 3- and 4- fluorobenzoic acid. Grinding 
was  carried  out  for  three  minutes  then  the  product  stored  for  at  least  24  hours  at  room 
temperature. The analysis of these experiments was by DSC and it was found that the solvent 
free experiments replicated well the solvent evaporation technique (Figure 4.61; see Appendix 
4.A for more evidence). 
 
 
 
Fig. 4.61  DSC thermograms from the product of the co-crystallisation of benzimidazole with 4-chlorobenzoic 
acid crystallised from propanol (-) acetone (-), ethanol (-), methanol (-) and by the solvent free method (-). The 
results indicate that the solvent free method replicates the more traditional evaporation technique.   160 
 
Further studies to test the technique involved varying the grinding time and storage time after 
sample  preparation.  These  experiments  were  carried  out  on  the  benzimidazole  and  3-
chlorobenzoic acid molecular complexes as these were found to have at least two polymorphs 
and a possibly third observed in powder diffraction and DSC data; a multi-phase product such 
as this is obviously more of a challenge and potentially of more interest. Figure 4.62 shows 
the full DSC trace of the products from grinding benzimidazole and 3-chlorobenzoic acid 
together for 30 seconds, 2 minutes and 5 minutes. It can clearly be seem that when longer 
grinding times are used the outcome favours the thermodynamic product (e.g the most stable 
polymorph) and the resulting product is more uniform. It has been found that the molecular 
complexes prepared using solvent free grinding tend to be less crystalline and thus show 
broader peaks in both DSC and X-ray powder diffraction data. 
 
 
 
Fig. 4.62  DSC thermogram from the product of the solvent free co-crystallisation of benzimidazole with 3-
chlorobenzoic acid with grinding times of 30 seconds (-), 2 minutes (-) and 5 minutes (-). The results indicate 
that the thermodynamic product is favoured with increasing grinding time.  
 
The stability of the product of solvent free crystallisations was tested by analysing the product 
regularly over a 6 month period. Figure 4.63 displays the DSC traces of the solvent free 
grinding experiments of benzimidazole and 3-chlorobenzoic acid, for a grinding time of 2 
minutes.  It  was  found  that  the  longer  the  product  was  stored  the  greater  chance  the 
thermodynamic product would prevail, thus highlighting product stability issues. 
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Fig.  4.63    DSC  traces  of  the  product  of  the  solvent  free  co-crystallisation  of  benzimidazole  with  3-
chlorobenzoic acid grinding for 2 minutes and stored for no time (-), 24 hours (-) and 2 weeks (-). The results 
indicate that the thermodynamic product is favoured with increasing storage time.  
 
These  experiments  testing  the  solvent  free  co-crystallisation  technique  underline  that  this 
technique  is  capable  of  producing  molecular  complexes  that  the  traditional  solvent 
evaporation method can produce. It also highlights that this method has the potential to reveal 
rapidly the different phases / polymorphs that the system can produce.  
 
A wider study was then undertaken on a much greater range of co-molecules (Table 4.17). 
From the solvent-free co-crystallisation results it can be seen that there was a potential for 
three new molecular complexes of benzimidazole having been produced, with aspartic acid, 
5-chlorosalicylic acid  and glycine. The tradition solvent  evaporation method  mirrored the 
solvent-free results, by producing two new molecular complexes, benzimidazolium aspartate 
and  benzimidazole  and  5-chlorosalicylic  acid,  that  also  produced  different  polymorphs 
(Figure  4.64).  It  also  concurred  with  the  solvent-free  in  the  negative  results  and  the 
unsuccessful co-crystallisations of benzimidazole and glycine produced an oil (see appendix 
4.B).  
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Co-Molecule  Solvent Free Method  Solvent Evaporation Technique 
   DSC  DSC  Single Crystal 
ascorbic acid  SM  SM  - 
aspartic acid  NP  NP  NP 
Cysteine  SM  SM  - 
glutamic acid  SM  SM  - 
Glycine  NP  Oil produced  - 
Histidine  SM  SM  - 
Guanosine  SM  SM  - 
Thymine  SM  SM  SM 
Creatine  SM  SM  SM 
5-chlorosaliclyic acid  NP  NP  NP 
D-Valine  SM  SM  - 
Isobartituric acid  SM  insoluble  - 
D-alanine  SM  SM  SM 
Cytidine  SM  SM  SM 
Alenine  SM  SM  SM 
Thymidine  SM  SM  - 
Uracil  SM  SM  SM 
Guanine  SM  insoluble  - 
acetlysalicylic acid  SM  SM  - 
 
Table 4.17  Results from solvent-free and solvent evaporation co-crystallisations involving benzimidazole with 
a  range  of  co-molecules.  SM  represents  starting  materials  while  NP  represents  new  product.  Only  co-
crystallisation experiments with aspartic acid and 5-chlorosalicylic acid produced new molecular complexes. 
 
 
 
Fig.  4.64    DSC  patterns  of  starting  materials  benzimidazole  (-),  5-chlorosalicylic  acid  (-)  and  the  co-
crystallisation product of the two (-) formed by the solvent-free method. 
   163 
4.5.2  Molecular Complex of Benzimidazole and 5-Chlorosalicylic Acid 1:1 
 
Guided by the successful solvent free experiments, solvent evaporation experiments were set-
up  on  the  target  systems  using  four  common  solvents,  methanol,  ethanol,  propanol  and 
acetone. From these initial experiments it could be seen from the DSC thermogram of the 
products that there were at least three polymorphs present and that selective growth could be 
achieved for two of them (Figure 4.65) 
 
 
Fig. 4.65  DSC thermogram of the product from co-crystallisation of benzimidazole and 5-chlorosalicylic acid 
at 30ºC in propanol (-), acetone (-), ethanol (-) and methanol (-). Inset,  selective polymorph growth has been 
achieved for two of the co-crystal polymorphs by recrystallisation from methanol (-) Form I and ethanol (-) Form 
III. 
 
Further experiments were then set up to attempt to control the formation of the third possible 
polymorph and to promote the growth of diffraction quality crystals of all forms. Table 4.18 
summarises the results of co-crystallisation experiments at various temperatures and solvents, 
Form I is the most obtainable form followed by Form III, however Form II is only produced 
in conjunction with Form I.  The powder diffraction data, Figure 4.66a, highlights two clear 
Forms (I and III). Single crystal X-ray diffraction quality crystals were only obtained for 
Form I (Figure 4.66b)   164 
 
   Methanol  Ethanol  Propanol  Acetone 
10ºC             
20ºC           
30ºC         
35ºC         
Table. 4.18 – Visual Summary of the products obtained from varying the crystallisation conditions, Form I 
(blue), Form II (red), Form III (yellow)   165 
Fig. 4.66a  Powder patterns of the products of crystallisation from three different environmental conditions to promote growth of single component of; form I (blue) 
using methanol at 10ºC, form I and II mix phase (red) using ethanol at 10ºC and form III (yellow) using ethanol at 30ºC. Two different products can clearly be identified 
from these powder patterns, while form II is mixed with form I.   166 
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Fig. 4.66b  Powder x-ray diffraction pattern of benzimidazole and 5-chloro-2-hydroxybenzoic acid cocrystallised from methanol at 10ºC (blue) 
overlaid with the simulated powder pattern from solved structure solution of form I.  
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Structure Description 
 
The  molecular  ions,  BZNH
+  and  5-chloro-2-hydroxybenzoate  (5-Cl-2HBA
-)  form  a  1:1 
molecular  complex.    The  molecular  complex  was  obtained  using  the  solvent  evaporation 
method, with a 1:1 stoichiometric mixture of  benzimidazole (13mg) and 5-chlorosalicylic 
acid (17.5mg) dissolved in the minimum amount of methanol followed by evaporation at a 
constant temperature of 10ºC using an  Asynt hotplate. The crystals generated were block 
shaped and colourless.  Single crystal X-ray diffraction data were obtained using a Rigaku R-
axis/RAPID diffractometer at 100K, equipped with graphite monochromated Mo Kʱ radiation 
(λ = 0.71073 Å). The structure was solved using SIR92
30 within the CRYSTALS
31 program.  
The  crystallographic  data  are  summarised  in  Table  4.4.  Figure  4.67  shows  the  BZNH
+ 
molecule created as described in Section 4.2.1 As in other examples discussed above, the 
equalisation of the internal bond lengths, N1
 ʴ+-C1 1.328(1)Å and N2
 ʴ+-C1 1.321(2) Å, and 
bond angles, C1-N1
ʴ+-C2 107.99(9)º and C1-N2
ʴ+-C7 108.23(9)º is due to the protonation.  
The intramolecular hydrogen bond in the 5-Cl-2HBA
- molecules is relatively short with an 
O···O distance of 2.559(1)Å which is significantly shorter than the O···O distance of 2.577Å 
that  is  found  in  5-chlorosalicylic  acid  caffeine  molecular  complex
35  (CSD  reference 
CAFSAL). This is due to the intramolecular hydrogen bond being charged assisted, a result of 
the deprotonation of the 5-chlorosalicylic acid in the present case.  
 
 
 
Fig.  4.67  –  The  benzimidazolium  and  5-chloro-2-hydroxybenzoate  molecules  which  are  generated  in  the 
molecular complex with atom labelling.    168 
Table 4.19 – All the interactions that are present in the BZNH
+ 5-Cl-2-HBA
- molecular complex 
 
The main motif in the BZNH
+ 5-Cl-2-HBA
- molecular complex is a four molecule hydrogen 
bonded ring consisting of alternating co-molecules with partially charge assisted N
ʴ+-H····O
ʴ- 
hydrogen bonds, which can be described by the graph set notation symbol 
4
4 R (16) (Figure 
4.68). These moderate strength hydrogen bonds are of length N1
ʴ+-H····O2
ʴ- 2.660(1)Å and 
N2
ʴ+-H····O1
ʴ- 2.663(1)Å(Table 4.19). This hydrogen bonded ring motif is identical to that 
seen in the BZNH
+ 2-HBA
-, it uses the same hydrogen bond pattern E, it has similar lengths 
(2.622(1) Å and 2.649(1) Å) and is described by the same graph set notation. The difference 
between the structures is the results of the effect of the weaker interactions on the packing. 
 
 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O3···O1  2.559(1)  0.89(1)  1.75(2)  150(1) 
N1···O2  2.660(1)  0.89(2)  1.79(2)  165(1) 
N2···O1  2.663(1)  0.92(1)  1.78(1)  162(1) 
C1···O2  3.118(1)  0.92(1)  2.27(1)  153(1) 
C6···O3  3.561(1)  0.92(1)  2.70(1)  156(1) 
C6··C11  3.592(2)  0.92(1)  2.88(1)  135(1) 
Cl1···C5  3.541(1)  -  -  - 
π···π stacking  3.341  -  -  -   169 
Fig. 4.68 – The main motif of the benzimidazolium 5-chloro-2-hydroxybenzoate molecular complex; a  four 
molecule  hydrogen  bonded  ring  consisting  of  alternating  co-molecules  with  partially  charge  assisted  N
ʴ+-
H····O
ʴ- hydrogen bonds.  
 
There are two interactions that have the effect of stacking the rings upon one another creating 
a column of hydrogen bonded rings. This column runs along the b-axis and is held together by 
a  weak  hydrogen  bond  and  π∙∙∙π  stacking  interactions  (Figure  4.69).    The  π∙∙∙π  stacking 
interactions are between the BZNH
+ molecules and of length 3.341(2)Å (between carbons C2 
and C3) (Figure 4.66 black box). The weak hydrogen bond is one that is often seen in the 
molecular complexes involving BZNH
+ molecules, that is a hydrogen bond from the carbon 
sandwiched between the two nitrogens (C1) and a oxygen from the carboxylate group (O2) 
(Figure 66 red box).  This hydrogen bond, C1-H∙∙∙O2
ʴ-, has length of 3.118(1)Å and is the 
shortest of the weaker interactions that influence the packing in the molecular complex.  
 
  
Fig. 4.69 – The main motif of the benzimidazolium 5-chloro-2-hydroxybenzoate molecular complex; the four 
molecule hydrogen bonded ring consisting of alternating co-molecules, are expanding along the b-axis by a weak 
hydrogen  bond  and  π∙∙∙π  stacking  interactions.  Inset  black  box–  An  expanded  image  of  the  π∙∙∙π  stacking 
interactions that connect the hydrogen bonded rings together. Inset red box– An expanded image of the π∙∙∙π 
stacking interactions that connect the hydrogen bonded rings together.   170 
 
Expanding the structure along the a-axis, connecting the hydrogen bonded rings edge to edge, 
are two weak hydrogen bonds that form a bifurcated 
hydrogen bond (Figure 4.70). These weak hydrogen 
bonds  are formed between a  carbon of the  BZNH
+ 
and  the  hydroxyl  oxygen,  C6-H∙∙∙O3,  and  carbon 
(C11)  of  the  5-Cl-2HBA
-,  C6-H∙∙∙C11.  The 
asymmetrical bifurcated hydrogen bond has the major 
component as the C6-H∙∙∙O3 bond which has length 
3.561(1)Å  and  minor  component  C6-H∙∙∙C11  of 
length  3.595(2)Å.  These  weak  hydrogen  bonds 
expand the structure along the a-axis and are the only 
interactions that do so (Figure 4.71). 
 
 
Fig.  4.71  – The  main  motif  of  the  benzimidazolium  5-chloro-2-hydroxybenzoate  molecular  complex;    four 
molecule hydrogen bonded ring consisting of alternating co-molecules, are expanding along the a-axis by two 
weak hydrogen bonds, C-H∙∙∙C and C-H∙∙∙O, that are circled in red. 
 
The hydrogen bonded rings stack upon each other along the b-axis through π∙∙∙π stacking 
interactions and a weak hydrogen bond (Figure 4.69). The a-axis is expanded by bifurcated 
weak hydrogen bonds (Figure 4.70) which leaves the c-axis that is expanded through halogen 
bonds (Figure 4.72). These halogen bonds, Cl1∙∙∙H-C5, are of length 3.541(1)Å and are the 
only interactions that expand the structure along the c-axis. 
 
Fig.  4.70  –  The  two  weak  hydrogen 
bonds,  C-H∙∙∙C  and  C-H∙∙∙O,  which 
expand the structure along the a-axis.    171 
  
Fig.  4.72  –  Halogen  bonds,  Cl∙∙∙HC,  connect  the  main  motif  of  the  benzimidazolium  5-chloro-2-
hydroxybenzoate molecular complex along the c-axis (green circle). 
 
4.5.3  Molecular Complex of Benzimidazole and L-Aspartic Acid 1:1 
 
The molecular ions BZNH
+ and aspartate form a 1:1 molecular complex with one another.  
The  molecular  complex  was  obtained  using  the  solvent  evaporation  method,  with  a  1:1 
stoichiometric mixture of BZN (12mg) and aspartic acid (14mg) dissolved in the minimum 
amount of methanol/water mixture followed by evaporation at room temperature. The crystals 
generated  were  needle  shaped  and  colourless.  Single  crystal  X-ray  diffraction  data  were 
obtained using a Bruker-Nonius Kappa CCD diffractometer at 100K, equipped with graphite 
monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using SIR92
30 
within the CRYSTALS
31 program. The crystallographic data are summarised in Table 4.3 and 
the inter- and intramolecular interactions are listed in Table 4.20.  
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Table. 4.20 – The interactions that are found within the benzimidazolium aspartate molecular complex 
 
In  the  molecular  complex,  the  BZN  molecule  is  protonated  as  discussed  in  section  4.3.1 
forming a BZNH
+ molecule (Figure 4.73). The BZNH
+ bond legnths are delocalised reflected 
in the equalisation of the internal bond lengths, N1
 ʴ+-C1 1.313(3)Å and N2
 ʴ+-C1 1.318(3)Å, 
and bond angles, C1-N1
ʴ+-C2 107.2(2)º and C1-N2
ʴ+-C7 107.5(2)º.   
 
The L-aspartic acid molecule has not only undergone deprotonation but also transferred the 
other  carboxylic  acid  proton  to  the  amine  group.    In  its  native  crystal  structure
36  (CSD 
reference LASPRT04) the L-aspartic acid already exists as the zwitterion (protonation of the 
amine from one of the carboxylic acid groups), however still contains one carboxylic acid 
group. The deprotonation of both carboxylic acid groups results in a negative charge that is 
found to be delocalised over both the carboxylate groups. This can be seen by the degree of 
normalisation of the bond lengths with comparison to the protonated form (Table 4.21). 
 
  Aspartate (Å)  Aspartic Acid (Å) 
C8-O1  1.259(2)  1.257(1) 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N1···O1  2.615(2)  0.97(3)  1.65(3)  170(2) 
N2···O3  2.596(2)  0.87(3)  1.73(3)  177(3) 
N3···O1  2.776(2)  0.87(2)  1.84(3)  166(2) 
N3···O4  2.796(2)  0.95(3)  1.87(3)  172(2) 
N3···O2  2.759(2)  0.95(3)  1.87(3)  137(2) 
C1··O2  3.430(3)  0.94(2)  2.67(2)  138(2) 
C1···O4  3.459(3)  0.94(2)  2.66(2)  144(2) 
C5···O3   3.370(3)  0.94(3)  2.46(3)  161(2) 
C5···π  3.672(3)  -  -  - 
Fig. 4.73 – The benzimidazolium and aspartate molecules which are generated in the molecular complex 
with atom labelling.  
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C8-O2  1.238(2)  1.254(2) 
C11-O3  1.250(2)  1.214(2) 
C11-O4  1.2228(3)  1.315(1) 
Table 4.21 – A comparison of the bond lengths found in the aspartate molecule in its molecular complex with 
benzimidazolium and those of the parent aspartic acid.  
 
There  are  host  of  hydrogen  bonds  within  the  BZNH
+  aspartate  molecular  complex  with 
lengths ranging from relatively strong distances of 2.596Å to relatively weak distances of 
3.377Å. The BZNH
+ molecules are involved in the strongest hydrogen bonds which are two 
partially charge assisted N
ʴ+-H····O
ʴ- hydrogen bonds of lengths N1
ʴ+-H····O1
ʴ-, 2.615(2) and 
N2
ʴ+-H····O3
ʴ-  2.596(2)Å.  These  hydrogen  bonds  combine  to  create  a  linear  chain  of 
alternating aspartate and BZNH
+ molecules that lie above and below the chain (Figure 4.74). 
 
 
Fig. 4.74 – The main hydrogen bonds within the BZNH
+ aspartate molecular complex create a linear chain of 
alternating co-molecules. 
 
The amine group on the aspartate molecule is involved in three hydrogen bonds that are all of 
similar strengths (Figure 4.75). These hydrogen bonds are the next most influential after those 
involving the BZNH
+  molecule. They  are of lengths  N3-H∙∙∙O1
ʴ-, 2.776(2)Å (green),  N3-
H∙∙∙O4
ʴ-, 2.796(2)Å (red) and N3-H∙∙∙O2
ʴ-, 2.759(2)Å (blue).  
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Fig. 4.75 – The amine group of the aspartate molecule is involved in three hydrogen bonds, N3-H∙∙∙O1
ʴ- (green), 
N3-H∙∙∙O4
ʴ- (red) and N3-H∙∙∙O1
ʴ-(blue).  
 
There are two weak hydrogen bonds that are influential within the structure. One is a three 
centred hydrogen bond (bifurcated) involving the carbon sandwiched between the nitrogens 
and an oxygen from each carboxylate group (Figure 4.76; a). These are of length C1-H∙∙∙O2
ʴ- 
3.430(3)Å and C1-H∙∙∙O4
ʴ- 3.459(3)Å. The other weak hydrogen bond is also intermolecular 
and also involves an carboxylate oxygen (Figure 4.76; b). This hydrogen bond, C5-H∙∙∙O3
ʴ-, is 
of length 3.370(3)Å and makes up the contingent of hydrogen bonds within this molecular 
complex 
 
 
Fig. 4.76 – The weak hydrogen bonds within the BZNH
+ aspartate molecular complex: bifurcated hydrogen 
bonds (a) and C5-H∙∙∙O3
ʴ- hydrogen bonds (b). 
 
There  are  sets  of  lesser  interactions  that  are  influential  within  this  structure,  whose 
significance can be seen by looking at the extending structure. Figure 4.77 highlights how the 
linear chains of alternating co-molecules are connected through the hydrogen bonds involving 
the amine group. This has the effect of creating layers along the b-axis, with the first layer 
a 
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being the linear chain (A), next the amine hydrogen bonds (B), back to linear chains (A), then 
the lesser interactions (C) before returning to A, then repeating this sequence B,A,C,A,B…. 
 
 
Fig. 4.77 – View along the b-axis of the expanded benzimidazolium aspartate molecular complex. The red line  
(-) indicates the chain of alternating co-molecule (Figure 4.74), the yellow box (-) indicates hydrogen bonds 
involving the amine group of the aspartate (Figure 4.75) and the black box is where the lesser interactions  
between the BZNH
+ molecules operate(Figure 4.76). 
 
The lesser interactions are CH∙∙∙π edge to face interactions involving the BZNH
+ molecules. 
They are of length 3.622(3)Å (c) and 3.716(3)Å (d) (Figure 4.78) .   176 
 
Fig. 4.78  – The CH∙∙∙π edge to face interactions between the BZNH
+ molecules. 
 
4.6   Conclusions 
 
Of all the possible hydrogen bonding patterns of the uncharged species (Figure 4.12) and 
charged species (Figure 4.13) and the many possibilities of potential hydrogen bond motifs 
and supramolecular synthons, there were only four unique hydrogen bonding patterns (Figure 
4.79) and three hydrogen bond motifs (Figure 4.80) (excluding the hydrate for the hydrogen 
bonds) are observed. 
 
From  Figure  4.79,  hydrogen  bond  1  incorporates  all  NH∙∙∙O  hydrogen  bonds  which 
corresponds to hydrogen bond pattern E and F in Figures 4.12 and 4.13 and E and F in Table 
4.3.  This,  as  would  be  predicted,  is  the  most  influential  intermolecular  hydrogen  bond 
between the co-molecules and can vary, quite considerably, in strength. This hydrogen bond, 
as will be displayed throughout the rest of the results sections, is robust, dependable and 
flexible. The OH∙∙∙O hydrogen bond (Figure 4.79-2, Figure 4.12 and 4.13–G and Table 4.3-
G) between a hydroxyl and carboxylate oxygen, is a very common hydrogen bond for crystal 
engineers for its dependability and flexibility. In this body of work it promotes the ladder 
motif  and  is  the  most  influential  hydrogen  bond  listed  in  Figure  4.79,  as  when  there  is 
potential for this type of hydrogen bond (not available in the 2-HBA molecular complexes) it 
forms  and  determines  the  rest  of  the  structure.    There  is  no  better  example  than  in  the 
benzimidazole and 3,5-dihydroxybenzoic acid molecular complex, where the benzimidazole 
molecules seem to fit in where they are allowed. The other OH∙∙∙O hydrogen bond, Figure 
4.79-4, a carboxylic acid dimer (carboxylic acid and a carboxylate group) is only seen in the 
c 
c 
d 
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BENZ
+ 2-HBA
 1:2 molecular complex, even though the carboxylic acid dimer is renowned 
in forming and is seen in many of the starting materials of the hydroxybenzoic acids and in 
other molecular complexes of which they are involved. The BZN
 dimer (Figure 4.79-3, Figure 
4.12-C) only formed when there was an excess of BZN to the other co-molecule however 
examples in Chapters 5 and 7 will show that this is not always the case. For this hydrogen 
bond to form there needs to be a non protonated nitrogen atom. 
 
 
       
 
          
Fig. 4.79 – The four unique hydrogen bonds that were the only hydrogen bonds in all the crystal structures in 
Chapter 4, in order of occurrence 1, N
ʴ+H∙∙∙O
ʴ-, 2, OH∙∙∙O
ʴ-, 3, N
ʴ+H∙∙∙ N
ʴ+, 4, OH∙∙∙O. 
 
Figure 4.80 shows the three motifs, hydrogen bond ring, chains of hydroxyl-benzoic acid 
dimers  with  connected  BZN,  and  the  ladder,  with  slight  variations  between  the 
supramolecular  synthons  within  the  ladder  structures.  Firstly,  the  hydrogen  bonded  rings 
formed in the BENZH
+ 2HBA
- 1:1 molecular complex, using solely hydrogen bond pattern 1, 
is regularly seen in other molecular complexes in chapters 5, 6 and 7. with some derivatives. 
On  the  other  hand,  the  ladder  motif  is  only  seen  in  the  hydroxybenzoic  acid  molecular 
complexes, which is due to the availability of the hydroxyl group to form hydrogen bond 
pattern G (2 in Figure 4.79). Within the ladder motifs, there are two slight derivatives, ladders 
with rungs of BZN molecules and ladders with alternative rungs of BZN molecules. These 
derivatives are neatly shown in the BZNH
+ 3HBA
- polymorphs where they both adopt the 
different styles. It would not be surprising if more polymorphs of the BZN and 3- / 4-HBA  
molecular complexes adopting the ladder motifs not discovered during this work were found, 
for example BZNH
+ 3-HBA
- 1:1 forming the alternative step ladder motif and the BZNH
+ 4-
HBA
- 2:1 forming the ladder with every step motif.  
1 
2 
3 
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Fig.  4.80  –  The  motifs  of  the  molecular  complexes  from  Section  4.5  excluding  benzimidazolium  4-
hydroxybenzoate hydrate and benzimidazolium 3,5-dihydroxybenzoate. The three unique hydrogen bond motifs 
are shown, the hydrogen bonded rings (BENZH
+ 2HBA
- 1:1), chains hydroxybenzoic acid dimers and the ladder 
motif. 
 
Even with six new structures being determined with these set of molecules, I believe there are 
still a real possibility to obtain more, for example BZN and 3-HBA/4-HBA in a 1:2 ratio 
could adopt a dimer structure similar to the Benz:2H-BA 1:2 complex or the ladder motif. 
However due to the likely motifs that the structures would adopt, it would be highly unlikely 
for some structures to be obtained, for example BZN and 2-HBA in a 2:1 ratio is unlikely to 
occur as the 2-HBA would need to adopt the ladder motif. Also I do not think the BZN 4-
HBA 1:1 molecular complex would occur as the geometry of the potential 4-HBA chains 
would be straight which would not allow the BZN to fit into the structure.  
 
A weak hydrogen bond has been found in nearly all the structures, indicating a high degree of 
reliability. The carbon – oxygen hydrogen bond involving the carbon sandwiched between the 
protonated nitrogens can be shorter than normal carbon oxygen hydrogen bonds due to the 
Benz:3H-BA 1:1 
Benz:3H-BA 2:1 I  Benz:3H-BA 2:1 II 
Benz:4H-BA 2:1  Benz:2H-BA 1:1 
Benz:2H-BA 1:2 
Hydrogen bonded rings of 
synthons (D) and (E) 
Ladder with stiles of HBA 
(G) and rungs of BZN ( D) 
Ladder with stiles of HBA (G) and 
alternate rungs of BZN dimers ( D and 
C) 
HBA dimers (G) held by 
BZN (D) and (E) 
Ladder with stiles of HBA (G) and 
alternate rungs of BZN dimers ( D and C) 
Ladder with stiles of HBA 
(G) and rungs of BZN dimers 
( D and C)   179 
electronegative  nature  of  the  carbon  with  lengths  as  short  as  3.091Å  (normally  around 
3.2~3.5Å
##) However there are structures when this hydrogen bond lies within the normal 
range. These carbon-oxygen hydrogen bond always uses the carbon labelled C1 (or C8 when 
more  than  one  BZN  in  the  asymmetric  unit)  in  structures  and  is  found  to  be  reliable  in 
structures found throughout this project.  
 
When  scrutinising  the  ΔpKa  difference  values  (Table  4.4)  for  the  molecular  complexes 
obtained, it can be seen that the rule governing if a salt or co-crystal will form has been 
accurate. There was no  ΔpKa value under 0, therefore no co-crystals would be expected, 
which  has  occurred.  The  majority  of  the  ΔpKa  values  do  lie  within  the  0~3  range  that 
normally  means  prediction  is  impossible,  however  in  these  cases  the  salt  form  always 
prevails.  
 
The solvent free grinding method, validated to an extent in the experiments described, is a 
very old method giving a new lease of life. There is debate over whether the term solvent free 
is correct (refer to Section 1.5) but there can be no debate that this technique works and is 
able to generate new materials and even materials unobtainable from normal solvent methods.   
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4.8   Appendix  
4.8.1  Appendix 4.A - DSC Thermograms of Solvent Free Co-crystallisations of 
BZN with Halo-BA 
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4.8.2  Appendix 4.B - DSC Thermograms of Solvent Free Co-crystallisations of 
BZN with a Range of Co-molecules 
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5  Solvent  Mediated  Molecular  Complex  Polymorphism  and 
Isomorphic Formation 
 
This  chapter  will  focus  on  the  co-crystallisation  of  benzimidazole  with  various  halo-
substituted benzoic acids.  The primary  aim of this  work was  to  promote and control  the 
formation  of  molecular  complex  polymorphs  through  varying  crystallisation  conditions 
including choice of solvent and crystallisation temperature. Powder X-ray diffraction (PXRD) 
and differential scanning calorimetry (DSC) were primarily used for characterisation of the 
resulting products due to difficulties in the growth and isolation of single crystals of all forms. 
 
The theme of controlling the formation of polymorphs, as previously discussed  at section 
1.4.1, is of utmost importance to many different areas of industry. The quote by McCrone
1, 
―the number of forms known for a compound is proportional to the time and money spent in 
research on the compound‖ highlights the poor understanding of polymorph formation and 
the often serendipitous nature of discovery.  
 
In addition to the molecular complex polymorphs obtained, isostructural series of compounds 
have been produced (refer to Section 1.4.3) where the sole chemical difference is the identity 
of the halogen atom; isostructures were however not obtained in a predictable manner. 
 
This  chapter  will  also  look  at  the  influence  of  halogen  atoms  involved  in  intermolecular 
interactions,  including  halogen  bonding  and  halogen  –  π  interactions.  These  weaker 
interactions are becoming increasingly important in molecular complex design, however they 
have historically been hard to use in crystal structure design due to their less directional and 
predictable nature (refer to Section 1.2.7). 
 
5.1   Introduction 
 
The complete series of mono-substituted iodo-, bromo-, chloro- and fluoro-benzoic acids have 
been  used  as  co-molecules  in  the  attempted  synthesis  of  molecular  complexes  of 
benzimidazole. Halobenzoic acids themselves have many uses in the chemical industry, for   187 
example  4-chlorobenzoic  acid  is  used  as  an  intermediate  in  the  manufacturing  of  dyes, 
fungicides and pharmaceuticals
2. However it was not for these reasons alone that they were 
selected as co-molecules. 
 
The carboxylic acid functional group found on halobenzoic acids is universally popular for 
crystal engineers as in many cases it forms predictable hydrogen bonds
3. Benzoic acids are 
often found to produce hydrogen bonded dimers between the carboxylic acid groups, and this 
is always observed in the pure halobenzoic acid crystal structures.  This dimer motif has also 
been found to persist in some molecular complexes.  
 
The presence of halogens in molecules is also known to influence the crystal packing and so 
this aspect has also been investigated. As discussed (Section 1.2.7) halogen interactions have 
increasingly become an area of interest with much research concentrating on the manipulation 
of these interactions and their use in design of extended architectures.  
 
5.1.1  2-Fluorobenzoic Acid 
 
2-Fluorobenzoic acid (Figure 5.1) is of interest in metabolism studies
4, however only one 
molecular  complex  of  this  material  has  been  deposited  in  the 
Cambridge  Structural  Database  (CSD).  4-(1H-pyrazol-1-
ylmethyl)benzamide 4-fluorobenzoic acid (CSD reference OCIQEX) 
(Figure  5.2)  was  discovered  by  Aakeroy
5  in  2006.  The  main 
supramolecular  synthon  is  a  double  hydrogen  bond  between  the 
carboxylic acid and carboxamide groups. It can also be noted that the 
fluorine atom on one of the fluorobenzoic acid groups is disordered 
over two sites; this also occurs in the 2-fluorobenzoic acid molecular 
complex  generated  during  this  project.  There  is  no  structure  of  2-
fluorobenzoic acid starting material in the CSD. 
 
Fig.  5.1  –  2-
fluorobenzoic acid. 
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Fig. 5.2 – Basic building block of the 2-fluorobenzoic acid: 4-(1H-pyrazol-1-ylmethyl)benzamide molecular 
complex structure found in the CSD with a fluorine atom on one of the fluorobenzoic acid groups is disordered 
over two sites 
 
5.1.2  3-Fluorobenzoic Acid 
 
3-Fluorobenzoic acid (Figure 5.3), like 2-fluorobenzoic acid, has no known structural data 
and  only  one  molecular  complex  structure  in  the  CSD.  3-fluorobenzoic  acid  has  been 
cocrystallised with 4-acetylpyridine (CSD reference HOLJAU) within the Wilson group in 
2009
6 (Figure 5.3). The only hydrogen bond within this structure is an O-H∙∙∙N bond.  
 
     
Fig. 5.3 – LHS, 3-fluorobenzoic acid; RHS, 3-fluorobenzoic acid : 4-acetylpyridine molecular complex with the 
fluorine atom disorded over two positions (common with fluorine atoms) explaining the overlap of the hydrogen 
and fluorine atoms.  
 
5.1.3  4-Fluorobenzoic Acid 
 
4-Fluorobenzoic  acid  is  used  as  an  intermediate  for  the  production  of  pesticides  and 
pharmaceuticals
2.  The structure of the starting material was reported in 1992 (CSD reference 
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PFBZAD01)
7 with a carboxylic acid dimer as the main supramolecular synthon (Figure 5.4). 
This structure also contains a halogen bond, F∙∙∙O-H, of 3.246Å which connects the linear 
carboxylic acid dimers. 
 
     
Fig. 5.4 – Basic building block of the 4-fluorobenzoic acid crystal structure, RHS, 4-fluorobenzoic acid. 
 
4-fluorobenzoic acid has also been successfully cocrystallised with isonicotinamide in a one 
to  one  ratio  (CSD  reference  ASAXUN)
8  and  as  bis(N,N'-bis(2-
fluorobenzylidene)ethylenediamine-N,N')-silver(i)  4-fluorobenzoate  4-fluorobenzoic  acid 
solvate  (CSD  reference  UCIWIN)
9.  The  4-fluorobenzoic  acid:  isonicotinamide  molecular 
complex (Figure 5.5) contains heterodimers connected through an O-H∙∙∙N hydrogen bond. Of 
particular interest is that a 4-fluorobenzoic acid dimer is held together by a relatively strong 
halogen bond, F∙∙∙F, of distance 2.618 Å. 
 
 
Fig. 5.5 – Basic building block of the 4-fluorobenzoic acid : isonicotinamide molecular complex. 
 
5.1.4  2-Chlorobenzoic Acid 
 
2-Chlorobenzoic  acid  is  used  as  an  intermediate  in  manufacture  of  drugs  especially 
mefenamic acid and also in the manufacture of dyes and pigments. Its crystal structure was 
solved by Braga and co-workers in 2008
10 (Figure 5.6). 
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Fig. 5.6  The carboxylic acid dimer that is the main supramolecular synthon in the 2-chlorobenzoic acid crystal 
structure; RHS, 2-chlorobenzoic acid. 
 
During the same research, 2-chlorobenzoic acid was also successfully cocrystallised with 2-
methlybenzoic acid (Figure 5.7). The carboxylic acid dimer is once again the main hydrogen 
bond  motif  with  weaker  hydrogen  bonds  building  up  the  structure.  Both  independent 
molecules  have  the  chloro  and  methyl  substituents  disordered  over  two  sites  of  equal 
occupancy. 
 
 
Fig. 5.7 – The main building block of the 2-chlorobenzoic acid : 2-methylbenzoic acid molecular complex. Both 
independent molecules have the chloro and methyl substituents disordered over two sites of equal occupancy 
 
5.1.5  3-Chlorobenzoic Acid 
 
3-Chlorobenzoic acid is used as a raw material in the production of the drugs loratadine
11 
(antihistamine) and amfebutamone
12 (antidepressant). The structure of this molecule (Figure 
5.8) was solved in 2003 (CSD reference MCBZAC01)
13 at room temperature and to an R-
factor of 6.29%. The carboxylic dimer has surprisingly been distorted from the normal planar 
geometry with the carboxylic groups lying at 87.3º to one another while still maintaining 
medium strength hydrogen bonds (2.558 Å). This must be a consequence of the Cl∙∙∙O-C 
halogen bond with the chlorine having a steric effect on the carboxylic dimer.  
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Fig. 5.8- Crystal structure of the 3-chlorobenzoic acid molecule; RHS, 3-chlorobenzoic acid. 
 
3-Chlorobenzoic  acid  has  successfully  been  cocrystallised  with  a  range  of  co-molecules 
including  2,5-dibromo-1-(di-isopropylamido)-3,4-diphenyl-2,5-dihydrophosphole  1-oxide 
(CSD reference – EDUWOP)
14, triphenylphosphine oxide (CSD reference – MACJEG)
15, 2-
picoline  (CSD  reference-  ROKQEN)
16  and  hemikis((1RS,2RS,3RS)-3-N,N-
dibenzylaminocyclohexane-1,2-diol N-oxide) (CSD reference – POYXOR)
17 among others. 
Of particular interest is the 3-chlorobenzoic acid : 2-picoline N-oxide molecular complex 
(Figure 5.9), containing a simple O-H∙∙∙O hydrogen bond as the main synthon and the halogen 
interaction assisting in expanding the structure.  
 
 
Fig. 5.9 – Building block of the 3-chlorobenzoic acid 2-picoline N-oxide molecular complex.  
 
5.1.6  4-Chlorobenzoic Acid 
 
4-Chlorobenzoic acid is probably the most industrially useful halobenzoic acid as it is used as 
an  intermediate  for  manufacturing  dyes,  fungicides,  pharmaceuticals  and  other  organic 
chemicals  and  is  also  a  preservative  in  adhesives  and  paints
2.  The  structure  shows  the 
carboxylic  acid  dimer,  with  dimers  linked  through  halogen  bonds  of  Cl∙∙∙Cl  3.366(2)Å 
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distance in length (Figure 5.10).  It has been studied with neutron diffraction by Wilson
18 
where it was found that the acidic proton is disordered over two sites with the occupancies 
changing with differing temperature.   
 
     
Fig. 5.10 – Structure of 4-chlorobenzoic acid highlighting the carboxylic acid dimer being held together by a 
chlorine-chlorine halogen bond, RHS, 4-chlorobenzoic acid. 
 
This molecule has three molecular complexes reported in the CSD, N,N-dimethylformamide 
(CSD reference – ACERAC)
19, (P)-tryptamine (CSD reference – FINZIM)
20 and 4-amino-N-
(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide  4  (CSD  reference  –  YIZQAA)
20  (Figure 
5.11).  
 
 
Fig. 5.11 – LHS, structure of the 4-chlorobenzoic acid : N,N-dimethylformamide molecular complex,  RHS, 4-
chlorobenzoic acid : sulfadimidine molecular complex. 
 
5.1.7  2-Bromobenzoic Acid   
 
There are no structures of any sort involving 2-bromobenzoic acid 
(Figure  5.12)  in  the  CSD  and  information  in  the  literature  is 
limited to basic chemical properties. 
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Fig.  5.12  –  2-bromobenzoic 
acid molecule.   193 
5.1.8  3-Bromobenzoic Acid 
 
There  are  limited  uses  and  information  on  3-bromobenzoic 
(Figure 5.13) acid in the literature, however it is involved in one 
structure  reported  in  the  CSD.  Bis(bis(m2-3-bromobenzoato-
O,O')-(2,2'-bipyridyl)-(3-bromobenzoato-O,O')-terbium(iii)) 
bis(3-bromobenzoic  acid)  dihydrate  (CSD  reference  - 
TIDXAG)
21  is  a  metal  organic  framework  with  six  3-
bromobenzoic acid molecules coordinating to the terbium metal 
centre and one hydrogen bonding to a water molecule.  
 
5.1.9  4-Bromobenzoic Acid 
 
4-Bromobenzoic  acid  is  a  known  intermediate  in  the  preparation  of  drugs,  dyes  and 
pigments
22. Its structure was solved in 2004 with CSD reference - BRBZAP02
23 (Figure 5.14) 
showing that the carboxylic acid dimers are being held together by O∙∙∙H-C hydrogen bonds 
(with C∙∙∙O distances of 3.415(5)Å) to form layers. The layers are connected vertically by - 
stacking interactions with these columns of layers interacting with one-another through long-
distance bromine – bromine interactions of 3.835 Å. 
 
    
Fig. 5.14 – The 4-bromobenzoic acid structure highlighting the carboxylic acid dimers being held together by 
weak C-H∙∙∙O hydrogen bonds; RHS, 4-bromobenzoic acid. 
 
5.1.10 2-Iodobenzoic Acid 
 
O HO
Br
Fig.  5.13  –  3-bromobenzoic 
acid molecule. 
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2-Iodobenzoic acid is a starting material for the preparation of iodosobenzoate (an oxidant 
which performs the synthesis of carbonyl compounds from primary/secondary alcohols) and 
flufenamic acid (with anti-inflammatory properties). Its structure was solved (Figure 5.15) in 
2002
24, which showed how the carboxylic acid dimers are held together by I∙∙∙I halogen bonds 
of 3.916Å in length. There are no other structures containing 2-iodobenzoic acid in the CSD. 
 
     
Fig. 5.15 – Structure of 2-iodobenzoic acid (CSD reference - OIBZAC01); the carboxylic acid dimer is held 
together by iodine-iodine halogen bonds. RHS, 2-iodobenzoic acid. 
 
5.1.11 3-Iodobenzoic Acid 
 
3-Iodobenzoic acid (Figure 5.16) is used in the organic synthesis of iodine-containing small 
molecules. There is no structural data for this molecule however it has been cocrystallised 
with N-carboxymethyl-N,N'-dimethylpiperazine (CSD reference SIXBAD)
25 (Figure 5.16), in 
which the 3-iodobenzoic acid does not form carboxylic acid dimers.  
 
     
Fig.  5.16  –  LHS-  3-iodobenzoic  acid;  RHS,  structure  of  3-iodobenzoic  acid  and  N-carboxymethyl-N,N'-
dimethylpiperazine molecular complex. 
 
5.1.12 4-Iodobenzoic Acid 
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The  structure  of  4-iodobenzoic  acid  has  been  extensively  studied  by  single  crystal  X-ray 
diffraction  at  various  times  (CSD  references  BENMOW,  BENMOW01
26  and  the 
BENMOW02
26 series) and over various temperatures (CSD references  – BENMOW02 to 
BENMOW09)
27.  There  is  a  difference  in  the  space  group  reported  between  the  older 
structures (BENMOW and 01) and the newer structures (BENMOW02 series), however the 
difference is a P21/n to P21/a change between symmetrically equivalent structures.  
 
The structure shown in Figure 5.17 shows that the carboxylic acid dimer is again the main 
hydrogen  bond  motif    with  I∙∙∙I  halogen  bonds  (distances  ranging  from  3.932(9)Å  to 
3.957(1)Å) connecting them together. 
 
      
Fig. 5.17 – The structure of 4-iodobenzoic acid; carboxylic acid dimers are held together by iodine iodine 
interactions. RHS, 4-iodobenzoic acid. 
 
4-Iodobenzoic acid is involved in four molecular complexes all from the same body of work 
by Aakeroy (2009)
28. These complexes are with 3-(2-amino-4-methylpyrimidin-6-yl)pyridine 
(AMP-P) toluene solvate (Figure 5.18, top left), 3-(AMP-P) 2,3,5,6-tetrafluoro (Figure 5.18, 
top right), 4-(AMP-P) (Figure 5.18, bottom left) and 1-(AMP-P) (Figure 18, bottom right). 
There are no carboxylic acid dimers formed in these structures, instead Figure 5.18 visually 
highlights  the  robustness  of  the  carboxylate  /  amino-pyrimidine  hydrogen  bond  motif 
throughout these systems. 
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Fig. 5.18 – Top left, basic building block of the 3-(AMP-P)  toluene 4-iodobenzoic acid solvate with CSD 
reference – COWHOM, top right, the 3-(AMP-P) 2,3,5,6-tetrafluoro 4-iodobenzoic acid  molecular complex 
main hydrogen bond motif with CSD reference – COWHUS, bottom left, the molecular complex of 4-(AMP-P) 
4-iodobenzoic acid which has CSD – reference COWJAA and lastly bottom right, 1-(AMP-P) 4-iodobenzoic 
acid with CSD reference – COWJOO. 
 
5.2   Summary of Results 
Benzimidazole has successfully been cocrystallised with a range of halo-benzoic acids (Table 
5.1)  generating  a  range  of  molecular  complexes.  These  molecular  complexes  have  been 
analysed, where possible, by single crystal X-ray diffraction and subsequently powder X-ray 
diffraction  and  DSC.  Neutron  diffraction  data  collected  at  the  ILL  Grenoble  were  also 
collected on several of these molecular complexes. 
 
Benzimidazole  Ortho  Meta  Para 
Fluorobenzoic Acid       
Chlorobenzoic Acid       
Bromobenzoic Acid       
Iodobenzoic Acid       
Table 5.1 – Summary of the successful (blue) and unsuccessful (grey) co-crystallisation experiments between 
benzimidazole and the various halobenzoic acids.  
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To date no solid material has been generated through the co-crystallisation of benzimidazole 
and  2-chloro/bromobenzoic  acid,  regardless  of  the  solvent  or  temperature  regime  used. 
However, it is worthwhile to note that the co-crystallisation of these materials produces an 
oil-like substance suggesting that a low melting point complex may have been formed. All the 
benzimidazole  and  iodobenzoic  acid  co-crystallisation  experiments  produced  only  single 
components, regardless of the wide range of physical conditions used.  
 
The main aim was to identify if these systems could generate molecular complex polymorphs 
and then selectively control the growth of each polymorph. Table 5.2 highlights the systems 
where molecular complex polymorphism occurred and could be selectively controlled through 
solvent and / or temperature changes. It can be seen that polymorphism has been confirmed in 
the systems that involve benzimidazole with 3-chlorobenzoic acid, 4-chlorobenzoic acid and 
4-bromobenzoic acid. 
  
Benzimidazole  Ortho  Meta  Para 
Fluorobenzoic Acid       
Chlorobenzoic Acid       
Bromobenzoic Acid       
Iodobenzoic Acid       
Table 5.2 – Summary of the systems where molecular complex polymorphism was confirmed by single crystal 
data (blue), polymorphism identified using powder data (green), no polymorphism occurred (yellow) and no 
molecular complex generated (grey). 
 
During analysis of the results, it was noted that there were many similarities between the 
different molecular complexes generated. The primary hydrogen bond in nearly all molecular 
complexes is a  partially charge assisted N
ʴ+-H∙∙∙O
ʴ- hydrogen bond with a proton transferring 
from the carboxylic acid group to the unprotonated nitrogen of the benzimidazole (Section 
5.2.1). The consequence of the occurrence of the same supramolecular synthons generating 
the same motif, with the co-molecules only changing in the attached halogen atom, resulted in 
the  identification  of  isostructures.  Table  5.3  summarises  where  these  isostructures  have 
occurred. 
 
 
Benzimidazole  Ortho  Meta  Para   198 
Fluorobenzoic Acid       
Chlorobenzoic Acid       
Bromobenzoic Acid       
Iodobenzoic Acid       
Table 5.3 –A summary of the molecular complexes that have generated isomorphic structures (blue and yellow), 
with grey indicating no isomorphism. 
 
5.2.1  Benzimidazolium Ion 
 
Where  the  crystallisation  product  is  in  a  1:1  stoichiometric  ratio  of  benzimidazole  and  a 
carboxylic  acid  containing  molecule,  the  benzimidazole  is  protonated  through  hydrogen 
transfer from the carboxylic acid group onto the normally unprotonated nitrogen atom in the 
five-membered ring, creating a benzimidazolium molecule (BZNH
+) (Figure 5.19). The effect 
of the proton  transfer on the benzimidazolium molecule is  a delocalisation of the charge 
across the five-membered ring, reflected in the equalisation of the internal bond lengths N
ʴ+-
C-N
ʴ+ and bond angles C-N
ʴ+-C (Table 5.4). The delocalisation of the charge has the effect of 
creating a partial positive charge on both the nitrogens. This effect has been reported in many 
structures involving benzimidazole and imidazole.  
 
         
Fig. 5.19 – LHS, a typical benzimidazolium molecule where both nitrogens are protonated; RHS, the Fourier 
difference map generated where the H atoms located on a nitrogen atom have been omitted from the model, 
clearly shows that both nitrogen atoms are protonated.   
 
The consequence for the co-molecule that has been deprotonated is the creation of a negative 
charge. The negative charge is found to be delocalised over the carboxylic acid group by 
consideration of the normalisation of the bond lengths in the carboxylate group.   199 
 
Molecular 
Complexes 
BZN   
3-ClBA I 
BZNH+   
3-ClBA- 
II 
BZNH+  
4-ClBA- 
BZNH+   
4-BrBA-  
BZN  
3-BrBA
*  
BZNH+  2-
FBA-  2-
FBA 
BZN 
BZNH+ 
4-FBA 
 4-FBA-   
N-C(Å) 
2
nd molecule 
1.328(8)  1.329(2)  1.335(3) 
1.334(2) 
1.335(2) 
1.327(3) 
1.319(3)  1.3305(1)  1.359(3) 
1.329(2) 
N-C(Å) 
2
nd molecule 
1.358(9)  1.342(2)  1.340(2) 
1.339(2) 
1.328(3) 
1.329(2) 
1.335(3)  1.3252(1)  1.323(2) 
1.331(3) 
C-N-C(º) 
2
nd molecule 
107.5(4)  106.3(1)  107.8(1) 
108.0(0) 
107.2(2) 
108.3(2) 
106.6(2)  108.16  108.0(2) 
107.9(2) 
C-N-C(º) 
2
nd molecule 
105.2(5)  107.8(1)  108.6(1) 
108.5(2) 
108.3(2) 
108.0(2) 
108.0(2)  108.17  108.1(2) 
104.4(2) 
Table 5.4 – The N
ʴ+-C-N
ʴ+ bond lengths and C-N
ʴ+-C bond angles for the molecular complexes discussed in 
Chapter 5. *Note that BZN 3-BrBa has, on average, partial iomic species of the co-molecules 
 
5.2.2  Primary Hydrogen Bonds 
 
Consideration  of  the  co-molecules  involved  in  the  successful  generation  of  molecular 
complexes of benzimidazole would point to a series of possible hydrogen bonds that could be 
generated (Figure 5.20). All these hydrogen bonds have many examples in the Cambridge 
Structural Database and have been of interest in their own right.  
 
Fig. 5.20  The potential homo-hydrogen bonds (A, B and C) and hetero-hydrogen bonds (D, E and F) that can 
be exhibited between a benzimidazole and carboxylic acid group.  
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As indicated, certain hydrogen bonding motifs appear in various different molecular complex 
structures. For ease of defining, the most prominent hydrogen bonds that appear in at least 
two of the structures will be outlined and labelled for future reference (Figure 5.21) and their 
scalar quantities given (Table 5.5). Note that this does not include secondary interactions that 
may play as influential a part in the structure as these primary hydrogen bonds. 
 
 
Fig.  5.21  -  The  most  prominent  hydrogen  bonds  within  the  benzimidazole  :  halobenzoic  acid  molecular 
complexes: N-H∙∙∙N hydrogen bond (A), N-H∙∙∙O hydrogen bond (B) and O-H∙∙∙O hydrogen bond (C).  
 
A 
B 
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Molecular 
Complexes 
BZN   
3-ClBA I 
BZNH+   
3-ClBA- 
II 
BZNH+  
4-ClBA- 
BZNH+   
4-BrBA-  
BZN  
3-BrBA
*  
BZNH+ 
2-FBA- 2-
FBA 
BZN 
BZNH+ 
4-FBA 
 4-FBA-   
Hydrogen 
Bonds 
A
,  N
ʴ+
-
H
·
·
·
·
N
ʴ
-
 
D∙∙∙A(Å)  -  2.677(2)  -  -  2.693(3)  -  2.750(2) 
D-H(Å)  -  1.338(1)  -  -  0.76(5)  -  0.94(2) 
H∙∙∙A(Å)  -  1.338(1)  -  -  1.94(5)  -  1.81(2) 
D-H∙∙∙A 
angle(º) 
-  180.00(9)  -  -  171(6)  -  179(2) 
B
,  N
ʴ+
-
H
·
·
·
·
O
ʴ
-
 
D∙∙∙A(Å)  2.575(7) 
2.760(5) 
2.830(2)  2.606(2) 
2.682(2) 
2.642(2) 
2.900(2) 
2.832(2) 
2.597(2) 
2.667(2) 
2.638(2) 
2.850(2) 
2.848(2) 
2.843(3)  2.719(3) 
2.691(3) 
 
 
2.800(2) 
2.687(2) 
D-H(Å)  0.95195) 
0.950(5) 
0.84(2)  0.93(2) 
1.05(3) 
0.97(2) 
0.87(2) 
0.87(2) 
0.94(3) 
0.78(2) 
0.92(3) 
0.77(2) 
0.77(2) 
0.80(4)  0.91(5) 
0.90(4) 
0.85(2) 
0.93(2) 
H∙∙∙A(Å)  1.640(5) 
1.874(4) 
2.00(2)  1.56(3) 
1.80(2) 
1.67(2) 
2.15(2) 
2.27(3) 
1.65(3) 
1.91(2) 
1.72(3) 
2.17(2) 
2.36(3) 
2.06(4)  1.85(4) 
1.79(5) 
2.13(3) 
1.77(3) 
D-H∙∙∙A 
angle(º) 
166.5(3) 
154.1(3) 
172(3) 
 
176(2) 
169(3) 
157(2) 
144(2) 
122(2) 
178(3) 
163(3) 
147(2) 
141.6(2) 
123(2) 
170(3)  162(4) 
171(5) 
135(2) 
179(2) 
C
, O
H
·
·
·
·
O
ʴ
-
 
D∙∙∙A(Å)  -  2.492(2)  -  -  2.493(3)  2.5764(1)  2.528(2) 
D-H(Å)  -  1.246(1)  -  -  0.68(4)  0.856(5)  1.03(3) 
H∙∙∙A(Å)  -  1.246(1)  -  -  1.82(4)  1.767(5)  1.50(3) 
D-H∙∙∙A 
angle(º) 
-  180.00(8)  -  -  169(5)  156.7(4)  177(3) 
Table.  5.5  – The  hydrogen  bond  scalar  quantities,  donor  –  acceptor (D∙∙∙A),  donor  –  hydrogen  (D-H)  and 
hydrogen  –  acceptor  (H∙∙∙A)  distances,  and  hydrogen  bond  angle  (D-H∙∙∙A)  for  the  molecular  complexes 
discusses in Chapter 5. *Note that BZN 3-BrBa has, on average, partial iomic species of the co-molecules 
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5.3   Crystallographic Data 
Compound  BZN  3-ClBA I  BZNH+  3-ClBA- II  BZNH+ 4-ClBA- 
Formula  C7 N2 H6, C7 O2 Cl H4  C7 N2 H6.5, C7 O2 Cl, H4.5  C7 N2 H6, C7 O2 Cl H4 
ΔpKa (1:1)  1.69  1.69  1.53 
Crystallisation 
Conditions 
acetone, ~2-4ºC  methanol, ~2-4ºC  methanol, ~2-4ºC 
Molecular  weight  / 
gmol
-1 
274.70  274.45  274.71 
Temperature (K)  100  100  100 
Space Group  P -1  P 21/c   P -1 
a (Å)  3.802(6)  4.0009(6)  9.334(4) 
b (Å)  12.358(13)  11.7056(17)  11.207(4) 
c (Å)  14.706(14)  26.480(4)  12.230(5) 
ʱ (
o)  109.37(2)  90  84.173(10) 
β (
o)  99.18(4)  94.074(8)  77.990(12) 
γ (
o)  101.46(3)  90  86.837(10) 
Volume (Å
3)  619.5(13)  1237.0(3)  1243.8(9) 
Z  2  4  4 
θ range (˚)  3.028-27.484  1.542-33.011  3.077-27.483 
Completeness (%)  97.1  99.8  99.8 
Refln Collected  2745  41466  28693 
Independent  2745  4637  5698 
Refln 
(obs.I>2sigma(I)) 
2745  3982  3982 
Rint  0.096  0.071  0.046 
Parameters  172  205  431 
GooF on F
2  0.9044  1.0505  0.8945 
R1 (Observed)  0.1372  0.0694  0.0344 
R1 (all)  0.1372  0.0694  0.0520 
wR2 (all)  0.1219  0.1553  0.0852 
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BZNH+  4-BrBA-   BZN 3-BrBA
*   BZNH+ 2-FBA- 2-FBA  BZN BZNH+ 4-FBA 4-FBA-   
C7  N2  H6, C7  O2 
Br H4 
C7  N2  H6.5, C7  O2 
Br H4.5 
C7  N2  H6, C7  O2  F 
H4, C7 O2 F H5 
C7 N2 H6, C7 O2 F H5 
1.57  1.72  2.26  1.38 
Ethanol,  room 
temperature 
Ethanol, ~2-4ºC  Methanol,  RT  then 
~2-4ºC 
Methanol,  RT  then  ~2 -
4ºC 
319.16  638.32  398.36  516.50 
100  200  100  100 
P -1  P 21/c   P 21/c  P -1 
9.4515(5)  4.15350(10)  12.8630(8)  8.0327(4) 
11.2228(5)  11.6939(2)  11.3722(8)  12.1791(7) 
12.1857(5)  26.3600(5)  12.8196(8)  13.2117(8) 
84.102(2)  90  90  89.525(4) 
78.200(2)  93.8799(10)  103.134(3)  75.621(3) 
86.568(2)  90  90  74.452(3) 
1257.55(10)  1277.39(5)  1826.2(2)  1203.86(12) 
4  2  4  2 
3.051-27.481  1.549-27.442  1.626-28.088  1.594-30.665 
99.5  99.7  99.5  97.7 
29425  20237  46454  25201 
5749  2925  4425  7294 
5388  2378  3893  4496 
0.031  0.086  0.53  0.052 
431  220  1  431 
0.9433  0.9669  1.0791  1.1595 
0.0232  0.0336  0.0551  0.0491 
0.0248  0.0446  0.0635  0.0889 
0.0607  0.0990  0.1525  0.1575 
Table. 5.6 – Crystallographic data for the molecular complexes discussed in Chapter 5. *Note that BZN 3-BrBa 
has, on average, partial iomic species of the co-molecules 
   204 
5.4    Results and Discussion 
 
5.4.1  Molecular Complex Polymorphism 
 
The  most  interesting  set  of  molecular  complexes  with  regard  to  polymorphism  are  those 
containing benzimidazole and 3-chlorobenzoic acid. Three molecular complex polymorphs 
have been discovered using powder diffraction with two of those producing single crystal 
structures.  There  are  possibly  two  benzimidazole  :  4-chlorobenzoic  acid  molecular 
complexes, one producing single crystal data with the other having been identified through 
powder  XRD  and  DSC.  The  same  is  true  for  the  benzimidazole  :  4-bromobenzoic  acid 
molecular complexes, where two possible polymorphs have been identified.  
 
5.4.1.1 Benzimidazole and 3-Chlorobenzoic Acid 1:1 
 
Benzimidazole and 3-chlorobenzoic acid has been the most intensively studied system during 
this project. Co-crystallisation experiments have ranged from using a wide range of solvents, 
various different temperatures, evaporation occurring in different types of glassware, the use 
of solvent-free and solvent-drop grinding experiments. An array of analytical techniques were 
deployed in characterising the resulting products.  
 
Initial experiments were set-up using just four different types of solvent, methanol, ethanol, 
propanol  and acetone with evaporation occurring  at  room temperature.  From these initial 
experiments three different products could already be observed to form, from the DSC (Figure 
5.22) and X-ray powder diffraction data (Figure 5.23). 
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Fig. 5.22  DSC data from the products of crystallisation of benzimidazole and 3-chlorobenzoic acid from four 
common solvents. Two different polymorphs can be clearly identified by two distinct melting points, but a third 
polymorph can also be identified in the samples crystallised from 1-propanol (1proh) and acetone. The shoulder 
on the principal peaks in these traces, representing the third polymorph, can be seen in the enlarged inset, taken 
from the acetone trace. 
 
 
Fig. 5.23  Powder patterns of the products of crystallisation from four common solvents propanol (-), acetone  
(-), methanol (-) and ethanol (-). Two different products can clearly be identified from these quick powder 
patterns (collected on the Rigaku R-axis/RAPID single crystal diffractometer) with crystallisation from propanol 
and acetone forming one product and methanol and ethanol the other.  
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Evidence  of  the  third  possible  polymorph  has  been  established  using  powder  diffraction 
(Figure 5.24). These were identified after intensive studies into finding the optimal conditions 
to promote the growth of Form III. Acetone at 10ºC using the Microvate and acetone at ~2-
4ºC using the walk in fridge, gave for a period of time the Form III polymorph (which then 
transformed to Form I over a period of weeks).   
 
Fig. 5.24  Powder patterns of the products of crystallisation from three different environmental conditions to 
promote growth of single component of; form I (blue) using propanol at 10ºC, form II (yellow) using acetone at 
~2-4ºC and form III (red) using acetone at 10ºC. Three different products can clearly be identified from these 
powder patterns.  
 
The  aim  was  to  promote  selective  growth  of  a  particular  molecular  complex  polymorph 
through controlling the conditions. This obviously required an extensive range of conditions 
to  be  explored  initially  to  find  the  conditions  that  promoted  selective  growth.  This  then 
allowed the growth of crystals suitable for X-ray diffraction by exploiting these conditions. 
Table 5.7 gives a visual display showing the products observed by varying the experimental 
environmental conditions.   207 
 
  Methanol  Ethanol  Propanol  Acetone 
2~4ºC           
10ºC               
20ºC                 
30ºC             
Table 5.7 – The results of co-crystallisation experiments on the benzimidazole and 3-chlorobenzoic acid system 
in creating  Form I (blue), Form II (yellow), Form III (red). 
  
Unfortunately due to the limited conditions that promoted the growth of benzimidazole 3-
chlorobenzoic acid molecular complex Form III, single crystals were never obtained. Thus, 
high quality powder X-ray diffraction data were acquired (Figure 5.25), collected over two 
days on the Bruker D8 diffractometer with varying exposure time with the aim of solving the 
structure from this data. Although the technique of solving crystal structures from powder 
data is still relatively new, it has proven very successful by using programs such as DASH 
(refer to Section 2.2.4). However, due to the many unknowns regarding the possible structure 
of Form III – including molecular stoichiometric ratio, proton transfer, solvent inclusion – a 
solution was never found.   208 
 
Fig. 5.25  Powder pattern of benzimidazole and 3-chlorobenzoic acid Form III collected over a 33 hour period.     209 
Two molecular complex polymorphs of benzimidazole and 3-chlorobenzoic acid have been 
analysed successfully by single crystal X-ray diffraction, Forms I and II. They display two 
very different hydrogen bonding motifs, although these motifs are not unexpected.  
 
5.4.1.1.1  Benzimidazole : 3-Chlorobenzoic Acid Molecular Complex 1:1 Form I  
 
The benzimidazole (BZN) : 3-chlorobenzoic acid (3-ClBA) Form 1 molecular complex is a 
equimolar material obtained using the solvent evaporation method. Using a 1:1 stoichiometric 
mixture  of    benzimidazole  (12mg)  and  3-chlorobenzoic  acid  (16mg)  dissolved  in  the 
minimum amount of acetone followed by evaporation at a constant temperature of between 2 
and 4ºC using a walk in fridge gave crystals that were needle shaped and colourless.  Single 
crystal X-ray diffraction data were obtained using a Rigaku R-axis/RAPID diffractometer at 
100K,  equipped  with  graphite  monochromated  Mo  Kʱ  radiation  (λ  =  0.71073  Å).  The 
structure was solved using SIR92 within the CRYSTALS program. The crystallographic data 
are summarised in Table 5.6. This is one of only two molecular complexes which contain 
BZN and a carboxylic acid containing molecule in a 1:1 ratio where proton transfer has not 
occurred (Table 5.4). The data quality is relatively poor and thus accurate hydrogen positions 
are  not  fully  reliable.  However  there  is  no  residual  electron  density  observed  around  the 
unprotonated nitrogen atom of the BZN and is instead clearly associated with the carboxylic 
acid group (Figure 5.26).  
 
   
Fig. 5.26 – LHS, Fourier difference map of the residual electron density in BZN : 3-ClBA molecular complex 
with the proton associated with the carboxylic acid group removed, RHS, the BZN and 3-ClBA  molecules 
involved in the molecular complex with associated atom labelling. 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N2···O2  2.575(7)  0.951(5)  1.640(5)  166(3)   210 
Table. 5.8 – The intermolecular interactions involved in the BZN : 3-ClBA Form I molecular complex 
 
The result of the absence of proton transfer is that the BZN and 3-ClBA remain in their 
neutral state with no charge delocalised over the atoms and therefore no normalisation of 
bond lengths or angles.  
 
There are two primary hydrogen bonds within this structure; both are slight derivatives of 
hydrogen bond B (Figure 5.21) with only the positioning of the hydrogen the difference. The 
shorter of the two has the hydrogen on the oxygen, O2-H∙∙∙N2, which has length 2.575(7)Å 
while the other of length 2.760(6)Å has the hydrogen on the nitrogen, N1-H∙∙∙O1 (see Table 
5.5  for  hydrogen  bond  data).  The  supramolecular  synthons  arrange  themselves  into  an 
equimolar  hydrogen  bonded  ring  system  that  can  be  described  by  the  graph  set  notation 
symbol 
4
4 R (16). This hydrogen bonded ring system is the motif of the molecular complex 
and contains two occurrences of each co-molecule (Figure 5.27).  
  
     
Fig. 5.27 – LHS, the main motif of the BZN : 3-ClBA Form I molecular complex; an equimolar hydrogen 
bonded ring system held together by N-H···O and O-H∙∙∙N hydrogen bonds; RHS, view along the b- axis that 
highlights the spatial arrangement of the equimolar hydrogen bonded ring system. 
 
N1···O1  2.760(6)  0.950(5)  1.874(4)  154(3) 
Cl1···Cl1  3.325(3)  -  -  - 
C1···O2  3.272(8)  0.950(6)  2.518(5)  136(4) 
C10···O2  3.355(6)  0.951(4)  2.631(4)  132(3)   211 
The hydrogen bonded rings are expanded by weaker interactions in all directions. The most 
influential are chlorine–chlorine interactions that expand the structure along the ab-diagonal 
axis (Figure 5.28). These interactions are of length 3.325(3)Å and are highly directional. 
 
Fig. 5.28 – View along the  a-axis of the BZN : 3-ClBA Form I  molecular complex  highlighting  how the 
chlorine chlorine interaction connects the rings together (green circles). 
 
The carbon located between the two nitrogens in the BZN molecule, a common hydrogen 
bond donor, is hydrogen bonded to an oxygen belonging to a different ring motif. Each of 
these carbons hydrogen bonds to an oxygen in opposite directions which results in stacks of 
hydrogen bonded rings which lie along the a-axis (Figure 5.29 LHS). This weak hydrogen 
bond, C1-H∙∙∙O2, is of length 3.272(8)Å (Figure 5.29 RHS). 
 
          
Fig. 5.29 – LHS, view along the b-axis of the BZN 3-ClBA Form I molecular complex highlighting how the 
hydrogen bonded rings stack upon one another. RHS, the weak hydrogen bond, C1-H∙∙O2, which stacks the rings 
upon one another. 
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The weakest interaction present in the BZN : 3-ClBA Form I molecular complex expands the 
structure along the b-axis. This weak hydrogen bond exists between two 3-ClBA molecules of 
different rings and involves a carbon of the benzene ring and carbonyl oxygen, C10-H∙∙∙O2, 
that has length 3.355(6)Å (Figure 5.30). 
 
 
Fig. 5.30  View along the a-axis of the BZN 3-ClBA Form I molecular complex. The hydrogen bonded rings, 
the main motif of the structure, are expanded along the b-axis by weak C-H∙∙∙O hydrogen bonds. 
 
Figure  5.31  is  a view of the extended structure of the  BZN : 3-ClBA  Form  I molecular 
complex. The main motif, hydrogen bonded rings, (blue circle) are stacked upon one another 
through carbon oxygen hydrogen bonds as seen in Figure 5.27. These stacks of hydrogen 
bonded rings are expanded along the b-axis by another weak carbon oxygen hydrogen bond 
(Figure 5.30) (red circle) to create blocks. Lastly these blocks are connected through chlorine–
chlorine interactions as describe in Figure 5.28 which completes the structure (green circle).  
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Fig. 5.31 – An extended view along the a-axis of the BZN 3-ClBA Form I molecular complex. The hydrogen 
bonded ring motif (blue circle), is expanded along the b-axis by weak C-H∙∙∙O hydrogen bonds (red circle) and 
the ab-diagonal by chlorine-chlorine interactions. 
 
5.4.1.1.2  Benzimidazole : 3-Chlorobenzoic Acid Molecular Complex 1:1 Form II  
 
Form II of the benzimidazole (BZN) : 3-chlorobenzoic acid (3-ClBA) molecular complex 
contains the ionic species in a 1:1 ratio, where each benzimidazole has an average 0.5+ charge 
and each 3-chlorobenzoic acid an average 0.5– charge.  The molecular complex was obtained 
using the solvent evaporation method, with a 1:1 stoichiometric mixture of  benzimidazole 
(12mg)  and  3-chlorobenzoic  acid  (16mg)  dissolved  in  the  minimum  amount  of  methanol 
followed by evaporation at a constant temperature of between 2 and 4ºC using a walk in 
fridge.  This  generated  crystals  that  were  blocky  and  colourless.  Single  crystal  X-ray 
diffraction data were obtained using a Bruker ApexII diffractometer at 100K, equipped with 
graphite monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using 
SUPERFLIP within the CRYSTALS program. The crystallographic data are summarised in 
Table 5.6.  
 
Form  II  of  the  BZN  :  3-ClBA  molecular  complex  contains  the  ionic  species  of  the  co-
molecules, rather than their neutral states found in Form I. The BZN molecule is partially   214 
protonated through hydrogen transfer from the carboxylic acid group on the 3-ClBA molecule 
onto the normally unprotonated nitrogen atom in the five-membered ring forming a BZNH
0.5+ 
molecule (Figure 5.32). Therefore the 3-ClBA molecule retains a share of the proton forming 
a 3-ClBA
0.5- species. A centre of symmetry midway between two BZNH
0.5+ molecules means 
that the hydrogen atom in this group is disordered over two positions, and overall the two 
hydrogen-bonded  benzimidazole molecules exhibit  a total  1+ charge.  Equally, the two 3-
ClBA
0.5- molecules also have a proton positioned on a centre of symmetry and therefore the 
hydrogen atom in this hydrogen bond is disordered over two positions (Figure 5.33). The 
result of the proton transfer on the BZNH
0.5+ molecule is delocalisation of the partial charge 
across the five-membered ring which has the effect of creating a partial positive charge on 
both nitrogens (Table 5.4). The 3-ClBA
0.5- molecules also exhibit partial normalisation of the 
carbon oxygen bond lengths due to the partial deprotonation.  
 
 
Fig. 5.32 – The co-molecules involved in the BZNH
0.5+ : 3-ClBA
0.5- molecular complex (BZN : 3-ClBA Form II) 
with atom labelling. 
 
Table. 5.9 – The interactions that are present within the BZN : 3-ClBA Form I molecular complex 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O1···O1  2.494(1)  1.246(1)  1.246(1)  180(1) 
N1···N1  2.676(1)  1.338(1)  1.338(1)  180(1) 
N2···O1  2.830(1)  0.84(2)  2.00(2)  172(3) 
C1···O2  3.074(1)  0.97(2)  2.17(2)  155(2) 
C13···Cl1  3.354(1)  -  -  - 
C12···π  3.724(1)  -  -  -   215 
           
Fig. 5.33 – LHS, a MCE Fourier difference map generated where the H atoms located on the N atom have been 
omitted from the model, clearly showing that the proton is split over two sites; RHS, a MCE Fourier difference 
map generated where the H atoms located on the carboxylic acid group have been omitted from the model, again 
clearly showing that this proton is split over two sites. 
 
The major difference between the polymorphs is the motifs they adopt. Form I adopts the 1:1 
equimolar  hydrogen  bonded  ring  motif  containing  N-H∙∙∙O  and  O-H∙∙∙N  hydrogen  bonds, 
whereas  the  dominant  Form  II  motif  is  a  chain  of  alternate  co-molecule  dimers,  linked 
together through N
ʴ+-H∙∙∙O
ʴ- hydrogen bonds (Figure 5.34).  
 
     
Fig. 5.34 – LHS, the supramolecular synthon of the BZN : 3-ClBA Form II molecular complex, co-molecule 
dimers, linked together through N
ʴ+-H∙∙∙O
ʴ-  hydrogen bonds, RHS, the main motif of the BZN : 3-ClBA Form I 
molecular complex, an equimolar hydrogen bonded ring system held together by N-H···O and O-H∙∙∙N hydrogen 
bonds. 
 
The 3-ClBA
0.5- dimer contains the strongest hydrogen bond within the structure, which has 
length O1
ʴ-∙∙∙O1
ʴ-, 2.4944(3)Å. This is shorter than the distance found within the carboxylic   216 
acid dimer of the 3-ClBA starting material (2.558(4)Å). The native BZN
 structure has N-
H∙∙∙N hydrogen bonds of length 2.8845(3)Å, in this case it is also shortened to 2.6757(3)Å. In 
both the BZNH
0.5+ and 3-ClBA
0.5- the reason for the shortened hydrogen bond lengths is the 
presence of partially charged co-molecules, which creates a partially charge assisted hydrogen 
bond. The hydrogen bond that exists between the dimers, a N2
ʴ+-H∙∙∙O1
ʴ- hydrogen bond, is 
on the long side at 2.8300(4)Å in comparison to other N
ʴ+-H∙∙∙O
ʴ- interactions. Table 5.5 
contains the full hydrogen bond details. 
 
The  molecular  complex  also  contains  a  secondary  supramolecular  synthon  that  is  an 
equimolar hydrogen bonded ring connecting two of the motifs together, that can be described 
by the graph set notation 
4
4 R (14) (Figure 5.35). This supramolecular synthon uses two weak 
hetero-hydrogen  bonds;  one  is  the  hydrogen  bond  that  holds  the  dimers  together,  N2
ʴ+-
H∙∙∙O1
ʴ-(a), while the other uses the carbon most susceptible to hydrogen bonding and the 
other oxygen of the carboxylic acid group, C1-H∙∙∙O2
ʴ- (b). This hydrogen bond has length 
3.0740(3)Å and is the only interaction that oxygen O2 is involved in. The hydrogen bonded 
ring expands the structure along the a-axis, which can be seen in Figure 5.34 LHS, this has 
the effect of stacking the layers of the motif upon one another.  
 
Fig. 5.35 – The secondary supramolecular synthon of the BZN : 3-ClBA Form II molecular complex that links 
the motifs together along the a-axis. 
 
The c-axis is expanded through two weaker interactions that can be seen Figure 5.36. The 
most influential is a halogen bond between the chlorine and a carbon of another 3-ClBA
0.5- 
molecule (c). The C13-H∙∙∙Cl halogen bond is of length 3.3536(3)Å which is of similar in 
a 
a 
b 
b   217 
length to the chlorinechlorine interaction found in Form I. The other lesser interaction is a C-
H∙∙∙π bond between C12 of the 3-ClBA
0.5- molecule and the π-electrons of BZNH
0.5+. The 
length of this interaction is rather long at 3.7241(5)Å. 
 
 
Fig. 5.36 – The lesser interactions c, halogen bond and d, C-H∙∙∙π interaction, that expand the structure along the 
c-axis. 
 
The BZN : 3-ClBA Form II molecular complex has a motif that is a chain of alternate co-
molecule  dimers,  linked  together  through  N
ʴ+-H∙∙∙O
ʴ-  hydrogen  bond  that  expands  the 
structure along the b-axis. The secondary supramolecular synthon, an equimolar hydrogen 
bonded ring of weak hydrogen bonds, expands the structure along the a-axis while the c-axis 
is expanded by a halogen bond and C-H∙∙∙π interaction (Figure 5.37). For comparison the 
main motif of the BZN 3-ClBA Form I molecular complex is hydrogen bonded rings which 
are stacked upon one another through weak carbon oxygen hydrogen bonds. These stacks of 
hydrogen  bonded  rings  are  expanded  along  the  b-axis  by  another  weak  carbon  oxygen 
hydrogen bond to create blocks which are expanding through chlorine–chlorine interactions 
(Figure 5.31).   
 
c 
d   218 
 
Fig. 5.37 – LHS, an extended view along the a-axis of the BZN : 3-ClBA Form II molecular complex. The 
motif, a chain of alternating co-molecule dimers (blue) is expanded along the c-axis via halogen bonds (green), 
RHS, an extended view along the a-axis of the BZN : 3-ClBA Form I molecular complex. The hydrogen bonded 
ring motif (red circle) is expanded along the b-axis by weak C-H∙∙∙O hydrogen bonds (red box) and along the ab-
diagonal by chlorine-chlorine interactions (green circle). 
 
5.4.1.2 Molecular Complex of Benzimidazole and 4-Chlorobenzoic Acid 1:1. 
 
The  study  into  the  benzimidazole  and  4-chlorobenzoic  acid  system  yielded  two  possible 
molecular complex polymorphs. The successful co-crystallisation experiments began by using 
the evaporation technique with just four different solvents at room temperature (Figure 5.38) 
  
 
Fig. 5.38 – DSC thermogram of the products from benzimidazole and 4-chlorobenzoic acid co-crystallisations in 
acetone  (-)  ethanol  (-),  methanol  (-)  and  propanol  (-).  It  can  clearly  be  seen  that  there  are  two  distinct 
endothermic changes that relate to phase changes around 123ºC and 132ºC. 
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A more extensive study similar to that carried out for the benzimidazole and 3-chlorobenzoic 
acid  system  was  undertaken  with  the  aim  to  grow  selectively  each  of  the  molecular 
complexes. A visual summary can be seen in Table 5.10. 
 
  Methanol  Ethanol  Propanol  Acetone 
Room T           
10ºC             
20ºC               
30ºC           
Table 5.10 – The results from the co-crystallisation experiments between benzimidazole and 4-chlorobenzoic 
acid with Form I (high temperature phase) shaded in blue and Form II (low temperature phase) in red. 
 
Powder X-ray diffraction studies of pure Form II resulted in an amorphous pattern, however 
experiments  on  what  is  thought  to  be  a  mixed  phase,  crystallised  using  acetone  at  room 
temperature, produced evidence for at least two forms (Figure 5.39). 
 
 
Fig. 5.39 - Powder patterns of the products of crystallisation from two different environmental conditions to 
promote growth of single component of Form I (blue) using ethanol at room temperature and a mixed phase of 
Forms I and II (red) using acetone also at room temperature.     220 
 
From these findings, it should be possible to produce stable samples of Form II under the 
correct conditions.  This is tentatively termed a polymorph here as there are many similarities 
with  this  molecular  complex  system  and  that  of  benzimidazole  and  4-bromobenzoic  acid 
where two polymorphic forms can be clearly identified. 
 
The molecular ions, BZNH
+ and 4-ClBA
- form a 1:1 molecular complex with one another.  
The material was obtained using the solvent evaporation method, with a 1:1 stoichiometric 
mixture of benzimidazole (14mg) and 4-chlorobenzoic acid (16mg) in the minimum amount 
of acetone  followed by evaporation at  a constant  temperature of ~2-4ºC using a walk  in 
fridge.  The  crystals  generated  were  block  shaped  and  colourless.  Single  crystal  X-ray 
diffraction  data  were  obtained  using  a  Rigaku  R-axis/RAPID  diffractometer  at  100K, 
equipped with graphite monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was 
solved  using  SIR92  within  the  CRYSTALS  program.    The  crystallographic  data  are 
summarised in Table 5.6.  
 
As described in Section in 5.2.1, a BZNH
+ molecule is generated through hydrogen transfer 
from the 4-ClBA (Figure 5.40). This has the effect of normalising the internal BZNH
+ carbon 
– nitrogen bond lengths (Table 5.4) and the carbon – oxygen bond lengths on the 4-ClBA
-  
 (Table 5.11).  There are two of each co-molecule within the asymmetric unit.  
 
Fig. 5.40 - The molecular ions, two of each co-molecule BZNH
+ and 4-ClBA
- 
that make up this molecular complex, with atom labelling.  The numbers, 1 to 
4, designate their molecule number. 
Table.  5.11  -  The  carbon  – 
oxygen  bond  lengths  within 
the two 4-ClBA
- molecules.  
 
 
 
 
Molecule 3 
C3-O1
ʴ- (Å)  1.288(2) 
C3-O1
ʴ-(Å)  1.250(2) 
Molecule 4 
C3-O1
ʴ-(Å)  1.261(2) 
C3-O1
ʴ-(Å)  1.271(2)  1  2  3  4   221 
 
Table. 5.12 – The inter- and intramolecular interactions found within the BZNH
+ 4-ClBA
- molecular complex 
 
The two 4-ClBA
- molecules have separate roles within the structure; one is involved in a 
hydrogen bonded ring, while the other acts to connect rings together. The same is seen with 
the BZNH
+ molecules. The hydrogen bonded ring uses molecules 1 and 3, described by the 
graph set notation 
4
2 R (8), that is made up of hydrogen bonds in the style of form B, through 
N2
ʴ+-H∙∙∙O1
ʴ- and N2
ʴ+-H∙∙∙O2
ʴ- hydrogen bonds.  The nitrogen of the BZNH
+ is involved in a 
double hydrogen bond of distance 2.900(2)Å and 2.832(2)Å (Table 5.12 for full interaction 
details)  (Figure  5.41).  This  ring  is  one  of  the  supramolecular  synthons  that  make  up  the 
structure. 
 
Fig. 5.41 – The supramolecular synthon, the hydrogen bonded rings, involves one of each co-molecule. 
 
The hydrogen bonded rings are connected together by the other co-molecules, molecules 2 
and 4. They achieve this by forming a greater ring network which is the main motif for this 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N2···O1  2.900(2)  0.87(2)  2.15(2)  144(2) 
N2···O2  2.832(2)  0.87(2)  2.27(3)  122(2) 
N1···O3  2.642(2)  0.97(2)  1.67(2)  157(2) 
N3···O4  2.682(2)  1.05(3)  1.80(2)  169(3) 
N4···O2  2.606(2)  0.93(2)  1.56(3)  176(2) 
Cl1···π  3.311  -  -  - 
C···Cl2  3.412(1)  -  -  -   222 
molecular complex and described by the graph set notation symbol 
8
8 R (32). Figure 5.42 
shows the motif coloured in a way that the symmetry equivalent molecules are the same 
colour, thus the supramolecular synthon (small hydrogen bonded ring) is yellow and green 
while molecules 2 and 4 are red and blue respectively. Three moderate hydrogen bonds hold 
the two smaller rings together; a, N
ʴ+-H∙∙∙O
ʴ- 2.642(2)Å, and b, 
 N
ʴ+-H∙∙∙O
ʴ- 2.682(2)Å and c 
N
ʴ+-H∙∙∙O
ʴ-, 2.606(2)Å (Table 5.5). It can be seen that the ring is not closed off to other 
hydrogen bonds, the BZNH
+ molecules involved in the supramolecular synthon (molecule 1) 
can further expand the structure to create the next motif (Figure 5.42 red circle). 
 
 
 
Fig.  5.42    The  motif    of  the  BZNH
+  and  4-ClBA
-  molecular  complex  with  molecules  coloured  that  are 
symmetry related, i.e. molecule 1 yellow, molecule 2 red, molecule 3 green and molecule 4 blue. Highlighted by 
a red circle is the BZNH
+ molecules that further expand the structure. 
 
The only other significant interactions within the structure involve the chlorine atoms, the 
chlorine on molecule 4 is involved in a halogen–π interaction of length 3.311Å (measuring to 
a centroid position) with the other 4-ClBA
- molecule (Figure 5.43), while the chlorine on 
molecule 3 acts as the acceptor in a halogen bond with a C-H group on molecule 4 with length 
3.415(2)Å.  
a 
b 
c   223 
 
 
Fig. 5.43 – The halogen bond and halogen–π interactions that exist between the two 4-ClBA
- molecules. 
The images in Figure 5.44 show the extended structure looking along the b and c axis. They 
both demonstrate that the motif, the extended ring network, expands the structure along the b 
and c directions while the halogen interactions  connect the motifs together which therein 
expand the structure along the c-axis (green shaded area).  
   
Fig. 5.44 –  LHS, view along the b-axis of the BZNH
+ : 4-ClBA
- molecular complex; RHS, view along the c-
axis. Both images show the hydrogen bonded network that is held together by halogen interactions (green box 
and line). 
 
5.4.1.3 Molecular Complex of Benzimidazole and 4-Bromobenzoic Acid 1:1 
 
The benzimidazole : 4-bromobenzoic acid molecular complex does not just show similarities 
with the benzimidazole and 4-chlorobenzoic acid in terms of forming polymorphs, but their 
structures are also isomorphic.    224 
 
Table 5.13 shows part of the range of crystallisation conditions used in trying to selectively 
grow each molecular complex polymorph. As can be seen from the DSC (Figure 5.45) and 
powder X-ray diffraction data (Figure 5.46), control of the different  forms was relatively 
simple. 
 
  Methanol  Ethanol  Propanol  Acetone 
Room T         
20ºC           
30ºC             
Table 5.13 – The results from the co-crystallisation experiments between benzimidazole and 4-bromobenzoic 
acid with Form I (high temperature phase) shaded in blue and Form II (low temperature phase) in red. 
 
 
Fig. 5.45 – DSC thermogram of the products of benzimidazole and 4-bromobenzoic acid co-crystallisations in 
acetone (-) and methanol (-). It can clearly be seen that there are two distinct endothermic changes that relate to 
phase changes around 123ºC and 142ºC. 
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Fig. 5.46 - Powder patterns of the products of crystallisation from four different environmental conditions to 
promote growth of single component of Form I (blue) using propanol and ethanol and Form II (red)  using 
acetone and methanol all at room temperature. The product pattern from the benzimidazole and 4-chlorobenzoic 
acid cocrystallisations 
 
As stated, the molecular complex BZNH
+ : 4-ClBA
- is an isostructure of the BZNH
+ : 4-
BrBA
- molecular complex. Therefore the report on this structure will give a brief description – 
refer to BZNH
+ : 4-ClBA for full details. BZNH
+ and 4-BrBA
- form a 1:1 molecular complex 
with one another.  The material was obtained using the solvent evaporation method, with a 
1:1 stoichiometric mixture of benzimidazole (12mg) and 4-bromobenzoic acid (18mg) in the 
minimum  amount  of  ethanol  followed  by  evaporation  at  room  temperature.  The  crystals 
generated  were  block  shaped  and  colourless.  Single  crystal  X-ray  diffraction  data  were 
obtained  using  a  Bruker  Nonius  Kappa  diffractometer  at  100K,  equipped  with  graphite 
monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using SIR92 
within the CRYSTALS program.  The crystallographic data are summarised in Table 5.6.  
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As described in Section 5.2.1 a BZNH
+ molecule is generated through hydrogen transfer from 
the 4-BrBA. This has the effect of normalising the internal BZNH
+ carbon – nitrogen bond 
lengths (Table 5.4) and the carbon – oxygen bond lengths.  
 
As in the BZNH
+ : 4-ClBA
- molecular complex the motif is a extended hydrogen bonded ring 
described by the graph set notation symbol 
8
8 R (32). The motif is made up of two smaller 
equimolar hydrogen bonded rings (
4
2 R (8)) involving one pair of co-molecules. The other co-
molecules join these rings together. All the interactions between the co-molecules are through 
moderate N
ʴ+-H∙∙∙O
ʴ- hydrogen bond.  There are five unique N
ʴ+-H∙∙∙O
ʴ- hydrogen bonds in the 
molecular complex and their scalar quantities are in Table 5.5.  The motifs hydrogen bond run 
along the b- and c-axis while halogen bonds extend the structure along the a-axis (Figure 
5.47). 
 
   
Fig. 5.47 –  LHS, View along the b-axis of the BZNH
+ : 4-BrBA
- molecular complex; RHS, view along the c-
axis. Both images show the hydrogen bonded network that is held together by halogen interactions (green box 
and line). 
 
5.4.2  Isomorphism 
 
“Two crystals are said to be isomorphic if they have the same structure, but not necessarily 
the  same  cell  dimensions  nor  the  same  chemical  composition,  and  with  a  'comparable' 
variability  in  the  atomic  coordinates  to  that  of  the  cell  dimensions  and  chemical   227 
composition”
29. Analysis of the molecular complexes generated between benzimidazole the 
halobenzoic acid series resulted in the serendipitous discovery of two series of isostructures as 
discussed in Section 5.2 (Table 5.3) 
 
Benzimidazole  Ortho  Meta  Para 
Fluorobenzoic Acid       
Chlorobenzoic Acid       
Bromobenzoic Acid       
Iodobenzoic Acid       
Table  5.3  –A  summary  of  the  molecular  complexes  –  those  that  have  generated  isomorphic  structures  are 
coloured (blue and yellow) with grey indicating no isomorphism. 
 
The benzimidazolium : 4-chlorobenzoate and benzimidazolium : 4 bromobenzoate molecular 
complexes also produced polymorphism and thus were discussed in Sections 5.4.2 and 5.4.3, 
respectively.  The  benzimidazole  :  3-chlorobenzoic  acid  Form  II  (section  5.4.1.3)  is  the 
isomorphic partner of the benzimidazole : 3-bromobenzoic acid molecular complex. 
  
5.4.2.1 Molecular Complex of Benzimidazole and 3-Bromobenzoic Acid 1:1 
 
Co-crystallisation experiments between benzimidazole and 3-bromobenzoic acid produced a 
new molecular complex which has been identified by powder X-ray diffraction (Figure 5.48) 
and  its  structure  determined  by  single  crystal  X-ray  diffraction.  DSC  analysis  was  less 
conclusive in this case as it produced a thermogram similar to that from the product of the 
benzimidazole  3-chlorobenzoic  acid  co-crystallisation  experiments  (Appendix  A)  which 
produced three polymorphs. Although molecular complex polymorphism was found in the 
isostructural polymorphs of benzimidazolium : 4-chlorobenzoate and benzimidazolium : 4-
bromobenzoate, the range of crystallisation conditions used have to date only produced a 
single form of benzimidazole : 3-bromobenzoic acid. 
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Fig. 5.48  Powder patterns of the products of crystallisation from three different environmental conditions to 
promote the growth the benzimidazole : 3-bromobenzoic acid molecular complex using methanol at 10ºC (red) 
ethanol  at  10ºC  (blue)  and  acetone  at  10ºC  (yellow).  The  powder  pattern  of  Form  II  benzimidazole  3-
chlorobenzoic acid, the corresponding isomorphic structure 
 
The  molecular  complex  contains,  on  average,  the  partial  ionic  species  of  benzimidazole 
(BZN) and 3-chlorobenzoic acid (3-ClBA) in a 1:1 ratio, where each benzimidazole has an 
average  0.5+  charge  and  each  3-chlorobenzoic  acid  an  average  0.5–  charge.  This  is  a 
consequence of the presence of two of each type of molecule in the asymmetric unit where the 
H atom is disordered over two positions. The result of the proton transfer on the BZNH
+ 
molecule is delocalisation of the partial charge across the five-membered ring which has the 
effect of creating a partial positive charge on both the nitrogens (table  5.4). The 3-BrBA
- 
molecules also observe partial normalisation of the carbon oxygen bond lengths due to the 
partial deprotonation. 
 
Block shaped colourless crystals were obtained using the solvent evaporation method, with a 
1:1 stoichiometric mixture of benzimidazole (12mg) and 3-bromobenzoic acid (18mg) in the 
minimum  amount  of  ethanol  followed  by  evaporation  at  ~2-4ºC.  Single  crystal  X-ray 
diffraction data were obtained using a Bruker Kappa diffractometer at 200K, equipped with 
graphite monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using   229 
SIR92 within the CRYSTALS program. The crystallographic data are summarised in Table 
5.6.  
 
      
Fig. 5.49 – LHS, the supramolecular synthon of the BZNH
+ : 3-BrBA
- molecular complex, dimers of each co-
molecule are connected through a N
ʴ+-H∙∙∙O
ʴ- moderate hydrogen bond,  RHS, the secondary supramolecular 
synthon of  that links the motifs together along the a-axis. 
 
The primary supramolecular synthons, dimers of the co-molecules held together through a 
N
ʴ+-H∙∙∙O
ʴ- moderate hydrogen bond (see Table 5.5 for hydrogen bond details) (Figure 49 
LHS), connect along the b-axis to create a chain; this is the motif of the structure. These 
chains are held together through the secondary supramolecular synthon which is an equimolar 
hydrogen bonded ring made up of a weak C-H∙∙∙O and moderate N
ʴ+-H∙∙∙O
ʴ- hydrogen bond 
which expands  the structure along the  a-axis  (Figure 5.49 RHS). The  c-axis  is expanded 
through lesser halogen and C-H∙∙∙π bonds (Figure 5.50).   230 
 
Fig. 5.50 – View along the a-axis of the extended structure of the BZNH
+ : 3-BrBA
- molecular complex, the 
motifs (blue box) are held together through weak halogen and C-H∙∙∙π interactions (brown box).  
 
5.4.3  Benzimidazole and Fluorobenzoic Acid Structures  
   
The co-crystallisations between benzimidazole and halobenzoic acids also produced two new 
molecular complexes involving fluorobenzoic acid. 
 
5.4.3.1 Molecular Complex of Benzimidazole and 2-Fluorobenzoic Acid 1:2 
 
A  1:1  stoichiometric  mixture  of  BZN  (12mg)  and  2-fluorobenzoic  acid  (2-FBA)  (14mg) 
dissolved in the minimum amount of methanol followed by evaporation at room temperature 
to generate an oil, which then was transferred to a walk in fridge, ~2-4ºC, to form a new 
molecular complex. The molecular complex consists of the molecular ions BZNH
+ and 2-
fluorobenzoate (2-FBA
-) and the neutral molecule 2-fluorobenzoic acid that forms a 1:1:1 
molecular complex with crystals that are block shaped and colourless (Figure 5.51). Single 
crystal X-ray diffraction data were obtained using a Bruker Apex II diffractometer at 100K, 
equipped with graphite monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was   231 
solved using SIR92 within the WINGX program.  The crystallographic data are summarised 
in Table 5.6. In this molecular complex as in others, hydrogen transfer from the carboxylic 
acid group on the 2-FBA
 molecule onto the normally unprotonated nitrogen atom in the five-
membered ring forms BZNH
+ molecules (see Section 5.2.1). The result is a delocalisation of 
the charge across the five-membered ring as reflected in the internal bond lengths and angle 
(Table 5.4).  
 
 
Fig. 5.51 – The BZNH
+, 2-FBA and 2-FBA
- molecules, from left to right, that make up the BZNH
+ : 2-FBA
- : 2-
FBA molecular complex, with atom labelling. 
  
Interacti
on 
Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds    2-FBA  2-FBA
- 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º)  C-O(Å)  1.317(1)  1.255(1) 
N1···O3  2.696(1)  0.90(4)  1.79(5)  171(5) 
N2···O3  2.723(1)  0.91(4)  1.85(5)  162(5)  C-O(Å)  1.209(1)  1.264(1) 
O2···O4  2.576(1)  0.85(5)  1.76(5)  156(4) 
C13···F1  3.347(1)  -  -  -  Twisting 
(º)  
0.64  36.63 
C1···O4  3.019(1)  0.93(3)  2.44(4)  120(3) 
Table 5.14 – LHS, The interactions that are involved in the molecular complex of BZN and 2-FBA, RHS, bond 
lengths and degree of twisting of the carboxylate group data for the 2-FBA and 2-FBA
- molecules. 
 
The 2-FBA
 molecule retains the proton on the carboxylic acid group and thus there is no 
normalisation of bond lengths (Table 5.14). On the other hand the ionic species, 2-FBA
-, has 
been deprotonated and the consequential bond normalisation has occurred. The 2-FBA
- ion is 
also  disordered  over  two  sites  with  the  best  model  having  occupancy  levels  of  F2a:F2b, 
0.75:0.25.   
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There are three primary hydrogen bonds within the  BZNH
+ : 2-FBA : 2-FBA
- molecular 
complex, two of form B and one of form A (Figure 5.52). The form B hydrogen bonds, N1
ʴ+-
H∙∙∙O3
ʴ- and N2
ʴ+-H∙∙∙O3
ʴ-, are moderate in strength with lengths 2.6955(2)Å and 2.7226(1)Å 
respectively  (Table  5.5).  The  form  A  hydrogen  bond  between  the  2-FBA  and  2-FBA
- 
molecules is slightly shorter at 2.5764(1)Å.    
 
 
Fig. 5.52 – The primary hydrogen bonds within the BZNH
+ : 2-FBA : 2-FBA
- molecular complex.  
 
The form B hydrogen bonds between the molecular ions arrange their molecules into a zigzag 
chain along the b-axis, this is the motif of the structure (Figure 5.53).   
   
Fig. 5.53 – The motif of the BZNH
+ : 2-FBA : 2-FBA
- molecular complex, zigzag chains between the BZNH
+ 
and 2-FBA
- co-molecules using the N-H∙∙∙O form B hydrogen bond. LHS, view along the a-axis; RHS, view of 
the b-axis. 
 
Connecting motifs together is achieved through weaker interactions, one of which is a C-H∙∙∙F 
halogen  bond  that  expands  the  structure  along  the  ac-diagonal  axis  (Figure  5.54).  This 
halogen bond is between two 2-FBA molecules, C13-H∙∙∙F1, and is 3.3466(2)Å long. 
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Fig. 5.54 – LHS, two motifs of the BZNH
+ : 2-FBA : 2-FBA
- molecular complex held together along the ac-
diagonal axis by halogen bonds (yellow circle); RHS, view of the halogen bonds, C-H∙∙∙F.   
 
Expanding the structure along the bc-diagonal axis is a C-H∙∙∙O weak hydrogen bond (Figure 
5.55). The C1-H∙∙∙O4 interaction has length 3.0189(2)Å. There are other lesser interactions 
within the structure, however those are not significant and only assist in the interactions that 
have already been mentioned. 
 
  
Fig. 5.55 – The C-H∙∙∙O hydrogen bond that expands the structure along the bc-diagonal axis. 
 
5.4.3.2 Benzimidazole and 3-Fluorobenzoic Acid  
 
The co-crystallisation experiments between benzimidazole and 3-fluorobenzoic acid produced 
a powder which has been analysed using both DSC and powder X-ray diffraction (Figure 
5.56). These patterns indicate that a new material has been formed with a melting point of 
71ºC, much lower than that for both 3-fluorobenzoic acid (121-125ºC) and benzimidazole 
(170-172ºC).  A  wide  range  of  crystallisation  environments  were  tried  to  promote  crystal 
growth, unfortunately no crystals suitable for single crystal X-ray diffraction studies were 
generated. The X-ray powder pattern and main DSC thermogram of the molecular complex 
was generated using the solvent drop method with methanol as the solvent.  
   234 
 
 
 
Fig 5.56 – top, X-ray powder diffraction patterns of benzimidazole : 3-fluorobenzoic acid (red), 3-fluorobenzoic 
acid  (blue)  and  benzimidazole  (green)  clearly  indicating  a  new  product  has  been  produced,  bottom,  DSC 
thermogram of the same materials; benzimidazole : 3-fluorobenzoic acid (purple), 3-fluorobenzoic acid (red) and 
benzimidazole (green)  again indicating a new product is formed, insert, patterns of other co-crystallisations 
experiments.  
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5.4.3.3 Molecular Complex of Benzimidazole and 4-Fluorobenzoic Acid 1:1 
     
The molecular complex between BZN and 4-fluorobenzoic acid (4-FBA) contains one of each 
co-molecule and one of each of their ionic forms in a 1:1:1:1 ratio. The molecular complex 
was  obtained using the  solvent  evaporation method, with a 1:1  stoichiometric mixture of  
BZN (12mg) and 4-BA (12mg) dissolved in the minimum amount of acetone followed by 
evaporation at  a constant  temperature of between 2 and 4ºC using a walk  in  fridge. The 
crystals generated were plate shaped and colourless. Single crystal X-ray diffraction data were 
obtained  using  a  Bruker  Apex  II  diffractometer  at  100K,  equipped  with  graphite 
monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using SIR92 
within the CRYSTALS program. The crystallographic data are summarised in Table 5.6 with 
the interactions involved in the molecular complex listed in Table 5.15.  
 
This is the other example of a molecular complex which contains a BZN and a carboxylic 
acid  containing  molecule  in  a  1:1  ratio  where  proton  transfer  has  not  occurred.  In  this 
structure proton transfer occurs between one set of co-molecules but not the other (Figure 
5.57). The result is that one BZN molecule has been protonated forming a BZNH
+ molecule 
and  one  of  the  4-FBA  molecule-has  been  deprotonated  forming  a  4-FBA
-  molecule.  The 
consequence of the proton transfer on the molecular ions is discussed in Section 5.2.1, while 
one pair of BZN and 4-FBA molecules remain in their neutral state. 
 
 
Fig. 5.57 – LHS, the BZNH
+ and BZN dimers with atom labelling; RHS, the 4-FBA
 and 4-FBA dimers with 
associated labelling. 
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Table 5.15 – The interactions found in the BZN and  4-FBA molecular complex. 
 
As can be seen in Figure 5.54, each neutral molecule and its ionic counterpart interact with 
one another using hydrogen bond forms A and B. These hydrogen bonds are two of the four 
primary hydrogen bonds in the molecular complex with length, N-H∙∙∙N, 2.750(3)Å and ,O-
H∙∙∙O, 2.528(3)Å (see Table 5.15 for full hydrogen bond details). These hydrogen bonds have 
the effect of creating dimers of each co-molecule, which in turn are held together by the other 
primary  hydrogen  bond,  form  C,  creating  the  supramolecular  synthon.  The  two  N-H∙∙∙O 
hydrogen  bonds  differ  slightly  in  their  acceptor  atom  strengths,  with  one  involving 
deprotonated carboxylate oxygen while the other involves the neutral carboxylic acid oxygen. 
This  explains  the  differences  in  strengths,  2.687(2)Å  and  2.800(2)Å.  The  supramolecular 
synthons  combine  to  form  a  zigzag  chain  of  co-molecules,  the  motif  of  this  molecular 
complex (Figure 5.58). 
 
 
Fig. 5.58 – View along the a-axis of the BZN : 4-FBA molecular complex, showing the main motif, a zigzag 
chain of dimers held together by N
ʴ+-H∙∙∙O
ʴ-  hydrogen bonds that expand the structure along the ab-diagonal 
axis. 
 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N2···N3  2.750(3)  0.750(2)  1.81(2)  179(2) 
O3···O2  2.528(3)  1.03(3)  1.50(3)  1.77(3) 
F2···C4  3.191(3)  -  -  - 
F1···C11  3.297(3)  -  -  - 
C1···O1  3.287(2)  0.95(2)  2.55(2)  135(2) 
C12···π  3.499  -  -  -   237 
Connecting the chains along the c-axis are two halogen bonds of length a, 3.191(3)Å and b, 
3.297(3)Å (Figure 5.59). These C-H∙∙∙F halogen bonds are the only interactions that expand 
the structure along this direction. 
 
 
Fig. 5.59 – The a-axis of the BZN : 4-FBA  molecular complex, showing the  main  motifs (blue line) held 
together along the c-axis by C-H∙∙∙F halogen bonds (a and b). 
 
The carbon located between the two protonated nitrogens of the BZNH
+, C1, is involved in a 
weak hydrogen bond with the 4-FBA
- molecule (Figure 5.60). The C1-H∙∙∙O1 hydrogen bond 
has length 3.287(2)Å and is helped to expand the structure along the a-axis by a C-H∙∙∙π 
interaction of length 3.439Å (measured to a centroid between carbons, C19 and C20). 
a  b 
a 
b   238 
   
Fig. 5.60 – The a-axis is expanded by two interactions; a C-H∙∙∙O weak hydrogen bond (blue circle) and a C-
H∙∙∙π interaction (red circle).   
 
The structure is layered with the 4-FBA
- molecule the only molecule that does not lie along 
the c-axis and which promotes interactions between the layers. Figure 5.61 is an extended 
view  along  the  c-axis  which  highlights  two  of  the  interactions  between  the  layers,  π∙∙∙π 
interactions (yellow circle) and C-H∙∙∙O weak hydrogen bonds (green circle). The C-H∙∙∙O 
weak  hydrogen  bonds,  C-H∙∙∙O2  and  C-H∙∙∙O3,  have  lengths  3.396(2)Å  and  3.264(2)Å 
respectively, while the π∙∙∙π interactions are 3.360(4)Å in length. 
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Fig. 5.61 –Top, view along the c-axis of the BZN: 4-FBA molecular complex which highlights the two types 
interactions that exist between the layers: a π∙∙∙π stacking interaction between the BZN dimers (yellow circle) 
and the weak C-H∙∙∙O hydrogen bonds (green circle) between the 4-FBA molecules, bottom LHS, π∙∙∙π stacking 
interactions, bottom RHS,  C-H∙∙∙O weak hydrogen bonds. 
 
5.5   Conclusions  
 
The co-crystallisation experiments between benzimidazole and the halo-benzoic acid series 
resulted  in  the  formation  of  seven  previously  undiscovered  molecular  complexes, 
benzimidazole with the following co-molecules: 2-fluorobenzoic acid, 4-fluorobenzoic acid, 
3-chlorobenzoic acid, 4-chlorobenzoic acid, 3-bromobenzoic acid and 4-bromobenzoic acid. 
Co-crystallisation experiments between benzimidazole and 3-fluorobenzoic acid produced a 
new material identified through DSC and powder analysis, however structure determination 
was  unfeasible.  Two  experiments  produced  oils,  those  between  benzimidazole  with  2-
chlorobenzoic and 2-bromobenzoic acid while co-crystallisation experiments with the iodo 
range of halo-benzoic acids produced only starting materials.  
 
The aim of the work was to investigate the occurrence of molecular complex polymorphism 
and to control selectively the form produced. The results show that polymorphism is common 
within  molecular  complexes,  with  three  of  the  seven  newly  discovered  systems  showing 
evidence of this. Fortunately, controlled growth of a selective polymorph can be achieved 
through changes in crystallisation conditions, as shown for the three materials that showed 
polymorphism.  Unfortunately, it only takes small changes in these conditions to promote 
other forms, for example co-crystallisations between benzimidazole and 3-bromobenzoic acid 
using acetone Form polymorph I at 30ºC, but Form II at 20ºC. 
 
Whilst polymorphism can be unpredictable, the types of hydrogen bonds formed between the 
co-molecules are much less so.  The three primary hydrogen bonds described in Section 5.3   240 
are the only hydrogen bonds within these structures, which is also the case for those structures 
described in Chapter 4: ―Towards selective molecular complex formation: challenging crystal 
engineering‖.  These  dependable  hydrogen  bonds,  N-H∙∙∙O,  N-H∙∙∙N  and  O-H∙∙∙O,  scalar 
quantities for which are given in Table 5.5, have slight ranges in length but always form the 
primary hydrogen bonds in the structures. In the case of benzimidazole with 3-chlorobenzoic 
acid, of the two forms that were structurally determined, Form I adopts the motif of chains of 
dimers while Form II adopts the motif of hydrogen bonded rings. All the other structures in 
the chapter falls into one of these two motifs, in an even split. No firm conclusions can be 
made to why a molecular complex forms a certain motif; further work would be needed. 
 
When  evaluating  the  ΔpKa  difference  values  (Table  5.6)  for  the  molecular  complexes 
obtained, it can be seen that the rule governing if a salt or co-crystal will form has been 
accurate. All of the cocrystallisations had ΔpKa values within the 0~3 range that normally 
means prediction is impossible, which is the case as in the example of polymorprhism within 
the BZN 3CL molecular complex, one form formed the co-crystal while the other formed the 
salt. The cases where the ratio of co-molecule was not 1:1, they tended to form a mixture of 
salt and co-crystal.   
 
In all seven of the structurally determined molecular complexes the halogen atom is involved 
in either a halogen bond or other significant halogen interaction.  These interactions tend to be 
individual in the role they adopt, they are often the only interaction that expands the structure 
in a particular direction. For example in the benzimidazole : 4-fluorobenzoic acid molecular 
complex the halogen bond is the only interaction that expands the structure along the c-axis. 
This body of work shows that the halogen bond is significant and is key in determining the 
overall packing in these structures. 
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5.7   Appendix  
5.7.1  Appendix A – DSC Thermograms of the Co-crystallisation Experiments of 
BZN and 3-BrBA.  
 
Key – The thermograms relate to co-crystallisations of BZN : 3-BrBA in different solvent; propanol (green), 
acetone (blue), acetone (brown), ethanol (pink) and methanol (dark blue)    243 
6  Increasing the Competition – The Introduction of Competing 
Hydrogen Bonding Sites 
 
This chapter will investigate the effect of introducing nitrogen containing functional groups 
into  the  co-molecule  on  the  supramolecular  synthons  obtained  on  co-crystallisation  with 
benzimidazole  and  imidazole.  The  effect  on  proton  transfer,  hydrogen  bonding  motifs, 
crystallisation ratios, weaker interactions and the formation of solvates will be discussed. 
 
The first focus will be on challenging the synthons and hydrogen bond motifs created by co-
crystallisation  of  benzimidazole  with  co-molecules  containing  carboxylic-  and  hydroxyl- 
functional  groups such as those found in Chapters 4 and 5, by introducing another basic 
nitrogen into the co-molecule. This additional basic nitrogen will take the form of carboxyl 
and hydroxyl substituted pyridines and should compete on two fronts: firstly with the other 
basic  nitrogen  on  the  benzimidazole  for  proton  transfer;  secondly  for  involvement  in  the 
potential hydrogen bonds. If left unprotonated, this will compete with the carboxylic acid 
group to be the primary hydrogen bond acceptor and if protonated, it will compete with the 
other protonated nitrogen on the benzimidazole for the primary hydrogen bond donor role.  
 
The  second  section  will  look  at  electronic  effects  introduced  in  the  previously  reported 
molecular  complexes  of  nitro-substituted  benzoic  acid  molecular  complexes  with 
benzimidazole and imidazole This particularly looks at effects such as the normalisation of 
the internal bond lengths, a consequence of the proton transfer, the strength of the hydrogen 
bonds  with  the  variation  in  the  position  of  the  nitro  group  and  the  role  of  the  weaker 
interactions that affect the packing of the structures.   244 
Fig.  6.1  –  The  structure  of  picolinic  acid 
showing the main hydrogen bonds between the 
molecules. Proton disorder can be seen between 
the  carboxylic  acid  hydrogen  bond  and  the 
weaker N-H∙∙∙H-N hydrogen bond. 
6.1   Introduction 
 
The co-molecules to be used in this chapter are picolinic acid, nicotinic acid, isonicotinic acid, 
hydroxypicolinic acids and nitrobenzoic acids. Of this range of compounds, the most widely 
recognizable is nicotinic acid, which is also known as vitamin B3. Two of the nitro substituted 
benzoic acids are commercially important while of the hydroxy substituted picolinic acids 3-
hydroxypicolinic acid is used as a matrix for nucleotides in mass spectrometry. 
 
6.1.1  Picolinic Acid 
 
Picolinic  acid  is  used  as  an  intermediate  to  produce  pharmaceuticals  (especially  local 
anesthetics) and metal salts for the application of nutritional supplements. Picolinic acid is 
also a chelating agent in the body. The acid is believed to form a complex with zinc that 
facilitates  the  passage  of  zinc  through  the 
gastrointestinal  wall  and  into  the  circulatory 
system
1. Picolinic acid has been studied by X-
ray  diffraction  on  three  occasions,  with  the 
latest  structure  determination  being  in  1998 
(CSD reference PICOLA02)
2. A hydrogen atom 
was found to be 50:50 disordered between the 
heteroatom in the ring and the carboxylic acid 
group  (Figure  6.1).  There  are  dimers  of 
picolinic acid molecules linked through a single 
O–H····O hydrogen bond which are connected 
to  one  another  by  N–H∙∙∙N  hydrogen  bonds 
(Figure  6.1)  and  weaker  C-H∙∙∙O  hydrogen 
bonds. Picolinic acid has been complexed with a range of organometallic molecules including 
thalium
3  and  uranium
4  among  others,  however  of  particular  interest  are  the  complexes  it 
forms with other small organic molecules. One of the most recent complexes reported was 
with L-tartaric acid
5 (CSD reference DULGIB) (Figure 6.2 LHS).  The deprotonated form, 
picolinate, has been found in a range of structures coordinated to metals including; samarium, 
europium, holmium, erbium, yttrium
6 and in hydrogen bonded complexes with other small   245 
organic  molecules  including  2-amino-5-methylpyridinium
7  (CSD  reference  TUPVAC) 
(Figure 6.2 RHS). 
       
Fig. 6.2 – LHS, protonated picolinic acid : L-tartrate acid molecular complex; RHS, the molecular complex of 
picolinate and 2-amino-5-methylpyridinium, where the picolinic acid  has been deprotonated.  
 
6.1.2  3-Hydroxypicolinic Acid 
 
3-Hydroxypicolinic acid is used as a matrix for nucleotides in MALDI mass spectrometry 
analyses. There is no reported crystal structure of 3-hydroxypicolinic acid or any molecular 
complexes  with  other  organic  molecules  within  the  CSD.  There  are  examples  of  the 
deprotonated  form,  3-hydroxypicolinate,  with  metals  and  organic  molecules  including; 
thallium
3, 2,4-diamino-(p-chlorophenyl)-6-ethylpyrimidinium
8 and acetoguanaminium
9 (CSD 
reference QUWXIQ) (Figure 6.3). 
 
Fig. 6.3 – Basic building block of the acetoguanaminium 3-hydroxypicolinate monohydrate molecular complex. 
 
6.1.3  6-Hydroxypicolinic Acid 
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6-Hydroxypicolinic  acid  has  recently  been  used  as  a  raw  material  in  the  pharmaceutical 
sector. Its structure was determined in 1998
10 and is more properly referred to as 2-oxo-1,2-
dihydropyridine-6-carboxylic acid (CSD reference POVFIP) (Figure 6.4 LHS). A hydrated 
structure (CSD reference NIGZEJ01)
11 (Figure 6.4 RHS) contains the same double hydrogen 
bond unit, but with the hydrate molecules hydrogen bonding carbonyl and carboxylic groups. 
 
        
Fig. 6.4 – LHS, the structure of 6-hydroxypicolinic acid (2-oxo-1,2-dihydropyridine-6-carboxylic acid) and, 
RHS, a hydrate form.  
 
There  are  examples  of  complexes  involving  the  deprotonated  form  with  small  organic 
molecules including  chloro- and bromo- substituted 2-amino-pyridinium
7 (CSD references 
SUZNEH  and  SUYXIU)  (Figure  6.5).  There  are  also  a  large  number  of  examples  of  6-
hydroxypicolinic  acid  complexes  with  metals  for  example;  copper  (CSD  reference 
BOPXOU)
12,  manganese  (CSD  reference  EXOYIZ)
13  and  lanthanum
  (CSD  reference 
PACSUI)
14 to name but a few. 
 
 
Fig.  6.5  –  The  molecules  involved  in  the  6-hydroxypicolinic  acid  2-amino-5-chloropyridinium  molecular 
complex. 
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6.1.4  Nicotinic Acid 
 
Nictotinic  acid,  also  known  as  vitamin  B3,  is one  of  the  forty  to  eighty  essential  human 
nutrients. A lack of vitamin B3 can lead to pellagra whose symptoms include high sensitivity 
to light, aggression, dermatitis and insomnia among 
a host of others but is classically referred to as the 
four D's: diarrhea, dermatitis, dementia and death. 
The  first  of  the  three  published  structures  of 
nicotinic acid dates from 1953
15. The most recent 
structure  was  published  in  1983  by  Scheringer  et 
al
16  (CSD  reference  NICOAC02)  with  the  main 
hydrogen bond being between the nitrogen and the 
hydroxyl oxygen (Figure 6.6). There are only two 
structures of the neutral molecule contained in the CSD in complex with other small organic 
molecules.  These  are  with  4-aminobenzoic  acid  (CSD  reference  SESLIM)
17  and  3,5-
dinitrobenzoic acid (CSD reference AWUDEB)
18. Other molecular complexes in the CSD 
show examples of both cations, where the nitrogen is protonated
5 (CSD reference DULGEX) 
(Figure  6.7  LHS),  and  anions,  where  the  carboxylic  acid  group  is  deprotonated
7  (CSD 
reference PUKDEF) (Figure 6.7 RHS).  There are no examples of co-crystallisation products 
containing the zwitterionic form. 
 
.     
Fig. 6.7 – LHS, 3-carboxypyridinium hydrogen (2R,3R)-tartrate molecular complex where the nitrogen has been 
protonated; RHS, the molecular complex 2-amino-5-methylpyridinium nicotinate, where the carboxylic group on 
the nicotinic acid has been deprotonated.  
 
6.1.5  Isonicotinic Acid 
 
Fig. 6.6 – The nicotinic acid 
supramolecular synthon showing the 
dominating O-H∙∙∙N hydrogen bond.   248 
The structure of isonicotinic acid was determinded in 1976 by Shimade et al
19 (CSD reference 
ISNICA) and is found to have an O-H····N hydrogen bond (Figure 6.8 LHS). There are a host 
of structures where isonicotinic acid coordinates to metals, both through the basic nitrogen, 
for example with platinum
20 (CSD reference BOXJEE), and through the carboxylic group, for 
example  with  gadolinium
21  (CSD  reference  RUBLIK).  There  are  no  structures  of  neutral 
isonicotinic acid with other small organic molecules reported in the CSD, however there are 
complexes of both the protonated cationic and deprotonated anionic forms.  There are also 
examples where the zwitterion has been created by intramolecular proton transfer from the 
carboxylic acid group to the nitrogen. This has been found in a body of work by Zaworotko et 
al
22 with co-molecules citric acid (CSD reference RUWGAS), gallic acid (CSD reference 
RUWGUM), quercetin (CSD reference RUWHUN)  and 3,4-dihydroxybenzoic (Figure 6.8 
RHS) acid (CSD reference RUWHOH). 
 
 
Fig. 6.8 – LHS, the O-H····N hydrogen bond.in the crystal structure of isonicotinic acid; RHS, the molecular 
complex of isonicotinic acid protocatechuic acid monohydrate, with the zwitterionic form of isonicotinic acid. 
 
6.1.6  2-Nitrobenzoic Acid 
 
2-Nitrobenzoic acid is used as an intermediate in the manufacturing of pharmaceuticals, dyes 
and pigments.  The most recent crystal structure of 2-nitrobenzoic acid was published by 
Portalone
23 in 2009 (Figure 6.9). The structure consists of a conventional hydrogen bonded 
carboxylic acid dimer (R2
2(8)) with an inversion centre in the middle of the hydrogen bonded 
ring and the nitro groups twisted out of the plane. The crystal structure of 2-nitrobenzoic acid 
with benzimidazole in a 3:1 ratio has already been reported, creating the benzimidazolium 2-
nitrobenzoate  bis(2-nitrobenzoic  acid)
24  molecular  complex  (Figure  6.9)  (CSD  reference   249 
Fig. 6.10  The hydrogen bonded carboxylic acid 
dimer of benzimidazolium and 2-nitrobenzoic acid.  
 
XIBWAH). In this structure one of the 2-nitrobenzoic molecules is disordered over two sites.  
In common with all structures involving benzimidazole and a carboxylic acid containing 
molecule,  there  has  been  proton  transfer  with  the  basic  nitrogen  of  the  benzimidazole 
absorbing a proton.  The ratio of 3:1 among the constituent molecules is however unusual. 
     
Fig. 6.9 –  LHS, the hydrogen bonded dimer of 2-nitrobenzoic acid  with the  two  molecules related by an 
inversion centre in the middle of the hydrogen bonded ring and the nitro- groups twisted out of the plane; RHS, 
the  molecular  complex  of  benzimidazolium  2-nitrobenzoate  bis(2-nitrobenzoic  acid)  showing  some  of  the 
hydrogen bonds between the molecules. 
 
6.1.7  3-Nitrobenzoic Acid 
 
3-Nitrobenzoic acid is a precursor to 3-aminobenzoic acid, which in turn is used to prepare 
some dyes. It is prepared by nitration of benzoic acid and is a factor of 10 times more acidic 
than benzoic acid itself. Its crystal structure was 
solved  in  1990  by  Domenicano
25  (CSD 
reference  MNBZAC04)  (Figure  6.10)  and 
exhibits  the  common  carboxylic  acid  dimer 
motif.  The  structure  was  solved  at  room 
temperature  and  this  explains  why  the 
carboxylic  acid  hydrogen  is  found  to  be  disordered  over  two  positions.  The  molecular 
complex  of  3-nitrobenzoic  acid  in  a  1:1  ratio  with  both  benzimidazole,  creating  the 
benzimidazolium 3-nitrobenzoate
2 molecular complex (CSD reference SUZZES) (Figure 6.11 
LHS), and imidazole, producing the imidazolium 3-nitrobenzoate
2 molecular complex (CSD 
reference SUZZUI) have previously been reported (Figure 6.11 RHS).  
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Fig.  6.11  –  LHS,  the  supramolecular  synthon  of  benzimidazolium  and  3-nitrobenzoic  acid;  RHS,  the 
supramolecular synthon of imidazolium and 3-nitrobenzoic acid. 
 
Both of these molecular complexes show proton transfer from the carboxylic acid group to the 
unprotonated nitrogen of the co-molecule. They produce the common N
ʴ+H∙∙∙O
ʴ- hydrogen 
bond, but this creates two very different motifs. The benzimidazolium molecular complex 
forms zigzag chains, while the imidazolium molecular complex forms into a hydrogen bonded 
ring system. 
 
6.1.8  4-Nitrobenzoic Acid 
 
4-Nitrobenzoic acid is a precursor in the synthesis of the anaesthetic Procaine. Its crystal 
structure has been solved by single crystal X-ray and neutron diffraction (CSD references 
NBZOACO4  and  NBZOAZ05
26, 
respectively).  The  crystal  structure 
displays  the  common  carboxylic  acid 
dimer  motif  (Figure  6.12)  with  the 
protons  in  the  hydrogen  bond  showing 
disorder at 302K.  
 
4-Nitrobenzoic  acid  has  been  co-crystallised  with  both  benzimidazole  and  imidazole  by 
Hashizume
27  in  2001.  The  benzimidazolium  4-nitrobenzoate  molecular  complex  (CSD 
reference SUZZIW) exhibits the common N
ʴ+H∙∙∙O
ʴ- supramolecular synthon which creates 
a  zigzag  chains  motif  (Figure  6.13  LHS).  The  imidazolium  4-nitrobenzoate
28  molecular 
complex  (CSD  reference  SABPEQ)  also  forms  the  N
ʴ+H∙∙∙O
ʴ-  suparmolecular  synthon, 
however on this occasion the motif is the hydrogen bonded ring system that has been seen 
many times before (Figure 6.13 LHS). This is the same pattern as that observed for the 3-
nitrobenzoic acid molecular complexes. 
Fig. 6.12 - The hydrogen bonded dimer of 4-
nitrobenzoic acid.   251 
 
 
 
 
 
Fig. 6.13 –LHS, benzimidazolium 4-nitrobenzoate molecular complex that contains the synthon N
ʴ+H∙∙∙O
ʴ-, 
which  forms  into  zig-zag  chains;  RHS,  the  imidazolium  4-nitrobenzoate  molecular  complex  also  forms 
N
ʴ+H∙∙∙O
ʴ- hydrogen bonds, which in this case assemble to form hydrogen bonded rings. 
 
6.2   Summary of Results 
 
Molecular  complexes  of  benzimidazole  with  a  series  of  picolinic  acids  have  been 
characterised  in  this  work.    This  includes  the  first  reported  molecular  complexes  of  3-
hydroxy-  and  6-hydroxypicolinic  acid  with  another  small  organic  molecule.  These  new 
molecular  complexes  have  formed  in  a  variety  of  manners,  with  some  forming  as 
hemihydrates  and  solvates  (Table  6.1).  The  increase  in  the  competition  has,  as  expected, 
increased the difficulty in predicting the main supramolecular synthons in the structure, to 
such  an  extent  that  it  made  structure  solution  difficult  in  the  benzimidazolium  picolinate 
hydrate molecular complex.  This structure contains inherent disorder throughout the structure 
and the diffraction patterns showed strong diffuse scattering. 
 
  Picolinic Acid  3-hydroxypicolinic acid  6-hydroxypicolinic acid 
Benzimidazole  1:1 hydrate  1:1  1:1 & 1:1:2 acetic acid 
Imidazole    1:1   
Table 6.1 – Summary of the molecular complexes successfully generated (blue) between benzimidazole and 
imidazole with picolinic acid and its mono-substituted hydroxyl derivatives.  A diverse range of products was 
generated including a hemihydrate and solvate. 
 
The attempted co-crystallisation of benzimidazole with nicotinic and isonicotinic acids only 
produced an unknown hydrated form of nicotinic acid in single crystal form (Table 6.2) and a 
series of powders. Powder diffraction measurements of the products  were not completed; 
therefore it is still possible that molecular complexes with benzimidazole were produced but 
just did not produce single crystals.    252 
 
  Picolinic Acid  Nicotinic Acid  Isonicotinic Acid 
Benzimidazole  1:1 hydrate  Nicotinic acid hydrate   
Table 6.2 – Summary of the molecular complexes successfully generated (blue) between benzimidazole and 
picolinic, nicotinic and isonicotinic acids. Apart from the new molecular complex (benzimidazole : picolinic acid 
hydrate) only single crystals of a new hydrate of nicotinic acid was formed. 
 
The  aim  of  investigating  the  molecular  complexes  generated  between  benzimidazole  and 
imidazole with mono-substituted nitrobenzoic acids was to understand the effect, if any, that 
the charged nitro-group has on the supramolecular synthons generated. The structures that 
have already been determined and deposited in the CSD are summarised in Table 6.3.  
 
  2-Nitrobenzoic Acid  3-Nitrobenzoic Acid  4-Nitrobenzoic Acid 
Benzimidazole       
Imidazole       
Table 6.3 – Summary of the molecular complexes found in the CSD. Blue shading corresponds to molecular 
complex found while grey represents no molecular complexes found. 
  
6.2.1  Benzimidazolium 
 
Where  the  crystallisation  product  is  in  a  1:1  stoichiometric  ratio  of  benzimidazole  and  a 
carboxylic  acid  containing  molecule,  the  benzimidazole  is  protonated  through  hydrogen 
transfer from the carboxylic acid group onto the normally unprotonated nitrogen atom in the 
five-membered ring creating a benzimidazolium molecule (BZNH
+) (Figure 6.14). The result 
of the proton  transfer on the benzimidazolium molecule is  a delocalisation of the charge 
across the five-membered ring, reflected in the equalisation of the internal bond lengths N
ʴ+-
C-N
ʴ+ and bond angles C-N
ʴ+-C (Table 6.4). The delocalisation of the charge has the effect of 
creating a partial positive charge on both the nitrogens. This effect is seen in all the molecular 
complexes that have been structurally determined and discussed in this chapter.  
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Fig. 6.14 – LHS, a typical benzimidazolium molecule where both nitrogens are protonated; RHS, the Fourier 
difference map generated where the H atoms located on a nitrogen atom have been omitted from the model, 
clearly showing that both nitrogen atoms are protonated.   
 
The consequence for the co-molecule that has been deprotonated is the creation of a negative 
charge. The negative charge is found to be delocalised over the carboxylic acid group by 
consideration of the normalisation of the bond lengths in the carboxylate group. 
 
Molecular 
Complexes 
BZNH
+  PA
- 
hemihydrate 
BZNH
+  
3-HPA
-   
IMIDH
+  
3-HPA
- 
BZNH
+   
6-HPA
-  
BZNH
+   
6-HPA
- diacetic 
N-C(Å) 1st 
2
nd molecule 
1.329(2)  1.331(3)  1.337(5) 
1.333(5) 
1.343(2)  1.341(3) 
N-C(Å) 1st 
2
nd molecule 
1.334(2)  1.332(3)  1.337(5) 
1.329(5) 
1.330(2)  1.328(5) 
C-N-C(º) 1st 
2
nd molecule 
107.0(3)  108.0(2)  108.0(3) 
108.2(3) 
107.7(1)  108.2(2) 
C-N-C(º) 1st 
2
nd molecule 
106.1(3)  107.9(2)  108.2(3) 
108.9(3) 
108.2(1)  108.6(2) 
Table 6.4 – The N
ʴ+-C-N
ʴ+ bond lengths and C-N
ʴ+-C bond angles for the molecular complexes discussed in 
Section 6.5. 
 
6.2.2  Hydrogen Bonding Motifs and Supramolecular Synthons 
 
In  contrast  to  the  molecular  complexes  generated  with  the  hydroxy-  and  halo-substituted 
benzoic acids (see Chapters 4 and 5) the introduction of another basic nitrogen into the system 
has led to the established hetero hydrogen bond, N
ʴ+H∙∙∙O
ʴ-, and homo hydrogen bonds,   254 
OH∙∙∙O
ʴ- and NH∙∙∙N
ʴ+, 
 being challenged (Figure 5.21). This, along with the presence of 
the hydroxyl groups found in the hydroxypicolinic acid molecule leads to an increase in the 
number  of  hydrogen  bonding  patterns  available  for  the  molecules  to  adopt  and  thus  an 
increased difficulty in predicting the supramolecular synthons which will form from this. 
 
Fig.  5.21    The  most  prominent  hydrogen  bonds  within  the  benzimidazole  :  halobenzoic  acid  molecular 
complexes: an N-H∙∙∙N hydrogen bond (A), an N-H∙∙∙O hydrogen bond (B) and an O-H∙∙∙O hydrogen bond (C).  
 
A 
B 
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6.3   Crystallographic Data 
Compound  BZNH
+ PA
- hydrate  BZNH
+ 3-HPA
-  IMIDH
+ 3-HPA 
Formula  C7N2H7,C6O2NH4, OH2  C7N2H7, C6O3NH4  C3N2H5, C6O3NH4 
ΔpKa (1:1)  4.54 / 0.15  4.39  5.85 
Crystallisation 
Conditions 
Methanol, ~2-4ºC  Methanol,  room 
temperature 
ethanol, ~2-4ºC 
Mol. weight / gmol
-1  259.26  257.25  207.19 
Temperature (K)  100  100  100 
Space Group  F d d 2  P 21/n  C c 
a (Å)  34.511(7)  14.7485(11)  26.514(3) 
b (Å)  9.2559(19)  5.0177(4)  3.7403(3) 
c (Å)  15.824(3)  15.9323(11)  18.7022(15) 
ʱ (
o)  90  90  90 
β (
o)  90  98.131(3)  94.043(3) 
γ (
o)  90  90  90 
Volume (Å
3)  5054.81  1214.46(3)  1850.1(3) 
Z  4  4  8 
θ range (˚)  3.104-27.502  3.525-27.482  3.081-27.478 
Completeness (%)  99.6  99.7  99.4 
Refln Collected  8135  16346  10876 
Independent  1496  2677  2102 
Refln 
(obs.I>2sigma(I)) 
1333    1798  1702 
Rint  0.046  0.052  0.0624 
Parameters  244  216  327 
GooF on F
2  1.3180  0.9693  0.9845 
R1 (Observed)  0.0574  0.0503  0.065 
R1 (all)  0.0657  0.0741  0.0597 
wR2 (all)  0.2167  0.1418  0.0751 
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Compound  BZNH
+ 6-HPA
-  BZNH
+ 6-HPA
- diacetic acid 
Formula  C7N2H7, C6O3NH4  C7N2H7, C6O3NH4, 2(CH4O2) 
Crystallisation Conditions  DMSO,  room 
temperature 
Acetic acid, ~2-4ºC 
Molecular weight / gmol
-1  257.25  377.35 
Temperature (K)  100  100 
Space Group  C 2/c  P -1 
a (Å)  14.8393(13)  7.8162(6) 
b (Å)  12.4978(10)  10.7954(8) 
c (Å)  13.7739(12)  11.8566(8) 
ʱ (
o)  90  61.624(2) 
β (
o)  113.328(4)  83.249(2) 
γ (
o)  90  78.779(2) 
Volume (Å
3)  2345.7(4)  863.05(11) 
Z  8  2 
θ range (˚)  2.211- 30.569  3.086-27.484 
Completeness (%)  97.2  99.6 
Refn Collected  42210  17383 
Independent  3502  3938 
Refln (obs.I>2sigma(I))  2859  3244 
Rint  0.0624  0.0359 
Parameters  216  320 
GooF on F
2  1.2511  1.2582 
R1 (Observed)  0.0537  0.0622 
R1 (all)  0.0654  0.0776 
wR2 (all)  0.1905  0.1673 
Table. 6.5 - Crystallographic data for the molecular complexes discussed in Chapter 6.   257 
6.4   Structural Descriptions of the Molecular Complexes 
 
6.4.1  Molecular Complex of Benzimidazole and Picolinic Acid 
 
The molecular ions, BZNH
+ and picolinate (PA
-) form a 1:1 hydrate molecular complex. The 
molecular  complex  was  obtained  using  the  solvent  evaporation  method,  with  a  1:1 
stoichiometric mixture of BZN (12mg) and picolinic acid (3-HPA) (12mg) dissolved in the 
minimum amount of methanol followed by evaporation at ~2-4ºC. The crystals generated 
were very large, block shaped and colourless.    Single crystal X-ray diffraction data were 
obtained  using  a  Rigaku  R-axis/RAPID  diffractometer  at  100K,  equipped  with  graphite 
monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using SHELXS-
97
28 within the WINGX
29 program. The crystallographic data are summarised in Table 6.5.  
 
The  crystals  generated  from  the  co-crystallisation  experiments  were  large  in  all  three 
dimensions,  however,  solving  the  structure  proved  difficult  due  to  the  large  amount  of 
disorder indicated by the strong diffuse scattering observed in the diffraction patterns (Figure 
6.15). 
 
 
Fig. 6.15 – A diffraction pattern frame from the single crystal X-ray diffraction experiment on a crystal of the 
benzimidazole : picolinic acid molecular complex showing the strong diffuse scattering. 
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The model that best fits the experimental diffraction data is shown in Figure 6.16 LHS. The 
BZNH
+ and PA
 molecules adopt 50:50 disordered positions within layers. In practice, on a 
local level, this corresponds to having a plane with the BZNH
+ and PA
 molecules alternating 
with one another and forms chains of N-H···O hydrogen bonds. Within these planes, it is 
statistically possible for two of the benzimidazole molecules to lie adjacent to each other 
introducing a discontinuity in the hydrogen bonded chains. Alternatively, a vacancy could be 
present.  It is not, however, possible for two picolinic acid molecules to lie adjacent to one 
another as two oxygen atoms would then come into very close contact (~1.7907(2)Å).   
   
Fig. 6.16 – LHS, the disordered model for the benzimidazolium picolinate hydrate molecular complex; RHS, the 
likely hydrogen bonded unit when considering the local ordering, i.e. with the disorder removed.  
 
The disordered water molecule also plays a role in the construction of these chains.  There is 
one 50:50 disordered H atom on the water which lies approximately within the same plane.  
The location of this hydrogen bond is directly 
correlated  to  the  location  of  the  carboxylate 
group as it forms a hydrogen bond to whichever 
oxygen  atom  is  not  involved  in  the  NH···O 
hydrogen  bond  to  the  neighbouring 
benzimidazole molecule.  The water molecule 
then  acts  as  a  hydrogen  bond  donor  to  a 
molecule in the plane below (Figure 6.17). 
 
Another  potential  source  of  disorder  could 
take the form of proton disorder in a similar manner to that found within the picolinic acid 
starting material and this could also be a driving force behind the observed diffuse scattering. 
In the pure picolinic acid crystal structure (Section 6.1.1), hydrogen disorder is found between 
the carboxylic acid group and the nitrogen heteroatom of the ring. Evidence of the occurrence 
of this effect in the present structure is inconclusive but it is most likely that there is no proton 
disorder.  If the nitrogen was protonated, there would be a strong likelihood of hydrogen 
Fig. 6.17 – The water molecule connects the layers 
of  alternately  hydrogen  bonded  co-molecules 
together.   259 
bonding from this site, but there are no oxygen atoms within a hydrogen bonding distance. 
However, the disordered nature of this system would make it difficult to identify any electron 
density corresponding to a hydrogen on the heteroatom of the pyridine ring. 
  
It is therefore most likely that the BZN molecule is protonated through hydrogen transfer 
from the carboxylic acid group on the PA molecule onto the normally unprotonated nitrogen 
atom in the five-membered ring forming a BZNH
+ molecule (Section 6.2.1).  This form of 
proton transfer is common and would normally result in a delocalisation of the charge across 
the  five-membered  ring  and  the  equalisation  of  the  internal  bond  lengths.  Although  it  is 
difficult to separate the positions of some of the atoms of the benzimidazole molecule from 
those of the picolinic acid molecule in this disordered situation, and some of the atoms have 
only been refined with isotropic thermal parameters, there is a clear equalisation of the bonds 
lengths with  N
 ʴ+C 1.336(2) Å and N
 ʴ+C 1.320(2) Å, and bond angles, CN
ʴ+C 107.5º 
and CN
ʴ+C 107.1º (see Table 6.4 for comparisons). This delocalisation of charge can also 
be found in the carboxylate group of the picolinate molecules where the carbon oxygen bond 
lengths are comparable to those found in other deprotonated carboxylate groups within similar 
systems, with CO bond lengths of 1.256(2)Å and 1.268(2)Å.  
 
The  main  hydrogen  bonds  in  the  BZNH
+  PA
  molecular  complex  are  charge  assisted 
N
ʴ+H····O
ʴ- hydrogen bonds that combine to create a flat chain of alternating co-molecules 
on  a  local  length  scale  (Figure  6.18).  The  N
ʴ+H····O
ʴ-  hydrogen  bonds  are  moderate  in 
strength with N
ʴ+H····O
ʴ- hydrogen bond lengths
 of
 2.692(4)Å and 2.675(5)Å.  The latter 
bond length can, however, only be taken as a guide value as the absolute position of one of 
the N atoms in the benzimidazole molecule is difficult to determine due to the close proximity 
of the disordered carboxylate carbon atom and thus it was only refined isotropically. It is 
likely that the N atom of the picolinic acid is involved in a asymmetric bifurcated hydrogen 
bond with the major N
ʴ+H····O
ʴ- hydrogen bond length
 of
 2.692(4)Å, and a corresponding 
minor hydrogen bond length of 3.061(4)Å. The atoms involved in this bifurcated hydrogen 
bond have both been refined with anisotropic displacement parameters.    260 
 
Fig. 6.18 – The main motif of the BZNH
+ PA
 molecular complex is a flat chain of alternating hydrogen bonded 
co-molecules. 
 
The water molecule has two 50:50  disordered  positions  for one of the H atoms  and one 
ordered  H  position.  Figure  6.19  shows  that  the 
disordered hydrogens on the water molecule point 
towards  the  oxygen  atoms  of  the  picolinate 
molecule  approximately  within  the  same  plane. 
The fully occupied hydrogen points towards the 
picolinate  on  in  a  different  plane.  On  a  local 
length scale, the hydrogen will take the position 
closest  to  that  of  the  picolinate  molecule.  One 
possible  short-range  order  model  is  shown  in 
Figure  6.20  where  the  water  molecules  form 
hydrogen  bonded  rings  with  the  picolinate 
molecules  in  parallel  chains.  These  moderate  OH····O
ʴ-  hydrogen  bonds  are  of  O····O 
length of 2.697(4)Å and 2.891(6)Å (both O atoms refined anisotropically). 
Fig. 6.19 – The water molecule, with two 0.5 
occupied  hydrogens  (yellow)  and  one  fully 
occupied  hydrogen  (white)  connects  the 
layers  of  alternately  hydrogen  bonded  co-
molecules together.   261 
 
Fig. 6.20 – LHS, the hydrogen bonded ring (hydrogen bonds shown in blue) involving two water molecules and 
two picolinate molecules that connect two flat chains of hydrogen bonded BZNH
+ PA
 molecules; RHS, view 
along the c-axis emphasising that the water molecule sits just out of the plane of the flat sheets of  hydrogen 
bonded BZNH
+ PA
 molecules. 
 
The high level of disorder makes it harder to identify the weaker interactions within this 
system. However consideration of the extended structure (Figure 6.21) makes it possible to 
explain the main interactions in the structure and provide possibilities for the others. The main 
interactions between BZNH
+ and PA
 are the N
ʴ+H····O
ʴ- hydrogen bonds that create flat 
chains  along  the  c-axis,  these  sheets  are  then  held  together  through  water  molecules 
effectively generating columns along the b-axis.  
 
       
Fig. 6.21 – LHS, the view along the c-axis of the BZNH
+ PA
 molecular complex showing the herringbone 
layers connected by water molecules; RHS, the view along the b-axis of the BZNH
+ PA
 molecular complex 
showing the channels of water. 
 
In the space between these columns there is only one clear interaction, a weak CH∙∙∙O
- 
hydrogen bond with C∙∙∙O lengths of 3.381(2)Å and 3.383(2)Å, depending on which position 
for the picolinic acid molecule is occupied, along the a-axis (Figure 6.22 LHS). There is also 
a strong possibility of some π∙∙∙π stacking interactions as the distances between the rings are   262 
~3.3083(5)Å  (between  two  N  atoms)  and  the  5-membered  ring  section  of  the  BZNH
+ 
molecules lie directly parallel to one another (Figure 6.22 RHS).   
 
         
Fig. 6.22 – LHS, weak CH∙∙∙O
- hydrogen bonds that lie along the a-axis; RHS, view showing that the BZNH
+ 
molecules lie directly parallel thus improving the chances of  π∙∙∙π stacking interactions. 
 
6.4.2  Molecular Complex of Benzimidazole and 3-Hydroxypicolinic Acid 1:1 
 
The  molecular  ions,  BZNH
+  and  3-hydroxypicolinate  (3-HPA
),  form  a  1:1  molecular 
complex with one another (Figure 6.23).  Single crystals were obtained using the solvent 
evaporation  method,  with  a  1:1  stoichiometric  mixture  of  BZN  (12mg)  and  3-
hydroxypicolinic  acid  (3-HPA)  (14mg)  dissolved  in  the  minimum  amount  of  methanol 
followed by evaporation at room temperature. The crystals generated were cube shaped and 
colourless.  Single crystal X-ray diffraction data were obtained using a Rigaku R-axis/RAPID 
diffractometer  at  100K,  equipped  with  graphite  monochromated  Mo  Kʱ  radiation  (λ  = 
0.71073 Å). The structure was solved using SIR92
30 within the CRYSTALS
31 program.  The 
crystallographic  data  are  summarised  in  Table  6.5.  In  the  molecular  complex,  the  BZN 
molecule  is  protonated  as  discussed  in  Section  6.2.1.  The  resulting  normalisation  of  the 
internal bond and angles is seen in Table 6.4. Within the molecular complex the 3-HPA
 
molecules  form  an  intramolecular  hydrogen  bond  between  the  hydroxyl  and  carboxylate 
groups. This intramolecular hydrogen bond, O1H∙∙∙O2
ʴ-, is of moderate strength with an 
O∙∙∙O distance of 2.537(3)Å and is consistent with that found within the 2-hydroxybenzoic 
acid molecular complex (2.551(3)Å, Section 4.5.1) and is shorter and stronger than found in 
its native crystal structure (2.622Å), reflecting the charge assisted nature. In common with the 
other carboxylate groups that have been deprotonated, the resulting negative charge is found   263 
Fig. 6.23 – The atom labelling for the molecular complex 
of  benzimidazolium  (LHS)  and  3-hydroxypicolinate. 
(RHS).  
to be delocalised over the group. This can 
be  seen  by  consideration  of  the  bond 
lengths in the carboxylate group, C8O2
ʴ- 
1.290(2)Å  and  C8O3
ʴ-  1.240(2)Å.  The 
consequence of the proton transfer is that 
there  are  now  three  possible  hydrogen 
bond  acceptor  sites  on  the  picolinate 
molecule:  the  two  oxygens  on  the 
carboxylate  group  that  have  a  partial 
negative  charge  and  the  pyridyl  nitrogen 
which is naturally basic.  
Table. 6.6 – The interactions involved in the BZNH
+ 3-HPA
 molecular complex with full data for the hydrogen 
bonds. 
 
The primary hydrogen bonds in the BZNH
+ 3-HPA
 molecular complex are; a partially charge 
assisted N
ʴ+H····O
ʴ- hydrogen bond between the nitrogen of the BZNH
+ and oxygen of the 
carboxylic acid group and a bifurcated N2
ʴ+H∙∙∙N3/O3
ʴ- hydrogen bond between the N2 of 
the BZNH
+ and N3 and O3 of 3-HPA
- (Figure 6.24). The strongest hydrogen bond is the 
NH∙∙∙O hydrogen bond and this is of moderate strength, with an N∙∙∙O distance of 2.732(3)Å, 
NH  1.06(3)Å,  O∙∙∙H  1.71(3)Å  and  angle  of  163.0(3)º  (labelled  a  in  Figure  6.24).    The 
bifurcated  bond  has  N∙∙∙N  and  N∙∙∙O  distances  of  2.909(3)Å  and  2.889(2)Å,  respectively 
Interaction  Label  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N1···O3  a  2.732(3)  1.06(3)  1.71(3)  163.0(3) 
N2···N3  b  2.909(3)  1.04(3)  1.88(3)  168.1(3) 
N2···O3  b  2.889(2)  1.04(3)  2.33(3)  112.4(2) 
O3···C4  3.337(3)  1.00(2)  2.65(2)  125(2) 
O3···C5  3.313(3)  0.99(2)  2.64(3)  125(2) 
π···π  3.260  -  -  - 
C···π  3.582(3)  -  -  - 
C···π  3.609(3)  -  -  - 
C···π  3.629(3)  -  -  -   264 
(labelled b in Figure 6.24) with hydrogen bond data shown in Table 6.6. This bifurcated 
hydrogen  bond  would  be  termed  symmetrical  with  regard  to  the  equal  strengths  of  the 
interactions, however the position of the hydrogen promotes an asymmetrical nomenclature as 
the hydrogen bond angles are 168.1(3)º and 112.4(2)º respectively. Therefore this bifurcated 
hydrogen bond, and the others of a similar nature, will be termed asymmetrical.  
 
The primary hydrogen bonds assemble the structure into an equimolar hydrogen bonded ring 
with alternating molecules which can be described by the graph set notation symbol 
4
4 R (18) 
(Figure 6.23).  This hydrogen bonded ring is the motif of the structure and is not dissimilar to 
the hydrogen bonded rings seen in Chapter 4. The difference is that the basic nitrogen on the 
3-hydroxypicolinic acid is a more appealing acceptor than the oxygen.   
 
       
Fig. 6.24 – LHS, the supramolecular synthon for the BZNH
+ 3-HPA
 molecular complex; a hydrogen bonded 
ring system held together by partially charge assisted N
ʴ+H····O
ʴ- and N
ʴ+H····N hydrogen bonds; RHS, the 
Fourier difference map (generated using MCE), where the hydrogen adjoining N2 has been removed from the 
model, showing the hydrogen atom to be clearly located on the N atom of the benzimidazolium molecule ion. 
The elongation of the electron density along the hydrogen bond illustrates the influence of the neighbouring 
oxygen molecule. 
 
The motifs, equimolar hydrogen bonded rings, are connected by weaker interactions in all 
three dimensions. Along the ac-diagonal, the hydrogen bonded rings are stacked on top of 
one-another through staggered face-to-face π-π interactions of spacings between the closest 
molecules of 3.096Å and 3.260Å (Figure 6.25).  
 
a 
b 
b 
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Fig. 6.25 – the stacking of the hydrogen bonded rings held together by π-π interactions. 
 
The  hydroxyl  group  of  the  3-HPA
  molecule  is  involved  in  a  DDHHA  weak  bifurcated 
hydrogen  bond  directed  along  the  c-axis  (Figure  6.25).  The  bifurcated  hydrogen  bond  is 
symmetric with C∙∙∙O distances of 3.313(3)Å and 3.337(3)Å (Figure 6.26, inset). 
 
Fig. 6.26 – The supramolecular synthons of the BZNH
+ 3-HPA
 molecular complex, are connected by weak 
bifurcated hydrogen bonds (circled in red) along the c-axis. Inset shows the bifurcated weak hydrogen bond 
circled in red in the main figure. 
 
In  addition,  along  the  ac-diagonal  there  are  weak  CH∙∙∙π  bonds  with  C∙∙∙C  distances  of 
3.582(3)Å, 3.609(3)Å and 3.629(3)Å (Figure 6.27). These are the only interactions that exist 
between the layers that expand the structure in this direction.  
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Fig. 6.27 – LHS, view of the c-axis of the BZNH
+ 3-HPA
 molecular complex, which indicates the interactions 
between the layers (circled in yellow); RHS an expanded view of the interactions that hold the layers together, 
with C-H∙∙∙π interactions circled in yellow. 
 
These three interactions, the π-π stacking interactions, the weak bifurcated hydrogen bonds, 
and the C-H····π bonds, connect the motifs together to create the extended structure. Figure 
6.28 illustrates the different roles that the intermolecular interactions play in the structure. 
 
 
Fig. 6.28 – The intermolecular interactions in the BZNH
+ 3-HPA
 molecular complex, with the supramolecular 
synthon circled in blue, the weak bifurcated hydrogen bonds in red and the C-H····π contacts in yellow. The π-π 
stacking goes into the plane of the page. 
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6.4.3  Molecular Complex of Imidazole and 3-Hydroxypicolinic Acid 1:1 
 
The  molecular  ions,  IMDZH
+  and  3-hydroxypicolinate  (3-HPA
),  form  a  1:1  molecular 
complex  with  one  another.    Single  crystals  were  obtained  using  the  solvent  evaporation 
method, with a 1:1 stoichiometric mixture of IMD (8mg) and 3-hydroxypicolinic acid (3-
HPA) (14mg) dissolved in the minimum amount of methanol followed by evaporation at ~2-
4ºC.  The  crystals  generated  were  needle  shaped  and  colourless.    Single  crystal  X-ray 
diffraction  data  were  obtained  using  a  Rigaku  R-axis/RAPID  diffractometer  at  100K, 
equipped with graphite monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was 
solved  using  SIR92
30  within  the  CRYSTALS
31  program.  The  crystallographic  data  are 
summarised in Table 6.5. In the molecular complex, the IMD molecule is protonated through 
hydrogen transfer from the carboxylic acid group in the fashion seen in Section 6.2.1. The 
result of the proton transfer on the IMDH
+ molecule is a delocalisation of the charge across 
the five-membered ring, reflected in the equalisation of the internal bond lengths and bond 
angles  (Table  6.4).    There  are  two  independent  IMDH
+  and  3-HPA
  molecules  in  the 
asymmetric unit (Figure 6.29).  Within the molecular complex the two independent 3-HPA
 
molecules both form intramolecular hydrogen bonds between the hydroxyl and carboxylate 
groups with O···O distances of 2.517(4) and 2.525(4) Å, respectively. These intramolecular 
hydrogen  bonds  are  of  moderate  strength  and  are  consistent  with  that  found  within  the 
BZNH
+ 3HPA
 molecular complex that had an O···O distance of 2.537(3)Å (Table 6.7).  
 
     
 
Fig.  6.29  –  The  atomic  labelling  for  the  two  independent  molecules  of  each  type  in  the  imidazolium  3-
hydroxypicolinate molecular complex.  
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Table  6.7  –  The  three  scalar  quantities  and  bond  angles  of  the  hydrogen  bonds  and  information  of  the 
interactions found in the IMDH
+ 3-HPA
 molecular complex  
 
The two primary hydrogen bonds in the IMDH
+ 3-HPA
 molecular complex are a partially 
charge assisted N
ʴ+H····O
ʴ- hydrogen bond between the nitrogen of the IMD
+ and oxygen of 
the carboxylic acid group (a and a‘ in Figure 6.30)) and a bifurcated N
ʴ+H∙∙∙N/O
ʴ- hydrogen 
bond between the other nitrogen of the IMDH
+ and the unprotonated nitrogen and oxygen of 
3-HPA
 (b and b‘ in Figure 6.30). Whilst the hydrogen bonds are the same in this molecular 
complex as found in the BZNH
+ 3HPA
 molecular complex, the motif is quite different. In the 
BZNH
+  3HPA
  structure  the  motif  was  a  hydrogen  bonded  ring  system  (Figure  6.24). 
However, in the imidazole equivalent, the motif is a zigzag hydrogen bonded chain (Figure 
6.30). 
 
The N
ʴ+H····O
ʴ- hydrogen bonds are of moderate strength with N····O distances of 2.651(4) 
and 2.649(5) Å (Table 6.8); these are slightly shorter than the N
ʴ+H····O
ʴ- hydrogen bond 
found  in  the  BZNH
+  3HPA
  structure  which  has  an  N····O  distance  of  2.732(3)Å.  The 
bifurcated hydrogen bonds, b and b‘, are again similar to those seen in the BZNH
+ 3HPA
 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N1···O4   a  2.651(4)  1.05(3)  1.60(3)  173(3) 
N4···N1   a’  2.649(5)  0.95(3)  1.70(3)  179(2) 
N2···N3   b  2.859(4)  1.00(3)  1.91(3)  157(2) 
N3···O1  b  2.866(4)  1.00(3)  2.22(3)  121(2) 
N5···N6   b’  2.786(5)  0.94(3)  1.88(3)  160(2) 
N5···O4   b’  3.011(4)  0.94(3)  2.41(3)  121(2) 
C2···O5  3.184(5)  0.98(4)  2.21(4)  171(3) 
C11···O2  3.414(5)  0.98(4)  2.46(4)  165(3) 
C17···π  3.707  -  -  - 
C17···π  3.703  -  -  - 
π···π  3.274 / 3.403  -  - 
π···π  3.334 / 3.378  -  -   269 
structure, with similar bond strengths (b‘ slightly less so) but vastly different hydrogen bond 
angles. Therefore these can be classified as asymmetrical bifurcated hydrogen bonds.  
 
 
 
          
 
Fig. 6.30 – Top,  view along the b-axis of the main motif of the IMDH
+ 3-HPA
 molecular complex, a zigzag 
chain of alternate co-molecules held together by partially charge assisted hydrogen bonds; bottom,  view along 
the a-axis of the main motif of the IMDH
+ 3-HPA
 molecular complex.  
 
The hydrogen bonded zigzag chains are connected along the ac-diagonal by weak CH∙∙∙O
ʴ- 
hydrogen bonds to create layers (Figure 6.31 LHS) that have C····O distances of 3.184(5)Å 
and  3.414(5)Å.  The  zigzag  chains  stack  through  staggered  face-to-face  π∙∙∙π  stacking 
interactions between like molecules (Figure 6.31 RHS). The distances  between the layers 
have been calculated by creating a plane through the atoms in the ring and measuring the 
distance  between  these  planes.  The  stacking  distances  are  relatively  short  with  IMDH
+ 
distances of 3.274Å and 3.403Å, and 3-HPA
- distances of 3.334Å and 3.378Å. 
 
a 
b 
a’ 
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Fig. 6.31 – LHS, the CH∙∙∙O
ʴ- hydrogen bonds (-) along the ac-diagonal, RHS, view along the c-axis of the 
staggered face-to-face π∙∙∙π stacking interactions that extend the structure along the b-axis. 
 
Figure 6.32 shows the extended structure of the IMDH
+ 3HPA
 molecular complex. The green 
zigzag line indicates the main hydrogen bonded zigzag motif while the transparent blue box 
shows the weak hydrogen bonds that exist between the layers and with the assistance of the 
π∙∙∙π stacking interactions into the plane of the paper along the b-axis. Parallel to the b-axis, 
there are also weak C-H∙∙∙π interactions (Figure 6.30 yellow box) with distances of 3.707Å 
and 3.703Å, respectively (Figure 6.30 insert).  
 
 
Fig. 6.32 – View along the b-axis of the extended IMDH
+ 3HPA
- molecular complex. The main motif, the zigzag 
chains of alternate hydrogen bonded co-molecules, is shown by the green line (-) and the weak hydrogen bonds 
are located within the transparent blue box (-). Inset shows the C-H∙∙∙π interactions that extend the structure 
along the b-axis. 
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6.4.4  Molecular Complex of Benzimidazole and 6-Hydroxypicolinic Acid 1:1 
 
The molecular ions, BZNH
+ and 6-hydroxypicolinate, which is more accurately described as 
2-oxo-1,2-dihydropyridine-6-carboxylic acid but will be referred to as the previous name (6-
HPA
) for consistency, form a 1:1 molecular complex with one another.  Single crystals were 
obtained using the solvent evaporation method, with a 1:1 stoichiometric mixture of BZN 
(12mg) and 6-hydroxypicolinic acid (3-HPA) (14mg) dissolved in the minimum amount of 
DMSO  followed  by  evaporation  at  room  temperature.  The  crystals  generated  were  block 
shaped and colourless.  Single crystal X-ray diffraction data were obtained using a Bruker 
Apex II diffractometer at 100K, equipped with graphite monochromated Mo Kʱ radiation (λ = 
0.71073 Å). The structure was solved using SIR92
30 within the CRYSTALS
31 program. The 
crystallographic data are summarised in Table 6.5.  
 
The BZN molecule is protonated through hydrogen transfer from the carboxylic acid group on 
the 6-HPA molecule (Figure 6.33) resulting in a delocalisation of the charge across the five-
membered ring (see Section 6.2.1). The effect of deprotonation on the 6-HPA
 molecule is not 
in this case limited to changes in the carboxylate group; it also undergoes lactam - lactim 
tautomerism, where the hydrogen from the hydroxyl group (O3) transfers to the previously 
unprotonated nitrogen in the benzene ring (N3) (Figure 6.34). This form of tautomerism is 
also referred to as amide – imidic acid tautomerism and is found in heterocyclic rings, most 
commonly nucleobases such as guanine, thymine and cytosine
31.  
 
      
Fig. 6.33 – the benzimidazolium and 6-hydroxypicolinate molecule ions which are generated in the molecular 
complex, with atom labelling.  
Fig. 6.34 – schematic diagram of the lactam - lactim tautomerism (imidic acid) that the 6-hydroxypicolinic acid 
molecule undergoes, forming 2-oxo-1,2-dihydropyridine-6-carboxylic acid. 
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Table. 6.8 – The three scalar quantities and bond angles of the hydrogen bonds with lables and information of 
the interactions found in the BZNH
+ 6-HPA
 molecular complex 
 
There is one other example in the CSD where a 6-hydroxypicolinic acid has lost a proton (at 
the  carboxylic  acid)  and  undergone  tautomerism  (lactam-lactim),  the  metal  organic 
framework  with  titanium  as  the  metal  centre  (CSD  reference  RIYDEJ)
33.  Within  the  6-
hydroxypicolinate molecule the carbon-oxygen distances differ quite substantially from other 
related  molecules  that  are  co-crystallised  with  benzimidazolium  (Table  6.9).  The  most 
obvious difference is in regard to the hydroxyl carbon-oxygen length (C-O3); the oxygen here 
is  deprotonated  and  forms  a  double  bonded  carbonyl  bond  to  the  ring.  By  comparing 
structures found within the CSD, in general,  complexes involving hydroxypicolinic acids 
show that the carboxylic acid bond lengths tend not to be normalised as much as those that 
involve the hydroxybenzoic acid molecules. For the 6-hydroxypicolinate molecules this may 
be down to the loss of the conjugated benzene ring, however the 3-hydroxypicolinate still 
retains this conjugation. 
 
Bond  BZNH
+           
6-HPA
 
BZNH
+           
6-HPA
  
di-acetic acid 
BZNH
+  
3- HPA
 
IMIDH
+  
3-HPA
 
BZNH
+  
2-HBA
 
BZNH
+  
3-HBA
 
C-O1  1.2700(1)  1.273(2)  1.289(3)  1.284(2)  1.273(1)  1.270(1) 
C-O2  1.2382(1)  1.251(4)  1.240(3)  1.244(2)  1.264(1)  1.260(1) 
C-O3  1.2553(1)  1.280(3)  1.350(3)  1.367(2)  1.3552(2)  1.360(1) 
Interaction  Label  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N1···O4   f  2.644(2)  1.09(3)   1.56(3)  172.2(2) 
N4···N1   g  2.640(2)  0.94(3)   1.74(3)  160.2(3) 
N2···N3   e  2.915(2)  0.88(2)   2.05(2)  166.4(2) 
C5···O2  h  3.302(2)  0.98(3)  2.34(3)  168(2) 
C3···O1   i  3.183(2)  1.01(2)  2.42(2)  132(2) 
C9···π   3.578  -  -  - 
C10···π  3.588  -  -  - 
π···π  3.306  -  -  -   273 
Table 6.9 – The carbon-oxygen bond distances for six different molecular complexes. The numbering of the 
oxygen refers to Figure 6.31, with oxygens 2 and 3 always being on the same of the molecule.  
 
Figure 6.33 shows that the basic nitrogens on the BZNH
+ and 6-HPA
 are all protonated. The 
consequence is that there are now three equal strength hydrogen bond donors shared between 
the  two  co-molecules.  The  BZNH
+  molecules  contain  two  of  these  donor  sites  and  no 
hydrogen bond acceptors, whereas there are three hydrogen bond acceptors and one hydrogen 
bond donor on the 6-HPA
 molecules.  Therefore BZNH
+ can only form hydrogen bonds to 
molecules of a different type, and 6-HPA
 can only act as hydrogen bond donor to molecules 
of the same type. 
 
A hydrogen bonded ring motif is formed which can be described by the graph set notation 
symbol 
6
6 R (32) (Figure 6.35).  The 6-membered hydrogen bonded ring is made up of two 
partially charge assisted 6-HPA
 dimers (e in Figure 6.35) with the BZNH
+ molecules linking 
these  together  through  two  partially  charge  assisted  N
ʴ+H····O
ʴ-  (f  in  Figure  6.35)  and 
N
ʴ+H····O  (g  in  Figure  6.35)  hydrogen  bonds.  These  collectively  form  the  main 
supramolecular  synthon  in  the  molecular  complex  with  the  partially  charged  assisted 
N
ʴ+H····O
ʴ- and N
ʴ+H····O hydrogen bonds having relatively short N····O distances with 
respective bond angles of 2.644(2)Å and 2.640(2)Å(see Table 6.8 for full hydrogen bond data 
and list of interactions). This is relatively short in comparison to other N
ʴ+H····O
ʴ- hydrogen 
bonds that tend to be of length 2.7Å and above. The 6-HPA
 dimers, which equally could also 
be  referred  to  as  pseudo  base  pairs,  are  made  up  of  partially  charge  assisted  NH····O
ʴ- 
hydrogen bonds of length 2.915(2)Å (0.88(2)Å, 2.05(2)Å, 166.4(2)) with an inversion centre 
located in the centre of the hydrogen bonded ring.  
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Fig. 6.35 – The main motif of the BZNH
+ 6-HPA
 molecular complex; a hydrogen bonded ring system held 
together by 6-HPA
 dimers  (e) and partially charge assisted N
ʴ+H····O
ʴ- (f) and N
ʴ+H····O (g) hydrogen 
bonds. 
 
The 6-membered hydrogen bonded rings are connected by equivalent hydrogen bonds f and g, 
creating a chain along the b-axis (Figure 6.36). The 6-HPA
 molecules are coplanar and the 
BZNH
+ molecules lie at ~77º to this plane. 
 
 
Fig. 6.36 – the chains of BZNH
+ 6-HPA
 rings along the b-axis, viewed along a. 
 
These chains of hydrogen bonded rings are connected in all three-dimensions by an array of 
weaker  interactions.  Three  of  these  interactions  are  shown  in  Figure  6.37,  two  of  them 
promote a stacking of the motifs, while the other connects the stack motifs together. Firstly, 
the  shortest  of  these  interactions  are  weak  hydrogen  bonds  involving  the  carbon  located 
between  the  two  nitrogens  of  the  BZNH
+  molecule  and  one  of  the  carboxylate  oxygens, 
C1H∙∙∙ O1
ʴ- which is of C····O distance of 3.131(2)Å (Figure 6.37 LHS). These connect a 
BZNH
+ of one chain and a 6-HPA
 of another. There are also π∙∙∙π stacking interactions of 
approximate length 3.306Å (measured between two planes created using the adjacent 6-HPA
 
e 
g 
f 
e 
f 
g   275 
molecules, LHS Figure 6.37) between 6-HPA
 molecules stacking the chains along the c-axis. 
These are the two interactions that are highlighted within the red circle in Figure 6.37, middle. 
Also between the chains, there are two C-H∙∙∙π interactions, C9H∙∙∙π and C10H∙∙∙π, with the 
aromatic hydrogens of 6HPA
 acting as hydrogen bond donors and the aromatic ring of the 
BZNH
+ acting as the π acceptor. The C∙∙∙C distances are 3.578(3) and 3.588(3) Å. (Figure 
6.37 RHS). 
  
 
 
  
 
 
 
 
Fig. 6.37 – LHS, the weak hydrogen bonds C1H∙∙∙ O1
ʴ- and π∙∙∙π interactions between two chains. These are 
two interactions that stack the chains along the a-axis. Middle, view along the b-axis showing the stacking of the 
chains. Highlighted in red are the interactions viewed in Figure 6.33, LHS. Circled in blue are those interactions 
from Figure 6.33, RHS. The interactions within the green circle are the moderate hydrogen bonds involved in the 
hydrogen bond ring motif. RHS, the CH∙∙∙π interactions are the blue dotted lines in the centre of the image. 
 
The final significant interactions within the molecular complex are two weak hydrogen bonds. 
These  are  CH∙∙∙O
ʴ-  hydrogen  bonds  between  the  oxygens  of  the  carboxylate  group  and 
carbons from the BZNH
+ molecule and propagate along the ac-diagonal (Figure 6.38). These 
have C∙∙∙O distances of 3.302(2)Å (h in Figure 6.38) and 3.183(2)Å (i in Figure 6.38). The 
three molecules shown in Figure 6.38 are from three different chains. 
 
 
h 
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Fig.  6.39    The  benzimidazolium,  6-
hydroxypicolinate  and  acetic  acid 
molecules  which  are  generated  in  the 
molecular  complex,  with  atom 
labelling.  
Fig. 6.38 – The CH∙∙∙O
ʴ-  weak hydrogen bonds  connect three different chains  within the  BZNH
+ 6-HPA
 
molecular complex. 
 
6.4.5  Molecular  Complex  of  Benzimidazole  and  6-Hydroxypicolinic  Acid 
Diacetic Acid Solvate 1:1:2 
 
The  molecular  ions,  BZNH
+  and  6-hydroxypicolinate  (IUPAC  name,  2-oxo-1,2-
dihydropyridine-6-carboxylic acid), (6-HPA
) form a 1:1:2 acetic acid molecular complex. 
Single crystals were obtained using the solvent evaporation method, with a 1:1 stoichiometric 
mixture  of  BZN  (12mg)  and  6-hydroxypicolinic  acid  (6-HPA)  (14mg)  dissolved  in  the 
minimum amount of acetic acid followed by evaporation at room temperature. The crystals 
generated were block shaped and brown.  Single crystal X-ray diffraction data were obtained 
using  a  Rigaku  R-axis/RAPID  diffractometer  at  100K,  equipped  with  graphite 
monochromated  Mo  Kʱ  radiation  (λ  =  0.71073  Å).  The  structure  was  solved  using 
SUPERFLIP
34 within the CRYSTALS
31 program.  The crystallographic data are summarised 
in Table 6.6. The BZN molecule is protonated through hydrogen transfer from the carboxylic 
acid group on the 6-HPA molecule as discussed in Section 6.2.1. Table 6.4 gives the resulting 
normalised bonds lengths and angles of the BZNH
+ molecule (Figure 6.39). The 6-HPA
 
molecule  has  also  undergone  lactam  -  lactim  tautomerism,  where  the  hydrogen  from  the 
hydroxyl  group  (O3)  transfers  to  the  previously 
unprotonated  nitrogen  in  the  pyridine  ring  (N3).  The 
negative  charge  is  delocalised  over  the  carboxylate 
group; evidence for this is seen in the normalisation of 
the carbon oxygen bond lengths, C8O1
ʴ- 1.273(2) Å 
and C8O2
ʴ- 1.251(4)Å. The carbonyl group has a bond 
length  of  C12O3  1.280(3)Å.  There  are  also  two 
distinct  acetic  acid  molecules  within  the  molecular 
complex; both retain their neutral properties. 
 
BZNH
+  again  only  has  hydrogen  bond  donor  groups 
and the 6HPA
 has one donor and three acceptors.  In 
addition,  the  acetic  acid  molecule  has  one  traditional   277 
donor and one acceptor sites; however protonated oxygens can act as both acceptors and 
donors.  The presence of acetic acid disrupts the pseudo base-pairing of the 6-HPA
 which 
was present in the unsolvated complex, which instead forms heterodimers with the acetic acid 
molecules.  The motif of the molecular complex is a linear chain of alternating co-molecules 
BZNH
+ and 6-HPA
 with acetic acid molecules satisfying the remaining hydrogen bonding 
sites (Figure 6.40). 
 
 
Fig. 6.40 – The hydrogen bonded chains of the BZNH
+ : 6-HPA
 acetic acid solvate molecular complex is a flat 
linear chain of alternating hydrogen bonded co-molecules. 
 
The linear chain of alternate BZNH
+ and 6-HPA
 molecules are held together by two different 
partially charge assisted NH∙∙∙O hydrogen bonds of approximately equal strength along the 
ac-diagonal. The first is between the BZNH
+ and the carboxylate group, a, N1
ʴ+H∙∙∙O4
ʴ-,
 of 
N∙∙∙O  distance  2.762(4)Å,  and  the  other  between  the  BZNH
+  and  carbonyl  group,  b, 
N1
ʴ+H∙∙∙O2
 of N∙∙∙O distance 2.736(4)Å. The acetic acid molecules have two important roles 
in this structure. Firstly they are a key part of the main motif, the flat linear chain (Figure 
6.41). One of the acetic acids creates a hydrogen bonded ring with graph set notation 
2
2 R (8) 
by hydrogen bonding with the tautomeric nitrogen and carbonyl group of the 6-HPA
 (Figure 
6.41,  labelled  c).  These  are  of  D∙∙∙A  lengths  of  N3H∙∙∙O6  2.915(4)Å  and  O7H∙∙∙O3 
2.606(4)Å. The other acetic acid hydrogen bonds to the carboxylate group, O4H∙∙∙ O1
ʴ-, and 
is the strongest hydrogen bond in the structure with length of 2.498(4)Å (Figure 6.41 d)(Table 
6.10). 
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Fig.  6.41  –  The  hydrogen  bonding  scheme  in  the  BZNH
+  6-HPA
  acetic  acid  solvate  molecular  complex, 
highlighting the role of the acetic acid molecules in creating the linear chain. 
Table 6.10 – The three scalar quantities and  bond angles of the hydrogen bonds a,  b, c, d  and list of the 
interactions between the molecules in the benzimidazole and 6-hydroxypicolinic acid diacetic acid solvate.  
 
The other important role of the acetic acid molecules is connecting the structure along the c-
axis.  Figure 6.42 shows two of the motifs where the only interactions  between them  are 
CH∙∙∙O weak hydrogen bonds between acetic acid molecules (Figure 6.42 inset). These weak 
hydrogen bonds have lengths C∙∙∙O7 3.575(3)Å and C∙∙∙O5 3.601(3)Å respectively. 
 
Interaction  Label  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N1···O4   a  2.762(4)  0.95(3)  1.79(3)  176.2(3) 
N2···O3   b  2.736(4))  0.97(4)  1.82(4)  163.1(3) 
N3···O6   c  2.915(4)  0.88(4)  2.06(4)  164.7(3) 
O7···O2  c  2.606(4)  0.97(6)  1.66(7)  166.0(5) 
N2···O3   d  2.498(4)  1.04(4)  1.46(4)  174.8(4) 
O7···C   3.537(3)  0.98(5)  2.85(4)  131(3) 
O5···C  3.601(3)  0.96(3)  2.73(3)  150(3) 
π···π  3.339  -  -  - 
O4···C   3.366(4)  0.95(4)  2.46(4)  120(3) 
O5···C  3.290(4)  0.96(3)  2.70(4)  161(4) 
 
 
c  d 
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Fig. 6.42 – Two motifs of the BZNH
+ 6-HPA
 diacetic acid molecular complex showing how the two adjacent 
linear chains are connected along the c-axis through weak CH∙∙∙O hydrogen bonds (circled in red) between the 
acetic acid molecules; inset – expanded image of these hydrogen bonds. 
 
With the linear chains extending the structure along the ab-diagonal and the weak hydrogen 
bonds connecting these chains along the c-axis, this creates a plane of molecules (Figure 6.43 
LHS). These planes of molecules are connected along the ab-diagonal by π∙∙∙π interactions 
and two hydrogen bonds. The hydrogen bonds are between the two independent acetic acid 
molecules (Figure 6.43 RHS). The C-H∙∙∙O hydrogen bonds are weak with C∙∙∙O lengths of 
3.366(4)Å and 3.290(4)Å.  The π∙∙∙π interactions is relatively short in length with the distance 
measured between two carbons at 3.339(4)Å (red) and 3.886(3) (blue) in length (Figure 6.43 
middle). 
 
 
Fig. 6.43 – LHS, view along the c-axis showing the layered nature with the weaker interactions along the ab-
diagonal, weak hydrogen bonds (light blue) and π∙∙∙π interactions (dark blue); middle, the π∙∙∙π interaction (blue); 
RHS, the weak C-H∙∙∙O hydrogen bonds between the acetic acid molecules.   280 
 
6.5   Systematic  Structural  Study  of  Nitrobenzoic  acid  :  Benzimidazole  / 
Imidazole Molecular Complexes  
 
Molecular complexes of mono-substituted 2-, 3-, 4-nitrobenzoic acid have been generated 
with  both  benzimidazole  and  imidazole.  Apart from  the  benzimidazolium  2-nitrobenozate 
molecular complex, the rest of this family of structures was published in 2001 in a paper 
entitled Two-component molecular crystals from N-heteroaromatics and nitrobenzoic acids 
by Hashizume
27 (Table 6.11). The focus of this paper was on generating chiral crystals from 
achiral molecules. The method of co-crystallising two-component molecular crystals from 
organic acids and bases is one of the most promising methods in developing chiral crystals
28. 
 
  2-Nitrobenzoic Acid  3-Nitrobenzoic Acid  4-Nitrobenzoic Acid 
Benzimidazole  2:1     
Imidazole       
Table 6.11 – Summary of the molecular complexes found on the CSD. Blue shading corresponds to molecular 
complexes being present, while grey represents no molecular complexes found. 
 
In  this  section,  the  electronic  effects  of  the  nitro  group  on  the 
supramolecular synthons obtained will be investigated (Figure 6.44). As 
a result of the chemical bonding in the nitro group, the nitrogen atom is 
positively charged and each oxygen atom has a partial negative charge. 
For this reason the nitro group has a powerful attraction for electrons.  
This is in contrast to all the other molecular complexes reported in this 
work. Effects such as proton transfer, the normalisations on the internal 
bond lengths, the strength of the hydrogen bonds with the varying position of the nitro group 
and the influence of the nitro group in the packing arrangements of the structure will be 
discussed.   
 
6.5.1  Proton Transfer 
 
Fig. 6.44  The 
structure of the 
nitro group.   281 
The one common thread that runs through all the molecular complexes in this work is that 
where there is an equimolar ratio of carboxylic acid groups to BZN or IMD molecules in the 
molecular  complex,  then  there  will  be  proton  transfer.  The  proton  transfers  from  the 
carboxylic  acid  group  to  the  unprotonated  nitrogen  on  the  BZN  or  IMD  molecule  and 
typically  results  in  the  normalisation  of  the  internal  bond  lengths.  In  the  four  structures 
published by Hashizume
27 the molecular complexes all formed in a 1:1 ratio and so there was 
also 100% proton transfer (Figure 6.45).  
 
     
      
Fig.  6.45  –  The  structures  of  1,  benzimidazolium  4-nitrobenzoate  2,  benzimidazolium  3-nitrobenzoate  3, 
imidazolium 3-nitrobenzoate 4, imidazolium 3-nitrobenzoate. 
 
6.5.2  Normalisation of the Internal Bond Lengths and the Effect on Hydrogen 
Bond Length 
 
The effect of proton transfer on the co-molecules involved are the normalisation of the bond 
lengths  (carbon-oxygen  and  carbon-nitrogen  for  the  carboxylate  or  imidazolium  groups, 
respectively) and a delocalisation of the resulting charge across the functional group. Table 
6.12 lists a range of similar molecular complexes, where the nitro group has been replaced 
with either a hydroxyl or halo group, with the resulting outcome on the internal and hydrogen 
bond lengths.  
 
If the molecular complexes involving the nitrobenzoic acids are excluded, the CO bond 
lengths are all similar with the minimum value being 1.230Å and the maximum 1.297Å. The 
mean value is 1.264Å. The carboxylic acid bond distances are normally ~1.36Å for a CO 
single bond and ~1.23Å for a double bond, therefore the mean value found in the molecular 
1 
2 
3 
4   282 
complexes  corresponds  to  greater  than  double  the  single  bond  character  and  utilising  the 
hydrogen bonds that were seen. This might be expected since the carboxylate oxygens are 
acting as the hydrogen bond acceptor within the structures. The nitrobenzoic acid molecular 
complexes (shaded yellow in Table 6.12) do not all follow this trend; the BZN-2NBA and 
BZN-3NBA fall within the range of the other molecular complexes by adopting more double 
bond characteristics, however, the other three structures exhibit much stronger single bond 
characteristics. Their carbon-oxygen bond lengths range from 1.314-1.329Å which is a little 
shorter than the normal 1.36Å length expected of a carbon oxygen single bond in a carboxylic 
acid. Similarly, the nitrogen-carbon bond lengths within the BZN and IMD molecules in most 
of  the  molecular  complexes  (i.e.  not  including  the  nitrobenzoic  acid  complexes)  take  a 
maximum value of 1.347Å, a minimum of 1.304Å and a mean of 1.330Å. This mean value 
has greater single bond characteristics when compared to the pure crystal structures of BZN 
and  IMD which have C-N bond lengths  of 1.315Å and 1.316Å  for the double bond and 
1.348Å and 1.336Å  for single bonds,  respectively. This  again might be expected as both 
nitrogens have been protonated and act as the donors within the hydrogen bonds found in the 
crystal structures. However, once again, in the nitrobenzoic acid molecular complexes, the 
BZN and IMD molecules have carbon-nitrogen bond distances with different characteristics 
to those of the other molecular complexes. With carbon-nitrogen distances of between 1.250Å 
and 1.263Å, this is much more similar to that of a double bond and is even shorter than the 
double  bond  seen  in  the  crystal  structures  of  single  component  BZN  and  IMD.  In  these 
examples, as the bond lengths are short it might be expected that the nitrogens would be 
unprotonated; all complexes do, however, show proton transfer. 
 
The  N-H∙∙∙O  hydrogen  bond  distances  of  the  nitrobenzoic  acid  molecular  complexes  are 
similar to those found in the other molecular complexes therefore there is no obvious effect 
on the hydrogen bond distances induced by the nitro group.  
 
  C-O1(Å)  C-O2(Å)  N1-C(Å)  N2-C(Å)  HB1(Å)  HB2(Å) 
BZN-2NBA
24  1.214  1.273  1.319  1.308  2.728  2.887 
BZN-3NBA
2  1.269  1.234  1.316  1.325  2.550  2.718 
IMD-3NBA
2  1.328  1.314  1.252  1.258  2.644  2.745 
BZN-4NBA
2  1.323  1.326  1.250  1.263  2.647  2.660 
IMD-4NBA
2  1.320  1.329  1.256  1.256  2.644  2.742   283 
BZN-6HPA  1.270  1.238  1.330  1.342  2.644  2.640 
BZN-6HPA  1.273  1.251  1.341  1.328  2.763  n/a 
BZN-3HPA  1.289  1.240  1.332  1.331  2.733  2.889 
IMD-3HPS  1.284  1.244  1.337  1.337  2.649  3.011 
BZN-2HBA  1.264  1.273  1.331  1.333  2.646  2.621 
BZN-3HBA  1.260  1.270  1.330  1.325  2.697  2.700 
BZN-4HBA  1.258  1.271  1.322  1.347  2.695  2.717 
IMD-2HBA  1.247  1.279  1.304  1.317  2.699  2.729 
IMD-3HBA  1.284  1.244  1.330  1.324  2.654  2.667 
IMD-4HBA  1.25  1.28  1.33  1.33  2.66  2.74 
BZN-3BrBA  1.230  1.292  1.332  1.335  2.843  n/a 
BZN-4BrBA  1.239  1.283  1.329  1.328  2.597  2.848 
BZN-3ClBA  1.297  1.237  1.341  1.326  2.282  n/a 
BZN-4ClBA  1.251  1.288  1.334  1.339  2.642  2.688 
Table 6.12. – List of molecular complexes where BZN = benzimidazole, IMD = imidazole, NBA = nitrobenzoic 
acid,  HPA  =  hydroxypicolinic  acid,  HBA  =  hydroxybenzoic  acid  BrBA=  bromobenzoic  acid  and  ClBA  = 
chlorobenzoic acid. The bond lengths CO1, CO2 represent the lengths in the carboxylate group and  N1C, 
N2C the bond lengths between the nitrogen and central carbon in BZN and IMD. HB1 and HB2 represent the 
NH···O hydrogen bond lengths between the nitrogens on the BZN or IMD and the carboxylate group. 
 
6.5.3  Packing Effects 
 
The nitro groups within the molecular complexes do not form the predominant interactions. 
They do however; form weaker hydrogen bonds with aromatic hydrogen atoms.  
 
6.5.3.1   Benzimidazolium 3-Nitrobenzoate 
These  co-molecules  generate  a  spiral  structure  of  alternating  benzimidazolium  and  3-
nitrobenzoate molecules connected through partially charged assisted N
ʴ+H····O
ʴ- hydrogen 
bonds. Neighbouring spirals are connected via weak CH∙∙∙O
ʴ- hydrogen bonds involving an 
oxygen  of  the  nitro  group  and  an  aromatic  hydrogen  of  the  benzimidazolium  of  C···O 
distance of 3.553(6)Å (Figure 6.46).  
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Fig. 6.46 – The benzimidazolium 3-nitrobenzoate molecular complex structure viewed along the c-axis. The 
spiral hydrogen bond  motif runs along the  b-axis  with the  weak  CH∙∙∙O
ʴ- hydrogen bonds (circled in red) 
connecting adjacent spirals.  
 
6.5.3.2  Benzimidazolium 4-Nitrobenzoate 
 
The benzimidazolium 4-nitrobenzoate structure adopts the same supramolecular synthons and 
motif as the benzimidazolium 3-nitrobenzoate molecular complex. Spirals of alternating co-
molecules are held together by N
ʴ+H····O
ʴ- hydrogen bonds and are then connected to one 
another through weak CH∙∙∙O
ʴ- hydrogen bonds.  Again the acceptor atom is an oxygen of 
the nitro group, but in this case, the donor is an aromatic hydrogen atom from another 4-
nitrobenzoate molecule (Figure 6.47).    285 
 
Fig. 6.47 – The benzimidazolium 4-nitrobenzoate molecular complex structure viewed along the c-axis. The 
spiral hydrogen bond  motif runs along the  b-axis  with the  weak  CH∙∙∙O
ʴ- hydrogen bonds (circled in red) 
connecting adjacent spirals.  
 
6.5.3.3  Imidazolium 3-Nitrobenzoate 
 
The main hydrogen bonds in the imidazolium 3-nitrobenzoate structure are two N
ʴ+H····O
ʴ- 
interactions  between  the  carboxylate  group  and  protonated  nitrogens  of  the  imidazolium. 
They arrange themselves into a four membered hydrogen bonded ring system containing two 
of  each  co-molecule.  These  hydrogen  bonded  rings  are  then  connected  through  several 
CH∙∙∙O
ʴ- weak hydrogen bonds involving the oxygens of the nitro group and π∙∙∙π stacking 
interactions between the IMDH
+ molecules (blue circle) (Figure 6.48). 
 
 
Fig.  6.48  –  The  imidazolium  3-nitrobenzoate  molecular  complex  structure  viewed  along  the  a-axis.  The 
hydrogen bonded rings (green boxes) are connected by weak carbon oxygen hydrogen bonds (circled in red) and 
π∙∙∙π interactions (blue).   
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6.5.3.4  Imidazolium 4-Nitrobenzoate 
 
The benzimidazole nitrobenzoic acid structures all share the same motif. The same can be said 
about the imidazolium structures. The imidazolium 4-nitrobenzoate molecular complex forms 
four membered hydrogen bonded rings held together by N
ʴ+H····O
ʴ- hydrogen bonds. These 
rings are connected through CH∙∙∙O
ʴ- weak hydrogen bonds involving the nitro group (Figure 
6.49). 
 
 
Fig.  6.49  –  The  imidazolium  3-nitrobenzoate  molecular  complex  structure  viewed  along  the  a-axis.  The 
hydrogen bonded rings (green boxes) are connected by weak carbon oxygen hydrogen bonds (circled in red).   
 
6.6   Conclusions 
 
The introduction of another basic atom into the system, in this case a nitrogen in the form of 
carboxyl and hydroxyl substituted pyridines, was intended to compete on two fronts; firstly 
with  the  other  basic  nitrogen  on  the  benzimidazole  for  proton  transfer,  secondly  for 
involvement in the potential hydrogen bonds. In regard to the proton transfer, in all the cases 
the proton from the carboxylic acid group has transferred to the benzimidazole molecule, as 
has  been  seen  in  all  but  two  examples  in  this  work  (BZN  :  3ClBA  and  BZN  :  4FBA). 
However, this does not tell the whole story, as picolinic acid and 6-hydroxypicolinic acid 
have  a  history  of  undergoing  tautomerisation  with  the  proton  transferring  between  the 
hydroxyl  and  the  basic  nitrogen.  In  both  cases,  within  the  molecular  complex  with 
benzimidazole, the co-molecule has undergone deprotonation with the proton transferring to 
the basic nitrogen of the benzimidazole. The result for the picolinic acid complex is that there 
is no proton available for tautomerisation to occur therefore it forms the zwitterion. The 6-  287 
hydroxypicolinic acid molecule does have an available proton for tautomerisation and has 
occurred. Therefore proton transfer from the carboxylic acid group to the basic nitrogen of the 
same molecule would not be preferred over proton transfer from the hydroxyl group to the 
nitrogen within these two molecules.    
 
When  the  basic  nitrogen  is  unprotonated,  the  established  NH∙∙∙O  hydrogen  bond  is  not 
favoured over a NH∙∙∙N hydrogen bond, with the NH∙∙∙O interaction forming the weaker 
part  of  a  bifurcated  hydrogen  bond  (Figure  6.50).    Therefore  it  has  competed  with  the 
carboxylic  acid  group  to  be  the  primary  hydrogen  bond  acceptor  and  this  designed 
intervention was successful. 
 
 
Fig.  6.50  –  The  bifurcated  hydrogen  bond  of  the  BZNH
+  :  3-HPA
-  molecular  complex,  with  the  major 
component the N-H∙∙∙N hydrogen bond and minor component being N-H∙∙∙O. 
 
The other possible outcome was that if the nitrogen was protonated, it would compete with 
the other protonated nitrogen on the benzimidazole for the primary hydrogen bond donor role. 
As the benzimidazole is found still to be protonated, the hydrogen bond donors from this 
molecule would be charged assisted and therefore still a more attractive prospect for hydrogen 
bond acceptors. With this being the case it was not surprising to see that in the benzimidazole 
and 6-hydroxypicolinic acid molecular complex the N atom of the pyridine was acting as a 
the donor in a hydrogen bond, however it was the weakest of the three primary hydrogen 
bonds within the structure at 2.915(2)Å. The solvate structure also had the named N atom 
within hydrogen bonds, it also produced one of the weaker hydrogen bonds in the structure 
and also had a length of 2.915(3)Å.  
 
Scrutiny of the ΔpKa difference values (Table 6.5) was not possible for molecular complexes 
containing the 6-hydroxypicolinic acid molecule as this value could not be obtained. For the 
molecular complexes where the values could be obtained the rule governing if a salt or co-  288 
crystal will form has been accurate. All the ΔpKa values lie above the 3 value that normally 
means a salt will be formed, which was the case.   
 
The second part of the chapter focused on the benzimidazole and nitro-substituted benzoic 
acid series of molecular complexes.  The object was to investigate if electronic properties 
affected structural features seen in other benzimidazole containing molecular complexes, for 
example proton transfer, the strength of the hydrogen bonds and the packing of the structures. 
As ever, proton transfer from the carboxylic acid group to the unprotonated N atom on the 
benzimidazole occurred, however the effect of this on the internal bond bonds of both the 
benzimidazole  and  carboxylate  group  was  very  different  to  previously  seen.  Whereas 
normally proton transfer promoted the normalisation of the NC and CO bond lengths, with 
distances around N∙∙∙C 1.33Å and C∙∙∙O 1.25Å representing NC bond lengths a little shorter 
than characteristic single bonds and CO lengths longer than characteristic double bond. In 
three out of the four molecular complexes containing 3- and 4-nitrobenzoic acid, the opposite 
effect  was  seen,  with  the  NC  lengths  adopting  more  double  bond  characteristics,  N∙∙∙C 
1.25Å, and CO greater single bond characteristics, 1.32Å.  These are the only molecular 
structures in all of the results generated in this work to behave in this way. 
 
The nitro-groups always formed weaker interactions that connected the main supramolecular 
synthons or motifs together in a way similar to those seen in the halo substituted benzoic acid 
structures. 
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7  A  Comparison  Study  of  Benzimidazole  and  Imidazole 
Containing Molecular Complexes with a Range of Related Co-
Molecules 
 
This chapter aims to compare the molecular complexes generated between BZN and IMD and 
a range of co-molecules.  The method adopted will consist of the direct comparison of a BZN 
molecular complex with the identical  IMD molecular complex, and  comparisons between 
BZN and IMD molecular complexes within a systematic series of co-molecules. There will be 
many  different  aspects  to  the  comparisons,  including  hydrogen  bond  strength,  physical 
properties  and  crystallographic  information;  however  there  will  be  one  main  theme 
throughout  them  all  –  crystal  engineering.  The  comparisons  will  focus  on  the  hydrogen 
bonding patterns and motifs taking into account the library of interactions that have been 
generated in the complexes discussed in previous chapters with the aim of explaining the 
structures generated.  
 
The co-molecules can be split into four categories, with each category having different areas 
of interest and associated aims: 
  the mono-hydroxy-benzoic acid series which have successfully  been  cocrystallised 
with BZN producing a library of hydrogen bonds with predictable motifs were used 
with IMD to further investigate the robustness and predictability of these motifs; 
  a related set of compounds, aromatic dicarboxylic acids, were cocrystallised with BZN 
and IMD to test further the robustness of the hydrogen bonds and motifs generated 
with the hydroxy-benzoic acid materials; 
  halo-substituted  benzoic  acids  were  cocrystallised  with  BZN  to  investigate  the 
occurrence  of  polymorphism  with  an  aim  to  control  selectively  the  growth  of 
individual forms. Cocrystallisations with IMD had a primary aim of investigating the 
influence of the halo- atom on the structure generated; 
  experiments  with  a  series  of  dicarboxylic  acids  with  varying  chain  length  and 
conjugation, for example fumaric and succinic acid, with both BZN and IMD were 
initially targeted at engineering network structures with differing pore sizes.  
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7.1   Introduction – Co-molecules 
 
7.1.1  2-/ 3-/ 4-Hydroxybenzoic Acid 
 
Refer to Sections 4.1.1 to 4.1.3, where these components are discussed. 
 
7.1.2  4-Fluoro- / 4-Bromo- Benzoic Acid 
 
Refer to Sections 5.1.3 and 5.1.9, where these components are discussed. 
 
7.1.3  Phthalic Acid 
 
Phthalic acid is an organic compound derived from benzene and used in the manufacture of 
dyes,  perfumes,  pharmaceuticals,  and  synthetic  fibres.  It  was  first  discovered  in  1836  by 
Auguste  Laurent,  who  initially  believed  it  was  naphthalenic  acid,  before  its  nature  was 
correctly determined years later. There are four entries of the same structure for phthalic acid 
in  the  CSD  with  differing  R-factor  and  associated  temperatures.  Figure  7.1  displays  the 
structure published by Ermer
1 (CSD ref PHTHAC02). The structure is made up of chains 
consisting of carboxylic acid dimers, which are held together through weaker interactions. 
 
Fig. 7.1 – Structure of phthalic acid, which is seen to exploit the carboxylic acid dimer motif. 
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Phthalic  acid  is  well  studied  and  is  found  as  a  component  in  a  large  number  of  crystal 
structures, for example in organometallics with cobalt and chromium
2, and cocrystallised in 
its  native  structure  with  cinnamamide
3  (CSD  ref  EBOSIX)  and  benzene-1,2-dicarboxylic 
acid
4 (CSD ref EBOSIX02) (Figure 7.2).
  There are also molecular complexes with phthalic 
acid in its deprotonated state, phthalate, with other small organic molecules including 4,4'-
iminodipyridinium
5 (CSD ref BOGTAT) and 2,6-dimethylpyridinium
6 (Figure 7.2) (CSD ref 
GUHREG).  There  are  also  many  examples  of  complexes  with  the  doubly  deprotonated 
phthalate molecule.  
 
       
Fig. 7.2 – LHS, crystal structure of the molecular complex of phthalic acid and benzene-1,2-dicarboxylic acid; 
RHS, the phthalate ion in the ionic complex formed with 2,6-dimethylpyridinium. 
 
7.1.4  Isophthalic Acid 
 
The main use of isophthalic acid is in the production of the synthetic fibre, polybenzimidazole 
(PBI), which has an extremely high melting point and does not readily ignite, because of its 
thermal  and  chemical  stability
7.  Therefore  PBI  is  used  to  make  protective  clothing,  for 
examples  fire-fighter  turnout  coats  and  suits,  astronaut  space  suits,  high  temperature 
protective  gloves,  welders'  apparel,  race  driver  suits,  braided  packing,  and  aircraft  wall 
fabrics
8. The crystal structure, solved by Derissen in 1974
9 (CSD ref BENZDC01), is similar 
to that of phthalic acid, where the carboxylic acid groups form dimers that create chains, with 
the chains held together through lesser interactions (Figure 7.3).   
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Fig. 7.3 – The crystal structure of isophthalic acid, which exhibits the common carboxylic acid dimer motif. 
 
Many crystal structures of isophthalic acid in organometallic complexes have been deposited 
in  the  CSD,  for  example  with  lithium,  sodium  caesium  and  rubidium
10.  Importantly, 
molecular complex structures  with  both  BZN
11 and  IMD
12  have already  been solved  and 
deposited in the CSD. The BZN : isophthalic acid structure (CSD ref VARJAA) shown in 
Figure 7.4 exhibits hydrogen bonding ring motifs that combine to form a sheet. There are 
issues  with  the  published  structure:  firstly  it  was  undertaken  at  room  temperature,  the 
hydrogens have not all been accounted for and there is disorder on both co-molecules. The 
IMD  :  isophthalic  acid  complex  (CSD  ref  MEQQOO),  also  shown  in  Figure  7.4,  is  a 
relatively well determined structure, however has it been solved at room temperature. The 
structure is made up of chains of alternate hydrogen bonded co-molecules. These chains also 
link through hydrogen bonds to chains above and below resulting in the stacking of these 
chains. These stacks are then linked through weaker interactions in the third direction.  
 
 
Fig. 7.4 – LHS, structure of the benzimidazole : isophthalic acid molecular complex; RHS, the structure of the 
imidazole : isophthalic acid molecular complex. 
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7.1.5  Terephthalic Acid 
 
Nearly all the world‘s supply of terephthalic acid is used to make polyethylene terephthalate 
(PET), which has two main uses, in synthetic fibres (around 60% of market) and in liquid 
bottle holders (around 30%)
13.  This polymer is the sole material in the bottle industry with 
the  major  advantage  of  being  recyclable  back  to  its  starting  materials;  it  has  resin 
identification  code  1  (a  set  of  symbols  placed  on  plastics  to  identify  the  polymer  type). 
Terephthalic acid has two other uses, of much lesser extent: in the production of polybutylene 
terephthalate (PBT) which is a thermoplastic engineering polymer used as an insulator in the 
electrical  and  electronics  industries;  and  in  research  laboratories  in  engineering  materials 
linked through hydrogen and coordination bonds. With terephthalic acid‘s major importance 
in industry, it is not surprising to see there are thirteen separate entries in the CSD. There are 
three  known  polymorphs,  two  different  triclinic  structures  (CSD  ref  TEPHTH
14  and 
TEPHTH12
15)  and  a  monoclinic  structure  (CSD  ref  TEPHTH13
16)  (Figure  7.5).  All  the 
structures  have  the  same  hydrogen  bond  pattern,  a  chain  of  terephthalic  acid  molecules 
connected  through  carboxylic  acid  dimers.  The  polymorphs  differ  in  their  packing 
arrangements. 
 
 
Fig. 7.5 – The carboxylic acid dimer that exists in all the terephthalic acid structures.  
 
There  are many compounds  and complexes  of terephthalic  acid  in  the CSD: with  metals 
including cadmium
17 and with small organic molecules, most significantly imidazole
18 (CSD 
ref HILSAX) (Figure 7.6). The structure of this imidazole : terephthalic acid complex consists 
of an interlinked hydrogen bonded network that expands in all three dimensions. 
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Fig. 7.6 – The imidazole : terephthalic acid molecular complex.  
 
7.1.6  Fumaric acid 
 
Fumaric acid is an unsaturated dicarboxylic acid with a four carbon chain, with the acid 
groups in trans position about the central C=C bond. They are in the cis conformation in the 
isomeric maleic acid. Fumaric acid has a fruit like taste and is a well known food additive. It 
is also used in the manufacturing of polyester resins and dyes. There are two polymorphs of 
the native structure, the latest was solved in 1966 by Brown
18 (CSD ref FUMACC) (Figure 
7.7), which adopts the carboxylic acid dimer motif that expands to form chains. 
 
 
Fig. 7.7 – The carboxylic acid dimer motif adopted in the fumaric acid structure. 
 
There are a few structures with fumaric acid as a component deposited in the CSD, of greatest 
importance is that with imidazole, imidazolium hydrogen fumarate. The structure was first 
solved in 2001
 with CSD reference MEQPED
12 and adopts the ladder motif, with chains of 
fumaric acid and steps of imidazole (Figure 7.8).  
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Fig. 7.8 – The ladder motif of the imidazolium hydrogen fumarate structure, with the uprights consisting of 
fumaric acid chains and the steps of imidazolium molecules.  
 
7.1.7  Succinic acid 
 
Historically succinic acid was known as spirit of amber and was used to ease rheumatic aches 
and pain. Nowadays it is used as a sweetener in the food industry
19. It is the saturated form of 
fumaric acid. There are two polymorphs of succinic acid, a triclinic
20 (Figure 7.9 LHS) and a 
monoclinic form
21 (Figure 7.9 RHS). They both are constructed by chains of succinic acid 
molecules  using  the  carboxylic  acid  dimer  (Figure  7.9  top),  but  differ  in  their  packing 
arrangements. 
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_____________________________________________________ 
        
Fig. 7.9 – top, the carboxylic acid dimer that is the main hydrogen bonding pattern for both polymorphs of 
succinic acid, with the packing shown below, LHS, triclinic form, RHS, monoclinic form. 
 
There are numerous examples of the occurrence of native succinic acid, and both its singly 
and  doubly  deprotonated  forms  in  molecular  complexes,  of  particular  interest  here  is  the 
imidazolium hydrogen succinate structure (Figure 7.10). This structure came from the body of 
work  by  MacDonald
12  that  also  reported  the  structures  of  imidazole  with  fumaric  acid, 
isophthalic acid, malonic acid and a range of other carboxylic acids. This work found that 
proton  transfer  occurred  and  resulted  in  N-H∙∙∙O  hydrogen  bonds  being  formed,  and 
MacDonald summarised the structures as follows: ―These strong hydrogen bonds generate 
two types of chains that intersect at the anions and form polar hydrogen-bonded layers with 
four different motifs. These layers serve as scaffolds with which to control molecular packing 
in two dimensions for engineering the structures of crystals. All imidazolium cations function 
as multidentate proton donors by forming two or three C−H···O hydrogen bonds in addition 
to  two  N−H···O  hydrogen  bonds.  Strong  O−H···O  and  N−H···O  hydrogen  bonds  define 
structure and connectivity within layers, while weaker C−H···O hydrogen bonds dominate 
interactions between layers in these salts”
12.  
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Fig. 7.10 – Basic building block of the imidazolium succinate ionic molecular complex. 
 
7.1.8  Maleic acid 
 
As stated, maleic acid is the cis- form of butenedioic acid and is primarily used in industry to 
form fumaric acid, the trans- form.  There are two polymorphic forms of maleic acid which 
are both discussed by. Jones
22. Form I (CSD ref MALIAC12), shown in Figure 7.11, consists 
of  sheets  of  hydrogen  bonded  maleic  acid  molecules  with  weaker  interactions  operating 
between the sheets. Form II has the same hydrogen bonding pattern, however the packing of 
the structure differs. 
 
 
Fig. 7.11  The structure of maleic acid Form I, showing the main hydrogen bonding pattern.  
 
There are numerous molecular complexes containing maleic acid and its protonated form. Of 
most interest here is the molecular complex with imidazolium (Figure 7.12). This structure, 
first solved in 1972, was re-determined by both X-ray and neutron diffraction in 1980
23 (CSD 
ref IMZMAL12 & IMZMAL13). The structure adopts the 1:1 hydrogen bonded ring motif, 
using  the  charge  assisted  N-H∙∙∙O  hydrogen  bonds  that  result  from  the  proton  transfer.   299 
Between the hydrogen-bonded rings are two interactions including C-H∙∙∙O weak hydrogen 
bonds.   
 
 
Fig. 7.12 – The hydrogen bonded ring motif of the imidazolium maleate molecular complex.  
 
7.1.9  Malonic acid 
 
Malonic acid is systematically known as propanedioic acid. Malonic acid is an important 
molecule within the body as it acts as a competitive inhibitor of succinate dehydrogenase in 
the respiratory electron transport chain. It has no real industrial applications in its native form. 
There  are  two  polymorphic  forms  of  malonic  acid  and  two  deuterium  isotope  induced 
polymorphs. The non-deuterated forms are triclinic
24 (CSD ref MALNAC02) and triclinic 
beta
25  (MALNIA04)  and  the  deuterated  forms  are  an  orthorhombic  alpha
26  (CSD  ref 
MALNAC03) and triclinic gamma
27 (CSD ref MALNA08). All the different forms have the 
same basic building block, a carboxylic acid dimer (Figure 7.13), with the structures adopting 
different packing arrangements. 
 
 
Fig. 7.13 – The basic dimeric hydrogen bonded building block of all the polymorphic forms of malonic acid. 
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The molecular complexes  deposited within the CSD containing the deprotonated form  of 
malonic acid, malonate, utilise a wide range of co-molecules, including metals and small 
organic molecules, such as neptunium
28, nickel
28 (CSD ref QARVAH), DL-histidine
29 (CSD 
ref CAMWOD) and most importantly for the work presented here, imidazole
11 (CSD ref. 
VARHOM). The malonate imidazolium hydrate complex (Figure 7.14) contains a disordered 
water molecule and disordered carboxylic acid groups. The structure adopts hydrogen bonded 
chains  of  alternate  co-molecules  which  are  held  through  hydrogen  bonds  to  the  water 
molecule in one direction to create a ladder style motif, while weaker hydrogen bonds form 
between  the  chains  to  create  layers.  A  molecular  complex  containing  malonic  acid  with 
benzimidazole has also been solved and published
30 (CSD ref MIZMUE). In this structure the 
main motif is a linear chain of hydrogen bonded alternate co-molecules (Figure 7.14). There 
are  a  few  problems  with  the  structure  which  are  likely  to  stem  from  the  fact  that  the 
diffraction experiment was undertaken at room temperature (20ºC) and that the hydrogens 
were fixed geometrically and allowed to ride on the parent carbon atoms. There is thus no 
proton  transfer  presented  in  the  published  structure,  which  is  unlikely  as  benzimidazole 
readily accepts protons from carboxylic acid groups when in a 1:1 molecular ratio, as is the 
case  here.  Also  the  carbon  oxygen  bond  lengths  are  inconsistent,  with  double  bonds 
apparently having longer distances than single bonds. The authors of this paper were focused 
on computational methods and used the diffraction experiment to support their measurements; 
unfortunately it was never considered that proton transfer might occur. 
 
     
Fig. 7.14 – The imidazolium malonate hydrate structure consists of chains of alternate co-molecules connected 
through the disordered water molecules.  
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7.1.10  Benzoic Acid 
 
Benzoic acid is a very important molecule, not necessarily in its native form but either in the 
salt form, where is it used as a food preservative as it inhibits the growth of mold/yeast
31 or as 
a  precursor  to  many  important  organic  chemicals.  Its  structure  was  first  solved  in  1955, 
however the most accurate structure, determined by neutron  diffraction, was published in 
1996 by Wilson et al
32 (Figure 7.15).  The molecules adopt the carboxylic acid dimer motif, 
with  the  protons  involved  in  the  hydrogen  bond  disordered  over  two  sites.  The  neutron 
experiment  found  that  the  occupancy  levels  on  these  two  sites  differed  with  varying 
temperature. 
 
Fig. 7.15 – The carboxylic acid dimer that is the building block of the benzoic acid structure. 
 
There  are  a  host  of  materials  that  contain  benzoic  acid  and  /  or  its  deprotonated  form 
(benzoate), including salts, molecular complexes, organometallics and solvates. A molecular 
complex with imidazolium was published in 2006
 (CSD ref HEPXUW) by Baruah et al
33. The 
structure adopts the linear chain motif with alternating hydrogen bonded co-molecules (Figure 
7.16). 
 
 
Fig 7.16 – The linear chain of alternating hydrogen bonded co-molecules that exists in the imidazolium benzoate 
molecular complex.   302 
7.2   Summary of Results 
 
Cocrystallisation reactions with IMD and BZN and a range of co-molecules have produced a 
series of molecular complexes. All of these have been analysed, primarily with single crystal 
X-ray diffraction. 
 
As discussed in Chapter 4, BZN has successfully been cocrystallised with the mono-hydroxy 
substituted benzoic acids series producing a range of molecular complexes with predictable 
hydrogen bonding patterns. The successful cocrystallisation of IMD with the same mono-
hydroxy  substituted  benzoic  acids  series  is  also  reported  here  to  produce  new  molecular 
complexes (Table 7.1). These new structures are all in a 1:1 molecular ratio, with proton 
transfer occurring (see Section 7.2.1) and utilising the hydrogen bond patterns that were seen 
within the other BZN structures studied.  
 
   Imidazole  Source  Benzimidazole  Source 
2-hydroxyBA  1:1  New  1:1 + 1:2  New 
3-hydroxyBA  1:1  New  1:1 + 2:1   New 
4-hydroxyBA  1:1  New  2:1   New 
Table 7.1. – Summary of the molecular complexes generated between cocrystallisation experiments between 
BZN  and  IMD  and  the  mono-substituted  benzoic  acid  series.  In  the  Source  column  of  the  table,  ―New‖ 
represents complexes previously undiscovered until this research and ―CSD‖ means the complex already been 
structurally determined and deposited in the CSD. 
 
Cocrystallisations  with  the  aromatic  dicarboxylic  acids  series  produced  previously 
undiscovered molecular complexes with BZN in a 1:1 molecular ratio (Table 7.2). The X-ray 
diffraction experiment of the BZN complex with terephthalic acid produced a suitable data set 
which  resulted  in  a  good  quality  structure,  but  problems  with  crystal  quality,  namely 
twinning,  has  resulted  in  poor  data  quality  for  the  molecular  complexes  of  BZN  with 
isophthalic and phthalic acid. The structures of complexes of imidazole with terepthalic and 
isophthalic acid were previously known, but not with phthalic acid. Unfortunately at the time 
of writing no suitable crystals of IMD with phthalic acid have been produced. 
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   Imidazole  Source  Benzimidazole  Source 
Terephthalic acid  1:1  CSD  1:1  New 
Isophthalic acid  1:1  CSD  1:1  CSD (RD) 
Phthalic acid   n/a  n/a  1:1  New 
Table 7.2 – Summary of the molecular complexes that exist between IMD and BZN with aromatic dicarboxylic 
acids. In the Source column of the table, ―New‖ represents molecular complexes generated for the first time 
during  this  research,  ―CSD‖  accounts  for  those  that  have  already  been  solved  while  ―RD‖  stands  for  re-
determined, i.e. cases where a new X-ray diffraction experiment was attempted to get a improved data set than 
that available in the literature. 
 
In  Chapter  5,  a  wide  range  of  new  molecular  complexes  containing  BZN  and  mono-
substituted  halo-benzoic  acids  were  reported  and  the  results  discussed.  Cocrystallisation 
experiments  were  also  set-up  using  the  mono-substituted  halo-benzoic  acid  series  with 
imidazole; the successful generation of molecular complexes with 4-fluoro- and 4-bromo- 
benzoic acids can be reported (Table 7.3). Unfortunately the other cocrystallisations did not 
produce suitable crystals for X-ray diffraction; however it is believed that with the correct 
crystallisation  conditions  that  can  be  rectified.  This  section  will  also  cover  the 
cocrystallisation of IMD and BZN with benzoic acid and the resulting molecular complexes 
generated.  
 
   Imidazole  Source  Benzimidazole  Source 
4-fluoroBA  1:1  New  1:1   New 
4-bromoBA  1:1  New  1:1   New 
Benzoic acid  1:1  CSD  1:2  New 
Table 7.3 – Summary of the successful cocrystallisations between IMD and mono-substituted halo-benzoic acid 
series with the corresponding BZN molecular complex. 
 
Cocrystallisations with a range of dicarboxylic acids produced four new molecular complexes 
(Table 7.4); BZN with fumaric acid, succinic acid, maleic acid and IMD with malonic acid all 
in a 1:1 molecular ratio and all with associated proton transfer. A model that better represents 
the benzimidazole and malonic acid complex has also been produced. Structures containing 
IMD with fumaric, succinic, maelic acid and a malonic acid hydrate have already been solved 
and deposited in the CSD.  
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   Imidazole  Source  Benzimidazole  Source 
Fumaric acid  1:1  CSD  1:1  New 
Succinic acid  1:1  CSD  1:1   New 
Maelic acid  1:1  CSD  1:1  New 
Malonic acid  1:1 (1:1 hydrate)  New (CSD)  1:1  CSD (RD) 
Table 7.4 – Summary of the successful cocrystallisation experiments between IMD and BZN with dicarboxylic 
acids. In the Source column of the table, ―New‖ represents molecular complexes generated for the first time 
during  this  research,  ―CSD‖  accounts  for  those  that  have  already  been  solved.  ―RD‖  represents  the 
benzimidazole : malonic acid molecular complex structure which has been greatly improved in this work from 
that reported in the CSD. 
 
7.2.1  Benzimidazolium, Imidazolium – Proton Transfer 
 
As  discussed  in  previous  chapters,  in  cases  where  the  crystallisation  product  is  in  a  1:1 
stoichiometric ratio of BZN and a carboxylic acid containing molecule, the BZN is protonated 
through hydrogen transfer from the carboxylic acid group onto the normally unprotonated 
nitrogen atom in the five-membered ring, creating a benzimidazolium molecule (BZNH
+). 
The same process occurs with IMD in the presence of a carboxylic acid containing molecule 
in a 1:1 stoichiometric ratio; an imidazolium molecule is created (IMDH
+) (Figure 7.17). The 
result of the proton transfer on the IMDH
+ molecule is a delocalisation of the charge across 
the five-membered ring, reflected in the equalisation of the internal bond lengths N
ʴ+-C and 
bond angles C-N
ʴ+-C. The delocalisation of the charge has the effect of creating a partial 
positive charge on both nitrogens. This effect has been reported in many structures involving 
BZN and IMD.  
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Fig. 7.17 – LHS, the imidazolium molecule with 4-bromobenzoate, in which both nitrogens are protonated. 
RHS, the MCE Fourier difference map generated where the H atoms located on a nitrogen atom have been 
omitted from the model, clearly showing that both nitrogen atoms are protonated.   
 
The consequence for the co-molecule that has been deprotonated is the creation of a negative 
charge, which is delocalised over the carboxylic acid group resulting in equalisation of the C-
O and C=O bond lengths in the carboxylate group. 
 
7.2.2  Potential Hydrogen Patterns and Hydrogen Bond Motifs 
 
The co-molecules involved in these studies have the same functional groups as those used in 
Chapters 4 and 5, pointing to a series of possible hydrogen bond patterns and supramolecular 
synthons identical to those seen in those chapters. Considering the formation of the molecular 
ion  species  and  the  hydrogen  bonding  patterns  seen  in  structures  discussed  in  previous 
chapters, a library of hydrogen bonding patterns and motifs can now be formed (Figure 7.18).  
It would be highly likely that the structures produced would adopt one of these hydrogen 
bonding patterns and likely to adopt one of the motifs. The motifs outlined are just the general 
trend, for example K represents the ladder motif which can also have a BZN dimer as the step 
and be a cross linked ladder, L represents the hydrogen bonded ring motif, which also has 
variances etc. 
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Fig. 7.18 – The library of hydrogen bond patterns that the molecular complexes are highly likely to adopt. E, F, 
G, H, I and J are all seen in other molecular complexes. The motifs are defined as the general descriptor of these 
interactions; K is the ladder motif, L is the hydrogen bonded ring motif, M is the co-molecule dimer motif while 
N is an example of a linear chain of alternate co-molecules.   
 
7.3   Crystallographic Data 
E 
F  G 
H  I 
K 
L 
M  N 
J   307 
Compound  IMD 2-HBA  IMD 3-HBA  IMD 4-HBA  IMD 4-FBA  IMD 4-BrBA  IMD Malonate 
Formula  C10 H10 N2 O3  C10 H10 N2 O3  C10 H10 N2 O3  C10 H9 F N2 O2  C10 H9 Br N2 O2  C6 H8 N2 O4 
ΔpKa (1:1)  4.01  2.91  2.42  2.84  3.03  4.16 
Cryst’ Conditions  Methanol, ~2-4ºC  Ethanol, RT  Methanol, ~2-4ºC  Acetone, ~2-4ºC  Methanol ~2-4ºC  Acetone, ~2-4ºC  
M. weight / gmol
-1  206.20  206.20  206.20  208.19  269.10  172.14 
Temperature (K)  100  100  100  100  100  100 
Space Group  P bca  P  21/n   P 21/n  P 21/c  P n a 21  P 21/c 
a (Å)  11.0916(12)  8.1947(15)  9.1930(4)  12.7412(18)  9.18790(10)  9.3531(2) 
b (Å)  10.9340(13)  12.604(2)  10.7841(4)  7.3249(11)  27.8801(3)  7.7079(2) 
c (Å)  16.674(2)  9.889(2)  10.4544(4)  10.5181(16)  3.9500(5)  11.5136(7) 
ʱ (
o)  90  90  90  90  90  90 
β (
o)  90  105.85(1)  112.790(2)  96.099(9)  90  113.9650(10) 
γ (
o)  90  90  90  90  90  90 
Volume (Å
3)  2022.1(4)  982.6(3)  955.52(7)  976.193)  1011.83(13)  758.49(5) 
Z  8  4  4  4  4  4 
θ range (˚)  2.443-24.815  2.683- 27.868  2.511-27.478  1.607-26.759  1.461-27.492  3.276-27.417 
Completeness (%)  0.994  0.994  0.995  0.997  0.998  0.973 
Reflections Collected  72325  10317  14100  15115  20365  7177 
Independent  1733  2326  2183  2075  4335  1676 
Refln (obs.I>2sigma(I))  1709  2319  1205  2067  4323  1673 
Rint  0.057  0.61  0.093  0.115  0.052  0.028 
Parameters  176  176  176  172  174  141 
GooF on F
2  1.2876  1.0885  1.1913  0.9195  1.0232  1.0478 
R1 (Observed)  0.0427  0.0398   0.0573  0.0380  0.0320  0.309 
R1 (all)  0.0551  0.0732  0.0448  0.0693  0.0340  0.0324 
wR2 (all)  0.1012  0.1162  0.0471  0.0924  0.0874  0.0775 
Table. 7.5 – Crystallographic data for the molecular complexes containing imidazolium. 
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Compound  BZN BA  BZN TerePHth  BZN PHth  BZN Fumarate  BZN succinate  BZN maelate  BZN malonate 
Formula  C21 H18 N2 O4  C15 H12 N2 O4  C15 H12 N2 O4  C11 H12 N2 O4  C11 H12 N2 O4  C11 N2 H11 O4  C10 H10 N2 O4 
ΔpKa (1:1)  1.34  2.02  2.64  2.50  1.37  3.70  2.7 
Cryst’ Conditions  Ethanol ~2-4ºC  Methanol~2-4ºC  Methanol, RT  Ethanol RT  Ethanol ~2-4ºC  Methanol, 40ºC  Acetone ~2-4ºC 
M. weight / gmol
-1  362.38  284.27  284.27  234.01  235.87  234.21  222.20 
Temperature (K)  100  100  100  100  100  100  100 
Space Group  P 21/n  P 21/c  P 212121  P -1  P 21/n  P 21/n  P -1 
a (Å)  10.0661(3)  9.7610(2)  4.623(4)  3.7362(1)  9.6333(2)  12.8558(17)  3.7614(2) 
b (Å)  16.8452(6)  7.96610(10)  11.254(10)  11.7687(3)  5.08570(10)  5.4500(6)  12.9268(5) 
c (Å)  20.8572(5)  17.0597(3)  25.85(2)  11.7550(3)  21.8908(4)  15.4641(18)  21.1808(9) 
ʱ (
o)  90  90  90  90.0212(11)  90  90  104.863(2) 
β (
o)  102.152(2)  98.2206(9)  90  90.5568(14)  97.2514(11)  91.516(4)  92.966(2) 
γ (
o)  90  90  90  91.9597(14)  90  90  94.865(3) 
Volume (Å
3)  3457.41(8)  1312.88(4)  1344.9(20)  516.54(2)  1063.90(4)  1083.1(2)  988.94(8) 
Z  8  4  4  2  4  4  4 
θ range (˚)  2.207-29.944  2.108-25.930  1.576-22.360  3.464-27.464  1.876-27.515  6-55  1.638-24.775 
Completeness (%)  100  0.998  0.968  0.995  0.998  0.994  0.994 
Reflections Collected  776600  25610  20069  10658  28914  12047  14831 
Independent  7889  2545  1018  2343  2452  2459  3394 
Refln (obs.I>2sigma(I))  4442  2545  1009  1711  2447  1796  3392 
Rint  0.172  0.056  0.105  0.083  0.043  0.0624  0.0726 
Parameters  487  238  190  192  200  194  349 
GooF on F
2  0.9155  0.9457  1.0131  0.9532  0.9745  0.981  1.0090 
R1 (Observed)  0.0484  0.0335  0.0356  0.0373  0.0347  0.0499  0.0433 
R1 (all)  0.0959  0.0541  0.0547  0.0593  0.0471  0.0713  0.0726 
wR2 (all)  0.0968  0.0853  0.0927  0.0957  0.0867  0.1211  0.0946 
Table. 7.6 – Crystallographic data for the molecular complexes containing benzimidazolium. PHth represents phthalic acid i.e. TerePHth is terephthalic acid.   309 
7.4   Imidazole with Mono Hydroxy Substituted Benzoic Acids 
 
The three new molecular complexes generated, imidazolium 2-hydroxybenzoate (IMDH
+ 2-
HBA
-),  imidazolium  3-hydroxybenzoate  (IMDH
+  3-HBA
-)  and  imidazolium  4-
hydroxybenzoate (IMDH
+ 4-HBA
-), are all formed in a 1:1 molecular ratio, with the common 
proton  transfer  transformation  occurring  (Section  7.2.1).  All  these  molecular  complexes 
exhibit only three different hydrogen bonding patterns, G, E and F (Figure 7.18 extract). They 
also form a motif common between the structures, which is a hybrid of the ladder and linear 
chain motifs seen previously (M and N). 
 
        
Fig. 7.18 extract – Extract from Figure 7.18 showing the hydrogen bonding patterns  within the  molecular 
complexes. 
 
Since  the  structures  of  IMD  and  BZN  with  the  mono-substituted  HBA  exhibit  the  same 
hydrogen bond patterns a comparison of their strengths can be undertaken (Table 7.7). This 
table  highlights  the  similarity  between  the  molecular  complexes  generated  in  terms  of 
hydrogen bond strength, with no vast difference in lengths or angles.  
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Molecular Complexes  BZNH
+   
2-HBA
- 
BZNH
+  
3-HBA
- 
BZNH
+  
4-HBA
- 
IMDH
+   
2-HBA
- 
IMDH
+  
3-HBA
- 
IMDH
+  
4-HBA
- 
Hydrogen Bonds 
N
ʴ+-
H····O
ʴ- 
 E and F 
D∙∙∙A(Å)  2.646(1) 
2.621(1) 
2.700(1) 
2.697(1) 
2.689(3) 
2.717(2) 
2.729(2) 
2.699(3) 
2.654(2) 
2.667(2) 
2.739(3) 
2.664(3) 
D-H(Å)  0.99(2) 
0.99(2) 
0.88(1) 
0.90(1) 
0.91(3) 
0.93(3) 
0.96(3) 
0.96(3) 
0.97(3) 
0.91(2) 
0.94(3) 
0.93(3) 
H∙∙∙A(Å)  1.67(2) 
1.64(2) 
1.82(1) 
1.80(1) 
1.78(3) 
1.79(3) 
1.78(3) 
1.75(3) 
1.70(3) 
1.78(3) 
1.85(3) 
1.74(3) 
D-H∙∙∙A 
angle(º) 
169(2) 
171(2) 
178(1) 
173(1) 
173(3) 
170(3) 
172(3) 
171(3) 
169(2) 
164(3) 
157(3) 
17493) 
O-H····O
ʴ- 
G 
D∙∙∙A(Å)  -  2.654(1) 
 
2.602(2) 
2.605(2) 
-  2.675(2)  2.614(3) 
D-H(Å)  -  0.87(1)  1.02(3) 
0.94(3) 
-  0.93(3)  0.98(4) 
H∙∙∙A(Å)  -  1.79(1)  1.60(3) 
1.69(3) 
-  1.76(3)  1.65(4) 
D-H∙∙∙A 
angle(º) 
-  172(1)  166(3) 
166(3) 
-  171(2)  170(4) 
Table. 7.7  The three scalar quantities and bond angles of the hydrogen bonds of N
ʴ+-H····O
ʴ- and  O-H····O
ʴ- found in the molecular complexes presented in Chapter 7.  311 
7.4.1  Molecular Complex of Imidazolium and 2-Hydroxybenzoic Acid 1:1 
 
As the 2-hydroxybenzoic acid molecule contains an intramolecular hydrogen bond,  which 
would be very difficult to break, of the three possible hydrogen bonding patterns, E, F and G, 
the latter would be very unlikely to occur for this complex. With only hydrogen bond patterns 
E  and  F  remaining  as  possibilities,  the  question  is  how  these  will  influence  the  overall 
structure. 
 
Structure Description 
 
The molecular ions, IMDH
+ and 2-hydroxybenzoate (2-HBA
-) form a 1:1 molecular complex.  
The  molecular  complex  was  obtained  using  the  solvent  evaporation  method,  with  a  1:1 
stoichiometric mixture of IMD (8mg) and 2-hydroxybenzoic acid (2-HBA) (14mg) dissolved 
in the minimum amount of methanol followed by evaporation at 2-4ºC. The crystals generated 
were block shaped and colourless. Single crystal X-ray diffraction data were obtained using a 
Bruker-Apex  II  diffractometer  at  100K,  equipped  with  graphite  monochromated  Mo  Kʱ 
radiation (λ = 0.71073 Å). The structure was solved using SIR92 within the CRYSTALS 
program. The crystallographic data are summarised in 
Table  7.5.  In  the  molecular  complex,  the  IMD 
molecule  is  protonated  through  hydrogen  transfer 
from  the  carboxylic  acid  group  on  the  2-HBA,  as 
described in Section 7.2.1 (Figure 7.19). The result is 
that the internal bond lengths are normalised to N1
ʴ+-
C1  1.304(3)Å  and  N2
ʴ+-C1  1.317(3)  Å,  and  bond 
angles  to  C1-N1
ʴ+-C2  108.1(2)º  and  C1-N2
ʴ+-C7 
107.7(2)º.   
Interaction  Label  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N2···O2   a  2.729(2) 
 
0.96(3)  1.78(3) 
 
172(3) 
 
N1···O1   b  2.699(3)  0.96(3)  1.75(3)  171(3) 
O3···O2   2.524  1.01(3)  1.56(3)  156(3) 
Fig.  7.19  –  The  imidazolium  and  2-
hydroxybenzoate ions which are generated 
in  the  molecular  complex/salt,  with  atom 
labelling.    312 
Table 7.8 – The three scalar quantities and bond angles of the hydrogen bonds and list of the interactions 
between the molecules in the IMDH
+ 2-HBA
- molecular complex..  
 
The 2-HBA molecule retains the intramolecular hydrogen bond (O3-H∙∙∙O2) found within its 
native structure. The intramolecular hydrogen bond is relatively short,  O···O distance of 
2.524(2)Å,  compared  to  that  found  in  the  native  crystal  structure,  O···O  distance  of 
2.6191(3)Å. This is due to the intramolecular hydrogen bond being charged assisted, a result 
of the deprotonation of the 2-HBA and is similar to that found in other 2-HBA
- molecular 
complexes reported in the CSD. The negative charge is found to be delocalised over the 
carboxylic acid  group indicated by the normalisation of the bond lengths in the carboxyl 
group, C8- O1
ʴ- 1.248(3)Å and C8- O2
ʴ- 1.278(2)Å.  
 
The two hydrogen bonds within the structure (hydrogen bond patterns E and F) are both 
partially charged assisted N
+-H∙∙∙O
- interactions of length (a) 2.729(2)Å and (b) 2.699(3)Å 
(Figure 7.20). These are the predominant interactions within the structure and combine to 
create an alternating chain of co-molecules forming arrow shapes (Figure 7.20 RHS). 
 
 
Fig. 7.20 – The two main hydrogen bonds within the molecular complex, a, N-H∙∙∙O forming pattern E and b, N-
H∙∙∙O forming pattern F; RHS, the resulting arrow head chain of alternate co-molecules. 
 
There are four weaker interactions that influence the expanded structure. The strongest is a C-
H∙∙∙O weak hydrogen bond, C3-H∙∙∙O3, of length 3.301(4)Å that expands the structure along 
the bc-diagonal (Figure 7.21). Further supporting the packing along this diagonal is a C-H∙∙∙π 
O3···C3  c  3.301(4)  0.98(3)  2.48(3)  140(2) 
C2···π   d  3.374  -  -  - 
C1···O2   e  3.337(3)  0.89(2)  2.70(2)  130(2) 
C8···O2  f  3.497(3)  0.97(2)  2.65(3)  145(2) 
a 
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interaction of 3.574Å (measured from C2 to a centroid between C7 and C8) (Figure 7.21 
RHS). 
  .  
Fig.  7.21    LHS,  the  weak  C-H∙∙∙O  hydrogen  bond,  c,  involving  the  hydroxyl  oxygen,  RHS,  the  C-H∙∙∙π 
interaction, d, that expands the structure along the bc diagonal. 
 
There is another weak hydrogen bond, from the carbon located between the nitrogens on the 
IMDH
+ and a carboxylate oxygen, C1-H∙∙∙O2, which is of length 3.337(3)Å (Figure 7.22). 
This interaction exists between the chains and interlinks them along the a-axis. The last of the 
weaker interactions that influence the structure is a C-H∙∙∙O weak hydrogen bond involving 
the carboxylate oxygen (Figure 7.22 RHS). This hydrogen bond is weak at 3.497(3)Å but is 
the only interaction that connects the chains along the c-axis. 
 
    
Fig. 7.22 – LHS, the C-H∙∙∙O weak hydrogen bond, e, that connects two of the chains together, RHS, another C-
H∙∙∙O hydrogen bond, f, this time expanding the structure along the c-axis. 
 
Figure 7.23 is a view of the expanded structure along the  b-axis. In this figure the main 
hydrogen bonds, a and b, expand the chains in a zigzag fashion (blue line). Connecting the 
chains along the face of the figure are the weaker interactions e, C-H∙∙∙O hydrogen bond, and 
f, C-H∙∙∙O hydrogen bond (coloured in red). That leaves the weaker interactions c, C-H∙∙∙O 
hydrogen bond and d, the C-H∙∙∙π interaction that connect the chains perpendicular to Figure 
7.23. 
c 
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Fig. 7.23 – An expanded image of the IMDH
+ 2-HBA
- molecular complex showing the hydrogen bonded chains 
(blue line) being connected by two C-H∙∙∙O hydrogen bonds (red box).  
 
7.4.2  Molecular Complex of Imidazolium and 3-Hydroxybenzoic Acid 1:1 
 
Having the hydroxyl group in the 3-position on the benzoic acid molecule, removing the 
possibility of intramolecular hydrogen bond formation, will result in the hydroxyl group being 
available  for  medium  strength  intermolecular  hydrogen  bonds.  In  the  BZN  molecular 
complexes (see Chapter 4) the predominant hydrogen bond for this group was pattern G, a 
hydroxyl – carboxylate hydrogen bond.  It is likely that this will be the case for the IMD 
structures  and  coupled  with  the  hydrogen  bond  patterns  seen  in  the  IMDH∙
+  2-HBA
- 
molecular complex (and in every other structure containing BZN or IMD), E and F, there is a 
possibility for the ladder motif to form. 
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Structure Description 
The molecular ions, IMDH
+ and 3-hydroxybenzoate (2-HBA
-) form a 1:1 molecular complex 
or salt.  The molecular complex was obtained using the solvent evaporation method, with a 
1:1  stoichiometric  mixture  of  IMD  (6mg)  and  3-hydroxybenzoic  acid  (3-HBA)  (14mg) 
dissolved in the minimum amount of ethanol and left to evaporate at room temperature. The 
crystals generated were block shaped and colourless. Single crystal X-ray diffraction data 
were  obtained  using  a  Bruker  Apex  II  diffractometer  at  100K,  equipped  with  graphite 
monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using SIR92 
within  the  CRYSTALS  program.  The 
crystallographic data are summarised in Table 7.5.  
  
Proton transfer has occurred (see Section 7.2.1 for 
details) resulting in the IMDH
+ anion having the N-C 
bonds  and  C-N-C  angles  normalised.  This  also 
creates an 3-HBA
- cation with the carboxylate group 
undergoing  normalisation  of  the  carbon  –oxygen 
bond lengths (Figure 7.24). The intra-/intermolecular 
interactions with relavent data are listed in Table 7.9. 
Table 7.9 – The three scalar quantities and bond angles of the hydrogen bonds and list of the interactions 
between the molecules in the IMDH
+ 3-HBA
- molecular complex..  
 
The main motif of the structure is a hydrogen bonded box consisting of two equivalents of 
each molecule acting as the sides with carboxylate groups as the corners (Figure 7.25). It can 
be seen that this shape is repeated along the b- and c-axis forming stacks of boxes. There are 
three unique hydrogen bonds within the structure that all occur at the corners of the boxes and 
Interaction  Label  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O3···O1   2.675(2)  0.93(3)  1.76(3)  171(2) 
N2···O2   2.654(2)  0.97(3)  1.70(3)  169(2) 
N2···O2   2.667(2)  0.91(2)  1.78(3)  164(3) 
C1···O1  a’  3.345(2)  0.92(2)  2.69(2)  129(2) 
C1···O2   b’  3.416(3)  0.92(2)  2.64(3)  142(2) 
C7···O3   3.273(2)  1.02(2)  2.48(2)  133(1) 
Fig.  7.24  –  The  imidazolium  and  3-
hydroxybenzoate ions which are generated 
in  the  molecular  complex/salt,  with  atom 
labelling.    316 
shape the structure (Figure 7.25 RHS). These three moderate hydrogen bonds are very similar 
in  strength,  O3-H∙∙∙O1  2.675(2)Å,  O1-H∙∙∙N1  2.654(2)Å  and  O2-H∙∙∙N2  2.667(2)Å,  and 
correspond to the common hydrogen bonding patterns G, E and F.  There are no weaker 
interactions  that  help  form  these  boxes.  Interestingly,  the  hydrogen  bond  that  is  most 
directional is that between the carboxylate and the imidazole groups, which is the opposite 
situation to that found in the BZN structures where the hydroxyl - carboxylate hydrogen bond 
is the main hydrogen bond thus creating the chains seen in those structures. 
  
 
Fig. 7.25  LHS, an expanded view of the IMDH
+ 3-HBA
- molecular complex along the a-axis, it can be seen 
that the structure is made up of hydrogen bonded boxes (red box) stacked upon each other, RHS, a expanded 
view of the yellow circle highlighting the corners of each box with the three hydrogen bonds that originate from 
this point.  
 
Connecting the motifs, 2D boxes stack upon one another, held together only by two weaker 
interactions. Firstly, a bifurcated hydrogen bond involving the carbon located between the two 
nitrogens of the IMDH
+ molecule and the oxygens involved in the hydroxyl – carboxylate 
hydrogen bond (Figure 7.26). The two interactions in this asymmetrical bifurcated hydrogen 
bond have similar lengths, with the hydrogen bond involving the partially negative oxygen 
slightly smaller: a‘- 3.345(2)Å and b‘- 3.416(3)Å. It is worth noting that the proton is directed 
towards  the  hydroxyl  oxygen,  which  has  the  slightly  longer  hydrogen  bond  length.  The 
bifurcated hydrogen bond expands the structure along the b-axis. Another weak hydrogen 
bond, C7-H∙∙∙O3, assists the bifurcated hydrogen bond in connecting the stacks along the b-
axis (Figure 7.26 RHS). This weak hydrogen bond has a length of 3.273(2)Å. 
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Fig. 7.26  LHS, bifurcated hydrogen bond and RHS, C-H∙∙∙O weak hydrogen bond that expands the stacks of 
boxes along the b-axis. 
 
7.4.3  Molecular Complex of Imidazolium and 4-Hydroxybenzoic Acid 1:1 
 
In this complex, the hydroxyl group is now in the 4-position on the benzoic acid molecule. 
This does not affect the motifs in the BZN structures so it is possible a similar motif to the 
IMDH
+ 3-HBA
- structure will prevail. It will also be very likely that the same hydrogen bond 
patterns, E, F and G form with very little reason for this not to be the case.   
 
Structure Description 
 
The molecular ions, IMDH
+ and 4-hydroxybenzoate (4-HBA
-) form a 1:1 molecular complex 
or salt (Figure 7.27).  The molecular complex was obtained using the solvent evaporation 
method, with  a 1:1  stoichiometric mixture of  IMD (6mg)  and 4-hydroxybenzoic  acid  (4-
HBA) (14mg) dissolved in the minimum amount of 
methanol followed by evaporation at 2-4ºC in a cold 
room. The crystals generated were plate shaped and 
colourless. Single crystal X-ray diffraction data were 
obtained  using  a  Bruker-Nonius  Kappa 
diffractometer  at  100K,  equipped  with  graphite 
monochromated Mo Kʱ radiation (λ = 0.71073 Å). 
The structure was solved using SUPERFLIP within 
the CRYSTALS program. The crystallographic data 
are  summarised  in  Table  7.5.  Proton  transfer  has 
a‘  b‘ 
Fig.  7.27  –  The  imidazolium  and  4-
hydroxybenzoate ions which are generated 
in  the  molecular  complex/salt,  with  atom 
labelling.    318 
occurred (see Section 7.2.1 for details) resulting in the IMDH
+ anion having the N-C bonds 
and C-N-C angles normalised, N1-C1 1.332(4)Å, N2-C1 1.328(3)Å and C2-N1C1 108.7(2)º, 
C3-N2-C1 108.2(2)º.  A similar effect is seen in the 4-HBA
- cation after the deprotonation 
leaving  the  negative  charge  delocalised  across  the  carboxylate  group  resulting  in  the 
normalisation of the C-O bond lengths, C4-O1 1.259(4)Å and C4-02 1.275(3)Å. 
Table 7.10 – The three scalar quantities and bond angles of the hydrogen bonds and list of the interactions 
between the molecules in the IMDH
+ 4-HBA
- molecular complex.  
 
The  IMDH
+  4-HBA
-  structure  adopts  the  same  motif  as  the  IMDH
+  3-HBA
-,  a  hydrogen 
bonded  box  consisting  of  two  equivalents  of  each  molecule  acting  as  the  sides  with 
carboxylate groups as the corners (Figure 7.28). The main difference is in the angles of the 
box. Within this structure they are close to 90º creating a very square box whereas in the 3-
HBA
- structure the box is more of a parallelogram shape. The hydrogen bonds are the same as 
found in the 3-HBA
- structure following the patterns E, F and G (see Table 7.10 for details). 
They are of moderate strength and two of them are slightly shorter than the corresponding 
interactions in the 3-HBA
- structure at E, N-H∙∙∙O 2.664(3)Å, F, N-H∙∙∙O 2.739(3)Å and G, O-
H∙∙∙O 2.614(3)Å.  
 
Interaction  Label  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N1···O1   E  2.664(3)  0.93(3)  1.74(3)  174(3) 
O2···O3   F  2.614(3)  0.98(4)  1.65(4)  170(4) 
N2···O2   G  2.739(4)  0.94(3)  1.85(3)  157(3) 
C1···π  3.838  -  -  - 
C1···O1   3.073(3)  0.96(3)  2.45(2)  118(2) 
N1···O1   3.537(3)  0.94(3)  2.62(3)  110(2)   319 
.   
Fig. 7.28 – LHS, the view along the c-axis of the motif of the IMDH
+ 4-HBA
- molecular complex, hydrogen 
bonded squares (red box) stack upon one another, RHS, extract from the yellow circle which shows the corners 
of the boxes with hydrogen bonds E, F and G highlighted.  
 
The stacks of boxes expand the structure along the a- and b-axes which leaves the expansion 
along the c-axis to be achieved by two weaker interactions. Figure 7.29 is the view along the 
a-axis when two stacks of boxes are expanded out. From this image the weaker interaction 
that expands the structure along the c-axis can be seen to be a C-H∙∙∙π interaction of length 
3.838Å (measured from a centroid between carbons C6 and C7 to C1). 
 
 
Fig.  7.29  –  View  along  the  a-axis  showing  two  stacks  of  boxes  held  together  along  the  c-axis  by  C-H∙∙∙π 
interactions (circled in red). 
 
Connecting the boxes along the ac-diagonal is a double hydrogen bond utilising the carbon 
located between the two nitrogens on the IMDH
+ and a nitrogen with the oxygen O1, C1-
E 
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H∙∙∙O1  and  N1-H∙∙∙O1  (Figure  7.30).  These  hydrogen  bonds  are  weak  at  3.021(3)Å  and 
3.073(3)Å respectively and have the effect of packing the stacks of hydrogen bonded boxes 
along the ac-diagonal. 
 
 
Fig. 7.30 – The double weak hydrogen bonds that expand the stacks of hydrogen bonded boxes along the ac-
diagonal. 
 
7.5   A  Comparison  of  the  Molecular  Complexes  of  Imidazole  and 
Benzimidazole with Halo Substituted Benzoic Acids 
 
As discussed in Chapter 5, a whole range of new molecular complexes containing BZN and a 
mono-substituted halo-benzoic acid have been produced. Cocrystallisation experiments were 
also set-up using the mono-substituted halo-benzoic acid series with imidazole. This resulted 
in  the  successful  generation  of  molecular  complexes  of  imidazole  with  4-fluoro-  and  4-
bromo-  benzoic  acids  (Table  7.3).  This  section  will  look  at  the  different  hydrogen  bond 
patterns produced but will focus on the roles of the halogen atom. The benzoic acid structures 
should help to highlight the roles that the halogen atoms play in the formation of a new 
molecular complex of different stoichiometry, a 1:2 benzimidazole : benzoic acid, which has 
been structurally determined. 
 
   Imidazole  Source  Benzimidazole  Source 
4-fluoroBA  1:1  New  1:1   New 
4-bromoBA  1:1  New  1:1   New 
Benzoic acid  1:1  CSD  1:2  New 
Table 7.3 repeated - Summary of the successful cocrystallisations between IMD and mono-substituted halo-
benzoic acid series with the corresponding BZN molecular complex. 
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The two newly characterised halo-substituted benzoic acid molecular complexes contain only 
the N-H∙∙∙O hydrogen patterns E and F. Table 7.11 compares the distances of these hydrogen 
bonds  with  those  in  the  benzimidazole  counterparts.  It  can  be  seen  that  there  is  no  real 
difference to the strength of the hydrogen bonds whether IMD or BZN is the co-molecule.  
This is also the case between the different IMD structures studied, where the hydrogen bond 
distances are a little shorter in the fluoro- complex compared to the bromo-substituted, but not 
by any significant margin. 
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Molecular Complexes  IMDH
+   
4-FBA
- 
BZNH
+  
4-FBA
 - 
IMDH
+  
4-BrBA
- 
BZNH
+  
4-BrBA
- 
IMDH
+  
BA
- 
BZNH
+ 
BA
- 
Hydrogen Bonds 
N
ʴ+-
H····O
ʴ- 
 E and F 
D∙∙∙A(Å)  2.670(2) 
2.626(2) 
2.800(2) 
2.687(2) 
2.680(2) 
2.710(2) 
2.597(2)  2.667(2) 
2.638(2) 2.850(2) 
2.848(2) 
2.613(3) 
2.666(3) 
2.776(4) 2.645(3) 
2.766(4) 2.680(3) 
D-H(Å)  0.92(2) 
0.99(2) 
0.85(2) 
0.93(2) 
0.83(3) 
0.93(3) 
0.94(3) 0.78(2) 
0.92(3) 0.77(2) 
0.77(2) 
1.02(6) 
0.90(5) 
0.88(3) 0.97(2) 
1.06(3) 0.82(3) 
H∙∙∙A(Å)  1.75(2) 
1.64(2) 
2.13(3) 
1.77(3) 
1.87(3) 
1.78(3) 
1.65(3) 1.91(2) 
1.72(3) 2.17(2) 
2.36(3) 
1.63(5) 
1.77(5) 
1.99(2) 1.69(2) 
1.85(2) 1.90(2) 
D-H∙∙∙A 
angle(º) 
173(2) 
176(2) 
135(2) 
179(2) 
165(3) 
177(2) 
178(3) 163(3) 
147(2) 141.6(2) 
123(2) 
160(5) 
173(5) 
148(2) 168(2) 
141(2) 157(2) 
Table  7.11    The  three  scalar  quantities  and  bond  angle  of  the  hydrogen  bonds  of  N
ʴ+-H····O
ʴ-  found  in  the  molecular  complexes  presented  in  section  7.5.  323 
7.5.1  Molecular Complex of Imidazolium and 4-Fluorobenzoic Acid 1:1 
 
The corresponding BZNH
+ structure with 4-FBA
- has dimers of each co-molecule connected 
to form zig-zag chains (as seen in Figure 5.58, repeated below). This sort of motif was seen in 
many of the BZNH
+ with halo-benzoic acid molecular complexes. It would be possible for 
this  motif  to  prevail  in  the  IMDH
+  structure,  however  this  would  require  partial  or  no 
protonation to occur, which is unlikely.  
 
 
Fig. 5.58 repeated – View along the a-axis of the BZN 4-FBA molecular complex, showing the main motif, a  
zigzag chain of dimers held together by N
ʴ+-H∙∙∙O
ʴ-  hydrogen bonds that expand the structure along the ab-
diagonal axis. 
 
Structure Description 
 
The molecular complex between IMD and 4-fluorobenzoic acid (4-FBA) contains one of each 
of their ionic forms in a 1:1 ratio, IMDH
+ : 4-FBA
-. The molecular complex was obtained 
using the solvent evaporation method, with a 1:1 stoichiometric mixture of  IMD (6mg) and 
4-fluorobenzoic  acid  (12mg)  dissolved  in  the  minimum  amount  of  acetone  followed  by 
evaporation at  a constant  temperature of between 2 and 4ºC using a walk  in  fridge. The 
crystals generated were block shaped and colourless. Single crystal X-ray diffraction data 
were  obtained  using  a  Bruker  Apex  II  diffractometer  at  100K,  equipped  with  graphite 
monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using SIR92 
within the CRYSTALS program.  The crystallographic data are summarised in Table 7.5. As 
described in Section in 7.2.1, a IMDH
+ molecule is generated through hydrogen transfer from 
the 4-FBA molecule (Figure 7.31 top). This has the effect of normalising the internal IMDH
+   324 
carbon – nitrogen bond lengths, N1-C1 1.325(2)Å and N2-C1 1.320(2)Å, and the carbon – 
oxygen bond lengths on the 4-FBA
-, C4-O1 1.256(2)Å and C4-O2 1.261(2)Å
 .   
 
There are two main hydrogen bonds within the structure, both partially charged assisted N-
H∙∙∙O interactions that correspond to hydrogen bond patterns E and F (Figure 7.31). These 
two moderate hydrogen bonds (E, N1-H∙∙∙O2, 2.687(2)Å F, N2-H∙∙∙O1, 2.800(2)Å) combine 
to form spiral chains of alternating co-molecules along the b-axis that is the main motif of the 
structure (Figure 7.31 bottom LHS). Figure 7.31 RHS looks through one of the spiral chains 
highlighting the cyclical nature of the structure with Table 7.12 giving the hydrogen bond 
data. 
 
 
Fig. 7.31 – (top) The imidazolium and 4-fluorobenzoate ions which are generated in the molecular complex/salt, 
with atom labelling. 
Table. 7.12 - The three scalar quantities and bond angles of the hydrogen bonds and list of the interactions 
between the molecules in the IMDH
+ 4-FBA
- molecular complex.  
 
Interaction  Label  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N1···O4   E  2.670(2) 
 
0.92(2) 
 
1.75(2) 
 
173(2) 
 
N2···O3   F  2.626(2)  0.99(2)  1.64(2)  176(2) 
C1···O2  3.065(2)  1.02(2)  1.26(2)  147(1) 
C9···F  M  3.490(2)  -  -  - 
C2···F   N  3.547(2)  -  -  -   325 
  
Fig. 7.31 – (bottom) LHS, the main motif of the IMDH
+ 4-FBA
- molecular complex, a spiral chain of alternate 
co-molecules  held  together  through  N-H∙∙∙O  hydrogen  bonds,  E  and  F,  RHS,  view  along  the  b-axis  of  an 
extended spiral chain showing its cyclical nature. 
 
The third most common hydrogen bond donor of the IMD/BZN molecule, the carbon located 
between the nitrogens, is once again involved in a significant hydrogen bond in this structure. 
The C-H∙∙∙O weak hydrogen bond is of a relatively short length for this type of hydrogen 
bond at 3.065(2)Å. It has the role of binding two spiral chains alongside one another (Figure 
7.32).  
 
 
Fig. 7.32 – LHS, the C-H∙∙∙O hydrogen bond that binds two spiral chains to one another, RHS, the effect the 
binding of the two spirals (red circle) has on the structure. 
 
The main motif, the spiral chains, expands the structure along the b-axis, the C-H∙∙∙O weak 
hydrogen bond then binds together two of the motifs. The structure is further expanded along 
the a- and c-axis through two weak hydrogen bonds of equal strength (Figure 7.33). Hydrogen 
E 
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bond M, C9-H∙∙∙F, has length of 3.490(2)Å while N, C2-H∙∙∙F, has length 3.547(2)Å. These 
are the only interactions that expand the structure along the a- and c- axes. 
 
 
Fig. 7.33  View along the b-axis of the extended structure of the IMDH
+ 4-FBA
- molecular complex showing 
the spiral chains (highlighted in red) held together by  weak hydrogen bonds (yellow lines) that connect the 
chains along the a- and c-axes. 
 
7.5.2  Molecular Complex of Imidazolium and 4-Bromobenzoic Acid 1:1 
 
The  corresponding  BZNH
+  structure  with  4-BrBA
-  adopts  a  hydrogen  bonded  ring  motif 
containing equal numbers of each co-molecule (as shown in Figure 5.56, repeated below). 
This sort of motif was seen in other BZNH
+ with halo-benzoic acid molecular complexes and 
is considered likely to occur in the IMDH
+ structures. The spiral chain motif, seen in the 
IMDH
+ 4-FBA
- complex, utilises the most prominent hydrogen bonds available, E and F, N-
H∙∙∙O, to a better effect than in the BZNH
+ 4-BrBA
- structure. In all the molecular complexes 
studied  containing  a  halobenzoic  acid,  the  halogen  group  is  a  significant  factor  in  the 
extended structure and is highly likely to be so again. 
 
M 
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Fig. 5.56 repeated – The b-axis of the BZN 4-BrBA molecular complex, showing the main motif, a hydrogen 
bonded ring using N
ʴ+-H∙∙∙O
ʴ- hydrogen bonds. 
 
Structure Description 
 
The  molecular  complex  between  IMD  and  4-bromobenzoic  acid  (4-BrBA)  contains  one 
equivalent  of each of their ionic  forms  in  a 1:1  ratio,  IMDH
+ :  4-BrBA
-.  The molecular 
complex  was  obtained  using  the  solvent  evaporation  method,  with  a  1:1  stoichiometric 
mixture of  IMD (6mg) and 4-bromobenzoic acid (18mg) dissolved in the minimum amount 
of methanol followed by evaporation at a constant temperature of between 2 and 4ºC using a 
walk in fridge. The crystals generated were plate shaped and colourless. Single crystal X-ray 
diffraction data were obtained using a Bruker Nonius Kappa diffractometer at 100K, equipped 
with graphite monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved 
using  SUPERFLIP  within  the  CRYSTALS  program.  The  crystallographic  data  are 
summarised in Table 7.5. As described in Section in 7.2.1 a IMDNH
+ molecule is generated 
through hydrogen transfer from the 4-BrBA molecule (Figure 7.34). This has the effect of 
normalising the internal IMDH
+ carbon – nitrogen bond lengths, N1-C1 1.331(3)Å and N2-C1 
1.323(2)Å, and the carbon – oxygen bond lengths on the 4-FBA
-, C4-O1 1.287(2)Å and C4-
O2 1.243(2)Å
 .   
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Fig. 7.34 – The imidazolium and 3-bromobenzoate ions which are generated in the molecular complex/salt, with 
atom labelling.  
Table. 7.13 - The three scalar quantities and bond angles of the hydrogen bonds and list of the interactions 
between the molecules in the IMDH
+ 4-BrBA
- molecular complex.  
 
The main motif in the IMDH
+ 4-BrBA
- molecular complex is a zigzag chain of alternative co-
molecules connected through moderate hydrogen bonds (Figure 7.35). These hydrogen bonds 
are  partially  charged  assisted  N
ʴ+-H····O
ʴ-  interactions  that  correspond  to  hydrogen  bond 
patterns E and F. They are of moderate strength with length N1-H∙∙∙O2 2.680(2)Å and N2-
H∙∙∙O2 2.710(2)Å and runs along the bc diagonal (Table 7.13). 
 
 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N1···O2  2.680(2)  0.83(3)  1.87(3)  165(3) 
N2···O2   2.710(2)  0.93(3)  1.78(3)  177(2) 
C1···O1  3.129(2)  0.97(2)  2.63(2)  110(1) 
C3···O1  3.183(2)  0.91(3)  2.34(3)  153(2) 
C9···Br   3.831(2)  -  -  - 
C7···Br  3.759(2)  -  -  -   329 
  
Fig. 7.35 – The main motif of the IMDH
+ 4-BrBA
- molecular complex, a zigzag chain of alternate co-molecules 
connected through moderate hydrogen bonds. 
 
The motifs stack on top of one-another along the c-axis using weak C-H∙∙∙O hydrogen bonds 
(Figure 7.36). These hydrogen bonds originate from the oxygen not involved in the moderate 
hydrogen  bonds  (O1)  and  connect  to  two  separate  carbons  in  the  IMDH
+  molecule,  C1 
3.129(2)Å and C3 3.183(2)Å (Figure 7.36 RHS). The distances between both copies of the 
IMDH
+ and 4-BrBA
- molecules are too long for any π stacking interactions. 
 
   
Fig. 7.36 – The motifs, zigzag chains of alternative co-molecules, are stacked upon one another along the c-axis 
held by weak C-H∙∙∙O hydrogen bonds; RHS, the weak hydrogen bonds that exists between the layers. 
 
The b-axis is expanded by interactions involving the bromine molecule which covers all the 
significant interactions within the structure (Figure 7.37). The bromine halogen bonds (brown 
circle)  are  of  length  C9-H∙∙∙Br  3.831(2)Å  and  C7-H∙∙∙Br  3.759(2)Å  and  are  the  only 
interactions that expand the structure along the b-axis. 
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Fig. 7.37 – The halogen bonds, C-H∙∙∙Br, that exist between the zigzag chains along the b-axis. 
 
A view along the a-axis of the extended IMDH
+ 4-BrBA
- molecular complex is shown in 
Figure  7.38.  From  this  the  main  motif  can  be  seen,  zigzag  chains  held  together  through 
moderate  N-H∙∙∙O  hydrogen  bonds  (blue  line,  Fig  7.35),  and  connected  to  another  motif 
through C-H∙∙∙O hydrogen bonds (red box, Fig 7.36) while they are further extended along the 
b-axis through halogen bonds (brown box, Fig. 7.37). 
 
 
Fig. 7.38 – An extended image of the IMDH
+ 4-BrBA
- molecular complex viewed along the a-axis, showing the 
main motif (blue line), the weaker C-H∙∙∙O hydrogen bonds (red box) and the bromine halogen bonds (brown 
box).   
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7.5.3  Molecular Complex of Benzimidazole and Benzoic Acid 1:2 
 
BZN has successfully been cocrystallised with benzoic acid (BA) forming a complex with a 
1:1:1  molecular  ratio  of  BZNH
+  :BA
-:  BA.  There  are  two  unique  molecules  of  each  co-
molecule, BZNH
+ , BA
- and BA within the unit cell. The molecular complex was obtained 
using the solvent evaporation method, with a 1:1 stoichiometric mixture of  BZN (12mg) and 
benzoic acid (12mg) dissolved in the minimum amount of ethanol followed by evaporation at 
a constant temperature of between 2 and 4ºC using a walk in fridge. The crystals generated 
were needle shaped and colourless. Single crystal X-ray diffraction data were obtained using a 
Bruker Nonius Kappa diffractometer at 100K, equipped with graphite monochromated Mo Kʱ 
radiation  (λ  =  0.71073  Å).  The  structure  was  solved  using  SUPERFLIP  within  the 
CRYSTALS program.  The crystallographic data are summarised in Table 7.6. As described 
in Section in 7.2.1 a BZNH
+ molecule is generated through hydrogen transfer from the BA 
molecule. This has the effect of normalising the internal carbon – nitrogen bond lengths and 
bond angles as seen in the nearly all the molecular complexes in this work. There is, however 
a 2:1 ratio in favour of BA over BZN molecules in this structure, with the effect that there are 
two  BAs  which  are  not  deprotonated  and  two  BAs  which  are  deprotonated  within  the 
asymmetric  unit.  This  results  in  six  different  molecules  within  the  asymmetric  unit.  The 
effects on the carbon – oxygen bond distances are, as expected, quite profound (Table 7.14) 
with  the  deprotonated  BA  molecules  having  normalised  bond  lengths  while  the  non-
deprotonated retain the bond length variations characteristic of the native form. 
 
  BA
32  Molecule 1  Molecule 2  Molecule 3   Molecule 4 
C-O (Å)  1.288(3)  1.262(4)  1.316(4)  1.324(4)  1.262(4) 
C=O (Å)  1.245(3)  1.263(3)  1.220(4)  1.225(4)  1.271(4) 
Table 7.14 – The carbon –oxygen bond lengths of benzoic acid (BA)
32 and the four benzoic acid molecules from 
the BZNH
+ :BA
-: BA molecular complex. 
 
The  molecules  involved  in  the  proton  transfer,  BZNH
+  and  BA
-,  create  partially  charge 
assisted N
ʴ+-H····O
ʴ- hydrogen bonds between the nitrogen of the BZNH
+ and oxygen of the 
carboxylate group. These are of moderate strength, a‘  2.978(3)Å, b‘  2.680(3)Å, c‘  
2.924(3)Å, d‘  2.645(3)Å and arrange themselves into a 1:1 hydrogen bonded ring system 
that can be described by the graph set notation symbol 
4
4 R (16). Attaching onto this inner ring   332 
are the BA molecules that position themselves so that the hydroxyl oxygen hydrogen bonds to 
a deprotonated oxygen, O-H∙∙∙ O
ʴ-, and the carbonyl oxygen to a protonated nitrogen, N
ʴ+-
H····O  (Figure  7.39).  These  hydrogen  bonds  are  also  moderate  in  strength  with  those 
involving the two oxygens slightly shorter, e‘ 2.570(3)Å, f‘ 2.776(4), g‘ 2.766(4)Å and h‘ 
2.562(2)Å  (Table  7.10).  This  creates  a  hydrogen  bonded  ring  system,  consisting  of  two 
occurrences  of  each  molecule,  BZNH
+,
  BA
-  and  BA  that  can  be  described  by  graph  set 
notation  as 
6
6 R (24).  This  hydrogen  bonded  ring,  the  motif  of  the  molecular  complex,  is 
relatively flat apart from the benzene ring of molecules 1 and 3 that are ~24.70º tilted with 
respect to each other. There are two bifurcated hydrogen bonds (g‘ : c‘ and a‘ : f‘) within this 
structure  that  are  borderline  between  being  termed  symmetrical  or  asymmetrical  as  the 
position of the hydrogen is relatively centred and the strengths of the interactions relatively 
equal  (Table  7.15).  Figure  7.39  has  been  produced  by  fixing  the  hydrogen  atoms  (found 
isotropically, placed on calculated positions and the thermal parameters fixed to 1.2 times to 
the atom to which they are bonded and no parameters refined during refinement) that are not 
involved in the main hydrogen bonds. 
 
 
 
Fig. 7.39 – The motif of the BZNH
+ : BA
-: BA molecular complex, an  ) 24 (
4
4 R  hydrogen bond ring system 
containing two of each molecule held together by N-H∙∙∙O (a‘, b‘, c‘, d‘, f‘ and g‘) and O-H∙∙∙O (e‘ and h‘) 
hydrogen bonds. The BA and BA
- molecules are labelled 1 to 4. 
a‘ 
b‘ 
c‘ 
d‘ 
e‘ 
f‘ 
g‘ 
h‘ 
Molecule 1 
Molecule 3 
Molecule 2 
Molecule 4   333 
Hydrogen Bonds  a’  b’  c’  d’  e’  f’  g’  h’ 
D∙∙∙A (Å)  2.978(3)  2.680(3)  2.924(3)  2.645(3)  2.570(3)  2.776(4)   2.766(4)  2.562(2) 
D-H (Å)  0.88(3)  0.82(3)  1.06(3)  0.97(2)  0.98(2)  0.88(3)   1.06(3)  0.97(2) 
H∙∙∙A (Å)  2.39(2)  1.90(2)  2.92(3)  1.68(2)  1.60(2)  1.99(2)   1.85(2)  1.59(2) 
D-H∙∙∙A angle (º)  124(2)  158(2)  123(2)  169(2)  173(1)  148(2)   142(2)  168(1) 
Table 7.15 – The hydrogen bond data for all the moderate hydrogen bonds in the BZNH
+ :BA
-: BA molecular 
complex. 
 
The hydrogen bonded rings stack upon one another along the a-axis (Figure 7.40) held in 
place by two different interactions. The most significant are π∙∙∙π interactions between the 
hydroxyl oxygens and the carbon located between the two nitrogens  in the BZN (blue circle) 
and an oxygen from the deprotonated BAs with the same carbon (blue circle). These are 
relatively strong interactions at 3.009(4)Å (deprotonated oxygen) and 3.219(4)Å (protonated) 
respectively. There are also intermolecular π∙∙∙π interactions, involving aromatic carbons from 
the co-molecules that have a length of 3.299(4)Å (red circle).  
 
 
Fig. 7.40 – View along the c-axis highlighting the stacking behaviour of the motifs with the π∙∙∙π interactions 
(red and blue ovals, and expanded in the blue and red boxes) that hold it them together. 
 
The  structure  is  expanded  along  the  b-axis  through  C-H∙∙∙O  weak  hydrogen  bonds  of 
3.497(4)Å in length (Figure 7.41). 
 
 
Fig. 7.41 – The C-H∙∙∙O weak hydrogen bond that expands the structure along the b-axis.   334 
 
Figure 7.42 highlights how the motifs, 6-membered hydrogen bonded rings, form a zigzag 
chain along the b-axis.  
 
   
Fig. 7.42  LHS, the blue shaded circles show where the C-H∙∙∙O weak hydrogen bonds (Figure 7.41) hold the 
motifs together; RHS, view along the b-axis highlighting the zigzag pattern formed by the motifs. 
 
The two images shown in  Figure 7.43 are viewed along the a-axis (LHS) and the c-axis 
(RHS) of the extended BZNH
+ :BA
-: BA molecular complex. These highlight how the main 
motif, 6-membered hydrogen bonded rings, stack upon one another and that the weak C-H∙∙∙O 
hydrogen bonds extend the structure. 
  
 
Fig. 7.43  LHS, the a-axis, RHS, the c-axis of the extended structure showing how the main motif (blue areas) 
is expanded by weak C-H∙∙∙O hydrogen bonds (yellow areas).  
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7.5.3.1  Imidazolium Benzoate 1:1 
 
The  molecular  ions,  imidazolium  and  benzoate,  form  a  1:1  molecular  complex  that  was 
published in 2006
33. The structure adopts the linear chain motif which, like other imidazolium 
molecular complexes, has a spiral nature (Figure 7.44). The chain is created through moderate 
N-H···O hydrogen bonds that utilise the hydrogen bond patterns E and F. The hydrogen bond 
distances  are  comparable  to  the  benzimidazolium  complex  at  E,  N∙∙∙O  2.613(3)Å  and  F, 
2.666(3)Å compared to 2.645(3)Å and 2.776(4)Å in the imidazolium complex. 
 
     
Fig.  7.44  –  LHS,  the  linear  chain  of  hydrogen  bonded  alternating  co-molecules  is  the  main  motif  in  the 
imidazolium benzoate structure
33; RHS, shows the cylcial nature of the motif. 
 
The motif is expanded throughout the structure by two interactions, the strongest is a weak 
hydrogen  bond  involving  the  carbon  located  between  the  nitrogens  on  the  imidazolium 
molecule and an oxygen. The other is a weak carbon – carbon hydrogen bond of around 
3.664(6)Å. 
 
7.6   Molecular  Complexes  Containing  Aromatic  Dicarboxylic  Acids  and 
Benzimidazole 
 
Cocrystallisations  with  the  aromatic  dicarboxylic  acids  series  produced  two  previously 
undiscovered molecular complexes, benzimidazole : terephthalic acid and benzimidazole : 
phthalic acid (Table 7.2).  
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   Imidazole  Source  Benzimidazole  Source 
Terephthalic acid  1:1  CSD  1:1  New 
Isophthalic acid  1:1  CSD  1:1  CSD (RD) 
Phthalic acid   n/a  n/a  1:1  New 
Table 7.2 repeated – Summary of the molecular complexes that exist between IMD and BZN with aromatic 
dicarboxylic acids. ―New‖ represents molecular complexes generated for the first time during this research, 
―CSD‖ accounts for those that have already been solved while ―RD‖ stands for re-determined, i.e. cases where a 
new X-ray diffraction experiment was attempted to get a improved data set than that available in the literature. 
 
The existence of two carboxylic acid groups on the benzoic acid brings potential similarities 
to the hydroxy-substituted benzoic acids molecular complexes with the real possibility of 
producing ladder style motifs. However there will also be a carboxylic acid group that is not 
deprotonated, increasing the number of potential hydrogen bond patterns. From Figure 7.18, it 
is  essentially  guaranteed  that  either  hydrogen  bond  pattern  E  or  F  will  be  found  in  the 
structures. Within the iso- and terephthalic acid structures hydrogen bond patterns I, J and a 
full carboxylic acid dimer are the only options available for the carboxylic acid groups. When 
the second carboxylic acid is in the ortho position, as in phthalic acid, there is the likely 
option that the hydroxyl section will create an intramolecular hydrogen bond, as seen in the 
other molecular complexes involving phthalic acid that have been generated, therefore motif 
N, a linear chain of alternating co-molecules, is very possible. However the hydroxyl group 
may not form an intramolecular hydrogen bond, therefore will seek to adopt hydrogen bond 
patterns as found in the iso- and terephthalic acid complexes. For these structures the potential 
motifs  are  thus,  in  order  of  possibility,  K,  the  ladder  style  (seen  in  the  3-  and  4-
hydroxybenzoic acid structures, L, the hydrogen bonded ring (as in benzimidazole and 2-
hydroxybenzoic acid) then N the linear chain.  
 
7.6.1  Molecular Complex of Benzimidazole and Phthalic Acid 1:1 
 
The molecular ions, benzimidazolium and phthlate, form a 1:1 molecular complex with one 
another (Figure 7.45).  Single crystals were obtained using the solvent evaporation method, 
with  a  1:1  stoichiometric  mixture  of  benzimidazole  (12mg)  and  phthalic  acid  (16mg) 
dissolved in the minimum amount of methanol followed by evaporation at room temperature. 
The crystals generated were needle shaped and colourless.  Single crystal X-ray diffraction   337 
data were obtained using a Bruker Apex II diffractometer at 100K, equipped with graphite 
monochromated  Mo  Kʱ  radiation  (λ  =  0.71073  Å).  The  structure  was  solved  using 
SUPERFLIP within the CRYSTALS program. The crystallographic data are summarised in 
Table 7.6. It can be seen that the data are only 96.8% complete with a theta range of 1.58-
22.36º, therefore the hydrogens atoms have been fixed to reduce the number of parameters 
(found isotropically, placed on calculated positions and the thermal parameters fixed to 1.2 
times to the atom to which they are bonded and no parameters refined during refinement. 
 
In the molecular complex, the BZN molecule is protonated as discussed in section 7.2.1. The 
result is the normalisation of the internal bond lengths (N1-C1 1.321(6)Å, N2-C1 1.326(5)Å) 
and angles (C2-N1-C1 107.8(3)º, C7-N2-C1 107.9(3)º) and the creation of a positive charge 
that is delocalised over the 5-membered ring.  
 
 
Fig. 7.45 – The molecules involved in the benzimidazolium phthlate molecular complex, with atom labelling. 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O2···O3  2.378(4)  1.179(3)  1.207(3)  170.6(2) 
N1···O4   2.691(5)  1.001(3)  1.710(3)  165.7(2) 
N2···O1  2.759(6)  1.000(3)  1.778(3)  165.0(2) 
N2···O2  3.038(5)  1.000(3)  2.403(3)  120.7(2) 
C4···O4   3.344(6)  0.909(5)  2.533(4)  148.9(3) 
C10···O1  3.329(6)  0.943(4)  2.681(4)  126.5(3) 
C5···π  3.847  -  -  -   338 
Table. 7.16 - The three scalar quantities and bond angles of the hydrogen bonds and list of the interactions 
between the molecules in the benzimidazolium phthlate molecular complex.  
 
Within  the  molecular  complex  the  phthalic  acid  molecule  is  deprotonated,  creating  the 
phthlate species. Within this molecule an intramolecular hydrogen bond between the hydroxyl 
and  carboxylate  groups  is  formed,  as  in  the  other  phthlate  molecular  complexes.  This 
intramolecular hydrogen bond, O2∙∙∙H∙∙∙O3, is strong with an O∙∙∙O distance of 2.378(4)Å 
which  is  consistent  with  the  hydrogen  bond  found  within  the  2,6-dimethylpyridinium 
hydrogen  phthalate  molecular  complex
6,  (2.398(2)Å).  The  intramolecular  hydrogen  bond 
results in the proton being shared over the two oxygens, this can be seen in the carbon  
oxygen  bond  distances  which  have  been  slightly  normalised,  C1-O1  1.233(6)Å,  C1-O2 
1.275(5)Å, C8-O3 1.280(5)Å and C8-O4 1.243(6)Å. The structure adopts the linear chain of 
alternating co-molecules arranged in a spiral fashion (Figure 7.46). This motif, which is an 
example of the linear chain of alternate co-molecules of motif N, utilises the robust hydrogen 
bond  pattern  E,  N-H∙∙∙O,  only.  The  N-H∙∙∙O  hydrogen  bonds  are  moderate  in  strength, 
N1∙∙∙O4,  2.691(5)Å,  with  an  asymmetrical  bifurcated  hydrogen  bond  having  distances  of 
N2∙∙∙O1, 2.756(5)Å and N2∙∙∙O2, 3.038(5)Å(Table 7.16). The motif expands  the structure 
along the a-axis.    
 
 
Fig. 7.46 – LHS, view of the main motif, linear chain of alternating hydrogen bonded co-molecules; RHS, view 
along the a-axis that highlights the spiral nature of the chain. 
 
Expanding the structure along the b-axis is a C-H∙∙∙O hydrogen bond that connects the spiral 
chains together (Figure 7.47). This weak hydrogen bond, C4∙∙∙O4, has length 3.344(6)Å and is 
the only interaction between the chains that expands the structure along the b-axis. 
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Fig. 7.47  View along the a-axis of three motifs, spiral chains of alternating hydrogen bonded co-molecules, 
that are held together by C-H∙∙∙O weak hydrogen bonds (blue circles). 
 
Expanding  the  structure  along  the  c-axis  are  two  interactions  involving  three  molecules. 
Again these interactions have the role of connecting two of the spiral chains together. The 
more  significant  of  these  is  a  C-H∙∙∙O  weak  hydrogen  bond,  with  C10∙∙∙O1  distance  of 
3.329(6)Å (green line in Figure 7.48). The other interaction is a C-H∙∙∙π interaction which is 
extremely weak at 3.847(7)Å in length (purple line in Figure 7.48). 
 
 
Fig. 7.48 – The weak hydrogen bond, C-H∙∙∙O (green line) and C-H∙∙∙π interaction (purple line), that expand the 
structure along the c-axis. 
 
Figure 7.49 is the extended structure viewed along the a-axis. From this it can be seen that the 
motif (coloured in red) which extends along the a-axis, is expanded along the b-axis using the 
C-H∙∙∙O weak hydrogen bonds (coloured in blue) and along the c-axis by the C-H∙∙∙O (green) 
and C-H∙∙∙C (purple) hydrogen bonds.   340 
 
 
Fig. 7.49  The extended structure viewed along the a-axis, showing how the motif (red) is expanded along the 
b-axis by weak C-H∙∙∙O hydrogen bonds (blue) and finally along the  c-axis by C-H∙∙∙O(green) and C-H∙∙∙C 
hydrogen bonds (purple).  
 
7.6.2  Molecular Complex of Benzimidazole / Imidazole and Isophthalic Acid 
 
Both the structures of the molecular complexes of benzimidazole
11 (CSD reference VARJAA) 
and imidazole
12 (CSD reference MEQQOO) with isophthalic acid are known (Table 7.17). 
Within  the  BZNH
+  structure,  both  the  co-molecules  are  disordered  therefore  accurate 
hydrogen positions are impossible to determine. Single crystal X-ray diffraction experiments 
performed during this project on crystals of the benzimidazole : isophthalic acid complex also 
proved difficult  due to  the poor quality  crystals  produced  (twinning).  Therefore, the data 
deposited in the CSD are used for the comparison work. 
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Complex  Space Gp  Cell Lengths (Å)  Cell Angles (º)  Volume / Z 
BZN : 
isophthalic 
acid 
P 21/c 
10.157(4) 
5.130(7) 
26.067(6) 
90 
90.98(4) 
90 
1358.03 
 
4 
IMDH
+ 
isophthalate 
P 21 21 21 
3.883(2) 
14.015(2) 
19.302(2) 
90 
90 
90 
1050.42 
 
4 
Table 7.17 – Basic crystal data for the benzimidazole : isophthalic acid molecular complex and the imidazolium 
isophthlate molecular complex. 
 
The structures produced were in a 1:1 molecular ratio with proton transfer occurring in the 
imidazole complex but it is undetermined if it also occurred in the benzimidazole complex 
(Figure 7.50). 
 
Fig.  7.50  –  LHS,  the  molecules  involved  in  the  imidazolium  isophthlate  molecular  complex;  RHS,  those 
involved  in  the  benzimidazole  isophthalic  acid  molecular  complex,  with  the  carboxylic  acid  protons  in 
undetermined positions. 
 
Structure Description 
 
The  benzimidazole  :  isophthalic  acid  molecular  complex  contains  four  unique  hydrogen 
bonds utilising the hydrogen bond patterns E, N-H∙∙∙O and J, O-H∙∙∙O (Figure 7.51). These 
hydrogen bonds are moderate in strength, A‘, 2.637(5)Å, B‘, 2.482(4)Å, C‘, 2.492(4)Å and 
D‘, 2.601(5)Å, and arrange the structure into linear chains of alternate co-molecules using 
hydrogen bond E, that link together through hydrogen bond J. This chain, containing a double 
line of alternate co-molecules, expands the structure along the a-axis. 
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Fig. 7.51 – The main motif of the structure, a double linear chain of alternate co-molecules held together through 
N-H∙∙∙O and O-H∙∙∙O hydrogen bonds. 
 
The  structure  is  expanded  by  lesser  interactions  including  C-H∙∙∙C  hydrogen  bonds  of 
3.766(7)Å (Figure 7.52) that expand the structure along the c-axis and C-H∙∙∙O interactions 
that stack the motifs upon one another.  
 
 
Fig. 7.52 – An extended structure showing the motifs (blue box) being expanded along the c-axis by carbon  
carbon hydrogen bonds (yellow box). 
 
The imidazolium isophthlate structure uses the same hydrogen bond patterns, E, N-H∙∙∙O and 
J,  O-H∙∙∙O,  however  with  one  less  moderate  hydrogen  bond.  Whereas  the  benzimidazole 
structure has two of each of these hydrogen bonds, the imidazole structure has only one O-
H∙∙∙O hydrogen bond. The effect is that rather than having flat linear chains that can stack 
upon one another, the imidazole complex structure has linear chains of isophthlate molecules 
with imidazole molecules connecting these chains together (Figure 7.53).  
 
A‘ 
B‘  C‘ 
D‘   343 
 
 
Fig. 7.53 – top, the view along the a-axis of the chains of isophthalic acid hydrogen bonding to the imidazolium 
molecule,  bottom,  view  of  the  b-axis  highlighting  how  the  imidazolium  molecule  hydrogen  bonds  to  two 
different chains on different layers. 
 
The  hydrogen  bonds  are  moderate  in  strength,  O∙∙∙O,  2.543(2)Å,  N∙∙∙N,  2.858(3)Å  and 
2651(2)Å and expand the structure along the b- and c-axes. 
 
7.6.3  Molecular Complex of Benzimidazole / Imidazole and Terephthalic Acid 
 
The molecular ions, benzimidazolium and terephthalate, form a 1:1 molecular complex with 
one another.  Single crystals were obtained using the solvent evaporation method, with a 1:1 
stoichiometric mixture of benzimidazole (12mg) and terephthalic acid (17mg) dissolved in the 
minimum amount of methanol followed by evaporation at ~2-4ºC in a cold room. The crystals 
generated were needle shaped  and colourless.    Single crystal  X-ray  diffraction data  were 
obtained  using  a  Bruker  Nonius  Kappa  diffractometer  at  100K,  equipped  with  graphite 
monochromated Mo Kʱ radiation (λ = 0.71073 Å). The structure was solved using SIR92 
within the CRYSTALS program.  The crystallographic data are summarised in Table 7.6.  
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The BZN molecule is protonated through hydrogen transfer from the carboxylic acid group on 
the terephthalic acid molecule (Figure 7.54) resulting in a delocalisation of the charge across 
the  five-membered  ring,  N1-C1  1.332(2)Å,  N2-C1  1.323(2)Å  (section  7.2.1).  The 
deprotonation of a carboxylic acid group, creating the terephthalate molecule, results in a 
negative charge on the carboxylate group that is normalised over the group, as seen in the 
carbon oxygen bond lengths, C8-O1 1.235(2)Å and C8-O2 1.277(1). The neutral carboxylic 
acid group retains its bond lengths, C14-O3 1.325(2)Å and C14-O4 1.217(2)Å. 
   
Fig. 7.54 – LHS, the benzimidazolium and terephthalate molecules involved in the molecular complex with atom 
labelling; RHS, the three main hydrogen bonds involved in the molecular complex, a‘ N-H∙∙∙O, b‘ N-H∙∙∙O and 
c‘ O-H∙∙∙∙O. 
 
The  benzimidazolium  terephthalate  molecular  complex  contains  three  distinct  hydrogen 
bonds that adopt the hydrogen bonding patterns E, F and J (Figure 7.54 RHS). The strongest 
is the oxygen – oxygen hydrogen bond, c‘ O3-H∙∙∙O2, that has length of O∙∙∙O 2.580(1)Å. The 
two N-H∙∙∙O hydrogen bonds are similar in strength at a‘ N1-H∙∙∙O2, 2.635(2)Å and  b‘ N2-
H∙∙∙O1 2.699(1)Å (Table 7.18). 
Table 7.18 – The hydrogen bond data for the hydrogen bonds in the benzimidazolium terephthalate molecular 
complex. 
 
Interaction  Label  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O2···N2  a’  2.635(2)  0.96(2)  1.71(2)  158.9(2) 
N2···O2   b’  2.699(1)  0.97(2)  1.74(2)  168.4(2) 
C1···O1  c’  2.580(1)  1.04(2)  1.55(2)  172.8(2) 
C1···O4  3.112(2)  1.00(1)  2.11(1)  174(1) 
a‘ 
b‘ 
c‘   345 
These three moderate hydrogen bonds arrange the structure into the ladder motif K, with 
uprights of terephthalic acid molecules that are bonded through the O-H∙∙∙O hydrogen bonds 
and  rungs  of  benzimidazolium  molecules  that  utilise  the  N-H∙∙∙O  hydrogen  bonds 
(Figure7.55).  This motif runs along the a- and c-axis and is common with the hydroxyl-
benzoic acid molecular complexes. 
 
 
Fig. 7.55 – The main motif of the benzimidazolium terephthalate molecular complex, a ladder with uprights of 
terephthalate molecules and rungs of benzimidazolium molecules.  
 
There is only one other significant interaction with this structure which expands the structure 
along  the  b-axis  (Figure  7.56).  A  carbon  –  oxygen  hydrogen  bond,  involving  the  carbon 
located between the two nitrogens and oxygen O4 (Figure 7.56 extract), is  3.112(2)Å in 
length. 
 
Fig. 7.56 – The main motif, a ladder of terephthalic acid uprights and benzimidazole rungs, stack upon one 
another through C-H∙∙∙O hydrogen bonds (red circle); insert, blown-up image of the C-H∙∙∙O hydrogen bond. 
 
Figure 7.57 shows two images of the extended structure viewed along the c-axis (LHS) and a-
axis (RHS). They both show how the motif expands the structure along the a- and c-axis 
while the weak C-H∙∙∙O hydrogen bond stacks these chains on top of one another along the b-
axis.    346 
 
     
Fig. 7.57  The extended structure of the benzimidazolium terephthalate molecular complex viewed along the c-
axis (LHS) and a-axis (RHS). 
 
Imidazole Structure 
 
The structure of the imidazole : terephthalic acid molecular complex was published in 2007
18 
(Table 7.19). The structure adopts the spiral linear chain motif, with alternating co-molecules 
hydrogen bonded together, that expands the structure along the b-axis (Fig. 7.58). With the 
other carboxylic acid group still available for hydrogen bonding the chain also expands along 
the  ac  diagonal  (Figure  7.59  LHS).  A  C-H∙∙∙O  weak  hydrogen  bond,  the  last  significant 
interaction within the structure, connects the motif along the a-axis (Figure 7.59 RHS). 
 
  Space Gp  Cell Lengths (Å)  Cell Angles (º)  Volume / Z 
Imidazolium 
terephthalate
  P 21/n  
9.6288(6) 
8.3351(6) 
9.8244(6) 
90 
113.8540(10) 
90 
721.124 
 
2 
Table 7.19 – Basic crystallographic data of the imidazolium terephthalate molecular complex.  
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Fig. 7.58 – LHS, the linear chain of alternating co-molecules that is the motif of the molecular complex; RHS, 
view along the b-axis highlighting the spiral nature of the chain.  
 
        
Fig. 7.59 – LHS, the motif, spiral chains (blue box), expands along the b-axis and ac-diagonal forming sheets; 
RHS, the C-H∙∙∙O weak hydrogen bond (red box) connects these sheets together along the a-axis.  
 
 
7.7   Benzimidazole  and  Imidazole  Molecular  Complexes  with  Non-Aromatic 
Dicarboxylic Acids 
 
Cocrystallisations  with  a  range  of  non-aromatic  dicarboxylic  acids  produced  four  new 
molecular complexes (Table 7.4); BZN with fumaric, succinic, maleic acids and IMD with 
malonic acid, all in a 1:1 molecular ratio and all with associated proton transfer (Section 
7.2.1).  An  improved  model  for  the  benzimidazole  and  malonic  acid  structure  has  been 
proposed  over  that  which  has  been  published.  Structures  containing  IMD  with  fumaric, 
succinic and maleic acid and a malonic acid hydrate have already been solved and deposited 
in the CSD, and are discussed here for comparison purposes.  
 
   Imidazole  Source  Benzimidazole  Source 
Fumaric acid  1:1  CSD  1:1  New 
Succinic acid  1:1  CSD  1:1   New 
Maelic acid  1:1  CSD  1:1  New 
Malonic acid  1:1 (1:1 hydrate)  New (CSD)  1:1  RD   348 
Table 7.4 repeated – Summary of the successful cocrystallisation experiments between IMD and BZN with 
dicarboxylic acids.  ―New‖ represents molecular complexes generated for the first time during this research, 
―CSD‖ accounts for those that have already been solved, while ―RD‖ stands for re-determined, i.e. cases where a 
new X-ray diffraction experiment was attempted to get a improved data set than that available in the literature. 
 
The main hydrogen bonds in these molecular complexes will undoubtedly come from the 
nitrogens of the benzimidazole and imidazole molecules and the carboxylic acid group of the 
dicarboxylic acids  series. Consideration of the many potential hydrogen bonds  that could 
form between them can be reduced by using the library of hydrogen bond patterns that have 
constantly  appeared  in  previous  structures  containing  these  characteristic  hydrogen  bond 
donor and acceptor groups.  The hydrogen bond patterns that have been identified in previous 
chapters, E through to J (Figure 7.18 pattern extract, repeated below), have once again been 
utilised in the structures studied in this chapter, including the aromatic dicarboxylic acids 
which are very similar in terms of functional groups to the dicarboxylic acid series presented 
in this section. It is therefore highly likely that hydrogen bond patterns E, F and J will prevail 
in  these  structures.  There  will  also  be  potential  for  carboxylic  acid  dimers,  as  seen  in 
hydrogen bond pattern I, to be used in the hydrogen bonds. 
 
Fig. 7.18 pattern extract – the library of hydrogen bond patterns that the molecular complexes are highly likely 
to adopt – E, F, G, H, I and J – are all seen in other molecular complexes.  
 
With regard to the potential motifs (Figure 7.18 motif extract, repeated below) that may be 
formed between the co-molecules, that will undoubtedly use hydrogen bond patterns E, F and 
I, there is a very high possibility that motif N, linear chain of alternate co-molecules, will be 
influential. There is also a possibility that the ladder motif may also appear, however this 
would only be an option where the chain is rigid and the carboxylic acid groups are in the   349 
trans  disposition,  i.e.  fumaric  acid.  A  specific  comment  can  be  made  with  regard  to  the 
imidazole molecules, in which there has been a high tendency for these structure to adopt the 
linear chain motif, N, with a spiral nature. It would be no surprise if these structures once 
more adopted this nature of chain. 
 
Fig. 7.18 motif extract – the motifs are the general modes of assembly of the molecules; K is the ladder motif, L 
is the hydrogen bonded ring motif, M is the co-molecule dimer motif while N is an example of a linear chain of 
alternate co-molecules.   
 
7.7.1  Molecular Complexes of Benzimidazole and Imidazole with Fumaric Acid  
 
Successful cocrystallisation experiments have produced the previously undetermined structure 
of benzimidazole with fumaric acid. The structure of the molecular complex salt imidazolium 
fumarate has previously been solved and published
12.   
 
In this case, following the logic being applied throughout this work, there is a real possibility 
of formation of an influential N-H···O hydrogen bond between the molecules, with it either 
adopting hydrogen bond pattern E or F. With one of the carboxylic acid groups undergoing 
deprotonation, there will be only one hydroxyl group in the structure. From the length of the 
carbon chain and the double bond on the chain, this hydroxyl group will be available for 
intermolecular  hydrogen  bonding.  This  would  promote  the  possibility  of  hydrogen  bond 
pattern I or J forming.  
 
Benzimidazolium Fumarate 
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The  molecular  ions  benzimidazolium  and  fumarate  form  a  1:1  molecular  complex.  The 
molecular  complex  was  obtained  using  the  solvent  evaporation  method,  with  a  1:1 
stoichiometric mixture of benzimidazole (12mg) and fumaric acid (12mg) dissolved in the 
minimum amount of ethanol and left to evaporate at room temperate. The crystals generated 
were needle shaped and colourless. Single crystal X-ray diffraction data were obtained using a 
Bruker Nonius Kappa diffractometer at 100K, equipped with graphite monochromated Mo Kʱ 
radiation  (λ  =  0.71073  Å).  The  structure  was  solved  using  SUPERFLIP  within  the 
CRYSTALS program. The crystallographic data are summarised in Table 7.5.  
 
In  the  molecular  complex,  the  benzimidazole  molecule  is  protonated  through  hydrogen 
transfer from one of the carboxylic acid groups on the fumaric acid molecule, as described in 
Section 7.2.1 (Figure 7.60). The result is that the internal bond lengths are now normalised, 
with N1-C1 1.323(2)Å and N2-C1 1.330(2) Å, and bond angles to C1-N1
ʴ+-C2 108.2(1)º and 
C1-N2
ʴ+-C7 108.2(1)º.   
 
 
 
 
Fig. 7.60 – The benzimidazolium and fumarate ions (two 
protons are shown, but both have 0.5 occupancy levels) 
which are  generated in the  molecular complex/salt,  with 
atom labelling.  
 
 
 
 
 
 
 
Table.  7.20  –  The  carbon  oxygen  bond 
lengths  in  the  benzimidazolium  fumarate 
and  imidazolium  fumarate  molecular 
complex.
Fumarate 
with 
BZNH
+ 
(Å) 
IMDH
+ 
(Å) 
C8-C1  1.286(2)  1.309(1) 
 C8-O2  1.238(2)  1.212(1) 
C11-O3  1.292(2)  1.238(1) 
C11-O4  1.240(2)  1.269(1)   351 
In  its  native  form,  the  fumaric  acid  molecule  adopts  the  carboxylic  acid  dimer  with  the 
hydroxyl groups in the molecule directed parallel to the molecule (Figure 7.61 LHS).  
 
 
 
 
  
Fig. 7.61 – LHS, The carboxylic acid dimer of the fumaric acid structure; RHS, the hydrogen bond between the 
fumarate molecules of the benzimidazolium complex, with the shared proton split over the two sites. 
Table 7.21 – A list of the hydrogen bonds and interactions in the benzimidazolium fumarate molecular complex. 
 
Within the molecular complex with benzimidazolium, one of the carboxylic acid groups of 
the fumaric acid has been deprotonated. The result is that the remaining proton becomes 
shared over the two carboxylic acid groups (Figure 7.61 RHS). This can be seen in the partial 
normalisation of the carbon – oxygen bond lengths of the carboxylic acid groups (Table 7.20). 
In the imidazolium fumarate molecular complex proton transfer has also occurred however 
the remaining proton is only associated with one carboxylic acid which can be seen in the 
carbon  –  oxygen  bond  lengths.  The  shared  protons,  associated  with  the  benzimidazolium 
complex, lie on an inversion centre between two of the same oxygen atoms, therefore each 
hydrogen within the asymmetric unit has a 0.5 occupancy levels, resulting in 1.0 occupancy 
levels  over  the  hydrogen  bond.  The  hydrogen  bond  involving  the  shared  protons,  a‘ 
O1∙∙H∙∙O1 and b‘ O3∙∙H∙∙O3, are of strong strength, a‘ 2.464(1) and b‘ 2.442(1), and creates a 
box comb chain of fumarate molecules along the b-axis (Figure 7.62)(Table 7.20). The box 
comb chain shape comes about because the one of the hydrogen bonds is ―face to face‖, a‘, 
while the other is ―edge to edge‖, b‘. 
 
Interaction  Label  Length  (Å) 
(D∙∙∙A(Å)) 
O1···O1  a’  2.464(1) 
O2···O2   b’  2.442(1) 
N1···O2  2.676(1) 
N2···O4  2.670(1) 
C4···C9   3.094(1) 
π···π  3.473(1)   352 
 
Fig. 7.62 – The box comb chain of fumarate molecules held together by oxygen – oxygen hydrogen bonds, a‘ 
and b‘. The hydrogens on the carboxylic acid groups have been removed.  
 
There are two other hydrogen bonds within the molecular complex, these follow the hydrogen 
bond pattern E, N-H∙∙∙O. These moderate hydrogen bonds of lengths N1∙∙O2 2.6767(1)Å and 
N2∙∙∙O4 2.6702(1) create chains of alternating co-molecules along the b-axis (Figure 7.63).  
 
 
Fig. 7.63 – The co-molecules arrange themselves into hydrogen bonded alternating co-molecules which expand 
along the b-axis. 
 
The two chains, fumarate chain (Figure 7.62) and the alternating co-molecule chain (Figure 
7.63), combine to form interconnected layers, with the benzimidazole molecule connecting 
two of the fumarate chains together, this expands the structure along the a-axis (Figure 7.64 
LHS). This has the effect of creating a column of layers interconnected by moderate hydrogen 
bonds that expands along the a- and b-axis (Figure 7.64 RHS). 
 
     
Fig. 7.64 – LHS, the benzimidazolium molecules connect the fumarate chains along the a-axis, resulting in the 
layers of fumarate and alternating co-molecules interconnecting to form columns of layers, RHS. 
b‘ 
a‘   353 
 
Between the columns are two very weak interactions which are shown in the inset to Figure 
7.64. These interactions connect the columns together along the c-axis (Figure 7.65). The 
carbon  carbon hydrogen bond (red line) has length C4-H∙∙∙C9 3.594(1)Å while the π∙∙∙π 
interaction  between  the  benzimidazolium  molecules  is  around  3.473(1)Å  in  length  (green 
line). 
 
 
Fig. 7.65 – the columns consisting of interconnected chains of fumarate molecules and alternating co-molecules 
are expanded along the c-axis by lesser interactions (yellow box), inset, expanded view of the lesser interactions.  
 
Imidazolium Fumarate 
 
The imidazolium fumarate structure was first structurally determined in 2001
12. The structure 
contains  a  stoichiometric  ratio  of  1:1  of  the  ionic  species  of  the  co-molecules  as  proton 
transfer  has  occurred  in  the  normal  way  (refer  to  Section  7.2.1).
  The  result  of  the 
deprotonation  on  the  fumarate  molecule  is  different  to  that  found  in  the  molecule  in  the 
benzimidazole  complex  structure  where  the  remaining  proton  was  disordered  over  the 
carboxylic acid groups. In the imidazolium structure, the remaining proton is associated with 
only one oxygen therefore normalisation of the carbon – oxygen bond lengths has resulted in 
one  of  the  carboxylic  acids  (Table  7.20).  The  imidazolium  molecule  undergoes  the 
rearrangement mentioned in Section 7.2.1. 
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The motif of the imidazolium fumarate structure is an amalgamation of the ladder style and 
alternating linear chain style (Figure 7.66). With the fumarate molecules hydrogen bonding to 
one-another through the hydrogen bond pattern J, O-H∙∙∙O, this creates chains of fumarate 
molecules with imidazolium molecules holding these chains together, i.e. the ladder motif. 
However, the fumarate molecules are not lined up to form long chains with one-another, but 
are ―facing‖ the imidazolium molecules and are using the hydrogen bond pattern E to form 
alternating co-molecule linear chains. This amalgamated motif expands the structure along the 
a-  and  c-axis  while  the  b-axis  is  expanded  by  π∙∙∙π  stacking  interactions  of  distance 
3.385(3)Å. 
 
 
Fig. 7.66 – The main motif of the imidazolium fumarate molecular complex, an amalgamation of the ladder and 
linear chain motifs. 
 
7.7.2  Molecular Complexes of Benzimidazolium and Imidazolium with Succinic 
Acid  
 
The  molecular  ions  benzimidazolium  and  succinate  form  a  1:1  molecular  complex.  The 
molecular  complex  was  obtained  using  the  solvent  evaporation  method,  with  a  1:1 
stoichiometric mixture of benzimidazole (12mg) and succinic acid (12mg) dissolved in the 
minimum amount of ethanol and left to evaporate at a constant temperature of 2-4ºC. The 
crystals generated were block shaped and colourless. Single crystal X-ray diffraction data 
were obtained using a Bruker Nonius Kappa diffractometer at 100K, equipped with graphite   355 
monochromated  Mo  Kʱ  radiation  (λ  =  0.71073  Å).  The  structure  was  solved  using 
SUPERFLIP within the CRYSTALS program.  The crystallographic data are summarised in 
Table 7.6.  
 
In  the  molecular  complex,  the  benzimidazole  molecule  is  protonated  through  hydrogen 
transfer from one of the carboxylic acid groups on the succinic acid molecule, as described in 
Section 7.2.1 (Figure 7.67). The result is that the internal bond lengths are now normalised, to 
N1
ʴ+-C1 1.332(2)Å and N2
ʴ+-C1 1.328(2) Å, and bond angles to C1-N1
ʴ+-C2 108.3(1)º and 
C1-N2
ʴ+-C7 108.3(1)º.   
 
 
Fig. 7.67 –The benzimidazolium and succinate ions which are generated in the molecular complex/salt, with 
atom labelling. 
Table. 7.22 – The carbon oxygen bond bonds in the benzimidazolium succinate and imidazolium succinate 
molecular complexes. 
 
Table 7.23 – The hydrogen bond data for the hydrogen bonds in the benzimidazolium succinate molecular 
complex. 
 
The succinate has two carboxylic acid groups, therefore only one has been deprotonated in 
order to fully protonate the benzimidazolium ion. The result is not full deprotonation of one 
Suc’ate   BZNH
+ (Å)  IMDH
+ (Å) 
C8-C1  1.240(1)  1.220(2) 
 C8-O2  1.292(1)  1.288(2) 
C11-O3  1.248(1)  1.219(2) 
C11-O4  1.285(1)  1.307(2) 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O2···O2  2.513(1)  1.256(1)  1.256(1)  180 
O4···O4   2.443(1)  1.221(1)  1.221(1)  180 
N1···O1  2.651(1)  0.97(2)  1.69(2)  172.7(2) 
N2···O3  2.634(1)  0.95(2)  1.73(2)  158.1(2) 
C5···π   3.550(2)  -  -  -   356 
carboxylic acid group while the other retains its proton, but rather that the proton that is left is 
split over the two hydroxyl sites. The hydroxyl oxygen then hydrogen bonds to a symmetry-
related oxygen through an inversion centre, therefore each hydrogen is 0.5 occupied within 
the asymmetric unit, but fully occupied over the hydrogen bond. The result on the carbon  
oxygen bond lengths is still a degree of normalisation due to the deprotonation, which is 
similar to that found in the succinate ion in the imidazolium complex that has been fully 
deprotonated (Table 7.22).  
 
The succinate molecule, as described, hydrogen bonds through an inversion centre using the 
hydrogen  bond  pattern  J.  There  are  two  of  these  moderate  hydrogen  bonds,  with  length 
O2∙∙∙O2 2.513(1)Å and O4∙∙∙O4 2.443(1)Å. The proton is centred, with the hydrogen bond 
angle at 180º. These form chains of succinate molecules that run along the a-axis (Figure 
7.68). The benzimidazolium ions have the role of connecting two of the chains together along 
the b-axis. This interaction uses N-H ∙∙∙O moderate hydrogen bonds that can be described as 
types E and F, of length 2.651(1)Å and 2.634(1)Å(see Table 7.23 for full details). The motif 
is  therefore  the  common  ladder  motif  with  uprights  of  succinate  ions  and  rungs  of 
benzimidazolium ions. 
 
Fig. 7.68 – The main motif of the benzimidazolium succinate molecular complex, the ladder style with uprights 
of succinate ions and rungs of benzimidazolium ions. 
 
Figure 7.69 is a view along the b-axis of the extended structure. From this it can be seen that 
the  main  motifs  run  perpendicular  to  the  page,  the  ladder  style  motif  (blue  box)  being 
expanded along the c-axis through C-H···π interactions of 3.550(2)Å in length (red box). This   357 
is the only other significant interaction with the structure – there are weak C-H···O hydrogen 
bonds  that  exist  between  the  adjoining  chains,  however  these  just  support  the  moderate 
N-H···O hydrogen bonds. 
 
 
Fig. 7.69 – the extended structure of benzimidazolium succinate molecular complex viewed along the b-axis, 
highlighting how the main motif (blue line) extends along the c-axis through C-H···π interactions (red box); 
inset, the C-H···π interaction. 
 
Imidazolium Succinate 
 
The structure of the imidazolium succinate molecular complex
12 contains a 1:1 molecular 
ratio of co-molecules with proton transfer occurring (see Section 7.2.1). The hydrogen bonds 
between the co-molecules are partially charge assisted N-H∙∙∙O interactions (HB pattern E) of 
length 2.715(2)Å and 2.871(2)Å. They align the co-molecules into chains that run along the 
ac-diagonal (Figure 7.70). 
 
   358 
Fig. 7.70 – the chain that is created through the N-H∙∙∙O hydrogen bonds between the co-molecules in the 
imidazolium succinate molecular complex. 
 
The hydroxyl oxygen that remains on the non-protonated carboxylic acid group hydrogen 
bonds to an oxygen in an adjacent chain below (Figure 7.71). This hydrogen bond is the 
strongest in the molecular complex at O∙∙∙O, 2.478(2)Å and expands the structure along the a-
axis. Supporting this interaction are weaker carbon – oxygen hydrogen bonds involving the 
carbon located between the nitrogens and the currently non-hydrogen bonded oxygen (blue 
circle). This hydrogen bond has length C∙∙∙O 3.082(2)Å and with the O-H∙∙∙O interactions 
creates layers of co-molecules. These layers are then stacked upon another using very weak 
carbon – oxygen hydrogen bonds of length 3.358(3)Å. 
 
 
Fig.  7.71  –  The  main  motif  of  the  imidazolium  succinate  structure,  layers  consisting  of  linear  chains  of 
alternating co-molecules that expand along the ac-diagonal (chains) and a-axis. 
 
7.7.3  Molecular Complexes of Benzimidazolium and Imidazolium with Maleic 
Acid  
 
The molecular ions, benzimidazolium and maleate form a 1:1 molecular complex with one 
another.  The molecular complex was obtained using the solvent evaporation method, with a 
1:1 stoichiometric mixture of  benzimidazole (14mg) and maleic acid (12.5mg) dissolved in   359 
the minimum amount of methanol followed by evaporation at a constant temperature of 40ºC 
using an Asynt hotplate. The crystals generated were block shaped and colourless.   
 
Single  crystal  X-ray  diffraction  data  were  obtained  using  a  Rigaku  R-axis/RAPID 
diffractometer  at  100K,  equipped  with  graphite  monochromated  Mo  Kʱ  radiation  (λ  = 
0.71073 Å). The structure was solved using SIR92 within the CRYSTALS program.  The 
crystallographic  data  are  summarised  in  Table  7.6  with  the  hydrogen  bond  data  and 
interaction listed in Table 7.24. 
 
In  the  molecular  complex,  the  benzimidazole  molecule  is  protonated  through  hydrogen 
transfer from one of the carboxylic acid groups on the maleic acid molecule onto the normally 
unprotonated nitrogen atom in the five-membered ring forming a benzimidazolium molecule 
(Figure 7.72). This form of proton transfer is common in all molecular complexes involving 
benzimidazole  and  a  carboxylic  acid  group  containing  molecule  where  the  crystallisation 
product  is  in  a  1:1  stoichiometric  ratio.  The  result  of  the  proton  transfer  on  the 
benzimidazolium molecule is a delocalisation of the charge across the five-membered ring, 
reflected in the equalisation of the internal bond lengths, N1
 ʴ+-C1 1.325(3)Å and N2
 ʴ+-C1 
1.326(3) Å, and bond angles, C2-N1
ʴ+-C1 108.05(19)º and C7-N2
ʴ+-C1 108.31(18)º.  The 
delocalisation of the charge has the effect of creating a partial positive charge on both the 
nitrogens.  This  effect  has  been  reported  in  many  structures  involving  benzimidazole  and 
imidazole (see Section 7.2.1).  
 
   
Fig. 7.72 – LHS, the benzimidazolium and maleate molecules which are generated in the molecular complex, 
with atom labelling. RHS, the Fourier difference  map generated  with the H atoms located on the N atoms 
omitted from the model; this clearly shows that both N atoms are protonated.   
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Table 7.24 – The hydrogen bond data for the hydrogen bonds in the benzimidazolium succinate molecular 
complex. 
 
The maleic acid molecule in its native crystal structure (refer to Figure 7.11) is configured 
such that there is an intramolecular hydrogen bond between the two carboxylic acid groups. 
Within  the  molecular  complex  with  benzimidazolium  this  intramolecular  hydrogen  bond 
persists  despite  the  proton  transfer  of  a  hydrogen  atom  to  the  benzimidazole.    The 
intramolecular hydrogen bond is relatively short with an O···O distance of 2.405(3)Å which 
is  significantly  shorter  than  the  O···O  distance  of  2.503Å  that  is  found  in  maleic  acid 
(polymorph MALIAC12)
22 (used for comparisons hereafter). This is due to the intramolecular 
hydrogen bond being charged assisted, a result of the deprotonation of the maleic acid. The 
negative charge is found to be delocalised over the carboxylic acid groups, by consideration 
of the normalisation of the bond lengths  in  the carboxyl  groups of the maleate molecule 
(Table  7.25).  The  delocalisation  also  results  in  the  presence  of  partially  charge  assisted 
intermolecular hydrogen bonds involving O3 and O7. 
 
 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O2···O3  2.405(3)  1.19(3)  1.2293)  178(3) 
N1···O1   2.751(3)  0.98(3)  1.77(3)  175(2) 
N2···O4  2.691(3)  0.99(3)  1.71(3)  172(3) 
C9···O2  3.275(3)  0.91(2)  2.65(2)  126(2) 
C10···O3   3.501(3)  0.98(3)  2.64(3)  147(2) 
C1···O4  3.175(3)  0.95(2)  2.23(2)  164(2) 
C4···O1   3.517(3)  0.94(3)  2.60(3)  165(2)   361 
 
 
Fig. 7.73 – The maleic acid molecule (top) and the 
maleate ion (bottom) showing the differences in the 
bond characteristics. 
Table  7.25  –  A  comparison  of  the  bond  lengths 
found in the maleate ion in its molecular complex 
with  benzimidazolium  and  those  of  the  neutral 
maleic acid molecule. 
 
 
From Table 7.16, it can be seen the C6-O7 and C6-O8 bonds have undergone a complete 
character  reversal.  The  single  bond  involved  in  the  intramolecular  hydrogen  bond  in  the 
maleic acid (C8-O2) has now more double bond characteristics while the double bond in 
maleic acid (C8-O1) has more single bond characteristics (Figure 7.73).  The proton that sits 
in the intramolecular hydrogen bond has an O
ʴ--H distance of 1.18(3)Å and a H···O
ʴ- distance 
of 1.22(3)Å.  This indicates the hydrogen atom has an affinity for both oxygens and thus 
adopts  an  approximately  central  position  within  the  hydrogen  bond.  However  Fourier 
difference maps (Figure 7.74), directly imaging the electron density of the hydrogen atom in 
this intramolecular hydrogen bond, suggests that the hydrogen atom is positioned slightly 
closer to O2 in an asymmetric position; this is similar to the behaviour observed in the native 
structure of maleic acid.  
 
 
Fig. 7.74 – LHS, 2D Fourier difference map, RHS, 3D Fourier difference map (MCE); both images show a 
slightly asymmetric location of the hydrogen atom in the intramolecular hydrogen bond of the maleate molecule. 
O O
O HO
O
O
HO
O
H
  Maleate (Å)  Maleic Acid (Å) 
C8-C9  1.437(3)  1.482(2) 
C8-O1  1.244(2)  1.308(2) 
C8-O2  1.289(2)  1.225(2) 
C11-O3  1.291(3)  1.308(2) 
C11-O4  1.237(3)  1.224(2) 
C11-C10  1.492(3)  1.487(2) 
C9-C10  1.334(3)  1.335(3)   362 
 
The main motif in  the  benzimidazolium maleate molecular  complex is  a zigzag chain  of 
alternate co-molecules in the ac direction, motif N. This is constructed of alternating charge 
assisted N
ʴ+-H····O
ʴ- hydrogen bonds of lengths 2.751(3)Å and 2.691(3)Å. These hydrogen 
bonds are moderate in strength and utilise the hydrogen bond pattern E (Figure 7.75). 
 
 
Fig. 7.75 – The main motif of the benzimidazolium  maleate molecular complex; a chain of alternating co-
molecules held together by alternating charge assisted N
ʴ+-H····O
ʴ- hydrogen bonds. 
 
The zigzag chains are held together along the b-direction by weaker C-H····O
ʴ- hydrogen 
bonds creating layers of these chains (Figure 7.76). These two weak hydrogen bonds have 
C····O
ʴ-  distances  of  3.275(3)Å  and  3.501(3)Å  and  C-H····O
ʴ-  angles  of  126.3(2)º  and 
146.6(2)º, resulting in a staircase arrangement of the zigzag chains (Figure 7.76 insert).   
 
  
Fig. 7.76  The zigzag chains that are the main synthon in the benzimidazolium maleate molecular complex are 
held together by weak hydrogen bonds connecting the maleate ions (insert). 
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Another C-H····O
ʴ- hydrogen bond, is formed between the carbon located between the two 
nitrogens (C1) of the benzimidazole molecule and an oxygen (O4) on a maleate ion. With a 
C-H····O
ʴ- length of 3.157(3) Å it can be classified as a weak hydrogen bond. These hydrogen 
bonds hold two layers together creating blocks of two layers of the main motif (Figure 7.77).  
 
 
Fig.  7.77  –  View  along  the  b-axis  showing  the  main  motif  (-)  of  the  benzimidazolium  maleate  molecular 
complex connected by the C-H---O
ʴ- hydrogen bond from the benzimidazolium molecule (-) (insert) to make a 
two layer block. 
 
The  blocks,  consisting  of  the  two  layers  of  the  main  motif 
(Figure 7.77),  are connected to  one another through another 
weak hydrogen bond. This interaction is between an aromatic 
hydrogen on the benzene ring of the benzimidazolium (C4) and 
an oxygen involved in the intramolecular hydrogen bond (O1) 
of the maleate ion with a C····O
ʴ- distance of 3.517(3)Å and a 
C-H...O angle of 164.6(2)º (Figure 7.78). Figure 7.79 shows 
how the layers are held by these two weak hydrogen bonds in 
alternate  fashion.  The  blue  lines  represent  the  chains  of 
alternate co-molecules, red lines indicating the weak hydrogen 
Fig. 7.78 - The weak hydrogen bond 
between  the  maleate  and 
benzimidazolium ions.   364 
bond seen in Figure 7.75 and the green lines indicate where the weak hydrogen bond in 
Figure 7.76 lies. 
 
 
Fig. 7.79 – View along the b-axis of the expanded benzimidazolium maleate molecular complex. The blue line  
(-) indicates the planes of the main motif (Figure 7.75), the red line (-) indicates the weak hydrogen bond that 
holds the planes together in alternate layers (Figure 7.75) with the green line (-) indicating the other  weak 
hydrogen bond (Figure 7.76).  
 
Imidazolium Maleate 
 
There are a few structures of the imidazolium maleate molecular complex within the CSD, the 
one that will be discussed was published in 1980 by Schlemper et al
23 (Table 7.26).  
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Maleate  Space Gp  Cell Lengths (Å)  Cell Angles (Å)  Volume (Å
3) / Z 
BZNH
+  P 21/n 
12.858(2) 
5.450(2) 
15.454(2) 
90 
91.516(4) 
90 
1083.1(2) 
 
4 
IMDH
+  P 21/c 
10.855(2) 
5.518(1) 
14.616(4) 
90 
102.87(2) 
90 
853.47(2) 
 
4 
Table 7.26 – Some basic crystal data for the benzimidazolium maleate molecular complex and the imidazolium 
maleate molecular complex. 
 
As  in  the  benzimidazolium  structure,  there  is  proton  transfer  from  the  maleate  to  the 
imidazolium,  which  results  in  the  maleate  ion  forming  with  the  associated  bond 
rearrangement  taking  place  (Figure  7.72,  Table  7.27).    This  results  in  two  very  strong 
hydrogen bond acceptor groups at each end of the maleate molecule, which when coupled 
with the two strong hydrogen bond donors within the imidazolium ion (N-H) it is almost 
certain that a hydrogen bond pattern of type E or F will prevail. The benzimidazolium maleate 
structure adopted the linear chain motif as did the imidazolium succinate structure, therefore 
there  is  a  very  strong  chance  that  a  linear  hydrogen  bonded  chain  with  alternating  co-
molecules would be likely. The presence of two hydrogen bond acceptors on the end of the 
molecule rules out the ladder motif, but not the hydrogen bonded ring motif. 
 
Figure 7.78 shows that the main motif of the imidazolium maleate is the hydrogen bonded 
ring motif (L) that is held together by partially charged assisted N-H∙∙∙O interactions. These 
hydrogen  bonds  as  moderate  in  strength  with  lengths  of  2.783(3)Å  (0.96(1)Å,  1.83(3)Å, 
170.7(1)º) and 2.786(4)Å (0.98(1)Å, 1.81(2)Å 173.4(2)º), respectively.  
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Fig. 7.80 – View along the c-axis of the motif of the imidazolium maleate structure, showing the hydrogen 
bonded ring. 
 
There are only two lesser interactions that complete the significant interactions within the 
structure, both C-H···O hydrogen bonds. The slightly weaker hydrogen bond expands the 
structure along the ab-diagonal which has length C∙∙∙O 3.2340(4)Å (Figure 7.81 blue circle). 
The  other  with  length  C∙∙∙O  3.1468(6)Å  (red  circle)  expands  the  structure  along  the  ac-
diagonal, but more importantly, with an angle between the two adjoining hydrogen bonded 
rings of ~68.7º.  This allows for the hydrogen bonded rings to stack upon one-another (Figure 
7.81 – RHS). 
 
 
Fig 7.81 – LHS, the main motif, hydrogen bonded ring, are expanded by C-H···O hydrogen bonds along the ab-
diagonal (blue circle) and ac-diagonal (red circle); RHS, the view along the a-axis of an extended imidazolium 
maleate structure. 
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7.7.4  Molecular Complexes of Benzimidazole and Imidazole with Malonic Acid  
 
Successful cocrystallisation experiments have produced the previously undetermined structure 
of imidazole with malonic acid and provided an enhanced model for the benzimidazole and 
malonic acid structure. In both structures there was proton transfer as described in Section 
7.2.1 and each complex is in a 1:1 molecular ratio.  
 
On the basis of previous findings, there will definitely be a NH···O hydrogen bond between 
the molecules, with it adopting hydrogen bond pattern E or F. With one of the carboxylic acid 
groups undergoing deprotonation, there will be only one hydroxyl  group in the structure, 
within the native structure of malonic acid there is no intramolecular hydrogen bond, and if 
this  configuration  is  maintained,  this  hydroxyl  group  will  be  available  for  intermolecular 
hydrogen  bonding.  This  would  promote  the  possibility  of  hydrogen  bond  pattern  I  or  J 
forming. The probable motifs would be K, the ladder style, or N the linear chain. 
 
Malonate 
 
The malonic acid molecule in its native crystal structure (refer to Section 7.1.9) is configured 
such that there is no intramolecular hydrogen bond between the two carboxylic acid groups. 
However within the molecular complex with benzimidazolium an intramolecular hydrogen 
bond is formed. The resulting intramolecular hydrogen bonds are relatively short with O···O 
distances of O2∙∙∙O3 2.440(2)Å and O4∙∙∙O5 2.449(2)Å which will be due to the delocalised 
negative  charge.    The  intramolecular  hydrogen  bond  was  initially  not  proposed  in  the 
published structure
30; this new model explains the discrepancies in the carbon – oxygen bond 
lengths and positions the hydrogens more accurately. In contrast, the imidazolium malonate 
structure does not contain the intramolecular hydrogen bond but retains the native form with 
the hydrogen open for intermolecular hydrogen bonds (Figure 7.82). This is in line with the 
situation in imidazolium malonate hydrate, in which even though the hydrogen positions are 
unknown, the carbon  oxygen bond distances and overall bond geometry are similar (Table 
7.27). There is no obvious reason for the differences in the malonate ion geometry between 
the different structures. 
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Fig.  7.82  –  The  malonate  ion  found  in  molecular  complexes  with  (from  left  to  right)  benzimidazolium, 
imidazolium, imidazolium hydrate, and in its native form, with atom labelling. 
 
  Malonate 
BZNH
+ (Å) 
Malonate  IMDH
+ 
(Å) 
Malonate  IMDH
+ 
Hydrate (Å) 
Native  Malonic 
Acid (Å) 
C4-O1  1.234(2)  1.249(1)  1.240(6)  1.285(3) 
C4-O2  1.292(3)  1.268(1)  1.250(5)  1.221(3) 
C6-O3  1.270(3)  1.214(1)  1.208(7)  1.231(2) 
C6-O4  1.251(3)  1.319(1)  1.285(6)  1.290(3) 
Table 7.27 – A comparison of the bond lengths found in the malonate ions in their molecular complexes with 
benzimidazolium, imidazolium, imidazolium hydrate and in its native form.  
 
Hydrogen Bond Data 
Benzimidazolium Malonate 
Interaction  Label  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
N2···O1  a’  2.701(3)  0.95(3)  1.75(3)  173(2) 
N3···O4   b’  2.676(3)  0.93(3)  1.75(3)  172(3) 
C1···O4  3.242(3)  0.95(2)  2.31(2)  165(2) 
C7···O6  3.229(3)  0.97(2)  2.26(2)  170(2) 
C···O1   3.443(3)  0.96(2)  2.52(2)  162(2) 
C···O3  3.369(3)  0.97(2)  2.42(2)  166(2) 
π···π   3.400(2)  -  -  - 
Imidazolium Malonate 
Interaction  Length  (Å) 
(D∙∙∙A(Å)) 
For Hydrogen Bonds 
D-H(Å)  H∙∙∙A(Å)  D-H∙∙∙A angle(º) 
O4···O2  2.563(1)  0.94(2)  1.63(2)  174(2) 
N1···O2   2.742(1)  0.90(2)  1.84(2)  165(2)   369 
Table 7.28 – The hydrogen bond geometry data and interaction details for the benzimidazolium malonate and 
imidazolium malonate molecular complexes. 
 
Benzimidazolium Malonate 
 
The molecular ions, benzimidazolium and malonate form a 1:1 molecular complex with one 
another.  The molecular complex was obtained using the solvent evaporation method, with a 
1:1 stoichiometric mixture of  benzimidazole (12mg) and malonic acid (10mg) dissolved in 
the minimum amount of acetone followed by evaporation at a constant temperature of 2-4ºC 
in a walk-in fridge. The crystals generated were plate shaped and colourless.   
 
Single  crystal  X-ray  diffraction  data  were  obtained  using  a  Bruker  Nonius  Kappa 
diffractometer  at  100K,  equipped  with  graphite  monochromated  Mo  Kʱ  radiation  (λ  = 
0.71073 Å). The structure was solved using SIR92 within the CRYSTALS program.  The 
crystallographic data are summarised in Table 7.6. 
 
In  the  molecular  complex,  the  benzimidazole  molecule  is  protonated  through  hydrogen 
transfer  from  one  of  the  carboxylic  acid  groups  on  the  malonic  acid  forming  a 
benzimidazolium  molecule  (Figure  7.83).  The  result  of  the  proton  transfer  on  the 
benzimidazolium molecule is a delocalisation of the charge across the five-membered ring, 
reflected  in  the  equalisation  of  the  internal  bond  lengths;  N1-C1  1.333(3)Å,  N2
  -C1 
1.326(3)Å, N3-C7 1.328(3)Å, N4
 –C7 1.329(3)Å and bond angles; C2-N1-C1 108.3(2)º and 
C3-N2-C1 108.6(2)º, C8-N3-C7 108.3(2)º and C9-N4-C7 108.4(2)º.  There are two of each 
co-molecule in the  asymmetric unit. The deprotonation of the malonic acid molecule has 
resulted in an intramolecular hydrogen bond being formed (refer to Malonate, section 7.1.9) 
and the normalisation of the carbon – oxygen bond lengths.  
N2···O1  2.765(1)  0.92(2)  1.85(2)  173(2) 
C1···O2  3.001(1)  0.95(2)  2.39(1)  150(1)   370 
 
Fig. 7.83 – The benzimidazolium and malonate molecules which are generated in the molecular complex, with 
atom labelling.  
 
There are two moderate hydrogen bonds within the structure, both are nitrogen  – oxygen 
interactions and follow hydrogen bond pattern E. The hydrogen bonds have length N2∙∙∙O1, 
a‘,  2.701(3)Å  and  N3∙∙∙O4,  b‘,  2.676(3)Å  and  align  the  co-molecules  into  a  linear  chain 
(Figure 7.84). This linear chain of alternating hydrogen bonded co-molecules is the motif of 
the structure, which follows motif N. Two of these motifs are connected along the b-axis by 
lesser C-H···O hydrogen bonds. This hydrogen bond involves the carbons located between 
the  nitrogens  on  the  two  BZNH
+  molecules  (C1  and  C7)  and  oxygens  O4  and  O6,  with 
lengths C∙∙∙O 3.242(3) and 3.229(3)Å. 
 
   
Fig. 7.84 – the main motif of the benzimidazolium malonate structure, linear chain of alternate hydrogen bonded 
co-molecules. Two of the motifs are connected together through carbon – oxygen hydrogen bonds (blue circle). 
 
While the C-H···O hydrogen bonds shown in Figure 7.84 connect two chains together, this is 
just one part of the two different types of interactions that expand the structure along the b-
axis, that work in an alternative fashion. The other interactions are also C-H···O hydrogen 
a‘ 
a‘ 
b‘ 
a‘ 
b‘ 
b‘   371 
bonds  with  lengths  of  3.498(3)  and  3.502(2)Å  (Figure  7.85  red  circle).  This  alternate 
interaction between the motifs runs along the b-axis creating a layer. 
 
     
Fig 7.85 – RHS, the chains of motifs are held together along the b-axis by two alternating layers of interactions, 
a relatively  stronger carbon  – oxygen hydrogen bond (blue box), and  a relatively  weaker carbon  – oxygen 
hydrogen bond (red circles); LHS, view of the  b-axis  with the interactions coloured in blocks to show the 
alternating layered nature. 
 
Between these layers of motifs are two interactions that expand the structure along the a-axis. 
There is  a C-H···O hydrogen bond between two malonate molecules which have lengths 
C∙∙∙O 3.443(3)Å and 3.369(3)Å  (Figure 7.86  yellow circle). The other interaction is  π∙∙∙π 
stacking interactions between the benzimidazolium molecules which have a length of around 
3.400(2)Å (measured between the two closest benzimidazolium molecules). These are all the 
significant interactions within the benzimidazole malonate molecular complex. 
 
 
Fig. 7.86 – the a-axis is expanded by two lesser interactions that stack the layers of motifs upon one-another. The 
shortest is a C-H···O hydrogen bond (yellow circle) while the other is a π∙∙∙π stacking interaction between the   372 
Fig. 7.87  The imidazolium and malonate 
ions which are generated in the molecular 
complex/salt, with atom labelling. 
benzimidazolium  molecules  (green  circle).  Insert  LHS,  the  C-H···O  hydrogen  bond;  insert  RHS,  the  π∙∙∙π 
stacking interactions. 
 
Imidazolium Malonate 
 
The  molecular  ions,  imidazolium  and  malonate  form  a  1:1  molecular  complex  with  one 
another.  The molecular complex was obtained using the solvent evaporation method, with a 
1:1  stoichiometric mixture of imidazole (8mg)  and malonic acid  (10mg) dissolved in  the 
minimum amount of acetone followed by evaporation at 2-4ºC. The crystals generated were 
block shaped and colourless.   
 
Single  crystal  X-ray  diffraction  data  were  obtained  using  a  Bruker  Nonius  Kappa 
diffractometer  at  100K,  equipped  with  graphite 
monochromated Mo Kʱ radiation (λ = 0.71073Å). The 
structure  was  solved  using  SUPERFLIP  within  the 
CRYSTALS  program.    The  crystallographic  data  are 
summarised in Table 7.6.  
 
As  reported,  the  imidazole  molecule  is  protonated 
through  hydrogen  transfer  as  shown  in  Section  7.2.1.  The  result  is  the  creation  of  an 
imidazolium ion, with the positive charge being delocalised over the ion (Figure 7.87). This is 
reflected  in  the  equalisation  of  the  internal  bond  lengths,  N1-C1  1.324(2)Å  and  N2-C1 
1.326(1)Å, and bond angles, C2-N1-C1 108.4(1)º and C3-N2-C1 108.8(1)º. The effect on the 
malonic acid molecule is that the carboxylic acid group that has been deprotonated, has a 
negative charge that is shared across the group. This can be seen in the normalisation of the 
carbon – oxygen bond lengths (refer to Malonate, section 7.1.9). 
 
There are three moderate hydrogen bonds within the structure, two of which follow hydrogen 
bond  pattern  F,  N-H∙∙∙O,  while  the  other  adopts  pattern  I,  O-H∙∙∙O.  The  hydroxyl   
carboxylate hydrogen bond, O4-H∙∙∙O2  2.563(1)Å, connects the malonate molecules together 
into  chains.  Connecting  these  chains  together  are  the  partially  charge  assisted  N-H∙∙∙O 
hydrogen bonds of length, N1∙∙∙O2  2.742(1)Å and N2-O1 2.765(1)Å (see Hydrogen Bond 
Data, Table 7.28), As Figure 7.88 demonstrates, the motif of the structure is the ladder style 
with uprights of malonate molecules and rungs of imidazole. This ladder is not flat, but more   373 
of a staircase shape due to the geometry of the malonate ion. The result is that the imidazole 
molecules lie on two levels. 
 
 
Fig. 7.88 – The main motif of the imidazolium malonate molecular complex, the ladder style with uprights of 
malonate ions and rungs of imidazolium, viewed along, LHS, the c-axis, middle, the b-axis, and RHS, the a-axis. 
 
The motif expands along the a- and c-axis while the b-axis is expanded through C-H···O 
hydrogen bonds involving the carbon located between the nitrogens, and an oxygen – oxygen 
interaction. The hydrogen bond has a distance of C1∙∙∙O2 3.001(1)Å (Figure 7.72 - green line) 
while the oxygen  – oxygen interaction is  on the limit of its sum  of van der Waals  radii 
(3.04Å) at 3.001(1)Å (Figure 7.89 - red line). 
 
 
Fig. 7.89 – The motif of the structure (blue interactions) is expanded along the b-axis by C-H···O hydrogen 
bonds (green interaction) and an oxygen – oxygen interaction (red line). 
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Figure 7.90 shows the extended structure viewed along the c-axis (LHS) and b-axis (RHS). 
From  these  images  the  main  motif,  ladder  style  with  uprights  of  malonate  and  rungs  of 
imidazolium molecules (blue shading) can be seen to be expanded along the b-axis by the 
carbon – oxygen weak hydrogen bond (red shading). 
 
 
Fig. 7.90 – LHS, view along the c-axis of the extended structure; RHS, view along the b-axis of the extended 
structure,  with  the  main  motif  (blue  shading)  being  expanded  along  the  b-axis  by  carbon  –  oxygen  weak 
hydrogen bonds (red shading). 
 
7.8   Conclusions 
 
The library of hydrogen bond patterns shown in Figure 7.18 has featured in all the molecular 
complexes discussed in  Chapter 7 with three of the four occurring more than once. This 
shows that the library of hydrogen bonding patterns is robust, dependable and in some cases 
very much predictable. There were also some slight derivatives of the motifs, for example the 
benzimidazolium  :  fumarate  structure  amalgamated  the  ladder  and  linear  chain  style.  A 
majority  of  the  imidazolium  molecular  complexes  adopted  the  linear  chain  of  hydrogen 
bonded alternating co-molecule motif with the addition of the chain having a spiral nature, for 
example in the imidazolium : 4-fluorobenzoic acid molecular complex (shown in Figure 7.31, 
repeated below). 
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Fig. 7.31 repeated – LHS, the main motif of the IMDH
+ 4-FBA
- molecular complex, a spiral chain of alternate 
co-molecules  held  together  through  N-H∙∙∙O  hydrogen  bonds,  E  and  F;  RHS,  view  along  the  b-axis  of  an 
extended spiral chain showing its circular nature. 
 
The halo-benzoic acid structures shown in this chapter, but also in Chapter 5, have shown the 
important  nature  of  the  halogen  atoms  in  forming  interactions.  From  these  findings,  the 
halogen interactions, including halogen bonds, have had little influence on formation of the 
main motif of the structure. However, they have contributed to the construction of a more 
stable  structure  by  creating  more  robust  interactions  than  corresponding  non  halogen-
containing molecules. For example in the imidazolium 4-fluorobenzoate structure, the main 
motifs are expanded by halogen bonds of F∙∙∙C distance of 3.490(2)Å (Figure 7.91) while in 
the benzimidazolium succinate molecular complex, the interaction that has a similar role is a 
carbon  carbon hydrogen bond of C∙∙∙C 3.552(1)Å in length.  
 
 
Fig.  7.91  –  LHS,  extract  from  Fig.  7.33,  view  along  the  b-axis  of  the  extended  structure  of  imidazole  4-
fluorobenzoate showing the spiral chains held together by halogen bonds (yellow lines) that connect the chains 
along the a- and c-axis; RHS, extract from Fig. 7.68 – the carbon - carbon weak hydrogen bond that expands the 
benzimidazolium succinate structure along the b-axis. 
 
The aromatic dicarboxylic acids produced structures with benzimidazole and imidazole that 
utilised the library of hydrogen bonds and in one case, benzimidazolium : terephthalic acid,   376 
produced  the  same  motif  as  the  corresponding  mono-substituted  hydroxy-benzoic  acid 
structure. 
 
The differences between the structures from BZN and IMD are evident, in no case did the 
main motif of equivalent complex structures stay the same. In every case between a BZN and 
IMD structure, there was both a different motif and a different packing arrangement. In one 
example, the malonate complexes, the co-molecule was  rearranged (Figure 7.80, repeated 
below) between the different molecular complexes. 
 
   
Fig. 7.82 repeated – the malonate ion found in molecular complexes with (from left to right) benzimidazolium, 
imidazolium, imidazolium hydrate, and in its native form, with atom labelling. 
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8  Conclusions and Future Work 
8.1   Hydrogen Bond Patterns/ Motifs 
Of all the possible hydrogen bonding patterns, the many possibilities of potential hydrogen 
bond motifs that could be generated between the BZN and IMD and all the co-molecules 
used, surprisingly only four unique hydrogen bonding patterns and four hydrogen bond motifs 
can be used to describe every structure generated (Figure 8.1). This shows that the library of 
hydrogen bonding patterns is robust, dependable and in some cases very much predictable. 
       
            
 
            
     
 
Fig. 8.1 – The library of hydrogen bond patterns that the molecular complexes discussed in this work are highly 
likely to adopt: E (N
ʴ+H∙∙∙O
ʴ-), F (OH∙∙∙O
ʴ-), G (N
ʴ+H∙∙∙ N
ʴ+) and H (OH∙∙∙O). The recurrent motifs found 
are defined as the general descriptor of these interactions: K is the ladder motif, L is the hydrogen bonded ring 
motif, M is the co-molecule dimer motif, while N is an example of a linear chain of alternate co-molecules.   
E 
F 
G 
H 
K 
L 
M  N   379 
 
Within this overall consistent picture of the outcomes of the attempts at ―crystal engineering‖ 
in these families of structures, there are some variations that need to be accounted for. For 
example, the BZN : 3-/6-hydroxypicolinic acid molecular complex structures (Section 6.4) 
are found to adopt a nitrogen  nitrogen hydrogen bond involving the pyridine nitrogen that is 
partially, but not fully, described by hydrogen bond pattern H. There are also some slight 
deviations  found  within  the  motifs,  for  example  the  benzimidazolium  fumarate  structure 
amalgamates the ladder and linear chain style (Section 7.7.1). However even accounting for 
these,  the  re-occurrence  of  the  hydrogen  bond  patterns  /  motifs  shown  in  Figure  8.1  is 
remarkable.  By  using  this  library,  the  major  hydrogen  bonds  and  likely  motifs  in  the 
molecular complexes of benzimidazole with any carboxylic acid containing co-molecule of 
similar size to those studies could be predicted, with some confidence. Given further time and 
more extensive investigation, more molecular complexes of BZN/IMD with carboxylic acid 
containing molecules could be produced and characterised. Further research could be carried 
out with a range of co-molecules that the findings in this work would predict to produce a 
molecular complex with benzimidazole; these could include alpha-hydroxy acids (glycolic 
acid, lactic acid and mandelic acid), tricarboxylic acids (citric acid, isocitric acid and aconitic 
acid),  and  keto  acids  (pyruvic  acid,  oxaloacetic  acid  and  levulnic  acids).  There  is  also 
potential  for  BZN/IMD  to  be  used  with  pharmaceuticals  in  producing  molecular 
complexes/co-crystals.  For  example  in  this  work  BZN/IMD  :  salicylic  acid  (2-
hydroxybenzoic  acid)  molecular  complexes  were  produced.  There  are  a  vast  amount  of 
pharmaceutically active ingredients that contain carboxylic acid groups that could be utilised 
in such further investigations. 
 
One rule that was followed during this research, and which was found to be useful, is that co-
crystallisation  experiments  tended  to  be  more  successful  between  molecules  of  similar 
sizes/weights. While examples of complexes have been produced where this is not the case 
(imidazole : 3-hydroxypicolinic acid), there are many more examples where it was. 
 
From Figure 8.1 it can be seen that hydrogen bond E incorporates all NH∙∙∙O hydrogen 
bonds. This, as would be predicted, is the most influential intermolecular hydrogen bond 
between  the  co-molecules  and  can  vary,  quite  considerably,  in  strength.  However  this 
hydrogen bond, as has been seen throughout this work, is robust, dependable and flexible. The   380 
OH∙∙∙O hydrogen bond between a hydroxyl and a carboxylate oxygen (F), is a very common 
hydrogen bond used by crystal engineers for its dependability and flexibility. In this body of 
work it promotes the ladder motif as it tends to be the shortest hydrogen bond of those listed 
in Figure 8.1 and therefore the most influential. This can be demonstrated, as when there is 
potential for this type of hydrogen bond (not available in the 2-HBA molecular complexes) to 
form, it does so, and thus determines the rest of the structure. There is no better example than 
in  the  benzimidazole  and  3,5-dihydroxybenzoic  acid  molecular  complex  (Section  4.5.8), 
where the 3,5-dihydroxybenzoic acid molecules create a network of chains with the BZN 
molecules fitting in where possible. The other OH∙∙∙O hydrogen bond shown in Figure 8.1 – 
H,  a  carboxylic  acid  dimer  (carboxylic  acid  and  a  carboxylate  group)  is  seen  in  a  few 
molecular  complexes  including  BZNH
+  :  2-HBA
  1:2  and  BZN  :  terephthalic  acid  and 
represents  the  hydrogen  bonds  found  between  carboxylic  acid  groups  in  the  series‘ 
investigated. The BZN
 dimer / nitrogen – nitrogen hydrogen bond (G), is the least predictable 
of all the hydrogen bonds, however it does always occur when there is a stoichiometric excess 
of BZN to the other co-molecules, in which case a non-protonated nitrogen is present.  These 
recurrent and predictable hydrogen bonds have ranges in length, however one of these always 
forms the primary hydrogen bond in the structure.  
 
A majority of the imidazolium molecular complexes produced during this work adopt the 
linear chain of hydrogen bonded alternating co-molecule motif (Figure 8.1 – N) with the 
chain  adopting  a  spiral  nature.    This  can  be  seen,  for  example,  in  the  imidazolium  :  4-
fluorobenzoic acid molecular complex (Figure 7.31; repeated below). The spiral structure, 
most famously known from DNA, can be exploited at the molecular level to generate new 
materials, and in more recent investigations as a potential means of generating chilarity in 
solid-state systems. The spirals tended to be held together by weak interactions, in this case 
halogen bonds, which can be altered (using different halogen atom) or replaced (by using 
methyl groups) to modify the structure selectively. This is one area where further research is 
required.   381 
     
Fig. 7.31 repeated – LHS, the main motif of the IMDH
+ 4-FBA
- molecular complex, a spiral chain of alternate 
co-molecules held together through NH∙∙∙O hydrogen bonds, types E and F, RHS, view along the b-axis of an 
extended spiral chain showing its circular nature. 
 
8.2   Ladder Motif 
 
The ladder motif, consisting of uprights of the carboxylic acid containing molecule and rungs 
of  BZN,  has  a  strong  tendency  to  occur  when  there  is  potential  for  the  carboxylic  acid 
molecules to create a chain. For example, 4-hydroxybenzoic acid molecules can hydrogen 
bond to one-another through the hydroxyl-carboxylate hydrogen bond (Figure 8.1 – F), unlike 
the 2-hydroxybenzoic acid  molecules where this  is  impossible. When generation of these 
chains was possible, the ladder motif prevailed. There is only one set of structures where the 
ladder motif was possible but did not occur, those comprising BZN/IMD with isophthalic 
acid.  The  resulting  structures  of  these  molecular  complexes  are  found  to  maximise  the 
hydrogen bond acceptor - donor pairing. If the chains had prevailed in these structures then 
there would have been a hydrogen bond acceptor site (oxygen) not involved in a hydrogen 
bond.  
 
Figure 8.2 highlights all the molecular complexes that produced the ladder motif (apart from 
the  benzimidazolium  3,5-dihydroxybenzoate  molecular  complex  and  associated  hydrates), 
which as can be seen, is very flexible. There are variations of the motif, ranging from a 
―traditional‖ straight ladder, as in the IMD : malonate structure, a wavy ladder as in BZN : 3-
HBA 1:1 and even a flat ladder, IMD : succinate. Also the differing ratios of co-molecules 
have resulted in different rung sizes, for example when there is an excess of BZN molecules   382 
present, they pair together which results in the poles being further apart, therefore offering the 
potential to generate a more porous materials. The study using the series of BZN/IMD with 
dicarboxylic acid chains attempted to create materials with differing pore sizes with differing 
co-molecules.  Unfortunately  insufficient  ladder  structures  were  created  to  allow  any 
conclusions to be formed. However it can be seen when comparing the structures shown in 
Figure  8.2  that  there  is  potential  to  form  materials  with  differing  pore  sizes.  It  is  this 
flexibility in the motif that increases its potential uses; the ability to create networks with 
differing pore sizes is a strong area of interest for a range of industries. Therefore further work 
is required to develop further the ladder motif. 
 
Within hydroxybenzoic acid complexes there are two slightly different variants: ladder with 
rungs of BZN molecules and ladder with alternate rungs of BZN molecules. These derivatives 
are neatly shown in the BZNH
+ 3HBA
 polymorphs where the two forms adopt the different 
styles. It would not be surprising if more polymorphs of the BZN : 3- / 4-HBA molecular 
complexes not discovered during this work were produced and found to adopt the ladder 
motifs, for example a BZNH
+ 3-HBA
 1:1 polymorph forming the alternate step ladder motif 
and the BZNH
+ 4-HBA
 2:1 polymorph forming the ladder with every step motif.  
 
 
BZN : 3H-BA 1:1  BZN : 3H-BA 2:1 I  BZN : 3H-BA 2:1 II 
IMD : Malonate 
BZN : 4H-BA 2:1 
IMD : Succinate  BZN: Terephthalate  BZN : Succinate   383 
Fig. 8.2 – The molecular complexes that formed the ladder motif, with uprights of the carboxylic acid containing 
molecule and rungs of benzimidazole. From top to bottom, left to right, benzimidazolium : 3-hydroxybenzate, 
benzimidazolium  :  4-hydroxybenzoate  2:1,    benzimidazolium:  3-hydroxybenzoate  2:1  Form  I, 
benzimidazolium :  3-hydroxybenzoate  2:1  Form  II,  imidazolium  :  malonate,  benzimidazole  :  terephthalate, 
benzimidazole : succinate and imidazolium : succinate.   
 
8.3   Proton Transfer 
 
Of the properties present in the molecular complexes produced, one aspect was found to be 
essentially certain to occur – proton transfer. Of all the molecular complexes produced and 
discussed,  there  were  only  two  molecular  complexes  that  showed  no  proton  transfer, 
benzimidazole : 3-chlorobenzoic acid Form I and benzimidazole : 4-fluorobenzoic acid (in 
each of these structures there were two equivalents of each molecule, one pair formed the 
charged species while the other remained in their neutral states). In addition in these systems 
both diffraction experiments have questionable data quality (completeness value of around 
97%)  and  no  neutron  diffraction  experiments  were  undertaken,  therefore  there  are  still 
uncertainties over proton position. 
 
However accepting the indicated proton transfer patterns, rationalising these is difficult. The 
empirical pKa rule, based on the ∆pKa value, (∆pKa = pKa(base)  pKa(acid)), does not fully 
explain  the  outcome,  since  with  pKa  values  for  3-chloroBA  being  3.84  and  that  for  4-
fluoroBA at 4.15, it would be predicted that other molecules within this range would also 
form the covalent molecular complex co-crystal rather than the salt when using the same 
solvent and temperature.  For example, the pKa values for 4-bromobenzoic acid (3.96), 4-
chlorobenzoic acid (4.00) and 3-hydroxybenzoic acid (4.08)) are similar, but it is not the case 
that covalent complex co-crystals are formed. Attempts were made to use varying pH levels 
of  the  crystallisation  solution  to  promote/discourage  proton  transfer,  with  the  conclusion 
being  that  in  basic  conditions  co-crystallisation  experiments  tended  to  be  unsuccessful; 
however this is not universal. There is no question that further work is required on this aspect, 
with a wider range of pH levels, better controlled experimental conditions and a wider range 
of co-molecules utilised. However these limited results add another set of examples that call 
into question the robustness of the pKa rule. 
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In the systems studied, proton transfer has in general promoted hydrogen bonding between the 
BZN/IMD and carboxylic acid group due, primarily, to the proton transferring from the acid 
to the basic nitrogen. While a proton transferring from one group to another does not require a 
hydrogen bond or infer that a hydrogen bond will be created, in this work they went hand-in-
hand. The proton transferring to the BZN/IMD resulted, in many cases, in there being only 
one hydrogen bond acceptor site for the donor sites to bond to, therefore only one possible 
hydrogen bond could occur. This charge assisted nitrogen-oxygen hydrogen bond (hydrogen 
bond pattern E in Figure 8.1) was very flexible but robust.  
 
8.4   Solvent-Free Crystallisation/Co-crystallisation 
 
The solvent free grinding method, validated to an extent in the experiments described during 
this work, is a very old method giving a new lease of life. There is debate over whether the 
term solvent-free is correct but there can be no debate that this technique works and is able to 
generate new materials and even materials unobtainable from normal solvent crystallisation 
methods.  The acceptance of this technique has grown extraordinarily over a very short period 
of time recently, with it becoming common place in crystallisation groups (and a wide range 
of others) to perform solvent-free experiments when dealing with new molecules or trying to 
form previously unreachable forms. The drivers of this technique are the increase in speed and 
decrease in cost of reactions, however problems arise in forming uniform and stable products. 
With further work and a greater understanding of the mechanisms involved, these problems 
will be resolved and the utility of the technique increased still further.  
 
8.5   Solvent Mediated Molecular Complex Polymorphism Formation 
 
The co-crystallisation experiments between BZN and the halo-benzoic acid series resulting in 
the formation of seven previously undiscovered molecular complexes, however the primary 
aim of the work was to investigate the occurrence of molecular complex polymorphism and to 
selectively control the form produce. The results show that polymorphism is common within 
molecular complexes, with three of the seven newly discovered systems showing evidence of 
this. Controlled growth of a selective polymorph has also been achieved through changes in   385 
crystallisation  conditions,  as  shown  for  the  three  materials  that  showed  polymorphism.  
However, it only takes small changes in these conditions to promote other forms, for example 
co-crystallisations between benzimidazole and 3-chlorobenzoic acid using acetone produced 
polymorph Form III at 30ºC, but Form I and III were produced at 20ºC (Table 5.7; repeated 
below). 
 
  Methanol  Ethanol  Propanol  Acetone 
2~4ºC           
10ºC               
20ºC                 
30ºC             
Table. 5.7 repeated – The results of cocrystallisation experiments on the benzimidazole and 3-chlorobenzoic 
acid system in creating Form I (blue), Form II (yellow), Form III (red). 
 
There are two examples where the structures have been fully determined for at least two of 
the possibly molecular complex polymorphs: BZN : 3ClBA (Figure 5.34, repeated below) and 
BZN : 3HBA 2:1 (Figure 4.39, repeated below). It can be seen that the structural differences 
are substantial, with two forms of the 3-chlorobenzoic acid complex in particular adopting a 
whole different motif.  
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Fig. 5.34 repeated – LHS, the supramolecular synthon of the BZN : 3-ClBA Form II molecular complex, co-
molecule dimers, linked together through N
ʴ+H∙∙∙O
ʴ-  hydrogen bonds, RHS, the main motif of the BZN : 3-
ClBA Form I molecular complex, an equimolar hydrogen bonded ring system held together by NH···O and 
OH∙∙∙N hydrogen bonds. 
   
Fig. 4.39 repeated – LHS, Form II, the ladder structure consists of uprights of 3-hydroxybenzoate molecules and 
rungs  of  hydrogen  boned  dimers  of  BZNH
+,  RHS,  Form  I,  the  ladder  structure  consists  of  stiles  of  3-
hydroxybenzoate molecules and alternate rungs of hydrogen bonded dimers of BZNH
+.   
 
8.6   Increasing the Competition – The Introduction of Competing Hydrogen 
Bonding Sites 
 
The work presented in Chapter 6, which saw an introduction of another basic atom into the 
system, was to add competition within the system on two fronts; firstly with the other basic 
nitrogen on the BZN for proton transfer and for involvement in the potential hydrogen bonds. 
With regard to the proton transfer, in all cases studied the proton from the carboxylic acid 
group has transferred to the benzimidazole molecule, as has been seen in all but two examples 
in this whole work. There are some variations which are discussed in Chapter 6. When the 
basic nitrogen is unprotonated, the established NH∙∙∙O hydrogen bond is not favoured over a 
NH∙∙∙N hydrogen bond, with the NH∙∙∙O interaction forming the weaker part of a bifurcated 
hydrogen bond (Figure 6.50, repeated below). Therefore it has competed with the carboxylic   387 
acid group to be the primary hydrogen bond acceptor and this designed intervention was 
successful. 
 
 
Fig. 6.50 repeated – The bifurcated hydrogen bond of the BZNH
+ : 3-HPA
- molecular complex, with the major 
component the NH∙∙∙N hydrogen bond and minor component being NH∙∙∙O. 
 
The other possible outcome was that if the nitrogen was protonated, it would compete with 
the other protonated nitrogen on the benzimidazole for the primary hydrogen bond donor role. 
As the benzimidazole is found still to be protonated, the hydrogen bond donors from this 
molecule would be charged assisted and therefore still a more attractive prospect for hydrogen 
bond acceptors. With this being the case it was not surprising to see that in the benzimidazole 
and 6-hydroxypicolinic acid molecular complex the N atom of the pyridine was acting as a 
the donor in a hydrogen bond, however it was the weakest of the three primary hydrogen 
bonds within the structure at 2.915(2)Å. The solvate structure also had the named N atom 
within  hydrogen  bonds,  which  also  produced  one  of  the  weaker  hydrogen  bonds  in  the 
structure and again had a length of 2.915(3)Å.  
 
8.7   A  Comparison  Study  of  Benzimidazole  and  Imidazole  Containing 
Molecular Complexes with a Range of Related Co-Molecules 
 
The differences between the structures from BZN and IMD are evident; in no case did the 
main motif of equivalent structures stay the same. In every case between a BZN and IMD 
structure, there was different motif and different packing arrangement. In one example, the 
malonate complexes, the co-molecule was rearranged (Figure 7.80, repeated below) between 
the different molecular complexes. The only common features were in the hydrogen bond 
patterns that the structures adopted.   388 
 
   
Fig.  7.80  repeated  –  the  malonate  ion  found  in  the  molecular  complexes  with  (from  left  to  right) 
benzimidazolium, imidazolium, imidazolium hydrate and its native form with atom labelling. 
 
8.8   Halogen Bonding 
 
The halogen containing structures shown in this work have shown the important nature of the 
halogen atoms in forming interactions. It does not appear that the halogen interactions, be 
they halogen bonds or other halogen-containing interactions, had much influence on the main 
motif of the structure. However they have contributed to the construction of a more stable 
structure by creating more robust interactions than those found in corresponding non-halogen 
containing molecules. For example in the imidazolium 4-fluorobenzoate structure, the main 
motifs are expanded by halogen bonds of F∙∙∙C distance of 3.490(2)Å (Figure 7.89, repeated 
below) while in the benzimidazolium succinate molecular complex, the interaction that has a 
similar role is a carbon-π interaction of C∙∙∙C 3.552(1)Å in length. From all the structures in 
Chapter  5  the  halogen  atom  is  involved  in  either  a  halogen  bond  or  halogen  interaction.  
These interactions tend to be individual in the role they adopt, they are the only interaction 
that  expands  the  structure  in  a  particular  direction,  for  example  in  the  benzimidazole  4-
fluorobenzoic acid molecular complex the halogen bond is the only interaction that expands 
the structure in the c-direction. This body of work shows that the halogen bond is significant 
and is key in determining the overall packing. 
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Fig. 7.89 repeated – LHS, extract from Fig. 7.33 View along the b-axis of the extended structure showing the 
spiral chains are held together by halogen bonds (yellow lines) that connect the chains along the a- and c-axis, 
RHS, extract from Fig. 7.69 – insert, the C-H···π interaction 
 
8.9   Concluding Remarks 
 
The robustness of both hydrogen bond patterns and the more extended motifs adopted by the 
molecular  complexes  that  contain  these  patterns  gives  real  promise  that  a  rational,  more 
predictive, approach to crystal engineering can be generated in families of compounds such as 
those  presented  here.    Subtle  variations  in  choice  of  co-molecules  and  in  crystallisation 
conditions has been shown to affect the crystal form adopted, both in terms of motifs and in 
some cases in polymorphic form adopted, including examples where polymorph control has 
been obtained.  In particular, it has been found possible during this work actually to make 
predictions about likely molecular association and packing of molecular complex structures 
that have been borne out by subsequent experiments. 
 
 